“Developing Countries”?
The River of Myths by Hans Rosling
Hans Rosling shows how countries are making progress in saving lives.

Hans Rosling shows how measurement reveals incredible progress in saving the lives of children in what were once labeled "developing countries." If the few countries that still have high child mortality rates can follow the path of Ethiopia, preventable child deaths may be history by 2030. We must continue to closely measure this progress.
Video created in partnership between The Gates Notes and Gapminder. #BillsLetter. License: Creative Commons 3.0.
Weather or not
Fighting climate change one text at a time
In Kenya, AI-powered weather forecasts are helping farmers adapt to a changing climate.

When I check the forecast for rain, I do it to answer fairly minor questions: Will I need an umbrella? Will my flight be delayed? Will my pickleball game get cancelled?
For smallholder farmers in Kenya, the stakes are much higher. If they plant their seeds too early, a dry spell might kill their crops before they have the chance to take root. If they plant too late, the crops might miss the rain entirely. When your family’s food and livelihood depend on getting the timing just right, a reliable weather forecast is incredibly valuable.
But in sub-Saharan Africa, it’s also been incredibly rare. That’s because global weather models are built from ground-station data, and Africa has fewer of these stations than any other inhabited continent. The result is forecasts that can accurately predict the rainfall in Missoula or Munich but are often far less accurate in Kenya’s Rift Valley, where 80 percent of the country’s staple maize crop is grown. As climate change makes weather patterns around the world increasingly erratic, today’s farmers are increasingly unable to rely on the seasonal patterns that guided generations before them.
Fortunately, AI offers us an affordable and fast solution. Over the past several years, a coalition of African institutions, researchers, and technology partners has been building a forecasting system with the technology at its center.
It starts with better information about the weather itself. On the ground, weather stations capture the basics like where it rained, when, and how much. But now, they’re supplemented by autonomous weather balloons up in the sky. For weeks at a time, these balloons float around and measure the temperature, humidity, and wind in places ground stations can’t reach and satellites can’t fully see either.
Then AI digests that information and puts it to work. While today’s AI models are far from perfect, they’re astoundingly good at squeezing immense insight out of limited data. In this case, they’re able to take the ground and sky observations, compare them to what was forecast, figure out the patterns behind the errors, and start correcting for them.
The more local data that comes in, the more the AI can finetune its models, and the better they get. As a result, a farmer in the Rift Valley can now get a weather forecast specific not just to her region but to her fields.
Of course, an accurate forecast only makes a difference if it reaches that farmer when she still has time to act on it. Even better if it’s delivered to her phone, in her own language, with advice she can use. That’s where a nonprofit called TomorrowNow comes in. I first saw their work on a trip to Kenya a few years ago and was impressed by how intuitive and impactful it is. Using AI, they translate the forecasts into easy-to-follow text message guidance like “plant this week,” “a dry spell is coming,” or “hold off on fertilizer.” Those text messages then reach farmers through organizations they already trust like One Acre Fund, which provides seeds and training to millions of them, and KALRO, Kenya's national agricultural research organization.
The results are undeniable. A rigorous two-year study of nearly 10,000 farmers found that those who got the text-message advisories grew 12 percent more food on average. That could be the difference between a family having to buy food and getting to sell their surplus. It's school tuition that gets paid and debts that are avoided. And the cost? Just 56 cents per farmer enrolled in the program. It’s hard to find a better bang for your buck than that in global health and development.
Today, Kenyan scientists at KALRO, working with TomorrowNow, are bringing AI-powered weather forecasts to more than five million farmers in Kenya; TomorrowNow’s goal is to reach 100 million across the rest of Africa and South Asia by 2030.
But even though international partners helped along the way, this system’s foundation—and the leadership deciding its future—is African. The observational backbone comes from institutions like the Trans-African Hydro-Meteorological Observatory, or TAHMO, which runs hundreds of weather stations across the continent. The forecasts draw on data from Kenya’s own meteorological authority. And the advisories are being built into the country’s permanent infrastructure rather than running alongside it as a donor project.
I've long argued that fighting climate change has to happen on two fronts: We have to cut emissions so the problem doesn’t get worse, and we have to help people who are most vulnerable to it adapt to the warming that's already occurred. The Gates Foundation invests a lot in this area, but the problem deserves much more attention and funding. And AI is making those investments go further than ever before.
When people ask me whether AI will exacerbate the gap between rich and poor, these are the innovations I talk about. Making sure AI's benefits reach everyone will take deliberate work, which the Gates Foundation committed over a billion dollars to at this year’s Goalkeepers event. The good news is: We already have proof that, when we’re intentional about it, this technology can be a great equalizer.

A daily fight
6 things you should know on World Polio Day
There’s good news and bad news about the eradication effort.

I’ve been following the fight against polio almost daily for more than two decades, ever since I got involved in the global coalition to eradicate it. But polio hardly ever makes headlines anymore, and most people are understandably not as focused on it as I am. So with World Polio Day coming up on Saturday, I want to give a quick update on how things are going.
Thanks to the world’s efforts—led by national governments with support from the Global Polio Eradication Initiative, which is a coalition of Rotary International, WHO, UNICEF, the United States CDC, the Gates Foundation, and the vaccine alliance known as Gavi—polio cases are down by 99 percent since 1988, and the virus is endemic in just two countries.
One of them, Pakistan, is making major progress. Thanks to continued vaccination programs and strong leadership from the government, the number of children newly paralyzed by polio there dropped from 74 in 2024 to 31 in 2025 and just 7 so far this year. I think it is possible to get to zero if we keep up this momentum.
In Afghanistan, unfortunately, polio cases have increased this year compared with last year. But the program is taking steps to do a better job getting the vaccine to all children, especially in the South region of the country. And it’s finding new ways to work with community leaders to hear from families who have doubts about vaccinations and to address their concerns.
Some encouraging news is coming out of Africa. Five variant polio outbreaks on the continent have been closed, interrupting transmission of the virus in those countries. It’s a testament to phenomenal work by governments at every level, local health workers, and the polio eradication initiative.
However, there continue to be outbreaks of variant polio in especially fragile settings. Humanitarian crises, weather-related disasters, and resource constraints are making it harder to vaccinate children. As global immunization rates remain low, the risk that the disease will spread internationally—even to places that have long been free of polio—is high.
India and South Asia have now been free of wild poliovirus for 15 years. This region, which is home to a quarter of the world’s population, recorded its last case of wild poliovirus in 2011. Staying polio-free since then is a huge accomplishment in itself. But countries in the region are also building on infrastructure and lessons from the polio program to expand people’s access to other public health services.
An affordable six-in-one vaccine is making it easier to protect children in low-income countries. In most low- and middle-income countries, children get their polio vaccines in two ways: orally, via a few drops in their mouth, and by injection. The injectable vaccines require two shots, the second one weeks or months after infants have received all their other routine shots. Many families don’t come back for this second visit, which means those children aren’t fully protected.
The six-in-one vaccine incorporates polio protection into the vaccines that children already get routinely, reducing the need for another injection later. When a baby gets the shots that protect them from whooping cough, tetanus, and so on, they’re also getting protection against polio.
Six-in-one vaccines aren’t new; they have been used in wealthier countries for years. The breakthrough was to develop one that’s affordable for low-income countries. Thanks to support from Gavi, Senegal and Mauritania are already using it, and Pakistan just approved its use last month.
I wish there were better news to share about funding. Even some of the most generous partners have cut back on their giving. GPEI, the eradication initiative I mentioned earlier, had to cut its budget by 30 percent this year. I am grateful to the donors who have stayed committed and to new donors who have made significant contributions in recent years. These include the Kingdom of Saudi Arabia, the United Arab Emirates, the European Investment Bank, Qatar, Australia, Canada, Monaco, and the United States.
This has accelerated a process that was already under way: lower-income countries taking more ownership of the program. For example, in the past 18 months, three more labs in Africa have been certified to do genomic sequencing of poliovirus samples. If the virus is detected somewhere on the continent, a sample can be sent to one of these labs, where scientists study its genome to figure out where it came from. The plan is to keep expanding capacity in Africa, further reducing the need to send samples overseas.
Unfortunately, none of this makes up completely for the funding shortfall. Around the world, leaders of polio programs are making painful tradeoffs. If this shortfall continues, we could lose decades of progress and see polio return everywhere. I’ll continue to do my part, supporting the work through the Gates Foundation and using my voice to raise awareness.
This is a winnable fight. It is giving us a blueprint for eradicating other diseases, including malaria. It has also created a global network of labs and experts that has alerted public health officials to outbreaks of cholera, measles, Ebola, and COVID-19 at the height of that pandemic.
But for me, what it comes down to is that we should eradicate polio because it is entirely preventable. There is no reason any child should ever be paralyzed by it again. That’s why I’m proud to be part of the global partnership that is committed to getting rid of it forever.
Body of evidence
Ramesh Ferris wants you to look at his legs
A powerful reminder of why polio eradication matters.

When Ramesh Ferris speaks in public, which he does a lot, he has an unusual way of getting to the stage. He crawls across the floor.
Ramesh was paralyzed by polio when he was six months old. Today, at age 46, he can walk with crutches and leg braces, but as an advocate for polio eradication, sometimes he chooses not to. He wants his audience to see what the disease does to the human body.
“I’m the voice of the polio survivors that I’ve met crawling in the streets of their communities,” he says. “Showing my legs is the most powerful tool I can use to educate people about the reality of what happens when kids don’t receive the polio vaccine.”
Ramesh contracted polio in 1980, when he was six months old. The first polio vaccine had been invented 25 years earlier, and millions of children had received it, but it still hadn’t reached low-income communities like the one in the state of Tamil Nadu, India, where he was born.
His birth mother had never heard of the disease, much less a vaccine for it. She just knew that her boy kept getting sick, and she couldn’t afford medical care for him, so she made what must have been an agonizing decision. She put him in the care of an orphanage in her community.
A year later, Ramesh was adopted by a Canadian couple who raised him and five other adopted children in the Yukon. Life was hard at times—kids at school mocked and bullied him—but he got expert medical care. Through three surgeries, doctors straightened his legs, and after intensive physical therapy, he learned to walk with crutches and braces.
When Ramesh was 22, he took a trip that changed his life. He went to India to meet his birth mother for the first time, so he could tell her how grateful he was that she had sacrificed so much so he could get the care he needed.
On the same trip, he had another powerful emotional moment. “I saw a fellow human being that had polio because he didn’t receive the polio vaccine as a child,” Ramesh says. “He was crawling around the streets as a beggar.” The person he was traveling with told him: “You’re looking at your life if you weren’t adopted.”
Since that time, Ramesh has been traveling around the world as a volunteer with Rotary International to spread the word about how much progress the world has made and the work that still remains. He’s raised awareness and funds with eye-catching campaigns including a 7,140 km trip across Canada… by hand bike.
We’re close to eradicating the disease—there were 52 cases of wild poliovirus in 2025, down from 350,000 in 1988—but finishing the job is a tough challenge that takes continued funding and effort.
People like Ramesh remind us not only how we can do it, but why we should.
The last mile
We’re closer than ever to eradicating polio
...And closer than ever to seeing a resurgence.

When most Americans think of polio, we probably picture President Franklin Delano Roosevelt. In 1921, at age 39, he was paralyzed by the virus and never regained the use of his legs. His story helped turn polio into a national cause. But in many ways, his experience was an anomaly.
After all, polio is overwhelmingly a childhood disease, with the vast majority of cases affecting those younger than five. That was true when FDR fell ill, and it’s true today. The typical patient isn’t an adult with an already established political career—it’s a little kid, often a little kid in a low-income country, who might never get the chance to take his first steps.
That injustice is one big reason I've spent the past two decades working to eradicate polio. The other reason is that eradication is actually possible, realistic, and well within reach. This is a disease we can get rid of—not just control, but eliminate everywhere. That is a rarity in global health.
The world has already made extraordinary progress. Back in 1988, when Rotary International and the World Health Assembly set the goal of eradication, the virus was paralyzing more than 350,000 children each year across 125 countries. Since then, cases have dropped by 99.9 percent. The strains known as Type 2 and Type 3 wild poliovirus have been eradicated. The entire African continent is certified wild-polio free. Only two countries—Afghanistan and Pakistan—still have persistent transmission of Type 1 wild poliovirus.
Now we're closer than ever to total polio eradication. But the last mile is proving the hardest because viruses find ways to exploit any immunity gaps or weaknesses. Wherever vaccination rates slip—even briefly—they can resurface.
One of the biggest challenges comes from what are called variant outbreaks. In communities where immunization is low, the weakened virus used in the oral polio vaccine can circulate asymptomatically and rarely, over time, mutate enough to regain the ability to cause paralysis in unvaccinated children.
While most variant outbreaks happen in places with extremely low vaccination coverage, poor sanitation, and weaker health systems, no place is risk-free until the world is polio-free. In 2022, the United States confirmed its first paralytic polio case in nearly a decade, and the virus was detected in New York wastewater samples. In the time since, variant polioviruses have also been found in the U.K., Ukraine, Indonesia, and other countries.
The good news is that today’s tools are better than anything we had even five years ago, and they make every dollar spent on the cause go further than ever before. We have a new oral vaccine, nOPV2, that’s far less likely to mutate and lead to new variant outbreaks; nearly two billion doses have already been given worldwide. New regional labs in Ghana, Nigeria, South Africa, and Uganda that test wastewater samples and sequence viruses have cut detection times by over 30 percent, which gives health workers a critical head start on outbreak response. And the surveillance network for polio is one of the most sophisticated ever built—also helping alert public health officials to outbreaks of cholera, measles, Ebola, and even COVID-19 at the height of that pandemic.
The Gates Foundation has been proud to support these advances as part of the Global Polio Eradication Initiative, a coalition of the WHO, UNICEF, the CDC, Gavi, Rotary International, and dozens of countries’ governments. It’s one of the most successful collaborations in the history of global health.
But right now, GPEI is facing a $1.7 billion funding gap, with various long-term donor governments cutting back their support. Without the right resources, vaccination campaigns may have to be scaled back, surveillance sites will likely close, and the virus could spread globally.
In the century since FDR was paralyzed by the virus, American leadership and generosity have helped turn polio into a fight the whole world could win. From the March of Dimes, which funded research, to the development of the first vaccines, to support for eradication campaigns, U.S. commitment has been decisive.
The world is at the brink of ending this terrible disease, and the stakes of this moment couldn’t be higher. If we finish the job, we free up billions of dollars for other health priorities and—most importantly—protect generations of children from a virus that has paralyzed millions. If we back down from the fight, up to 200,000 children could be paralyzed each year within a decade.
We have the scientific tools and infrastructure needed to cross the finish line. And we have hundreds of thousands of committed vaccinators who are determined to get us there—who go door to door across deserts, jungles, floodplains, and war zones to make sure no child is missed. I've met them, I've heard their stories, and I've seen how determined they are to finish the job.
We should be too.

Eyes on eradication
Optimism and resolve on Pakistan’s last mile to end polio
I made my first trip ever to Pakistan to learn about the country’s incredible efforts to wipe out polio.

Earlier this year, I made my first trip ever to Pakistan to learn more about the country’s incredible efforts to wipe out polio.
At the time of my visit in February, Pakistan had gone more than a year without a single child being paralyzed by the crippling disease. This was a huge achievement made possible by the skill and dedication of the polio program’s leadership and its more than 300,000 polio workers. Their energy and enthusiasm reminded me of what I saw in India and Nigeria when those countries were traveling the final mile to eliminate polio within their borders.
But the last mile is often the toughest. The gains made against this highly contagious disease are often fragile.
In recent weeks, the world received a sobering reminder of this fact when three new cases of wild poliovirus were detected in Pakistan: 12 and 15-month-old boys, and a two-year-old girl all living in the same district in Khyber Pukhtunkhwa Province, Pakistan, near the border with Afghanistan. (Pakistan and Afghanistan are the only two countries where the wild poliovirus has not been eliminated.)
It is heartbreaking to see these three children paralyzed by a preventable virus that has been eliminated in nearly every part of the world. (The government of Pakistan is providing rehabilitation services and other support to help the children and their families.)
At the same time, the emergence of these new cases was not entirely unexpected given the challenges of wiping out the virus in one of the most challenging places on Earth. The border region between Pakistan and Afghanistan, where the cases were detected, struggles with insecurity and misinformation that can sometimes prevent vaccinators from reaching every child who needs the polio vaccine.
When I learned about the new cases, I was disappointed. But I was also heartened by the response of Pakistan’s polio program. Despite having every reason to be frustrated, Dr. Shahzad Baig, who runs Pakistan’s National Emergency Operations Center for polio, said his team was not deterred. “This strengthens our resolve to reach every child with the polio vaccine,” he said.
After what I saw during my visit to Pakistan, I shouldn’t have been surprised by the team’s unfailing confidence. The polio workers are driven and detail oriented. They understand that running effective polio vaccination drives is not about getting one thing right. It’s about getting everything right that’s necessary to ensure all children get vaccinated.
In Pakistan, that has meant training 300,000 frontline workers who walk from house to house to vaccinate over 43 million children under the age of five; creating detailed maps for those teams to use to ensure no child is missed; running public information campaigns to inform communities about the risks of polio and the benefits of vaccination; organizing security to protect vaccinators; and building strong supply chains so vaccines are available across the country.
In between vaccination drives, Pakistan’s polio surveillance workers are constantly hunting for signs of acute flaccid paralysis in children and testing the environment for the presence of the virus. Pakistan currently has the largest environmental surveillance network in the world. From tiny villages to larger cities and urban areas, Pakistan’s system has the capacity to find the poliovirus wherever it exists.
The nerve center for all this work is the National Polio Emergency Operations Center, which was a highlight of my visit. A wall of screens in a control room displayed real-time information about vaccinations, security, and supplies, as well as detailed maps following the movements of polio workers. This data helps the team see where they need to make improvements to the vaccination programs to ensure they reach all the children. You probably know I have an insatiable appetite for data, especially health data. So, it should be no surprise I lingered here for longer than planned to look at all the information and learn from the polio experts who are as passionate about data as I am.
What was also remarkable to see is how Pakistan has continued to build community support for its polio activities by integrating them with other essential health programs, like routine immunization programs. During the pandemic, polio workers used their deep knowledge of local communities to reach out to families to raise awareness of COVID-19, teach them how to protect themselves with handwashing and mask wearing, and encourage people to get vaccinated.
Polio workers constantly battle rumors and misinformation about the polio vaccines. But by engaging openly with the public’s questions they’re making headway against this challenge.
I got a glimpse of part of this effort at a national immunization call center where doctors and other health workers respond to tens of thousands of queries every month from the public about immunization, including polio. If families hear a rumor about the polio vaccine, they can call for free and ask about it. Pakistan has reduced the number of vaccine refusals and I believe that the work of this call center is one of the key reasons why. The call center was set up to support polio inquiries, but due to the success of the program, the call center expanded its services to answer questions about COVID-19 vaccines and all other vaccines.
Pakistan’s polio effort also benefits from the strong support it receives from the very top of its government. I recently had an opportunity to speak with Pakistan’s new Prime Minister, Shehbaz Sharif, and it was clear that his administration is actively engaged in stopping transmission for good.
Even with the three new polio cases in Pakistan, the virus is still circulating at very low levels and the world has an historic opportunity to make sure this virus never paralyzes a child again. The fact is, we’ve never been closer to ending polio and it’s critical that the world doesn’t lose sight of this goal.
The last mile to end polio, of course, will be challenging. And that’s why it’s important that the world keep up its support for the polio programs in Pakistan and Afghanistan, so they don’t travel it alone.
I look forward to keeping you posted on their progress in the months ahead.

Polio progress
Going door to door, this hero brings the world closer to ending polio
19 million people who would have otherwise been paralyzed are now walking today thanks to heroes like Shumaila Rehmani.

The world is so close to ending polio.
Since the start of the global eradication effort in 1988, the number of polio cases worldwide has fallen 99.9 percent.
19 million people who would have otherwise been paralyzed are now walking today because of vaccines. And 1.5 million people are alive who would have otherwise died from the disease.
Much of the credit for this progress goes to the thousands of polio workers who have gone door to door vaccinating more than 3 billion children over the last 33 years.
October 24 is World Polio Day and to mark the occasion I’d like to share the story of one of these dedicated polio fighters.
Her name is Shumaila Rehmani.
Shumaila is a polio vaccinator in Pakistan, which is one of the two countries in the world—the other is Afghanistan—where the wild poliovirus is still endemic.
Shumaila’s job is to deliver the polio vaccine to every child under age five in the community she serves. While that probably sounds like a straightforward job, what it takes to get it done is not. Reaching every child requires hard work, meticulous planning, and patience.
During polio immunization drives in Pakistan, Shumaila sets out on foot early in the morning with a cooler filled with vaccines and a detailed plan for all the homes she needs to visit. Then she begins knocking on doors to give the oral polio vaccine drops to every child.
The overwhelming majority of families she visits want their children to be vaccinated. Some parents, however, out of fear or a lack of information, refuse to have their children vaccinated.
But Shumaila doesn’t give up.
She talks with the mothers and fathers, answering all their questions about polio and reassuring them that the vaccine is safe and effective. She also works with community and religious leaders to speak with families about the importance of vaccination.
Progress can be slow. In the community she serves, Shumaila says this year she initially had more than 250 families refuse vaccinations. But today, because of her efforts to work closely with the families, all but four of them have had their children vaccinated. And she continues to talk with those families to encourage them to get vaccinated.
And thanks to the thousands of dedicated health workers like Shumaila and the leadership of Prime Minister of Pakistan Imran Khan, there’s been just one case of wild polio in Pakistan so far this year, compared with 84 in 2020.
While the incredible efforts of Shumaila and other polio fighters have brought us to the brink of a polio-free world, COVID-19 has created new challenges. The pandemic has disrupted polio campaigns and routine immunizations in many parts of the world, causing outbreaks of other forms of polio to crop up in Africa and Asia.
That’s why the global polio program adapted its approach to help contain the spread of COVID-19 while also working to end polio. The Global Polio Eradication Initiative used its workforce and laboratory and disease surveillance network to respond to the pandemic, investigating suspected COVID cases, coordinating response operations, and training health care workers. In Pakistan, the national polio team now operates a toll-free number for anyone who wants to speak with a doctor about COVID, polio, or get any questions answered about routine immunization. They have received more than 17 million calls during the pandemic.
Like other polio workers, Shumaila has used her community relationships to raise awareness of COVID, teach families how to stay safe, and provide handwashing and hygiene lessons. This has made for longer days, but Shumaila says it’s easy to stay motivated. As a mother of three children herself, she is driven by her dream of a day when polio will no longer be a threat to her children or any child in Pakistan.
It’s a day she knows will come soon, she says. Again and again since the start of the global polio eradication effort, one country after the next has eliminated this crippling disease from within their borders. Less than a decade ago, for example, Nigeria accounted for more than half of all wild polio cases worldwide. But last year, Nigeria, along with the 47 countries in the African region, were certified free of the wild poliovirus.
With Afghanistan recently announcing it would conduct a nationwide polio campaign in November—the first in over three years to reach all children in the country—and Pakistan’s continued commitment to eradication, the final two polio endemic countries will hopefully soon follow others on the path to ending wild polio.
“If other countries can be polio free, why can’t Pakistan be?” Shumaila asks.
An epochal shift
The turbulent AI era is here. The choices we make now are critical.
We need a plan to ensure that the good outweighs the bad.

During my entire life I’ve only had two jobs. In the first one, I played a role in developing software to empower people through my work at Microsoft.
In my second one, which I started full time in 2008, I am giving back the wealth I made at Microsoft with the goal of making the world a healthier, better educated, and more equitable place. This is the job I will have for the rest of my life.
Both of these experiences inform my perspective on artificial intelligence. When I first learned about computers at age 13 I was fascinated by the idea of making them more intelligent and able to perform things that, at the time, only humans could do. Although the term “AI” was used from around the time I was born, the technology has only made significant progress in the last decade. It is now incredibly capable and it is continuing to improve at a mind-blowing rate. AI for the first time can replace and even exceed human cognition.
In terms of equity, AI will either be the greatest equalizer ever invented, or the worst source of injustice. The challenge is monumental. Even under the best circumstances, the transition to this new AI era will be one of the most turbulent times in human history. How will we use this technology to make the world a fairer place and keep it from widening the divide between rich and poor? How will we protect the people who are most vulnerable to the harms caused by artificial intelligence, including those who lose their livelihoods and the sense that they are in control of their future?
I believe that answering these questions and acting on the answers should be the world’s top priority. If the world takes the right steps AI will be a force for good and leave everyone better off.
Unfortunately, right now we are not preparing for it. I don’t see evidence that leaders, experts, and communities are confronting the challenges adequately. There is no plan to ease the entry into the AI era.
Part of the reason for this is that many commentators underestimate the extent of the impact AI will have. I think there are a few reasons why.
One is the fact that AI models still make mistakes. It is hard to envision any of them replacing human cognition when, not long ago, they couldn’t solve a simple Sudoku puzzle or figure out how many R’s are in the word strawberry.
But the reliability problem is being fixed quickly, as researchers create models that can check their own work and improve themselves. Soon they will be substantially better than humans at many tasks.
Another reason people underestimate AI is that analogies to the effects of past innovations are misleading. We have no experience with a technology that can be adopted quickly or that can think and move like a human. When the PC came along, it took twenty years to significantly change how we worked because the software had to be developed, the price had to come down, and people had to learn how to use the tools and incorporate them into their business processes. AI, on the other hand, runs on the devices we already have, and it uses natural language. We don’t have to adapt to it because it can adapt to us. It can watch the same training video that is used to train human workers and learn from existing data.
I want to acknowledge a potential bias. I have benefited enormously from the technology industry. Although I have diversified my portfolio quite a bit, I still have financial ties to it. I am working with Microsoft and other AI companies in my role as chairman of the Gates Foundation to try and ensure AI is deployed in ways that will truly benefit people around the world.
However, my views on AI are not motivated by the potential to make money for myself. Any profits generated by my investments, including those related to technology, will go to the Gates Foundation to tackle global inequity. Of course, readers will have to decide for themselves whether this clouds my view.
This time really is different.
For as long as I can remember, I’ve wished innovation could happen faster. With AI, my feelings are more complicated.
I wish the world could get the benefits rapidly and delay the problems it will cause as long as possible, but the benefits and problems are arriving at the same time. I believe we need time to prepare for the period of social, political, and economic upheaval we are about to enter. The people who need the most time are the ones who have the least—the accounting worker who’s replaced by a bot or the $20-an-hour worker who loses their job to a $10-an-hour robot.
Many observers say that this technology transition will be like previous ones. They give the example of how jobs in the United States shifted from agriculture to office work. However, that proceeded over several generations and created new jobs where human cognition was required. In this case, the technology can substitute for human cognition.
Because it can see, listen, speak, and reason and will eventually do physical work just as smoothly as any human, it will not just affect one sector. AI will take on work in law, customer service, medicine, software, and manufacturing. It will hit these industries rapidly, over the course of a decade rather than a few generations. There will be some new jobs, but without the right policies there will be far fewer than exist today.
If someone had a credible plan for slowing down AI advances globally, I would likely support it. However, I don’t think that’s going to happen. The geopolitical and economic incentives are pushing too hard to go full speed ahead.
To make sure we maximize the positive effects of this unprecedented technology and minimize the bad so we are better off overall, we need to understand both the benefits and the risks. I’ll start with the risks.
The transition to AI comes with three big risks.
I plan to write about each of these in more detail in the future, so I’ll touch briefly on them for now.
Many jobs will disappear forever.
In 1933, during the Great Depression, unemployment in the United States was roughly 25 percent. It remained in double digits for much of the following decade. It ultimately recovered as demand, investment, and growth returned.
AI may not reach this level, but its impact will not go away with an economic cycle. The jobs at most risk are entry- and mid-level, and the new jobs being created will mostly require skills that take many years to learn.
White-collar jobs are already being hit modestly. After the widespread adoption of generative AI, employment fell significantly among young workers in jobs that are especially vulnerable to replacement, but not among their older colleagues.
I think this trend will continue, but it will not be confined to a handful of industries or occupations. Jobs in sales and customer support (online and over the phone), software engineering, and paralegal work may be among the first affected, but the disruption will reach much further as AI takes on tasks that today still require trained workers: things like assessing loan applications, doing data analysis, and even triaging patients. A few areas like software engineering will generate new demand as the costs go down, so the net job loss in those areas will be less than in others as long as some tasks, such as design, are better done by humans.
Blue-collar jobs will be affected as well. Although robots are not as far along as AI, eventually their cost will be dramatically lower too. Many Americans I talk to don’t realize how fast dexterous robots are advancing because much of the advanced work is being done in other countries, primarily China. Or they may be confused by those videos of robots dancing badly that have been going viral lately. I think “smart” robots will begin to compete with people on some physical tasks—in the construction and hospitality industries, for example—by the end of the decade.
Robots and AI combined can create a vicious cycle. After one company adopts them and uses the savings to lower its prices, its competitors will feel immense pressure to do the same. If existing companies don’t adopt them, then start-ups will. Many people will shift to other jobs, but the turmoil of losing work, getting retrained, and finding other work will be significant. Market forces will make adoption go faster and faster and, unless we intervene, there will be fewer good jobs available and the benefits will accrue to a small group.
I’m especially worried about young people, who will enter a workforce with fewer entry-level openings. They understand the challenge because they are the most active users of AI and see both the capabilities and the rate of improvement. It’s no wonder that so many of them feel negatively about AI.
The biggest shift for workers will happen when AI provides nearly error-free work. At that point, it will be able to function on its own without a human checking in on it, and companies will have every economic incentive to let it.
This will lead to a fundamental change in how we think about work, income, and economic security. How will an economy that’s been built around employment operate if fewer people are working, or if many people are working fewer hours?
In a capitalist society, employment is the way most people get the money they need to pay for the basics of life as well as being a key source of dignity and social connection.
When a community has high unemployment, the ripple effects can be pervasive. Research suggests that in some parts of the United States, factory closures contribute to a rise in deaths from opioid overdoses. Now imagine similar pressures on both white-collar and blue-collar workers nationwide.
We have to think now about how to reduce job losses so that everyone can share in the prosperity that AI creates. Waiting until people are already displaced or underemployed will be too late. AI is a structural challenge to the way our economy is organized, and it requires thinking and action now.
AI will empower people (and perhaps AIs) to do more harm.
Long before AI entered the mainstream, there was information online about how to create weapons like bombs, bioweapons, even computer viruses. AI will make it much easier to not only get this information but act on it. Even criminals with very limited skills will be able to target victims at every scale: individuals, companies, and governments.
AI-enabled fraud, disinformation, deepfakes, and surveillance are the harms that many people will feel most keenly in their everyday lives.
AI capabilities are starting to be used for cyberattacks. The smartest cybersecurity experts I know are scared about the next few years, because the attackers are getting powerful new capabilities faster than the defenders can fix all the weaknesses. After all, the same AI model that can find a flaw in software so a company can fix it can also help a criminal exploit it. The resources needed to make an attack are going down significantly and we haven’t been able to separate those abilities from benign usage.
Think about the infrastructure that will be vulnerable: hospitals, financial institutions, water systems, power grids, systems for managing government benefits. When these institutions are attacked, it’s the patients, customers, and benefits recipients who stand to lose.
The same goes for bioterrorism. Although AI will lead to lifesaving advances in drugs and vaccines, it will also make it easier to design a deadly new disease. Again, the positive capabilities are hard to separate from the dangerous ones. This is a global problem.
The risks I’ve just mentioned are all about how AI will empower bad actors who have relatively little power now. The same tools will also concentrate power in places where it already exists. Autonomous weapons, for example, will make governments even more capable of using deadly force without a human being part of the decision. Monitoring and manipulating public opinion will be easier and cheaper, and more effective too.
Eventually, the power to use AI to harm people will not be limited to people or institutions. AI systems themselves already occasionally act in ways their designers didn’t intend. The technology is improving faster than anyone expected and in surprising ways, and as the models become more powerful, they could begin to act against our interests and we could lose control. I’ll have more to say about this in the future.
AI could stunt our kids’ development and replace human relationships.
When I was growing up in Seattle, I didn’t have that many friends aside from a few other boys who were like me. It took hard work and a lot of help from my mom to develop my social skills so I could relate to different kinds of people. I still draw on those lessons today at the age of 70.
I doubt I would have put in the same work if I had had an AI companion back then. They talk to you in ways you’re already comfortable with. They don’t push you outside your comfort zone. They are always available and never get mad at you. This gives them the potential to become highly addictive and to rob us of the lessons we learn from connecting with other people.
The body of evidence on this subject is still small and a bit mixed, but there are signs that we should be very concerned. For example, in one study of more than 1,100 people who use AI companions, researchers at Stanford and Carnegie Mellon found that those with smaller social networks were the most likely to turn to a chatbot for companionship. And the heavier and more emotionally personal that use became, the worse they felt.
Young people could be affected for their entire lives. In his book The Anxious Generation, Jonathan Haidt makes an observation about the effect of social media that is even more true for AI: “Like young trees exposed to wind, children who are routinely exposed to small risks grow up to become adults who can handle much larger risks without panicking. Conversely, children who are raised in a protected greenhouse sometimes become incapacitated by anxiety before they reach maturity.”
An AI companion designed to never upset you is a big, protected greenhouse.
We are only beginning to understand the dangers that the internet—especially social media—can pose to young people’s development. We’re seeing compulsive use, disrupted sleep, cyberbullying, and exposure to harmful content. AI could magnify many of these risks by making them more persuasive and difficult to escape, and we should not wait another generation to start taking them seriously. Countries including Australia, the United Kingdom, and Norway are adopting protections for children online. China has gone the furthest. Its rules restrict AI companion apps broadly, bar designs that foster emotional dependence, and ban virtual relatives and romantic partners for minors.
I’m also worried about AI’s impact on education. Ironically, the same tool that will allow people to learn more than ever could also lead to many people learning less. One preliminary survey suggested that heavier AI use was associated with less critical thinking. The effect was stronger for younger people.
This would be the worst possible time for humans to lose their critical thinking skills. In an era of deepfakes and misinformation that can be tailored to you individually, the ability to tell what is true from what is not becomes an essential life skill.
It’s unclear where to draw the line on these psychosocial problems. In some cases, AI may help people understand how to do better in their human relationships. It may be the only contact with the outside world for isolated elderly people and people with limited mobility, and it will be better than nothing. Wherever we end up drawing the line, it should be our decision, made intentionally.
The good things we do with AI could be very, very good.
It’s often said that we overestimate how much will change in the short term and underestimate how much will change in the long term.
With AI, I see something different going on. Some people see only the upside of AI and do not focus enough on the negatives. Others make the opposite mistake, which is to focus exclusively on the dangers—which are real—at the cost of missing the potential benefits.
We need both: deep concern about the AI harms we need to minimize, and grounded optimism about the positives if we maximize them for everyone.
Maximizing the benefits is just as important as minimizing the harms. If people see how AI makes their lives easier, it will help build the public trust that is necessary for managing the harder parts of the transition. If the first thing AI does in most people’s lives is take away their job, those who are already skeptical about it will outright reject it. This will make it harder to ever deliver on the benefits and it is another reason why governments, industries including the medical industry, and AI companies should be working together now.
With its ability to synthesize knowledge from every scientific field, AI can accelerate innovation in the world’s toughest technical challenges: providing reliable clean energy for everyone, combating climate change, growing enough food, eradicating diseases, and more. Researchers working on cancer treatments or nuclear energy can use AI to search through massive amounts of scientific literature. It can help them identify patterns that a human might miss and decide which experiments offer the most promise. When intelligence is no longer the limiting factor that it is today, smaller companies will be able to compete with organizations that have far larger research budgets. R&D and innovation will be supercharged.
Healthcare is one area where AI can help solve real-world problems. Many small American hospitals lack on-site specialists who can quickly diagnose a patient during a life-threatening emergency. In those places, AI could make sure a heart attack is caught in time and a family avoids the crushing expense of a medical emergency. Viz.ai is one example. It analyzes scans to detect strokes and other emergencies and helps medical teams coordinate their patients’ care. It is being used in nearly 2,000 U.S. hospitals.
AI will also help primary-care doctors make better diagnoses and keep in touch with their patients when they’re not in the clinic. It will help patients understand test results and complicated schedules for taking their medicine.
I surprise a lot of people when I tell them that a second area—agriculture—is where I see the fastest impact of AI in low-income countries. In most low-income countries, farmers don’t get reliable weather forecasts or advice on what seeds to plant, how to protect their crops and livestock from disease, or how to improve their soil. With population growth in these countries and the challenges of climate change, these farmers need more help than ever. Using AI, low-income farmers will soon be able to get better advice about all these things than even the richest farmers get today and increase their output substantially.
Government services are a third area where AI can make people’s lives easier. In the United States, I’ve met families who, understandably, were overwhelmed by the process of applying for health insurance, student aid, or food assistance. Faced with a huge stack of complicated bureaucratic forms, many felt like giving up. AI can streamline things dramatically so they get the help they need faster and the government can operate more efficiently. Governments can make the citizen’s experience far better, starting with those who need its safety net services the most.
Despite my concerns about its impact on our mental health, I think AI can also help a lot there. Most communities have too few counselors, psychiatrists, and addiction specialists. With the right privacy safeguards in place, AI tools could help people recognize warning signs. Then, if needed, they can offer evidence-based coping strategies and team up with a human to provide more responsive treatment.
AI can be a boon for education as well, despite the concerns I mentioned earlier. It can free teachers up to spend more time working with students one on one or in small groups and give them a clearer view of where the whole class is struggling. For students, an AI tool that preserves what researchers call “productive struggle”—the cognitive work that builds understanding—can strengthen learning. When a student first encounters a new idea, the AI gives substantive explanations and offers both questions and answers. Later, when it’s checking their comprehension, it holds the answer back and helps them arrive at it on their own.
Taken together, the advances in all these areas could make everyday life easier, more affordable, and less constrained by a person’s income or connections.
AI could give individuals and small businesses access to capabilities that today require expensive professional help or large staffs, while making products and services better and cheaper. It could help people with disabilities live more independently and enable workers and entrepreneurs with good ideas to accomplish far more than they can today.
Most importantly, it could give people back some of the time and attention now consumed by paperwork, bureaucracy, searching for reliable information, and tasks they cannot afford to pay someone else to handle. These benefits may seem modest, but multiplied across millions of lives, they would be profound: more people getting good advice when they need it and having greater freedom to focus on the lives they want to build.
In all these areas, the operative word is “can”—AI can improve life for people at every income level. But it won’t do that automatically. As with any new technology, we have to be deliberate about ensuring that it benefits everyone and not just a wealthy few. This will require governments and philanthropy to play a strong role so that less wealthy citizens and low-income countries are full beneficiaries.
The Gates Foundation has 19 years left of the 20 years in which it will spend its remaining $200 billion. AI will help it achieve its ambitious goals by both accelerating the discovery of vaccines and medicines for HIV, TB, malaria, and malnutrition and helping the healthcare workforce and patients know how to use those tools. The foundation’s goals include cutting the number of children who die every year in half again, as was done from 2000 to 2024. All of our work, not just health but also agriculture and education, will take full advantage of AI.
I will write much more about these efforts next month in the foundation’s annual Goalkeepers report—including our focus on making sure that AI models are available in the languages spoken by people in all the countries where we support work, and not just the ones that are common in rich and middle-income countries. Many of the leading AI companies, including OpenAI, Anthropic, Google, and Microsoft, are partnering with the foundation on all of these initiatives, which is making a big difference.
The world needs a plan.
It is great that some AI companies are proposing solutions to challenges raised by their own technology, but we should not expect them to lead the charge. Some of the issues are outside their area of expertise, and in a democratic society it’s not their role to decide these things.
Instead, solutions should be developed through a public democratic process that includes elected officials, policymakers, educators, health workers, local officials, and community leaders. Millions of people will have their lives disrupted, and we’ll need a stronger, more flexible social safety net to help them manage the transition. Local communities are already raising concerns about the energy and water needed for data centers. Without solutions, some groups will push for stopping AI development and deployment altogether.
The solutions should be shaped by our answers to the profound questions raised by AI, including how we preserve our humanity in a time when machines can out-think us. As people who spend their lives thinking about what it means to be human, religious leaders can play a key role in this. I was fascinated by Pope Leo XIV’s encyclical on AI, “On Safeguarding the Human Person in the Time of Artificial Intelligence.” It lays a strong foundation for the work that needs to be done.
In the coming months, I will share more ideas for making sure that AI’s benefits outweigh the harm it causes. Here are three to start, beginning with what I think is the most important one.
Build a new system for managing the transition.
The highest priority is a monumental task: creating a domestic and international framework for dealing with AI.
None of our current institutions were designed to handle a technology that spreads so fast and touches so many parts of our lives. So we’ll need to make new ones.
It’s hard to overstate what an enormous undertaking this will be. After the attacks of 9/11, the U.S. government went through its biggest reorganization since World War II for the purpose of improving just one function, national security.
AI will require much, much more. It will affect national security as well as employment, education, taxation, energy, elections, air and water, public health, the financial system, law enforcement, transportation, public lands, and IT systems.
These sectors overlap in ways our existing bureaucracy is not designed to manage. A labor department may understand workforce disruption but not security risk. A business regulator may understand market concentration but not AI’s effects on children and teenagers. Left to themselves, institutions will see only one part of the system, while the consequences of AI will ripple across the entire system.
At the national level, countries will need bodies that can set priorities across government agencies. The goal will be to make sure that every risk is accounted for. Otherwise, an AI-enabled attack might succeed because no one thought it was their job to stop it.
But even a country that gets its own house in order will still be exposed to risks that cross borders. This is why an international organization will need to be built in parallel.
It will be unlike any other institution we have ever created, though it can follow the model of some existing systems. There’s an inspections regime for nuclear weapons, regulations for international aviation, and agreements that protect the ozone layer. A new global organization for AI will need elements of all three and more.
It is fair to wonder whether the world’s institutions are up to the task of designing and implementing this new architecture. Government moves slowly when it moves at all, and polarization within and between countries makes it harder than ever to get things done. Some cooperation between the U.S. and China will be required.
We do not have the luxury of moving slowly. The place to start is with a process for building the right institutions before the disruption forces governments into crisis mode. National leaders should convene economists, technologists, labor experts, business leaders, and workers themselves regularly to identify where existing institutions are failing and what new authorities may be needed. Countries will need to learn from each other.
And the countries that host the leading AI developers and control critical parts of the supply chain should begin meeting now to set up shared norms, before competitive pressure makes it harder for them to cooperate.
Building the framework I’m talking about will take years, which is why we need to start now.
Set aside some jobs for humans.
My dad died of Alzheimer’s in 2020. In the later stages of his illness, he was cared for day and night by paid caregivers who understood him even when he struggled to express himself. He couldn’t always tell them when he was hungry, but they always knew.
My family and I will always be grateful to that amazing group of professionals. Something in the care they gave my dad was irreplaceably human. No robot could or should have done it.
I think about that team when the question of which jobs will disappear and which will remain comes up. I believe that as AI and robots improve, we’ll set aside certain things for only people to do. I’ve started calling this domain Human Reserved, and it’s an example of the kinds of ideas we’ll need to consider.
I like the phrase Human Reserved because it makes me think of nature reserves—places where we could put buildings and roads, but we choose not to because the loss would be too great.
We might set something aside as Human Reserved for economic reasons. For example, we may do it because allowing machines to take over a certain role will displace a large number of people who can’t easily change jobs. You can’t tell a 55-year-old who has worked in construction their whole career that they need to go work at an elder care facility and expect them to find it fulfilling.
Sometimes the decision to make something Human Reserved will be driven by other factors. In health, for example, imagine a robot giving you the awful news that you have an incurable disease. There’s no technical reason why it couldn’t. Yet it shouldn’t.
The Human Reserved domain will evolve over time—for example, we should consider setting aside some jobs now and phasing in AI slowly over years or decades with a commitment to preserve some jobs. Some areas, like education and mental health care, will be a mix, with a human in charge who’s using the technology to extend what they can do.
The lines will also vary from place to place. Some countries might insist on having humans take care of the elderly. But a country like Japan, which has a shrinking workforce and not enough young people to care for the old, may welcome a caregiving robot.
The idea of Human Reserved raises a host of questions I don’t have answers to. Who gets to decide what we reserve for humans? What criteria should we use? How do you keep companies from cheating and using robots anyway? What happens to international trade when one country lets robots make something and another country doesn’t? These will need to be worked out in public as part of the transition plan.
Rebalance how we tax labor and capital.
As workers are pushed into different jobs, they will need retraining and other support from the social safety net. But they will be working less, which means they will be paying less in income taxes, and government revenues will drop just when the demand for those services is greatest. The funds will have to come from somewhere at a time when budgets are stretched.
I believe we should tax AI tokens and robots. Right now, if you’re an employer and you hire someone, you pay payroll taxes on their earnings. But if you buy a robot, you can usually write it off right away as a business expense. The tax system nudges you toward replacing people with machines.
A tax would slow the rush away from human labor a little and raise money for retraining and a stronger safety net. It would need to be targeted so it does not slow down the purely beneficial uses of AI, like making medicine and education cheaper.
Critics of this idea point out that it’s not optimally efficient in an economic sense, but they’re not considering the broader value of work for individuals and society. And with all the accelerated innovation we will have, we’ll be able to afford a little inefficiency as the price for keeping people employed.
I proposed a robot tax years ago and most of the reaction was that it was a strange idea. I’m still a big proponent of it. Although it is not the whole solution to the threat of AI, it is part of a wise response.
However we raise money for more assistance, it needs to reach the people who need it most, including workers who lose their jobs to AI and robots, people whose hours or wages decline, and communities where the losses are concentrated. We need to start doing that work now so that the systems are ready when the need becomes acute.
What I’m doing.
I will use my voice and time to get AI and equity higher on the public agenda. I will raise the issue with lawmakers every time I visit Washington, D.C., and when I meet with leaders around the world. It will be front and center in my conversations with the people who are developing AI models. I will advocate for the national and international framework I described earlier. The Gates Foundation will help drive beneficial usage, including in Africa. Breakthrough Energy, a company I founded, will use AI to help companies develop cheap clean energy and help solve the climate problem. I will also be writing about AI on a regular basis.
My message to leaders is:
You have a chance to act now, before unemployment rises sharply, communities are hurting, and public trust has eroded. You can make sure that your government handles the problem holistically, rather than divvying it up into multiple bureaucratic fiefdoms. You can make sure AI benefits everyone. And you can work with other governments to meet this national and global challenge.
Finally, I will try to widen the circle of people shaping this debate. It should include workers, college students who are about to enter the workforce, community leaders, religious leaders and faith-based organizations, parents, educators, and others whose voices often aren’t heard but who have insight into how the transition will affect people’s lives.
How do we ensure that the benefits of AI reach people who do not already have wealth, influence, and access?
How do we strengthen the social safety net and help workers and communities thrive even when they’re displaced?
How should public institutions adapt?
And how do we preserve our humanity through all of this?
This unprecedented technology demands an unprecedented global response. If we get it right, the payoff for humanity will be phenomenal and the world will be a more equitable place.
I rarely stop thinking about AI—not because I have all the answers, but because the questions it raises are too consequential to leave to a small group of technologists. Leaders across academia, business, government, and civil society all have a role to play in shaping what comes next.
The doctor can see you now
Expanding access to health care through AI
Today’s AI can transform health care systems and support health care workers the world over.

A core principle underlying the Gates Foundation’s work is closing the innovation gap between rich countries and everyone else. People in poorer parts of the world shouldn’t have to wait decades for new technologies to reach them. That’s why we've worked for 25 years to accelerate access to life-saving medicines and vaccines in low- and middle-income countries.
It's also why, today, the Gates Foundation and OpenAI are announcing an initiative called Horizon 1000 to support several countries in Africa, starting in Rwanda, as they apply AI technology to improve their health care systems.
Over the next few years, we will collaborate with leaders in African countries as they pioneer the deployment of AI in health. Together, the Gates Foundation and OpenAI are committing $50 million in funding, technology, and technical support to back their work. The goal is to reach 1,000 primary healthcare clinics and their surrounding communities by 2028.
Today’s AI can help save lives
A few years ago, I wrote that the rise of artificial intelligence would mark a technological revolution as far-reaching for humanity as microprocessors, PCs, mobile phones, and the Internet. Everything I’ve seen since then confirms my view that we are on the cusp of a breathtaking global transformation.
All over the world, AI, in the form of LLMs and machine learning models, are improving far more quickly than I first anticipated. From science to education to customer service and more, AI tools are reshaping every facet of our lives.
I spend a lot of time thinking about how AI can help us address fundamental challenges like poverty, hunger, and disease. One issue that I keep coming back to is making great health care accessible to all—and that’s why we’re partnering with OpenAI and African leaders and innovators on Horizon 1000.
Not enough doctors in the house
We have seen amazing successes in global health over the past 25 years: child mortality has been cut in half, and there are now real pathways to eliminating or controlling deadly diseases like polio, malaria, TB, and HIV. But one stubborn problem that keeps slowing progress is the desperate shortage of health care workers in poorer parts of the world.
In Sub-Saharan Africa, which suffers from the world’s highest child mortality rate, there is a shortfall of nearly 6 million health care workers, a gap so large that even the most aggressive hiring and training efforts can’t close it in the foreseeable future.
These huge shortages put health care workers in these countries in an impossible situation. They’re forced to triage too many patients with too little administrative support, modern technology, and up-to-date clinical guidance. Partly as a result, the WHO estimates that low-quality care is a contributing factor in 6 to 8 million deaths in low- and middle-income countries every year, and that’s not even counting the millions who die because they aren’t able to access health care at all.
Rwanda leads the way
Today’s AI can help save those lives by reaching many more people with much higher-quality care.
Rwanda currently has only one health care worker per 1,000 people, far below the WHO recommendation of about four per 1,000. It would take 180 years for that gap to close at the current pace of progress. So, as part of the 4x4 reform initiative, Minister of Health Dr. Sabin Nsanzimana recently announced the launch of an AI-powered Health Intelligence Center in Kigali to help ensure limited health care resources are being used as wisely as possible.
As part of the Horizon 1000 initiative, we aim to accelerate the adoption of AI tools across primary care clinics, within communities, and in people’s homes. These AI tools will support health workers, not replace them.
On the horizon
Minister Nsanzimana has called AI the third major discovery to transform medicine, after vaccines and antibiotics, and I agree with his point of view.
If you live in a wealthier country and have seen a doctor recently, you may have already seen how AI is making life easier for health care workers. Instead of taking notes constantly, they can now spend more time talking directly to you about your health, while AI transcribes and summarizes the visit. Afterwards, AI can handle much of the onerous paperwork, so doctors and nurses can focus on the next patient.
In poorer countries with enormous health worker shortages and lack of health systems infrastructure, AI can be a gamechanger in expanding access to quality care. I believe this partnership with OpenAI, governments, innovators, and health workers in sub-Saharan Africa is a step towards the type of AI we need more of: systems that help people all over the world to solve generational challenges that they simply didn’t know how to address before. I invite others working on AI to think about how we can put these massively powerful tools to the best use.
This announcement is a great example of why I remain optimistic about the improvements we can make. I’m looking forward to seeing health workers using some of these AI solutions in action when I visit Africa, and I plan to continue focusing on ways AI technology can help billions of people in low- and middle-income countries meet their most important needs.
Buzz off
Small bugs, big breakthroughs
Science holds the key to stopping deadly pests like mosquitoes and screwworms.

What do humans and cows have in common? Among other things, we’re both victims of tiny insects.
For cows, the latest culprit is the New World screwworm. Despite the name, the screwworm is actually a type of fly that likes to lay its eggs on animals like cows, which creates an often-fatal wound on the animal’s hide. Screwworms once killed up to one million cattle a year here in the United States, and sixty years after we eliminated them in our country, they’re back.
For humans, one of our greatest nemesis is the mosquito. There are plenty of reasons to hate mosquitoes, but malaria is easily at the top of the list. The disease kills more than 600,000 people every year, most of them children, and it’s transmitted when a mosquito infected with a parasite called Plasmodium bites you.
Protecting people (or cattle) from an insect poses an interesting challenge. How do you stop something so small from hurting anyone? There are lots of different ways to approach the problem.
One approach is to keep insects out of the places where people are. There are already lots of tools that do this with mosquitoes, with more in the pipeline. The most widely used is the bed net, a gauzy sheet of fabric treated with an insecticide that kills any mosquito that tries to reach the person sleeping under it.
Bed nets are magical. In some places where malaria is endemic in Africa, they’ve reduced the number of children who die before the age of 5 by 20 percent. But there’s a problem: Mosquitoes can develop resistance to the insecticide used in bed nets, just like bacteria can evolve resistance to antibiotics.
Enter the dual active ingredient bed net. (You’ll often see them referred to as dual AI nets, even though they have nothing to do with artificial intelligence.) By treating bed nets with two different insecticides, scientists have been able to figure out how to negate a mosquito’s resistance and keep people safe. The catch is that dual AI nets are more expensive than regular bed nets, which is why the Global Fund and the Gates Foundation stepped in to make them affordable for the countries that needed them most. The results so far have exceeded my expectations. Dual AI nets now make up more than half of the bed nets used, just two years after they became available.
Bed nets have another flaw: They only protect you while you’re under them, even though mosquitoes are also active in the hours before you go to sleep and after you wake up. A new tool called a spatial emanator aims to bridge that gap. It basically works like a plug-in air freshener—but instead of releasing a nice fragrance, it slowly releases an insecticide at a low-enough dose that doesn’t harm people but drives away any mosquito that might enter your home.
When spatial emanators received the green light for use a year ago, they became the first new malaria-prevention tool the WHO has recommended in over a decade. I’m super excited about their ability to protect people from mosquitoes for more hours of the day.
Another approach to stopping insects is to target them at the population level. That’s how the world stopped screwworm the first time. In 1954, scientists figured out a way to use radiation to make the males sterile. They released the neutered insects into the target area, and since they couldn’t reproduce, the population died off. This approach worked sixty years ago, and it still works today (and scientists are working on even more effective methods).
What if we could use a similar approach to stop mosquitoes? Last year, I wrote about an incredible project in Tanzania called Transmission Zero. The idea behind it is simple: a mosquito that can’t give you malaria.
Tanzanian scientists have found a way to make Anopheles gambiae mosquitoes—the species responsible for most of the malaria in Africa—produce two types of molecules, naturally found in frogs and bees, that block the parasite from developing inside the insect. The mosquitoes would continue flying around, doing their mosquito business, but they wouldn’t be able to make anyone sick with malaria. Each time they mated with another mosquito, they would pass on the gene that protected them from the parasite. (I just published a new profile of Dr. Lina Finda from the Ifakara Health Institute in Tanzania, who is helping lead this work.)
These malaria-free mosquitoes could potentially help save tens of thousands of lives every year. And Tanzania isn’t the only country on the cutting edge of advancing this work. The Ugandan Virus Research Institute and the University of Sciences, Techniques and Technologies of Bamako in Mali are also doing pioneering work to move the field forward. Scientists are learning more every day about the role mosquitoes play in ecosystems, and research is now underway on two other species beyond Anopheles gambiae.
Dual AI bed nets, spatial emanators, and malaria-free mosquitoes are just the latest breakthroughs to come out of the robust malaria innovation pipeline. Treatments continue to get better, and vaccines are already proving to save lives, with even more effective next-gen vaccines to come. A lot of interesting work is underway with endectocides, a type of drug that could potentially make your blood toxic to mosquitoes. There’s even a fascinating trial that looks at whether targeting mosquito larvae in rice paddies could make a difference. The goal of this trial is to stop malaria, but early results from Nigeria and Rwanda indicate that larval control could boost rice yields as much as 50 percent, which would be incredible for farmers.
Unfortunately, while the R&D progress we’re making is remarkable, the same can’t be said for the fight against malaria overall. Donor governments are cutting health aid—including money for the Global Fund, which has saved more than 70 million lives to date by helping deliver lifesaving tools like bed nets. Last year, our partners across Africa pulled off a miracle to minimize the impact of the cuts. With support from our foundation, they found creative ways to distribute supplies that were already in warehouses across the continent.
This year, the picture looks different. While some funding has since been restored, cuts from multiple donor governments mean it's not yet enough to guarantee bed nets and other tools reach every family who needs them. Our foundation is doing everything we can to help close that gap. I continue to advocate for increased funding, because it is ridiculous to put the health of the world’s children at risk when we know how to save them.
I believe we can end malaria forever. We have some of the tools we need already, and I think we’ll have the rest soon. We can defeat mosquitoes, just like we stopped screwworm more than half a century ago and just like we’ll stop it again. The question is whether the world will choose to make it happen.
The choice is obvious to me. We have an opportunity to ensure that no child dies from malaria ever again. Let’s take it.
Lend an ear
The art and science of listening
Dr. Lina Finda is making sure African communities have a say in how the world fights malaria.

Dr. Lina Finda’s work sounds simple. “My job is to listen,” she says. But the reality is much more complicated. On a typical day, she has to walk into a village in southern Tanzania or a meeting hall in Uganda and gauge reactions to the idea of ending malaria by an unusual method: releasing more mosquitoes.
It’s not as crazy as it seems.
That’s because the mosquitoes she’s talking about in this case carry a gene that blocks the malaria parasite from developing, so the mosquito can’t get you sick even if you get bitten. (I just wrote about the project researching these malaria-free mosquitoes, Transmission Zero, along with the other tools that are helping us fight this disease.) Release enough of them into the wild and, in theory, the trait spreads on its own until the local mosquitoes can no longer transmit the disease.
The science is advancing, and it’s exciting. But none of these malaria-free mosquitoes have been released in Africa yet. Whether that ever happens is a decision that will be made by African governments and the people who live where these mosquitoes would circulate. Finda co-founded the African Conversations Initiative to make sure those people have a say. Her team is now working in eight countries: Tanzania, Kenya, Uganda, Rwanda, Zambia, Ghana, Nigeria, and Senegal.
The question that started it
Finda first learned about the potential of malaria-free mosquitoes in 2017, at the beginning of her PhD in public health.
“My thought was, oh my God, we might eliminate this disease in my lifetime,” she says.
All the scientists in the room with Finda were equally impressed and excited. But she knew this kind of idea would never leave a lab if there wasn’t community trust and buy-in.
So she asked herself a question: “How might other people react to this?” She dedicated the rest of her career to understanding the answer.
Listening and learning
Her first attempts to explain malaria-free mosquitoes went poorly. The process that creates malaria-free mosquitoes is hard to describe, and Finda assumed that a farmer with no formal schooling would never get there. So she gave up on finding the right words and told the truth instead: She didn’t know how to talk about it. “I was honest with the community members and saying, I really don’t know what to call this or how to talk about it.”
The response surprised her.
One of those community members was Aloyce Kimario, a farmer who also teaches at a primary school outside Ifakara. He had never heard of malaria-free mosquitoes before Finda came to see him. He had, however, spent his whole life rearing animals.
The pigs he keeps are a local breed, hardy against the diseases that circulate around Ifakara. But they’re small. When he wants animals big enough to sell well, he crosses them with a heavier breed and hopes the piglets come out with the best traits of both sides. There’s a Swahili phrase for this, kubadilisha mbegu, which translates to “changing the seed.”
So, Finda started asking farmers to describe their ideal animal. One told her he wanted a pig that was 90 percent of the heavy breed and 10 percent of the local one.
“So what this technology does,” she told him, “is it makes sure that you get exactly what you want.”
Aloyce can now explain the science behind malaria-free mosquitoes, and the case for them, without any help from Finda, in terms other farmers immediately understand.
What she wishes scientists understood
Finda admits to underestimating what local farmers would be able to grasp, and she says she sees the science community making the same mistake. Worse, she says, “they assume that when someone opposes something it is because they don’t know it, and if they could know it, then they would definitely accept it.”
“From my years of listening to everyone, I have learned that these groups are quite knowledgeable,” she says. They may not use the scientific terminology, “but they understand it in their context.”
Finda’s team has now sat down with national malaria programs, regulators, scientists, civil society organizations, faith leaders, and youth groups from more than 25 African countries. Each group worries about something the others don’t, and all of the worries are valid.
“You don’t ever hear someone say, I want to develop a solution for this disease. Let me go talk to a priest,” Finda says.
But that’s exactly what Finda did. One of the leaders she convened was the presiding bishop of the Moravian Revival Church in Tanzania, who had learned about genetically modified organisms while studying theology in the UK but had never encountered the idea applied to mosquitoes. He prayed about it and came out in favor. According to Finda, many Muslim leaders she connected with reached a similar conclusion. They just had to be asked.
Making sense of the numbers
Still, Finda has encountered substantial opposition and even anger.
When she presented the latest national malaria mortality figures to a group of community leaders in Nigeria, they took the statistics as an accusation and nearly threw her out. “You are saying that many people have died of malaria in Nigeria. Show us where they are buried,” they demanded. “Why aren’t our hospitals flooded with malaria patients?”
Finda learned a lesson from this that I’ve had to learn and relearn myself: It’s not the scale of lives lost or saved that captures people’s attention. It’s the individual stories.
“The mothers want to talk about the children they lost,” Finda says. “Those numbers do not mean anything at all.”
So now, when she meets with people, she starts by asking about their own experiences. Aloyce, the teacher-farmer, told her he gets malaria roughly twice a year. So do his children, with some episodes landing them in the hospital. The bishop told her his firstborn child died of it.
Finda herself got malaria around the age of six. Her mother was traveling, so it fell to Finda to administer chloroquine, the recommended treatment at the time, to herself and her toddler brother twice a day for seven days, while both of them were vomiting. She shares this experience, too.
The preparation is worth it
Finda thinks we are still at least a decade away from any government decisions to release malaria-free mosquitoes. In the meantime, African-led research will continue to advance scientific understanding that can inform these decisions and those required to strengthen regulatory systems to govern them. Everything she does is working up to that moment, and aimed at making it as anticlimactic as possible.
“When it is released in the newspapers or the radio or TV,” she says, “that should not be the first time that people hear about this technology.”
For many people, because of Finda’s work, it won’t be.
Bug fix
The buzz stops here
African scientists are engineering mosquitoes that can’t spread malaria.

A genetic cheat code
Moving ahead responsibly
No fever dream
How the U.S. got rid of malaria
This is how a parasite helped build the CDC and changed public health forever.

I spend a lot of time thinking and worrying about malaria. After all, it’s one of the big focuses of my work at the Gates Foundation. But for most Americans, the disease is a distant concern—something that happens “there,” not here.
That’s true today. It wasn’t always.
It was especially rampant in the South, from the Carolinas and the Mississippi Delta down to Florida and all along the Gulf Coast.
Every summer, people braced for the start of “fever season.” In her Little House on the Prairie books, Laura Ingalls Wilder wrote about what she called “fever ‘n’ ague.” A laundry list of presidents—including George Washington, Andrew Jackson, Abraham Lincoln, and Ulysses S. Grant—battled the disease.
During the Civil War, Confederate General Robert E. Lee was even counting on malaria to weaken Union troops, confident that “the climate in June will force the enemy to retire.” (It ended up crippling his own army more.)
Without modern medicine, or any understanding of how the disease spread, people reached for whatever remedies they could find: drinking vinegar and whiskey, rubbing onions on their skin, and boiling bitter herbs into tea. Powdered quinine, a substance derived from cinchona bark, actually worked—but it was expensive and hard to obtain, so few people had access to it.
For most people, the fevers kept returning year after year and summer after summer.
The first breakthrough came at the turn of the 20th century. Scientists finally proved that malaria was transmitted by mosquitoes—not, as had been previously thought, by contaminated water or poor air quality. (Malaria means “bad air” in medieval Italian.) It was a crucial discovery. Finally, people knew what to target. Across the South, some communities began draining swamps to try to control their mosquito populations. But most of these efforts were basic and improvised. What was needed was the kind of massive, coordinated, well-funded approach that only the federal government could mount. Enter one of the most ambitious and impactful infrastructure projects in American history: the Tennessee Valley Authority.
Enter one of the most ambitious and impactful infrastructure projects in American history
the Tennessee Valley Authority.
The TVA wasn’t created to fight malaria. Launched in 1933 as part of the New Deal, its mission was mainly economic: to bring electricity and jobs to the rural South, where some of the country’s poorest people lived, during the Great Depression. But the region also had some of the nation’s highest malaria rates, with 30 percent of its population infected. TVA leaders quickly realized their work wouldn’t succeed unless public health improved too.
So they incorporated malaria prevention into their projects. As engineers built dams and power plants across the region, they also drained thousands of acres of swamps, reshaped rivers, regraded land, and upgraded housing—which all helped to destroy mosquito breeding grounds. At the same time, public health campaigns educated people on installing window screens and eliminating standing water around their homes after storms. Then came World War II.
Then Came
world war II
As military bases popped up across the South, malaria became a growing threat to soldiers and defense industry workers. So the U.S. responded by launching a new program in 1942: the Office of Malaria Control in War Areas, headquartered in Atlanta. It was the federal government’s first centralized program created explicitly to fight malaria—and it laid the groundwork for what would become the Centers for Disease Control and Prevention, or CDC, which officially took over the malaria effort in 1947.
The goal of the campaign, which began with wartime control before transitioning to peacetime eradication, was simple but ambitious: Stop mosquitoes from spreading malaria, and stop people from carrying it.
ON THE MOSQUITO FRONT
The campaign launched the largest insecticide operation in U.S. history and paired it with an aggressive effort to destroy mosquito breeding grounds. Teams of sprayers went door-to-door with tanks of DDT strapped to their backs, covering millions of homes in what was essentially a chemical shield against mosquitoes. In some areas, airplanes dusted entire counties with insecticide. Meanwhile, construction crews drained ditches by hand or with bulldozers. In Florida, they used dynamite to blast open drainage paths from mosquito-infested marshland.
ON THE HUMAN SIDE
Quinine and later chloroquine—its synthetic successor—were distributed widely, especially in rural areas with high infection rates. These drugs cleared the parasite from the bloodstream, which meant that even if someone was bitten by a mosquito, they wouldn’t pass the disease on. Mobile teams traveled from town to town, testing and treating entire communities. In the Mississippi Delta, they even set up roadside treatment stations where people could stop for a dose on the way to work or school.
Public health messaging played a huge role, too. One memorable cartoon featured a mosquito named Bloodthirsty Ann—yes, short for Anopheles—that taught troops how to reduce their risk of contracting malaria. Its creator was a young army captain named Theodor Geisel, who eventually became better known as Dr. Seuss.
Perhaps the most impressive part of the program was its scale and speed. In just a few years, tens of thousands of public health workers across fifteen states were hired and trained. Doctors, nurses, scientists, teachers, technicians, and trusted community figures knocked on doors, gathered data, treated patients, and made sure no outbreak went unchecked. In 1951, America declared victory over malaria.
In 1951
AMERICA DECLARED VICTORY OVER MALARIA
I think about this history a lot when I’m visiting Sub-Saharan Africa, where the parasite still kills 600,000 people a year. Because in many ways, the strategy hasn’t changed: Stop transmission, clear infections, and build public health systems that prevent malaria from roaring back.
Malarious area of the United States
But the U.S. had some key advantages that made elimination much easier. Compared to the species responsible for most malaria today, our mosquitoes weren’t as efficient at transmitting the parasite. Our climate also limited transmission to the summer months; in tropical regions, people get infected year-round. And by the 1940s, our country had relatively strong infrastructure, even in rural areas, that many malaria-endemic countries today still lack.
ON THE TREATMENT SIDE
So the challenge today is much bigger. Fortunately, today’s malaria-fighting toolbox is much bigger—and better—too.
Instead of blanket spraying DDT, which has since been banned, modern prevention relies on safer insecticide-treated bed nets and indoor spraying techniques that use smaller doses of more targeted chemicals. Sugar baits, which lure mosquitoes to ingest a lethal dose of insecticide, are already helping reduce their numbers. And gene drive technology could soon block the parasite inside the mosquito itself—so even if someone gets bitten, they won’t get infected.
Chloroquine has been replaced by artemisinin-based combination therapies, or ACTs, which are more effective and less prone to resistance. New drugs like tafenoquine are helping eliminate recurring strains. Seasonal chemoprevention protects children during peak transmission months. And the first malaria vaccine has been approved, with more on the way.
Malaria elimination is never easy. But unlike a century ago, it’s no longer a mystery. The world knows how to stop this disease. We’ve done it before. And with the right investments and innovations, we can do it again—this time, for everyone.

Bite back
Great news for mosquito haters
With some breakthrough tools, the end of malaria could be here soon.

I was scrolling Reddit recently when I saw a video of a mosquito trying and failing to suck someone’s blood. Some of the replies were pretty funny, but I noticed that most of them were just some form of “How do I get this person’s superpower?” It was a great reminder of how universally hated these bloodsuckers are.
But I have good news—for Reddit users and everyone else: Real progress has been made in the fight against mosquitoes and specifically against malaria, the deadliest disease they carry. And I believe we’ll soon have the transformational tools needed to end malaria entirely.
Eradication is a goal Melinda and I set back in 2007, when we stood before a group of global health leaders and called for something many considered impossible: wiping malaria out completely from every country. And until that happened, our goal was—and is—to save as many lives as possible by maximizing the impact of the tools we already have. Eradicating the disease wasn't a new idea; the World Health Organization had made a similar declaration back in 1955. But that earlier campaign, while successful in many wealthier parts of the world, had fallen short across Africa, Asia, the Middle East, Eastern Europe, Central and South America, the Caribbean, and Oceania. Despite half a century of effort, malaria was still infecting up to half a billion people—and claiming a million lives—annually.
Today, the landscape has changed dramatically. In 2022—the last year we have data on—there were 249 million cases worldwide and 608,000 deaths. Those are staggering numbers, but they’re also improvements from where the world was back in 2007. Since then, 17 additional countries have been declared malaria-free by the World Health Organization. Outside of Africa, deaths from the disease have mostly been eliminated.

Proof of progress
Bad news isn’t the only news
There are reasons to be hopeful about the future, if you know where to look.

Sometimes when I tell people I’m optimistic about the future, they look at me like I’m crazy. How could I say that when there’s so much violence in the world, the international order seems to be collapsing, and AI may end up doing more harm than good?
I see all these problems too, and I’m deeply concerned about them. (I am working on a long memo about the risks and benefits of AI that I plan to publish later this month.)
But through my work with the Gates Foundation and other organizations, I also get to see signs of progress that help me stay optimistic.
To me, being hopeful about the future doesn’t mean you ignore the bad news. It’s actually the opposite: You look directly at it and then search for people who are doing something about it. In most cases, you’ll find them. And then you will start to see the broader trend of progress they are contributing to.
Here are some of my favorite signs of progress.
IN THE PAST:
- We’ve cut the number of children who die every year by more than half, from more than 9 million in 2000 to fewer than 5 million now.
- For the first time, we have a blood test for Alzheimer’s and drugs that may slow its progress.
- Electric vehicles now make up about one in four new cars sold worldwide, with sales topping 20 million in 2025.
- There are 1.5 billion fewer people living in extreme poverty today than in 1990, even though the population has risen 50 percent since then.
- Nearly 95 million girls have been fully immunized with HPV vaccine, so they’re much less likely to develop cervical cancer later in life.
- More than 86 percent of the world’s adults can read and write, up from about 68 percent in 1979.
IN THE PIPELINE:
- The newest obesity drug in trials produces nearly 30 percent weight loss, almost as good as what surgery achieves. The same class of drugs is expanding fast into related conditions, including sleep apnea, fatty liver disease, and hopefully, osteoarthritis.
- Scientists are developing a single-shot cure for sickle cell disorders, which kill tens of thousands of people every year, and it could be available within five years. The underlying technology is also being used to develop a single-shot HIV cure.
- We’re close to eradicating polio, which is endemic in only two countries. We’re nearly done with Guinea worm disease as well, cutting it from 3.5 million cases in 1986 to just ten last year.
- The mRNA technology behind some COVID vaccines is now being used for cancer vaccines, with nearly 100 in clinical trials for melanoma, lung, pancreatic, and other cancers.
- A new tuberculosis vaccine is in final-stage trials. If it works, it will be the first new TB vaccine in more than a century and could prevent tens of millions of cases over the next 25 years.
I love telling these stories. Here’s a video where you can see the amazing impact of the Green Revolution.
I find that trying to keep a positive attitude is valuable in itself. It keeps me grounded so I don’t swing toward one political extreme or another. I think the world might be less polarized if more people had a sense of the positive things that are going on in addition to the problems we need to solve.
You can find more videos here about progress. If you see one that strikes a chord for you, I’d encourage you to share it.

A remarkable transformation
Memories from an inspiring trip to Rwanda
Rwanda's long-term investments in people, strong institutions, and delivery have translated into real progress.

I just got back from the most incredible week in Rwanda. My favorite trips are always the ones that leave me feeling inspired and energized. And if you’re looking for reasons for optimism, Rwanda is a good place to start.
What stood out to me was how Rwanda's long-term investments in people, strong institutions, and delivery have translated into real progress. Over the last 25 years, the country has delivered one of Africa’s most remarkable health transformations. Since the year 2000, the number of children who die before the age of five has dropped by 73 percent. Maternal deaths have fallen by over 80 percent, and nearly all pregnant women now give birth in a health facility with a skilled birth attendant present.
I was lucky to meet many of the local leaders and innovators driving that progress. Africa is entering a new era that is increasingly shaped by African leadership, and it’s amazing to see firsthand. At the Gates Foundation, our role is to listen to leaders like the ones I met, and to support them with resources, data, and technical expertise so they can get the greatest value from every dollar they invest in saving and improving lives.
These were some of the highlights from the week:
Rwanda’s frontline health heroes: My trip started in Mwulire, where Gaudence Ngendahayo, a community health worker, showed me what her work looks like as she made the rounds in her catchment. Rwanda’s community health worker program is the backbone of its health system, and when you watch Gaudence work, it’s easy to see why. She goes house to house checking in on how families are doing. If someone isn’t feeling well, she either treats them herself or refers them to the health center nearby. (Around 60 percent of all malaria cases in Rwanda are treated by community health workers.) Along the way, she collects invaluable information that helps connect communities to the broader health system.
Primary healthcare in the community: If Gaudence isn’t able to treat someone herself, their next stop is the Mwulire Health Center. I visited the facility, which is primarily staffed by nurses and offers all of the services you would expect from a primary care provider: outpatient consultations, prenatal and maternal care, normal deliveries, family planning, immunization, and HIV and TB services. (More complex cases are referred to district hospitals.) It was interesting to learn more about how the data collected here flows through the health system to Rwanda’s National Health Intelligence Center, or NHIC, connecting every level of care and helping health workers make quick and informed decisions.
Digging into the data: Next was seeing the NHIC firsthand, where real-time data from clinics, hospitals, and community health workers is used to generate insights that the Ministry of Health uses to make quick, evidence-based decisions. Rwanda has done an incredible job building digital public infrastructure, or DPI, and I got to learn more about how its investments have paid off over the last decade. Rwanda has created a culture where data and evidence matter. They track what they're doing, they see what needs to improve, and they take action. The NHIC is also where Horizon 1000, our partnership with OpenAI to improve quality care by accelerating the adoption of AI tools in primary health clinics, is housed. I wrote about the initiative earlier this year, and it was exciting to see it taking shape on the ground. Seeing real pilots underway rather than plans on paper was one of the best parts of the trip. I can’t wait until the day we can point to a patient who got better healthcare because of it.
Manufacturing key medical supplies: Most people don’t think about the supply chain when they picture healthcare systems, but it’s essential to ensuring health workers have the tools they need. The staff at Mwulire Health Center use auto-disable syringes—injectors that can only be used once, which prevents the spread of bloodborne pathogens like HIV—made nearby at the TKMD Rwanda Manufacturing Facility. Being able to make key supplies locally makes the system more resilient and reduces its dependence on imported products, while also benefiting neighboring countries that rely on these essential medical products.
Up close with Rwanda’s digital transformation: I’ve followed Rwanda’s work on DPI closely for many years, but there is nothing quite like seeing it in person at the Upanzi Digital Experience Center at Carnegie Mellon University Africa. The Upanzi Network was created to build Africa’s capacity to develop, test, adopt, and govern open-source digital technologies—like identity, payments and cybersecurity—in a way that is secure, inclusive, trustworthy, and locally relevant. I got to see their DPI stack up close, which is built on open-source platforms like MOSIP and Mojaloop and is now being adopted by a growing number of African governments to run their national critical infrastructure. It was super interesting to hear from the young researchers shaping it with their lived experiences across Africa. This is exactly the kind of African-owned, African-built infrastructure that will improve lives across the continent.
Young innovators leading the way with AI: I always love meeting with brilliant young innovators, so I knew visiting the Rwanda AI Scaling Hub in Kigali would be fascinating and inspiring. I met founders who are using technology and AI to tackle local development challenges, from expanding access to healthcare to helping communities access critical services. Dr. Loza Admassu, founder of Ambucycle, is using data-driven logistics to improve emergency medical transport and connect patients more quickly to life-saving care. Audace Niyonkuru, founder of Digital Umuganda, told me about the efforts she’s leading to collect and curate African local-language voice data to help train AI models that better understand and serve African communities. What stood out was not just the technology itself but the ambition, creativity, and determination of young Africans who are building solutions for their own communities and creating innovations with the potential to benefit people around the world.
The next generation of African health leadership: If I had to pick one highlight of my trip, it would be my day at the University of Global Health Equity in Butaro. My friend Paul Farmer was working at the university when he died, and it was moving to see how his vision of equity continues to shape the university, the hospital, and the community around it. Watching medical students train for the kinds of emergencies they will one day manage in their own communities was especially inspiring. I was honored to help launch the Butaro Dialogues and speak with students from across the continent, including members of the Consortium of Medical Students' Associations. Their questions reflected both a deep understanding of today's challenges and an ambitious vision for a more equitable future of global health. Africa’s greatest resource has always been its people. Sitting across from these young people as they talked about their big ideas for global health, it was crystal clear that they are the next generation of leaders who will shape the continent’s future.
Growing farms with data and AI: My last stop was the One Acre Fund, an African-focused organization that helps millions of smallholder farmers get more out of every harvest. I met farmers who work with the program and leverage on-time delivery of seeds and fertilizer, along with hands-on training, to help their families grow more food and earn more money. (Rwandan farmers in the program generated $118 million in new profits last year alone.) One Acre Fund connects farmers with technology by building on Rwanda’s digital farmer registry and subsidy system, connecting government data with on-the-ground support. They then pull in AI-powered tools like Virtual Agronomist, which can answer farmers’ questions over WhatsApp using real data on their soil and local weather. I’m super excited to see how innovations like this can arm more farmers across Africa with the information they need.
My time in Rwanda reminded me how much progress can be made when innovation reaches the people who need it most. Across the country, scientists, entrepreneurs, and governments are driving breakthroughs that are practical, affordable, and designed for local needs. Rwanda has already achieved major progress with even greater opportunities ahead, and its young people are poised to shape not only the African continent, but the world.

















Gone for good
“AIDS-free generation” is no empty promise
New tools mean we’ll be able to stop the pandemic forever.

PrEP talk
From once a day to twice a year
Long-acting preventatives will save more lives from HIV/AIDS.

I’ve been working in global health for two and a half decades now, and the transformation in how we fight HIV/AIDS is one of the most remarkable achievements I’ve witnessed. (It’s second only to how vaccines have saved millions of children's lives.)
At the dawn of the AIDS epidemic, an HIV diagnosis was often a death sentence. But in the years since, so much has changed. Today, not only do we have anti-retroviral medications that allow people with HIV to live full, healthy lives with undetectable viral loads—meaning they can’t transmit the virus to others. We also have powerful preventative medications known as PrEP, or pre-exposure prophylaxis, that can reduce a person’s risk of contracting the virus by up to 99 percent when taken as prescribed. It’s an incredible feat of science: a pill that virtually prevents HIV contraction.
In theory, if we could get these tools to everyone who needs them and make sure they’re used correctly, we could stop HIV in its tracks. Because when people with the virus receive proper treatment, they can’t transmit it to others. And when people at risk take PrEP, they can’t contract it. In practice, however, getting these tools to people—and making sure they’re used correctly—is the hard part. Especially for PrEP.
That’s because current preventatives require people to take medication every single day. Miss a dose, and protection drops. It’s like trying to remember to lock your front door 365 times a year—if you mess up once, you’re vulnerable. For many people, the barriers stack up quickly. Some have to walk hours to reach a clinic. Others struggle to store medication safely or discreetly at home. And many face judgment and stigma for taking PrEP, especially young women in conservative communities. The very act of protecting yourself can lead to being shamed or ostracized.
That’s why I’m so excited about a new wave of innovations in HIV prevention. Scientists are in the process of developing several longer-lasting PrEP breakthroughs, each with distinct advantages that could help more people protect themselves on their own terms.
Lenacapavir, which requires only two doses per year through injection, could open HIV prevention up to people who can’t make frequent clinic visits. Cabotegravir, another injectable option that works for two months at a time, offers a more flexible dosing schedule than daily PrEP pills, too. Meanwhile, a monthly oral medication called MK-8572, still in the trial stage, could provide an alternative for people who prefer pills to injections. The Gates Foundation is even exploring ways to maintain a person’s protection for six months or longer. And researchers are working on promising PrEP options that include contraception, which would be particularly valuable for women who need both types of protection.
To understand how these options work in real life, and not just in labs, our foundation has supported implementation studies in South Africa, Malawi, and elsewhere. Unlike traditional clinical trials that test safety and efficacy in highly controlled settings, these studies examine how medications fit into people’s lives and work in everyday circumstances—looking at ease of use, cultural acceptance, and other practical challenges. This real-world understanding is crucial for successful adoption.
Some people ask me if these new preventative tools mean the Gates Foundation has given up on finding an HIV vaccine. Not at all. In fact, these advances push us to aim even higher in our research for a vaccine that could prevent HIV for a lifetime—and not just a few months at a time. Our goal is to create multiple layers of protection, much like modern cars have seatbelts, airbags, and even collision-warning sensors. Different tools work better for different people in different ways, and we need every tool we can get.
But even the most brilliant innovations make no difference unless they reach the people who need them most. This is where partnerships become crucial. Through grants to research institutions around the world, the foundation is working to lower manufacturing costs for HIV drugs so they’re accessible to everyone, everywhere. Then there are organizations like the Global Fund and PEPFAR, which have been instrumental in turning scientific advances into real-world impact.
The Global Fund—which needs to raise significant new resources next year to continue its work—currently helps more than 24 million people access HIV prevention and treatment. And PEPFAR has saved 25 million lives since its inception in 2003—a powerful example of how American leadership can build tremendous goodwill while transforming the world. Motivated by the belief that no person should die of HIV/AIDS when lifesaving medications are available, President George W. Bush created PEPFAR with strong bipartisan backing and it continues to serve as a lifeline to millions of people.
We're at a pivotal moment in this fight. Twenty years ago, many believed it would be impossible to deliver HIV treatment at scale in Africa’s poorest regions. Since then, we’ve made fantastic progress. Science has shown us promising paths forward—for better prevention options, easier treatment regimens, and, maybe one day, an effective vaccine. Our task now? Ensuring the life-saving innovations we already have reach the people whose lives they can save.

Game changer
Grassroot Soccer scores a hat trick for African youth
This organization uses the beautiful game to reach millions of young people with lifesaving services.

I’ve never been much of a soccer fan. (Tennis and pickleball are my favorite sports.) Still, seeing the athleticism and passion on display during the World Cup, I understand why soccer has earned the nickname “the beautiful game.” What makes soccer even more beautiful is the positive impact it can have off the field.
There may be no better example of this than the work of a unique non-profit organization called Grassroot Soccer, which was featured at a health innovation event where I spoke earlier this week.
For the last two decades, Grassroot Soccer has used the incredible popularity of the game to help young people across Africa navigate some of their toughest health challenges.
Despite significant progress in health and development in Africa, including a dramatic decline in child mortality, HIV/AIDS continues to be a leading cause of death among youth in Africa. Sexual violence threatens the health and safety of girls. A lack of access to contraceptives contributes to high rates of teen pregnancy. And mental health services are often unavailable.
Solving these challenges is difficult—and especially important given that 60 percent of Africans are under the age of 25. So, how can soccer make a difference?
Because it’s so popular, soccer offers a hook to capture the attention of young people. Grassroot Soccer uses the game to involve them in activities that encourage them to live healthier, more productive lives.
Here’s one simple example. In an activity called “Risk Field,” players are asked to dribble a soccer ball through cones labeled with some of the risky behaviors that young people often encounter, such as unprotected sex, HIV, multiple partners, and alcohol.
The local youth who serve as Grassroot Soccer coaches are a critical component of the program. Trained in basic counseling skills, the coaches play an important role as trusted mentors to the young participants.
The coaches also accompany adolescents to clinics where they can get HIV testing, contraceptives, and other services. (In some countries, young people might be turned away because of their age or criticized by health staff for seeking contraceptives and testing. The coaches serve as advocates to support their right to health services.) Coaches also conduct home visits to talk with parents and guardians about their programs and health services.
Founded in 2002 by Dr. Tommy Clark, a pediatrician and former professional soccer player, Grassroot Soccer initially focused on stopping the spread of HIV. (The Gates Foundation was an early funder of its work.) Today the organization works in more than 60 countries and has reached more than 18 million young people.
Studies have shown that its participants had better access to sexual and reproductive health services, were more likely to stick with their HIV treatment, and were less likely to experience depression.
That kind of impact gives everyone, even casual soccer fans like me, something to cheer about.

Inspired by a farmer
These married scientists are leading the way on HIV
The Abdool Karims revolutionized the fight against AIDS. Now they’re helping the world tackle COVID-19 too.

Quarraisha and Salim Abdool Karim are two of the most respected HIV/AIDS researchers in the world. This year, the wife-and-husband team has also helped shape the world’s response to COVID-19. But it was a more humble setting that sparked their careers in epidemiology more than 30 years ago.
They had met in medical school in their native South Africa before moving to New York City for graduate school. In 1988, shortly after they were married, they took a trip to Mexico, where they met up in a tiny village in the Sierra Madre mountains with a friend, a physician who had written a seminal textbook on health care in remote rural settings.
Outside the village’s health clinic, they saw a man pedaling a bicycle that was mounted on a stand and connected to a power cable. It turned out that a local farmer also doubled as the village’s dentist—a pretty good one, apparently—and volunteers would pedal the bike to power his drill.
“We watched how this community took their destiny in their own hands,” says Salim, “and they had the most amazing dental care from this bicycle powering a drill. It imprinted on us how people can really change their own world.”
It was a powerful lesson about the need for scientists to understand and collaborate with the people they’re trying to help. The experience in that village would shape the rest of their careers, especially when they created a research center in South Africa designed to address two of the biggest problems in HIV/AIDS in Africa.
By the 1990s, the disease was devastating the Abdool Karims’ home country—and still is today. One out of every five people in the world with HIV lives in South Africa. The couple saw two issues that were rarely on the agenda of other HIV experts. One was that young women were bearing a disproportionate burden in the epidemic, and that there was no way to control the epidemic if their needs weren’t addressed. The other was that people living with HIV are at a high risk of contracting and dying from tuberculosis—a link that’s now known as HIV-TB coinfection.
“These were very much our problems in Africa that few others were working on,” says Quarraisha, “and if we waited for solutions from elsewhere, it wasn’t going to come. We had to take the lead.”
In 2001, they brought together a group of researchers they felt could make a bigger impact on HIV and named the group CAPRISA (for the Center for the AIDS Program of Research in South Africa). Today CAPRISA runs three clinics where they provide antiretrovirals to people living with HIV and study new approaches to treating and preventing the disease. It is regarded as one of the world’s most influential AIDS research programs.
CAPRISA is probably best known for a landmark study published in 2010 proving for the first time that a microbicide—a gel that a woman could use before and after sex—can offer some protection from the virus. Scientists had been trying to make effective microbicides for nearly two decades, but the Abdool Karims’ formulation—one that used tenofovir, a drug normally given to people who already had HIV—was the first to offer any protection. Although the field has now moved on from microbicides and is focused on a more effective daily pill instead, the concept is still based on CAPRISA’s microbicide findings.
CAPRISA is as admired for the way it works as for its results. Inspired by the farmer-dentist they met in Mexico, Salim and Quarraisha make it a priority to empower the people they’re trying to help. They work closely with community leaders to make sure their research efforts are informed by realities on the ground and embraced by their neighbors. Here’s the story of one remarkable CAPRISA staff member, Gethwana Mahlase, and the way she represents the program in her community of Vulindlela.
Over the next few years, Quarraisha and Salim hope to build on their study of tenofovir as an HIV preventative. Right now, the best option is a pill you have to take every day, a regimen that can be hard to keep up. So CAPRISA is working on a form of the drug that could protect a woman for as long as a year at a time.
They’re also working on a fascinating approach called “broadly neutralizing antibodies,” which dates back several years. In 2012, they discovered that an HIV-positive woman in one of CAPRISA’s studies had a trait that was, as far as they knew, unique. The antibodies made by her immune system could attack not only the strain of HIV that she had, but also—this was the impressive part—80 percent of the other known strains of HIV from around the world. If they could isolate the cells that made these antibodies, reproduce them, and use them to create antibodies for other people, it would be a game changer.
After years of painstaking work with a number of partners, they were able to create the broadly neutralizing antibodies in a lab and test them in monkeys, with very positive results. Now the antibodies are being studied in humans for safety and, eventually, efficacy. If this approach works, you would need to get an injection just twice a year in order to get protection—a dosage that is far more practical than a daily pill. Success would also point the way toward the ultimate goal of an HIV vaccine.
Unfortunately, much of the Abdool Karims’ attention has been elsewhere this year. Drawing on their experiences from HIV and TB, they are helping guide the COVID-19 response in South Africa and around the world. It is a shame that they haven’t been able to focus on HIV/AIDS, but on the other hand, it is a reminder of how fighting old diseases like HIV helps the world prepare for new ones like COVID-19. Investing long-term in programs like CAPRISA—or work on polio or malaria—not only prevents deaths and disability from specific diseases, it also strengthens the overall field of global health. So when a pandemic comes along, we have a network of experts like Quarraisha and Salim ready to pitch in.
What strikes me about this couple is how upbeat they are, even in the face of devastating diseases like the coronavirus and HIV. Their motto at CAPRISA is, “Each day that you come to work, you should be looking for how today is going to be better than yesterday.” That is a lesson we can all take to heart.
Heroes
Strength in numbers
The story of this amazing woman living with HIV in Mozambique fuels my optimism about our world.

Last year, at an event in New York, I learned about an impressive woman whose story I want to share with you. Her name is Cacilda Fumo, she lives in Mozambique, and every year she helps save hundreds of lives—by reminding them they are not alone.
Mozambique has one of the highest HIV infection rates in the world. More than 1.6 million people—10 percent of the adult population—are living with HIV.
Cacilda was diagnosed with HIV in 2002. “When I first learned about it, I thought I would die,” she recalls. “I used to wake up early morning and check if I am alive or not.”
But then she started meeting other people living with HIV, and as their numbers grew so did her strength and her belief she would live. Cacilda was one of the first in Maputo to be open about her status. She started wearing a t-shirt emblazoned with a logo that reads: “HIV POSITIVE.”
At times, people rejected her because of her status. Many more in her community, however, admired her for her courage, helping her create an even larger circle of friends and supporters. They met every week, praying together, cooking together, and sharing their stories. Eventually, the group had about one hundred people, many of them receiving life-saving anti-retroviral treatment. Cacilda emerged as their leader.
About the same time, Mozambique’s Ministry of Health was struggling to improve the delivery of anti-retroviral treatment. While the program was successful in putting thousands of patients on treatment for the first time, medical staff were overburdened with caseloads. People on HIV treatment often walked miles to reach their clinic and waited in long lines to get care. Every year, about 30 percent of HIV patients dropped off their life-saving treatment.
Working with Doctors Without Borders, the government of Mozambique decided to try a new approach to simplify care to help keep more people on treatment. They started organizing small peer support groups for people on HIV treatment. The idea was simple. Make treatment easier by putting more control into the hands of the patients. A representative from each patient group could pick up all the drugs for the group each month, saving the rest of the group the hassle of going to the clinic. Members of the groups, known as Community antiretroviral therapy (ART) Groups or CAGs, would also support one another to ensure they were all staying on their treatment.
When the program reached Maputo, Cacilda was ready to join. She helped organize dozens of support groups from her network. Then she went one step further. She kept track of the groups, checking whether members were attending their meetings and taking their treatment. If someone fell off treatment, she took upon herself to locate them and find out what was wrong.
“We help people feel strong knowing they are not alone,” she says.
Some patients who stop treatment are addicted to alcohol and forget to take their treatment, she says. Some don’t understand how the treatment works and the stop taking their medication as soon as they feel better. Others get busy with their jobs and drift away.
Whatever the reason, Cacilda warns them of the dangers of stopping treatment and encourages them to restart. Her efforts to bring back residents of Maputo to treatment has become nearly full-time work. Most days residents of Maputo see Cacilda traveling on foot—which is remarkable because due to a childhood injury she uses crutches—through the dirty alleyways and crowded markets in search of people who have stopped treatment. She doesn’t give up until she finds them.
Cacilda’s persistence pays off—in lives saved. Cacilda estimates that she tracks down about 500 people every year and encourages them to resume their treatment.
That’s a remarkable achievement—one that proves how much difference one life can make in the world.
World AIDS Day
The fight against AIDS is filled with heroes. Learn how you can be one too.
Thanks to many heroes, the world has made amazing progress against HIV/AIDS.

On December 1st, the global community will observe World AIDS Day. This year I would like to mark it by highlighting the work of two heroes who are making a difference in the fight against this deadly disease.
Chief Jonathan Eshiloni Mumena is chief of the Kaonde people, who live along Zambia’s border with the Democratic Republic of Congo. Risking his position as his people’s leader, Chief Mumena challenged long-held traditions to encourage Kaonde men to embrace voluntary medical male circumcision as a strategy to prevent HIV transmission. (Male circumcision can reduce a man’s risk of acquiring or transmitting HIV by up to 60 percent.) I had the privilege of meeting Chief Mumena in 2012. His story is an inspiring tale of courageous leadership and deep compassion for his people.
Guided by her belief that health care is a basic human right, Dr. Krisana Kraisintu, a pharmacist from Thailand, has worked tirelessly to make medicines affordable to even the poorest in the world. Her development of generic versions of the lifesaving HIV drugs dramatically reduced treatment costs, saving and improving countless lives. She has also dedicated her pharmaceutical skills to reduce treatment costs for malaria and other diseases.
Of course, Chief Mumena and Dr. Kraisintu are just two of the countless individuals—doctors, policymakers, researchers, activists, and political leaders—whose contributions have helped turn the tide against the disease. Today, 19.5 million people receive lifesaving antiretroviral therapy, giving them the opportunity to live full, productive lives. Improved access to treatment has also meant that millions of babies are now born HIV-free.
Much of this progress has been made possible by the world’s enormous investments in efforts to defeat the epidemic, including the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the U.S. HIV/AIDS program known as PEPFAR, President’s Emergency Plan for AIDS Relief.
Still, many challenges lie ahead in the fight against the AIDS epidemic.
Funding for HIV control has been flat and there’s talk about cuts as the world turns to other priorities. Cuts in funding for HIV/AIDS would lead to sharp increases in deaths and new infections, reversing the gains that have been made the last decade. That’s why it’s more important than ever for the world to reaffirm its commitment to this fight. We need more AIDS heroes—from health care workers and advocates to global leaders. Together, we can bring an end to this public health threat.
If you want to be a hero this World AIDS Day, support the (RED) Shopathon. Our foundation is matching every dollar raised—up to $15 million—to fight HIV/AIDS in Africa.
Eye opener
What my favorite chart leaves out
Every year, 2 million babies are stillborn. A simple retinal scanner can change that.

If you’re anything like me, you have a favorite chart. Mine has been the same for years. It plots under-five mortality year over year—a figure that has dropped by half since the turn of the century, from over 10 million deaths in 2000 to fewer than 5 million in 2023.
In my view, this data is the strongest evidence we have that progress is possible, even in tough times, and that the investments the world has made in vaccines, oral rehydration, bed nets, and better nutrition are working.
But there's a rule in global health statistics that complicates the story: To count as a death, someone must have first been born alive. It sounds simple and obvious. But in practice, it isn't. That's because every year, about 2 million pregnancies end in stillbirth, which is when a baby is lost at 28 weeks or later. That's late enough that the mother has been feeling the fetus move for months. Many parents have already picked out a name. Often, the loss occurs in the final stretch of a pregnancy, or during labor itself, when everyone was expecting a healthy birth.
These tragedies should be central to how we measure child survival. Instead, they've fallen through the cracks—not quite a maternal health issue, not quite a child mortality issue. The UN didn't publish its first full global estimate of stillbirths until 2020, and stillbirth research is still badly underfunded in both rich and poor countries.
What gets measured gets managed, as the saying goes—and what doesn't, well, doesn't.
The data reflects this disparity. Stillbirths have fallen just 34 percent since 2000, compared to 50 percent for under-five mortality over the same period. In 81 countries—mostly low- and middle-income—the stillbirth rate hasn't meaningfully improved at all in 25 years. For every one stillbirth in Europe, there are roughly 40 in sub-Saharan Africa.
What's frustrating is that we know what causes, and therefore how to prevent, most stillbirths. One of the biggest drivers is pre-eclampsia—a dangerous spike in blood pressure during pregnancy—which is responsible for half a million fetal deaths every year, along with 70,000 maternal deaths. Beyond that, the bulk of stillbirths stem from a cluster of conditions we understand well: maternal infections, obstetric complications during labor, and chronic conditions like untreated diabetes.
If we could catch these problems earlier, we'd have a much better chance of intervening before it's too late. But that's hard to do in the rural clinics where most pregnant women receive care, which often have unreliable electricity, no specialists, and little in the way of lab equipment. By the time pre-eclampsia is obvious, or gestational diabetes has gone unmanaged through the third trimester, the harm is often irreversible. Even emergency intervention may not help.
But a few months ago, I got to hold a device that has the potential to make a huge impact: the Remidio fundus camera. You hold it up to a patient's eye to get a high-resolution image of their retina in seconds, no dilation required. A community health worker with a few hours of training can use it. The device itself is about the size of a handheld video camera, battery-powered, and portable enough to carry from village to village.
Why the retina? It's the only place in the body where you can see blood vessels from the outside.
Remidio is a medtech startup out of India, and its camera was originally built to screen for diabetic eye disease. With an AI system running on a phone the camera plugs into, it can pick up early signs of the disease that would otherwise require blood draws and specialist follow-up to catch. It's already been used that way for more than 15 million patients in 40 countries.
But that same hardware, with different software, can also flag the conditions that drive so many dangerous pregnancies. Gestational diabetes sharply increases the risk of pre-eclampsia, preterm birth, and fetal death, and in most of rural sub-Saharan Africa or South Asia, it usually isn't screened for at all, because the standard test requires a lab. A retinal scan offers a different way in. Remidio’s device is currently being used in India to screen pregnant women for conditions that drive stillbirth. And researchers are now adapting the same hardware to screen for anemia and hypertension, too.
A tool like Remidio’s won’t solve the problem of stillbirths alone. We also need more skilled birth attendants, better emergency obstetric care, and stronger health systems. But small, portable, affordable diagnostics in the hands of community health workers are exactly the kind of lever that can start to move a number that hasn't moved in a long time. That's a big part of why the foundation committed $2.5 billion to women's health research and development last year, our largest investment in this area ever.
In 25 years, I hope my favorite chart in the world will have two lines on it: one tracking under-five mortality, and one tracking stillbirths. With the right commitment, I believe both will have fallen dramatically, and both could be approaching zero.

Life and death
How to cut child mortality in half… again
We already know how to save millions of newborn lives.

When Paul Allen and I started Microsoft, we had an ambitious goal: to put a computer on every desk and in every home. A lot of people thought we were out of our minds. But we believed in the power and potential of these machines to change the world. So every day, we came to work determined to make it happen. Now, it’s hard to imagine the world any other way. In a few short decades, that goal became reality for billions.
In 1990, the possibility that the world would be able to cut child mortality in half over the next thirty years would have seemed just as remote. But that’s exactly what happened. And I believe the world can do it again by 2040—we can cut child mortality in half once more—and get even closer to ending all preventable child deaths.
My introduction to this issue came 27 years ago, when I read a piece in The New York Times about deadly drinking water in the world’s poorest countries that contained the following statistic: “Diarrhea kills some 3.1 million people annually, almost all of them children.” Learning that shocked me to my core. There’s no greater pain than the death of a child. The death of millions of them—from something easily treatable in much of the world—is tragedy after tragedy on an almost unfathomable scale.
Before long, I was learning everything I could about global health generally and child mortality specifically. And shortly after, the Gates Foundation, which was just getting off the ground, made it our mission to fight preventable health disparities like this around the world—with an emphasis on children whose lives were being cut short before they ever had a chance.
My look ahead
What it takes to take a breath
New tools can help millions more newborns—and their mothers—survive.

In a rural health clinic, a baby tries to take her first breath.
But her lungs aren’t ready. Because she was born too early, they haven’t developed the slick, soap-like substance that keeps her air sacs from collapsing. Without that substance—called lung surfactant—breathing becomes a desperate, exhausting act.
She’s suffering from respiratory distress syndrome, or RDS, a life-threatening condition that appears within hours of birth in premature babies. Unless she gets treatment, her oxygen levels will plummet and her organs will begin to shut down. In one study from India, every baby born with RDS outside of a hospital setting died. In Ethiopia and Nigeria, RDS is responsible for almost half of all neonatal deaths.
At hospitals in higher-income countries, there’s a way to save her: a liquid form of organically-derived surfactant delivered directly into the lungs. But the procedure requires a highly-trained specialist to guide a breathing tube down the newborn’s windpipe—avoiding the stomach and placing it just right—at a cost of up to $20,000. In many parts of the world, that kind of care simply doesn’t exist.
But what if any healthcare worker anywhere in the world could simply hold a small nebulizer to the baby's face and deliver surfactant as an easy-to-administer inhalant?
This breakthrough—a synthetic surfactant that’s stable enough to be delivered through a nebulizer—is still in development, drive in part by Gates Foundation-supported research at Virginia Commonwealth University, Seattle Children’s Research Institute, and The Lundquist Institute. But its promise is extraordinary: an RDS treatment that costs less to make, doesn’t require a specialist to administer, and eliminates the need for intubation.
In other words, a therapy currently limited to the most advanced hospitals could become accessible in rural clinics and community settings around the world. Even in places with top-tier care, it could make treatment gentler, faster, and easier to deliver. In the United States—where RDS still affects 24,000 newborns a year—it could reduce the risks that come with intubating babies who might weigh only two or three pounds.
It’s the kind of innovation that could help solve one of the most persistent problems in global health: delivering intensive care without an intensive care unit, and helping millions more babies survive their first, most fragile moments.
Since 1990, the mortality rate for children under five has been cut by more than half—an amazing mark of global progress. But another statistic hasn’t fallen as fast: the number of babies who die in their first month of life.
Each year, 2.3 million newborns don’t survive past their first 28 days. And the day a baby is born is the most dangerous day of their life. The single biggest cause of these deaths is prematurity. Nearly 900,000 babies a year die from complications related to being born too soon, including infection, underdeveloped organs, and RDS.
Lower cost, easier-to-deliver surfactant is one way to give newborns a fighting chance, but it’s not the only way. Around the world, simple, affordable interventions already exist to identify at-risk pregnancies earlier, prevent more preterm births, and ensure a healthy birthing experience for mothers. Not only are these tools designed to work in the hardest-to-reach places—many of them start working even before a baby takes that first breath.
One of these innovations is a new type of ultrasound that’s changing who can catch the risks of preterm birth—and where.
Around the world, two thirds of women never get an ultrasound screening during pregnancy. Traditional machines are bulky and expensive, with specialized training required to operate them and interpret their results. In places where medical resources are already stretched thin, these types of ultrasounds are rarely an option.
But now, we have ultrasound devices about the size of a phone that can be operated by a nurse or midwife—no on-site specialist required. They weigh less than a pound. They process scans instantly. Their AI interface automatically detects high-risk conditions, like a shortened cervix or signs of early labor, so patients are referred for further care. And they have built-in telehealth functions to share images with remote specialists when needed.
By finding and flagging risks early, these AI-enabled ultrasounds are giving healthcare workers more time to act. In some cases, that means transferring the mother to a higher-level facility. In others, it means providing her with antenatal steroids—an inexpensive, underused treatment that speeds up fetal lung development—and, when needed, medications that delay labor just long enough for those steroids to take effect.
Early warning is essential, but we can save even more lives by going further upstream, starting with the health of pregnant women themselves.
In many low-income countries, undernutrition isn’t an exception. It’s the norm. And the intense demands of pregnancy make nutritional deficiencies even worse—putting mothers at increased risk of complications or death in childbirth, and raising the odds of early labor, low birth weight, and developmental delays for their babies.
But there’s a surprisingly simple fix: a daily supplement called MMS, or multiple-micronutrient supplementation, developed by the United Nations. It contains 15 essential vitamins and minerals for pregnancy—like zinc to reduce the risk of early labor, folic acid to help prevent birth defects, iron and vitamin D for healthy birth weight, and iodine for brain development. For an entire pregnancy, it costs just $2.60.
If MMS became the standard prenatal supplement in every low- and middle-income country, it could save nearly half a million newborn lives each year—and prevent serious complications in 25 million births by 2040.
The innovations above focus on treating, detecting, and preventing premature birth, a huge threat to newborn survival. But one of the most powerful ways to protect babies, preterm or full-term, is by ensuring their mothers stay healthy through pregnancy and childbirth.
When a woman dies during delivery, her baby is 46 times more likely to die in that first month of life. That’s why any serious effort to tackle infant mortality must also address postpartum hemorrhage—which tragically kills 70,000 women a year and is the leading cause of maternal mortality. Fortunately, two innovations are already helping healthcare workers catch and treat it before it becomes fatal.
The first is a calibrated drape—a simple plastic sheet placed under a woman during delivery that collects blood and shows, through printed measurement lines, exactly how much she’s losing. It gives healthcare workers a fast, accurate way to spot dangerous bleeding before it becomes life-threatening. The second is a one-time, 15-minute iron infusion during pregnancy that treats severe anemia—so if a woman does hemorrhage during childbirth, she’s less likely to experience catastrophic blood loss and more likely to survive.
Neither of these tools is complicated or expensive. But in combination, they can make a life-or-death difference for mothers and the babies who depend on them.
Taken together, these innovations form a chain of survival. They help mothers stay healthy through pregnancy. They detect problems before they become emergencies. They give fragile newborns a fighting chance. And they make it possible for families to celebrate a baby’s birth rather than mourning a loss.
Some of these tools are already saving lives. Others are on the verge of doing so. But their impact will be limited unless we prioritize and fund their delivery, not just their development. The world needs to make sure these innovations don’t get stuck in labs or warehouses—so they can reach the mothers and babies who need them most.
My look back
The breakthrough that transformed the Gates Foundation
This is the story of how better data helped us cut child mortality in half.

We started the Gates Foundation 25 years ago to save and improve children’s lives. But no one can solve a problem they don’t fully understand. And back in 2000, the world’s understanding of childhood mortality was occasionally inaccurate, often imprecise, and almost always incomplete.
That’s why I believe the breakthrough that transformed our foundation in the two-and-a-half decades since wasn’t a single vaccine or treatment—it was a revolution in the world’s understanding of childhood mortality. Through advances in how researchers collect and analyze global health data, we now know much more about what kills children, where these deaths occur, and why some kids are more vulnerable than others. By putting those insights to work, we’ve been able to save lives.
The first challenge was knowing exactly what was killing children.
Reading the 1993 World Development Report opened my eyes to the scale of the problem: Around 12 million children under the age of five were dying every year, with a staggering disparity between rich and poor countries. But the available data was fragmented and inconsistent. That made it difficult to understand trends or allocate resources effectively.
So the foundation helped create the Institute for Health Metrics and Evaluation at the University of Washington, to give a permanent home to the Global Burden of Disease study—originally developed in the 1990s by researchers at Harvard University and the World Health Organization. We wanted to expand it from a static snapshot of the problem into a regularly updated tool that tracked how diseases impact people around the world. That gave us something the world never had before: a comprehensive—and current—picture of child mortality across every country.
Measuring symptom-based causes of children’s deaths was an important step. But broad disease categories like “diarrhea” or “respiratory infection” didn’t give us enough information to act on. We needed to know which specific pathogens were responsible for the most common and fatal cases. So the Gates Foundation funded two landmark studies to find out.
In 2013, the Global Enteric Multicenter Study, or GEMS, found that rotavirus was causing 20 percent of lethal diarrhea cases in kids. At the time, diarrhea was the second-leading infectious killer of children. While oral rehydration therapy had already helped bring down deaths over previous decades, GEMS helped fast-track the rollout of a more targeted tool—a new rotavirus vaccine—in the hardest-hit countries, in close partnership with Gavi, the Vaccine Alliance.
A year later, the Pneumonia Etiology Research for Child Health study, or PERCH, revealed that respiratory syncytial virus, or RSV, was a much more common cause of severe pneumonia—the leading infectious killer of kids around the world—than previously understood. (And not just in low- and middle-income countries, where 97 percent of RSV deaths occur, but in higher-income ones too, where the virus still fills pediatric hospital wards each winter.) That prompted us to expand our investments in RSV prevention, which led to the approval of the first maternal vaccines for RSV in 2023.
But understanding what causes childhood mortality wasn’t enough on its own, because deaths aren’t distributed evenly across countries—or even within them. That’s why our second challenge was to figure out where exactly children were dying.
At the time, most health data was collected at national or regional levels. That masked major differences in disease burden from one community to the next—and made it harder to target interventions effectively.
To solve this second challenge, the foundation invested in new approaches to health mapping that combined satellite imagery, GIS technology, GPS data, and local health surveys. These maps gave Ministries of Health and implementing partners unprecedented, anonymized detail about disease patterns and population distribution, down to individual neighborhoods, that transformed how and where public health resources are deployed—while still preserving the privacy of the individual children and families in these places.
In Pakistan—one of just two countries where wild polio remains endemic—advanced mapping tools have helped vaccination teams reach and protect kids in settlements that weren’t on any official maps. Across sub-Saharan Africa, better geographic data has transformed the fight against malaria by revealing that transmission often clusters in small, hyper-local pockets. Through the Malaria Atlas Project, countries like Nigeria can now track those patterns more precisely—and then get bed nets, testing, and treatment where they’ll have the greatest impact.
With better knowledge of what was killing children, and where, one more fundamental question remained: Why might one child die from a disease while another—who lives in the same place, faces the same risks, and gets the same treatment—survives? This was our third big challenge.
In theory, traditional autopsies would provide the answer. But in the places where most childhood deaths still occur, these invasive procedures are often impossible to perform—too costly, and sometimes opposed for religious, cultural, or personal reasons.
So in 2015, the foundation launched the Child Health and Mortality Prevention Surveillance network, or CHAMPS, which now operates in nine countries across Africa and South Asia. Working with in-country partners, CHAMPS pioneered a new autopsy alternative—using minimally invasive tissue sampling—that can determine causes of death quickly and accurately while respecting local customs and beliefs.
Through CHAMPS, we discovered that childhood deaths rarely have a single cause. Instead, kids often have multiple conditions at the same time, with malnutrition frequently leaving them much more vulnerable to a whole host of infections. (While it rarely shows up on death certificates, it’s an underlying cause of death in nearly half of all child mortality cases.) That finding helped solidify nutrition as a core focus of the foundation’s global health work—and the research, innovation, and product development we invest in. On the ground, we’re supporting partners as they integrate nutrition screening into routine care and train healthcare workers to manage multiple risks at once.
CHAMPS also demonstrated that inadequate prenatal care is responsible for a majority of stillbirths, newborn deaths, and maternal deaths, prompting us to further expand access to maternal health services—like prenatal vitamins and AI-enabled ultrasounds—in the communities where we work.
But the biggest takeaway from CHAMPS is also the most hopeful—and a reminder of why we started the Gates Foundation in the first place: So many childhood deaths could be prevented with existing interventions. We just need to ensure they reach the right children at the right time.
Twenty-five years in, our work on child mortality is far from complete. Still, the impact of what we have learned has been enormous
The Global Burden of Disease, GEMS, and PERCH studies helped shift global priorities by showing the world what was really killing kids—and where new vaccines and treatments could make the biggest difference. Better geospatial tools have empowered countries to pinpoint disease hotspots, find previously unmapped settlements, and distribute life-saving resources where they’re needed most. And CHAMPS is giving governments better data on why children are dying—data that’s now shaping policies, improving reporting, and guiding more effective care.
Most importantly, even as the number of children born every year has gone up, the number of overall childhood deaths has fallen by more than half—from 11.3 million in 1990 to 4.5 million in 2022. Playing a part in making that happen is the best job I’ve ever had, and the most meaningful work I’ve ever done.
At the Gates Foundation, we used to say we could cut child mortality in half again by 2040. The truth, though, is that goal feels further out of reach now—not because the science has stalled, but because support for global health has. The progress we’ve been part of was only possible because governments around the world, including here in the U.S., made long-term commitments to saving lives and followed through. That kind of leadership gave millions of children who would have died a chance at life—and made life better for millions more.
The last 25 years have shown us what’s possible. The next 25 will depend on whether the world keeps showing up for the children who need it most.
Life Line
A phone call that saves lives
m-mama uses mobile technology and community drivers to solve one of global health’s most persistent problems: Getting pregnant women to hospitals in time.

In the United States, when someone has a medical emergency, we take for granted that an ambulance will arrive. It will get to some places faster than others—a disparity driven by wealth and other factors. Still, by calling 911, we’re immediately connected to a vast fleet of emergency vehicles plugged into a system that’s designed to get people to hospitals in times of crisis.
But what about countries where ambulances aren’t readily accessible? What about places where even cars are scarce, where the nearest hospital with surgical capacity might be 100 miles away down an unpaved road, and where a family facing a medical crisis has no reliable way to get there or pay for the journey?
This is the reality for millions of pregnant women across sub-Saharan Africa.
Thanks to modern medicine, we now know how to prevent most maternal and newborn deaths. And maternal mortality has declined by 40 percent over the last two decades as a result. But hundreds of thousands of women and babies still die every year from complications during pregnancy and childbirth, because they can’t get to a place where someone can treat them in time.
In maternal health, this problem is called the “second delay.” It’s a terrible tragedy, one that the Gates Foundation has been trying to address for years.
Back in 2013, partners including Vodafone Foundation and local health organizations started tackling this problem by asking a simple question in rural Tanzania: What if you could create something like a 911 system that worked with whatever transportation was available in a community? They tested the idea in a few districts, and it worked well enough that they decided to scale it up. They called it m-mama.
m-mama works like this: When a community healthcare worker identifies an emergency—maybe it’s severe bleeding after delivery, or a premature baby who can’t breathe—they call a free hotline. A trained nurse dispatcher uses an app to figure out what kind of care is needed and where it’s available, then coordinates whatever transportation makes sense for that location (a community driver with a car where there are good roads, a motorcycle where there aren’t, a boat for island communities, even a horse for mountainous terrain.) The dispatcher stays on top of everything, tracking the journey, alerting the receiving facility, and handling payment at the end.
The numbers speak for themselves. Since 2013, m-mama has responded to more than 125,000 emergencies and saved an estimated 5,266 lives. And in regions where m-mama launched, maternal emergency transports more than doubled. That means there was a massive need that was going unmet for far too long. About 58% of the deliveries transported by m-mama end up requiring a C-section, compared to the 10-15% you would expect in the general population. These are genuinely high-risk cases that would have likely ended in tragedy without emergency transport.
What’s especially impressive about m-mama’s impact is that it hasn’t required building new hospitals or buying any expensive equipment. Instead, it makes existing health systems work better by coordinating resources that are already there—ambulances, facilities, healthcare workers—and filling gaps with options that cost a fraction of what traditional ambulances do.
And it is scaling. m-mama started as a pilot serving 750,000 people and now reaches 62 million in Tanzania. It’s gone nationwide in Lesotho. It just launched in Malawi and is scaling up in Kenya. There are plans for more countries across sub-Saharan Africa, supported in part by the Beginnings Fund—a partnership that includes our foundation, the Mohamed bin Zayed Foundation for Humanity, and other organizations working to improve maternal and newborn health across Africa.
The program is financially sustainable too. Once the program is up and running, the governments cover operating costs. m-mama has proven it can be owned and run locally, which is the only way something like this works long-term.
m-mama is a reminder that not all breakthroughs in global health are new drugs or sophisticated technology. Sometimes they’re just smart ways of getting the right care to the right person at the right time. When a mother or baby is in crisis, minutes can make the difference between life and death.
m-mama is making sure those minutes count.
The Year Ahead
Optimism with footnotes
As we start 2026, I am thinking about how the year ahead will set us up for the decades to come.

I have always been an optimist. When I founded Microsoft, I believed a digital revolution powered by great software would make the world a better place. When I started the Gates Foundation, I saw an opportunity to save and improve millions of lives because critical areas like children’s health were getting so little money.
In both cases, the results exceeded my expectations. We are far better off than when I was born 70 years ago. I believe the world will keep improving—but it is harder to see that today than it has been in a long time.
Friends and colleagues often ask me how I stay optimistic in an era with so many challenges and so much polarization. My answer is this: I am still an optimist because I see what innovation accelerated by artificial intelligence will bring. But these days, my optimism comes with footnotes.
The thing I am most upset about is the fact that the world went backwards last year on a key metric of progress: the number of deaths of children under 5 years old. Over the last 25 years, those deaths went down faster than at any other point in history. But in 2025, they went up for the first time this century, from 4.6 million in 2024 to 4.8 million in 2025—an increase driven by less support from rich countries to poor countries. This trend will continue unless we make progress in restoring aid budgets.
The next five years will be difficult as we try to get back on track and work to scale up new lifesaving tools. Yet I remain optimistic about the long-term future. As hard as last year was, I don’t believe we will slide back into the Dark Ages. I believe that, within the next decade, we will not only get the world back on track but enter a new era of unprecedented progress.
The key will be, as always, innovation. Consider this: An HIV diagnosis used to be a death sentence. Today, thanks to revolutionary treatments, a person with HIV can expect to live almost as long as someone without the virus. By the 2040s, new innovations could virtually eliminate deaths from HIV/AIDS.
Budget cuts limit how many people benefit from lifesaving tools, as we saw to devastating effect last year. But nothing can erase the fact that for decades we didn’t know how to save people from HIV, and now we do. Breakthroughs are a bell that cannot be unrung. They ensure that we will never go back to the world in 2000 where over 10 million children died from preventable causes every year—and they form the core of my optimism about where the world is headed.
But as I mentioned, there are footnotes to my optimism. Although the innovation pipeline sets us up for long-term success, the trajectory of progress hinges on how the world addresses three key questions.
1.
Will a world that is getting richer increase its generosity toward those in need?
The “golden rule” precept is more important now than ever with the record disparities in wealth. This idea of treating others as you wish to be treated does not just apply to rich countries giving aid. It must also include philanthropy from the wealthy to help those in need—both domestically and globally—which should grow rapidly in a world with a record number of billionaires and even centibillionaires.
Through the Giving Pledge, I get to work with a number of incredible philanthropists who set a great example by giving away substantial portions of their wealth in smart ways. However, more needs to be done to encourage higher levels of generosity from the rich and to show how fulfilling and impactful it can be.
Turning to aid budgets for poor countries, I am worried about one number: If funding for health decreases by 20 percent, 12 million more children could die by 2045. I know cuts won’t be reversed overnight, even though aid represented less than 1 percent of GDP even in the most generous countries. But it is critical that we restore some of the funding. The foundation’s Goalkeepers report lays out what is at risk and how the world can best spend the aid it gives.
I will spend much of my year working with partners to advocate for increased funding for the health of the world’s children. I plan to engage with a number of communities, including health care workers, religious groups, and members of diaspora communities to help make this case.
2.
Will the world prioritize scaling innovations that improve equality?
Some problems require doing far more than just letting market incentives take their course.
The first critical area is climate change. Without a large global carbon tax (which is, unfortunately, politically unachievable), market forces do not properly incentivize the creation of technologies to reduce climate-related emissions.
Yet only by replacing all emitting activities with cheaper alternatives will we stop the temperature increase. This is why I started Breakthrough Energy 10 years ago and why I will continue to put billions into innovation.
The world has made meaningful progress in the last decade, cutting projected emissions by more than 40 percent. But we still have a lot of innovation and scaling up to do in tough areas like industrial emissions and aviation. Government policies in rich countries are still critical because unless innovations reach scale, the costs won’t come down and we won’t achieve the impact we need.
If we don’t limit climate change, it will join poverty and infectious disease in causing enormous suffering, especially for the world’s poorest people. Since even in the best case the temperature will continue to go up, we also need to innovate to minimize the negative impacts.
This is called climate adaptation, and a critical example is helping farmers in poor countries with better seeds and better advice so they can grow more even in the face of climate change. Using AI, we will soon be able to provide poor farmers with better advice about weather, prices, crop diseases, and soil than even the richest farmers get today. The foundation has committed $1.4 billion to supporting farmers on the frontlines of extreme weather.
I will be investing and giving more than ever to climate work in the years ahead while also continuing to give more to children’s health, the foundation’s top priority. The need to ensure money is spent on the most important priorities was the topic of a memo I wrote in the fall.
A second critical area where the world must focus on innovation-driven equality is health care. Concerns about healthcare costs and quality are higher than ever in all countries.
In theory, people should feel optimistic about the state of health care with the incredible pipeline of innovations. For example, a recent breakthrough in diagnosing Alzheimer’s will revolutionize how we test for—and ultimately prevent—this disease, saving billions of dollars in costs. (Funding Alzheimer’s research is a particular focus for me.) There’s similar progress on obesity and cancer, as well as on problems in developing countries like malaria, TB, and malnutrition.
Despite so much progress, however, the cost and complexity of the system means very few people are satisfied with their care. I believe we can improve health care dramatically in all countries by using AI not only to accelerate the development of innovations but directly in the delivery of health care.
Like many of you, I already use AI to better understand my own health. Just imagine what will be possible as it improves and becomes available for every patient and provider. Always-available, high-quality medical advice will improve medicine by every measure.
We aren’t quite there yet—developers still have work to do on reliability and how we connect the AI to doctors and nurses so they are empowered to check and override the system. But I’m optimistic we will soon begin to scale access globally. I am following this work so the Gates Foundation and partners can make sure this capability is available in the countries that need it most—where there aren’t enough medical personnel—at the same time it is available elsewhere. We are already working on pilots and making sure that even relatively uncommon African languages are fully supported.
Governments will have to play a central role in leading the implementation of AI into their health systems. This is another case where the market alone won’t and can’t provide the solution.
A third and final area I will mention briefly is education. AI gives us a chance for the kind of personalized learning to keep students motivated that we have dreamed of in the past. This is now a focus of the Gates Foundation’s spending on education, and I am hopeful it will be empowering to both teachers and students. I’ve seen this firsthand in New Jersey, and it will be game changing as we scale it for the world.
All three of these areas—climate, health, and education—can improve rapidly with the right government focus. This year I will spend a lot of time meeting with pioneers all over the world to see which countries are doing the best work so we can spread best practices.
3.
Will we minimize negative disruptions caused by AI as it accelerates?
Of all the things humans have ever created, AI will change society the most. It will help solve many of our current problems while also bringing new challenges very different from past innovations.
When people in the AI space predict that AGI or fully humanoid robots will come soon and then those deadlines are missed, it creates the impression that these things will never happen. However, there is no upper limit on how intelligent AIs will get or on how good robots will get, and I believe the advances will not plateau before exceeding human levels.
The two big challenges in the next decade are use of AI by bad actors and disruption to the job market. Both are real risks that we need to do a better job managing. We’ll need to be deliberate about how this technology is developed, governed, and deployed.
In 2015, I gave a TED talk warning that the world was not ready to handle a pandemic. If we had prepared properly for the Covid pandemic, the amount of human suffering would have been dramatically less. Today, an even greater risk than a naturally caused pandemic is that a non-government group will use open source AI tools to design a bioterrorism weapon.
The second challenge is job market disruption. AI capabilities will allow us to make far more goods and services with less labor. In a mathematical sense, we should be able to allocate these new capabilities in ways that benefit everyone. As AI delivers on its potential, we could reduce the work week or even decide there are some areas we don’t want to use AI in.
The effects of this disruption are hard to model. Sometimes, when a game-changing technology improves rapidly, it drives more demand at lower cost and, by making the world richer, increases demand in other areas. For example, AI makes software developers at least twice as efficient, which makes coding cheaper while also creating demand elasticity for code. (Computing is a good historical example where lower costs actually caused the overall market to grow.)
Even with this complexity, the rate of improvement is already starting to be enough to disrupt job demand in areas like software development. Other areas like warehouse work or phone support are not quite there yet, but once the AIs become more capable, the job disruption will be more immediate.
We’re already starting to see the impact of AI on the job market, and I think this impact will grow over the next five years. Even if the transition takes longer than I expect, we should use 2026 to prepare ourselves for these changes—including which policies will best help spread the wealth and deal with the important role jobs play in our society. Different political parties will likely suggest different approaches.
By including these footnotes, particularly the last one, some readers may find my continued optimism even more surprising. But as we start 2026, I remain optimistic about the days ahead because of two core human capabilities.
The first is our ability to anticipate problems and prepare for them, and therefore ensure that our new discoveries make all of us better off. The second is our capacity to care about each other. Throughout history, you can always find stories of people tending not just to themselves or their clan or their country but to the greater good.
Those two qualities—foresight and care—are what give me hope as the year begins. As long as we keep exercising those abilities, I believe the years ahead can be ones of real progress.
The big chill
Can this cooler save kids from dying?
These innovations are helping deliver vaccines to the most remote places on earth.

Two of the things I love most about my job are getting to see amazing innovations and talk to remarkable people. During a recent trip to New York, I got to check both boxes. I met a woman named Papa Blandine Mbwey who is using a revolutionary new invention to help more kids get vaccinated.
Blandine has worked as a vaccinator in a remote part of the Democratic Republic of the Congo for over a decade. Most days, she travels on foot to villages all over her region so she can vaccinate kids who live too far from a health clinic to make the trip themselves.
Blandine’s job is complicated by a simple fact: vaccines must be kept between 2 and 8° C. If they get too warm, they spoil. If they get too cold, the water in them freezes, and they can stop working. Vaccines must stay within this temperature range through each step of what’s called the “cold chain.”
By the time Blandine reaches the children, the vaccines she’s carrying have traveled nearly 5,100 miles. They could have spoiled at any point during that journey, but vaccines are particularly at risk during the last two stops.
First there’s the health clinics where vaccinators like Blandine usually pick up their supply of vaccines. Many of these clinics are in areas with frequent power outages or no electrical grid at all, which means the refrigerators can’t always keep the vaccines cold.
But even if the vaccines survive the clinic, they still need to make it to the children. Most vaccinators carry them in ice-lined coolers. If you’ve used a cooler to keep your drinks cold at a picnic, you know the big problem with ice: it starts melting as soon as you take it out of the freezer. This means that some of the kids never get vaccinated, because coolers can’t keep vaccines cold long enough to reach them.
Several years ago, I asked a group of inventors called Global Good that I support to take on the cold chain problem. They came up with two remarkable innovations that are changing the game for vaccinators like Blandine.
The first is the MetaFridge. Although it looks like a regular refrigerator, MetaFridge has a hidden superpower: it keeps vaccines cold without power for at least five days. The electrical components are designed to keep working through power surges and brown-outs. During extended outages, an easy-to-read screen tells you how much longer it can stay cool without power so health workers know when to run a generator or move vaccines elsewhere. And if the fridge stops working properly, it transmits data remotely to a service team so they can fix it before vaccines are at risk of spoiling.
The other innovation Global Good invented is the Indigo cooler, which is the device you see Blandine using in the video above. It keeps vaccines at the right temperature for at least five days with no ice, no batteries, and no power required during cooling.
It sounds counterintuitive, but the Indigo needs heat before you can use it. When exposed to a heat source, water inside its walls evaporates and moves into a separate compartment. It can then sit on a shelf for months after heating, ready for use.
When it’s finally time to head out to the children, you open a valve, and the water starts moving back where it started. Because the pressure inside the Indigo has been lowered to the point where water evaporates at 5° C, the water particles take heat with them (the way sweating lowers your body temperature) and cool the storage area down to the perfect temperature for vaccine storage.
Both inventions are already making an impact in the field. A Chinese manufacturer started selling the MetaFridge last year, and a new solar-powered version will hit the market soon. One of the biggest surprises so far is just how much we’ve learned from its remote data monitoring capabilities. We knew the electrical grids in sub-Saharan Africa were unreliable, but we now know exactly how much the power fluctuates. This information will be helpful moving forward for health providers and anyone designing a product meant to work in these areas.
The Indigo is in the field trial phase. It’s still early, but the data suggests that the Indigo is allowing vaccinators to reach four times as many places as they could with the old ice-based coolers. That’s a big deal, and I’m excited to learn more.
Keeping vaccines cold when you’re delivering them to the most remote places on earth is a tough problem—and these devices show how innovation can help solve tough problems. I hope MetaFridge and Indigo inspire other inventors to find creative solutions.

Just the facts
Health aid saves lives. Don’t cut it.
Here’s the proof I’m showing Congress.

I’ve been working in global health for 25 years—that’s as long as I was the CEO of Microsoft. At this point, I know as much about improving health in poor countries as I do about software.
I’ve spent a quarter-century building teams of experts at the Gates Foundation and visiting low-income countries to see the work. I’ve funded studies about the effectiveness of health aid and pored over the results. I’ve met people who were on the brink of dying of AIDS until American-funded medicines brought them back. And I’ve met heroic health workers and government leaders who made the best possible use of this aid: They saved lives.
The more I’ve learned, the more committed I’ve become. I believe so strongly in the value of global health that I’m dedicating the rest of my life to it, as well as most of the $200 billion the foundation will give away over the next 20 years.
People in global health argue about a lot of things, but here’s one thing everyone agrees on: Health aid saves lives. It has helped cut the number of children who die each year by more than half since 2000. The number used to be more than 9 million a year; now it’s fewer than 5 million. That’s incontrovertible.
So when the United States and other governments suddenly cut their aid budgets the way they've been doing, I know for a fact that more children will die. We’re already seeing the tragic impact of reductions in aid, and we know the number of deaths will continue to rise.
A study in the Lancet looked at the cumulative impact of reductions in American aid. It found that, by 2040, 8 million more children will die before their fifth birthday. To give some context for 8 million: That's how many children live in California, Texas, Florida, New York, Pennsylvania, and Ohio combined.
I’ve submitted written testimony on this topic, which you can read below, for the Senate Appropriations Committee hearing occurring later today. In it, I discuss what’s already happened and what needs to happen next.
Testimony to the United States Senate Committee on Appropriations
June 25, 2025
Over the past 25 years—the same span of time I spent leading Microsoft—I have immersed myself in global health: building knowledge, deepening expertise, and working to save lives from deadly diseases and preventable causes. During that time, I have built teams of world-class scientists and public health experts at the Gates Foundation, studied health systems across continents, and worked in close partnership with national and local leaders to strengthen the delivery of lifesaving care. I have visited hundreds of clinics, listened to frontline health workers, and spoken with people who rely on these programs. Earlier this month, I traveled to Ethiopia and Nigeria, where I witnessed firsthand the impact that recent disruptions to U.S. global health funding are having on lives and communities.
Global health aid saves lives. And when that aid is withdrawn—abruptly and without a plan—lives are lost.
Yet, in recent months, some have questioned whether the foreign assistance pause has caused harm. Concerns about the human impact of these disruptions have been dismissed as overstated. Some people have even claimed that no one is dying as a result.
I wish that were true. But it is not.
It is important to note that while this hearing is about the Trump Administration’s $9 billion recission package, what is really at stake is tens of billions of dollars in critical aid and health research that has been frozen by DOGE with complete disregard for the Congress and its Constitutional power of the purse.
In the early weeks of implementing the foreign aid freeze, DOGE directives resulted in the dismissal of nearly all United States Agency for International Development (USAID) staff and many personnel at the Centers for Disease Control and Prevention (CDC). Some funding was later restored to allow for the continuation of what has been categorized as "lifesaving" programs. However, to date that designation has been applied narrowly and with limited transparency, in an inconsistent manner, often prioritizing emergency interventions when a patient is already in critical condition over essential preventative or supportive care.
For example, providing a child with a preventive antimalarial treatment, ensuring access to nutrition so that HIV/AIDS medications can be properly administered, testing pregnant women for HIV to see if they are eligible for treatment to prevent transmission to their children or identifying and treating tuberculosis cases early have not consistently qualified for exemption. As a result, many of the programs delivering these services have been suspended, delayed, or scaled back.
Recent reporting from the New York Times has shed light on the devastating human cost of the abrupt aid cuts. One especially tragic example is Peter Donde, a 10-year-old orphan in South Sudan, born with HIV, who died in February after losing his access to life-saving medication when USAID operations were suspended. His story is one of many.
During my recent visit to Nigeria, I met with leaders from local nonprofit organizations previously funded by the United States. One group shared the remarkable progress they had made in tuberculosis detection and treatment. In just a few years, case identification increased from 25 percent to 80 percent, a critical step toward breaking transmission and reducing the overall disease burden. That progress has now stalled. The grants that enabled this work were tied to USAID staff who have been dismissed, and with their departure, the funding ended, and the work stopped.
The broader effects of these sudden shifts are difficult to overstate. For example, funding for polio eradication has been preserved in the State Department budget but cut from the CDC—even though the two agencies collaborate closely on the program. This type of fragmented decision-making has left implementing organizations uncertain about staffing and operations. Many no longer feel confident that promised U.S. funds will materialize, even when awards have been announced. In some cases, staff continue to work without pay. Some organizations are approaching insolvency.
Meanwhile, in warehouses across the globe, food aid and medical supplies sourced from American producers are sitting idle—spoiling or approaching expiration—because the systems that once distributed them have been disrupted. Clinics are closing. Health workers are being laid off. HIV/AIDS patients are missing critical doses of medication. Malaria prevention campaigns, including bed net distributions and indoor spraying, have been delayed or canceled, leaving hundreds of millions of people unprotected at the peak of transmission season.
Efforts to track data that would illustrate the severity of this worsening crisis have also been severely compromised. Many of the people responsible for collecting and reporting health information—health workers, statisticians, and program managers—have been laid off or placed on leave. The systems that once monitored health outcomes are shutting down, and the offices where that data was once analyzed now sit empty. As a result, the true scope of the harm is becoming harder to measure, just as the need for information is most urgent.
The situation we face is not about political ideology, and it is not a debate over fiscal responsibility. U.S. government spending on global health accounts for just 0.2 percent of the federal budget. Shutting down USAID did nothing to reduce the deficit. In fact, the deficit has grown in the months since.
Furthermore, many of the allegations regarding waste, fraud, and abuse have proven to be unsubstantiated. For example, the widely circulated claim that USAID sent millions of dollars’ worth of condoms to the Gaza Strip is inaccurate. In fact, the Wall Street Journal reported that the program allocated approximately $27,000 for condoms as part of an HIV transmission prevention initiative—not in the Middle East, but in Gaza Province, Mozambique.
What we are witnessing because of the rapid dismantling of America’s global health infrastructure is a preventable, human-caused humanitarian crisis—one that is growing more severe by the day. DOGE made a deadly mistake by cutting health aid and laying off so many people. But it is not too late to undo some of the damage.
A Record of Progress—and What is at Risk
Since 2000, child mortality worldwide has been cut in half. Deaths from HIV/AIDS, tuberculosis, and malaria have declined significantly. And we are on the verge of eradicating only the second human disease in history: polio. These are not abstract statistics; they represent tens of millions of lives saved. None of this progress would have been possible without consistent, bipartisan U.S. leadership and investment.
Over the past several decades, the United States has built one of its most strategic global assets: a respected and robust public health presence. This leadership is not just a humanitarian achievement—it is a core pillar of American soft power and security. For example, a Stanford study analyzing 258 global surveys across 45 countries found that U.S. health aid is strongly linked to improved public opinion of the United States. In countries and years where U.S. health aid was highest, the probability of people having a very favorable view of the United States was 19 percentage points higher. Other forms of aid—like military or governance—did not have the same effect. Another example is the 2014 Ebola outbreak in West Africa. The rapid deployment of U.S. scientists, health workers, and CDC teams helped contain the virus before it could spread globally. Their presence allowed the U.S. to help shape the response strategy, speed up containment, and prevent a wider outbreak. Many African countries are facing the dual burden of rising debt and pressing health needs, forcing painful choices between repaying creditors, and protecting their citizens. Helping them navigate this challenge is not just the right thing to do—it is a strategic imperative. If the United States retreats, others will fill the gap, and not all of them will bring our values, our priorities, or our interests to the table. Preserving American global influence will require restoring the staff, systems, and resources that underpin it—before the damage becomes irreversible.
I understand the fiscal pressures facing Congress. I recognize the need to prioritize spending and to hold programs accountable for results. I also share the Trump Administration’s commitment to promoting efficiency and encouraging country-led solutions. But I believe those goals can—and must—be pursued while still protecting the programs that deliver the highest return on investment and the greatest impact on human lives.
The United States’ support for Gavi, the Vaccine Alliance; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the President’s Emergency Plan for AIDS Relief (PEPFAR); and the Global Polio Eradication Initiative (GPEI) represent some of the smartest, most effective investments our country has ever made. These initiatives are proven, strategically aligned with American interests, and cost-effective on a scale few other government programs can match.
Together, Gavi and the Global Fund have helped save more than 82 million lives. Gavi has helped halve childhood deaths in the world’s poorest countries and returns an estimated $54 for every $1 invested. The Global Fund has contributed to a 61% reduction in deaths from HIV/AIDS, TB, and malaria. PEPFAR has saved over 26 million lives and helped millions of children be born HIV-free. GPEI has brought us closer than ever to the eradication of polio. Pulling back now would not only jeopardize these historic gains—it would invite a resurgence of preventable disease, deepen global instability, and undermine decades of bipartisan American leadership.
This is not a forever funding stream for the U.S. Government. These programs set out clear pathways for countries to “graduate” from aid, which many have already done. For example, nineteen countries, including Viet Nam and Indonesia, have successfully graduated from Gavi support and now fully finance their own immunization programs. Others—from Bangladesh to Cote d'Ivoire—are on track to do the same. This is how U.S. development policy should work: catalytic, cost effective, and designed to help countries become self-reliant and drive their own progress. I agree that aid funding should have an end date, but not overnight. The most effective path to that end date is innovation. By investing in the development and delivery of new medical tools and treatments, we can drive down the cost of care, and in some cases, make diseases that were once a death sentence treatable, or even curable. Advances in therapies for chronic conditions like sickle cell disease, HIV, or certain types of cancers could transform lives and health systems. American innovation offers a sustainable exit strategy—one that reduces long-term costs, allows the United States to responsibly step back, and builds lasting trust and good will that far exceed the original investment.
Over the past 25 years, the Gates Foundation has invested nearly $16 billion in global health partnerships like Gavi, the Global Fund, and GPEI. We will continue to invest, through innovation, research, and close coordination with partners. But no private institution—or coalition of them—can replace the scale, reach, or authority of the U.S. government in delivering lifesaving impact at the global level.
The decisions made in the coming weeks will shape not only the lives saved in the near term—but the legacy of American leadership for generations to come.
Download a PDF of the testimony with appendices that include reflections from Gates Foundation staff in Africa on the impact of the U.S. aid cuts; analytical projections from respected organizations; and a selection of first-hand reporting from reputable news organizations and journalists.

No laughing matter
A gut-wrenching problem we can solve
Diarrhea used to be one of the biggest killers of kids—but now it’s one of the greatest global health success stories.

In 1997, I came across a New York Times column by Nick Kristof that stopped me in my tracks. The headline was “For Third World, Water Is Still a Deadly Drink,” and it included a statistic I almost didn’t believe: Diarrhea was killing 3.1 million people every year—most of them kids under the age of five.
I didn’t know much about the problem back then, except that it seemed so solvable. After all, in rich countries it felt like it already had been. My oldest daughter was a toddler at the time, and we never worried that an upset stomach would kill her. None of the other parents I knew worried about that either.
But in much of the world, kids without clean drinking water or basic sanitation were constantly being exposed to rotavirus, cholera, shigella, typhoid, and more—dangerous pathogens that spread easily when toilets are scarce and water is contaminated.
Nick’s column ended up changing my life. I sent it to my dad with a note: “Maybe we can do something about this.” He agreed. And after he traveled to Bangladesh to see the problem firsthand, we made a $40 million investment in vaccine research for diarrheal diseases. That grant helped shape what would become the Gates Foundation—and kickstarted decades of progress that’s now saved millions of lives.
Within a few years, I stepped away from Microsoft to focus on this work full-time. Once you’ve seen what’s possible in global health, it’s hard to do anything else.
When we first got involved, diarrhea was one of the biggest killers of kids worldwide. But over the past two and a half decades, these deaths have dropped by more than 70 percent.
The biggest breakthrough came from making vaccines for rotavirus, the leading cause of severe diarrhea and death in kids, affordable and accessible. When the vaccines first debuted in the early 2000s, they were priced at around $200 per dose—which meant they were completely out of reach for most families in most of the world. So the foundation partnered with vaccine manufacturers in India like Bharat Biotech and Serum Institute to develop high-quality, low-cost alternatives. Today, rotavirus protection costs about a dollar.
But getting the vaccines developed was only half the challenge. The other half was getting them to the kids who needed them most.
That’s where Gavi came in. The organization was set up a few years earlier to help low-income countries pay for lifesaving vaccines that had existed for decades but weren’t reaching the world’s poorest. But they were well-positioned to do the same with a new vaccine, and they did—purchasing the rotavirus vaccine for millions of children and supporting countries as they added it to their routine immunization programs. USAID played a huge role in this work, too, by helping local governments train community health workers and strengthen their vaccine delivery systems. Meanwhile, public health campaigns promoted treatments like oral rehydration salts and zinc supplements that can save a sick child's life for pennies. (Think of it as the medical-grade equivalent of Pedialyte.)
As all this was happening, countries quietly made enormous progress on clean water and sanitation too. Since 1990, 2.6 billion people around the world have gained access to safe drinking water—and the number of people who now have basic sanitation similarly has skyrocketed. These improvements help break a cycle where kids get sick, recover, and then get reinfected a few weeks later.
Despite the incredible progress, around 340,000 kids under five are still dying from diarrhea each year.
Part of the problem is that many kids still don't get vaccinated. Some live in places where health systems are weak or vaccines are hard to transport and store. Others are caught in conflict zones that make it dangerous for health workers to reach them.
And new challenges make the fight against diarrheal diseases even harder than it was 25 years ago. Shigella—one of the nastiest bacterial causes of diarrhea—is becoming more and more resistant to antibiotics, and we still don't have a vaccine. Climate change is making cholera and typhoid outbreaks more frequent, as floods contaminate water supplies and droughts force people to drink from unclean, unsafe sources.
For malnourished kids, everything is harder: They're more vulnerable to diarrheal diseases in the first place, and their damaged digestive tracts don't respond as well to oral vaccines or treatments. For families barely scraping by, diarrhea is both a medical crisis and an economic disaster. Parents miss work to care for sick kids. Kids miss school. Expenses pile up. It's one of the ways that disease keeps families trapped in poverty—and one of the reasons that a country’s public health is key to its development.
The encouraging news is that there’s a promising pipeline of innovations that builds on what we already know and could save even more lives.
At the foundation, we’re supporting scientists who are working on a vaccine for Shigella, which has become the leading bacterial cause of childhood diarrhea. We’re also funding efforts to combine different vaccines into a single shot, which would lower costs and make things easier for health workers and kids alike.
New delivery methods could make a big difference too. One example: vaccine patches for measles that don’t require needles, refrigeration, or trained staff to administer them. Just peel, stick, and protect.
We've already learned a lot about how chronic infections damage kids’ guts and make it harder for them to absorb nutrients or respond to vaccines. Now, scientists are researching how to repair that damage, which could help the sickest kids recover faster.
And outside the lab, environmental monitoring tools are being developed to detect early signs of outbreaks—by regularly testing sewage for typhoid, for instance. It’s like having an early warning system for epidemics.
We can’t afford to look away now
I’ve been talking about diarrhea for 25 years, even though it makes some people squeamish, because it’s a microcosm of global health. It’s proof that the world can come together to solve big problems. When we refuse to accept that some children won’t make it to their fifth birthday, we can save millions of lives.
But it’s also a warning of what can happen when we look away.
Right now, global health funding is being slashed around the world. According to one estimate, cuts to aid from the U.S. have already led to almost 60,000 additional childhood deaths from diarrhea. If nothing changes, by next January that number could rise to 126,000. These are projections, not final counts, but the reality is undeniable: When lifesaving programs are eliminated, kids pay the price.
Diarrhea is one of the most solvable problems in global health. We’ve come a long way, but we’re not done yet.
Lung Story Short
A book about tuberculosis, and everything else
Here’s how John Green turned a forgotten disease into a #1 NYT bestseller.

What do Adirondack chairs, Stetson hats, the city of Pasadena, and World War I have in common? According to John Green, all of their origin stories include tuberculosis.
In his new book, John argues that it’s impossible to separate the deadliest disease in history from, well, the rest of history. Adirondack chairs were designed by a man who vacationed in the New York mountains—a popular spot for TB patients seeking fresh air—and soon became staples of sanatorium porches across the country. John B. Stetson, who had TB himself, traveled west for dry mountain air and invented the cowboy hat to protect from sun, wind, and rain. Pasadena became a hub for TB treatment in the late 1800s, and TB “tourism” was a major driver of the city’s early economy, real estate, and identity. And the teenage assassins who killed Archduke Franz Ferdinand, which kicked off World War I? They were more willing to die for their cause since they were already dying of TB.
No wonder John calls this book Everything Is Tuberculosis. In so many ways, TB shaped the world we live in. Even though the disease is now both rare and treatable in rich countries, in poorer places it’s on the rise and still a death sentence for so many.
John is best known as the author of some of the best young adult novels of all time (at least according to my daughter Phoebe, whose encouragement led me to read The Fault in Our Stars and Turtles All the Way Down). So a lot of people were surprised when he announced that his next book would be about global health—about a disease most people in the western world think of in the past tense.
I wasn’t. After all, I first met John over a decade ago, when he joined me on a Gates Foundation trip to Ethiopia. While traveling, we talked about a lot of the big questions John wrestles with in Everything Is Tuberculosis—like why the place a person is born influences their odds of surviving childhood (or childbirth), and what people like us can do to increase those odds.
Since then, John has been an invaluable partner to the foundation, bringing his curiosity and clarity to our events and helping raise awareness of our work. But he’s also become a powerful advocate for global health in his own right. I don’t know anyone else who could turn a book about tuberculosis into a number one New York Times bestseller.
Everything Is Tuberculosis is poignant, smart, and at times infuriating. At its heart is the story of a boy named Henry, whom John met at a TB clinic in Sierra Leone. Henry was just six when he started showing classic signs of the disease: fatigue, weight loss, night sweats. But the first tests he got came back negative, so he was sent home from the hospital. By the time he was eventually diagnosed, Henry was already very sick.
He began treatment with the standard cocktail of decades-old antibiotics. It’s a brutal regimen that involves months of pills, painful injections, constant side effects—and, once the infection starts to subside, aching hunger from having an appetite again. The drugs only work if they’re taken consistently and on schedule, but that’s often unrealistic for patients. In much of the world, TB treatment means walking miles to a clinic, missing work or school, going into debt, and facing social stigma and isolation. Even though Henry’s mom did everything she could to support him, there were interruptions to his treatment, and eventually the TB became drug-resistant.
In the end, Henry got lucky. Even as he got sicker and ran out of options, his doctors wouldn’t give up on him. They fought to get him access to a personalized drug regimen—something that’s rarely available to kids in poor countries. That care ended up saving his life, and today Henry is thriving. After years stuck in the hospital, he’s caught up academically and now in university (and even has a YouTube channel where he shares his journey and advocates for other TB patients). John doesn’t romanticize Henry’s story as some kind of miracle. Instead, he uses it as proof: that TB is curable, that good care works, and that the real question isn’t whether we can save lives—but whether we’re willing to make that care available to everyone.
Even though John finished writing the book last year, he nails the urgency of this moment. He shows how a disease that most people in rich countries have forgotten is still killing over a million people a year, and how easily that number could keep climbing. That’s especially true now, as foreign aid cuts disrupt TB care across the globe. Henry might not be alive today if it weren’t for organizations like Partners In Health—funded in part by U.S. health aid—which fought to get him the treatment he needed. These aid cuts will be devastating for kids like him, who may lose access to treatment altogether. They’ll also lead to more interrupted care, more cases, more drug resistance, and more strains of an infectious disease that will be harder and more expensive for the entire world to contain.
This is a book about the central challenge of global health today: the reality that, in John’s words, “the cure is where the disease is not, and the disease is where the cure is not.”
A book about tuberculosis could be pretty boring, but John makes it super compelling by weaving in TB’s long and strange history, from the myth that it only afflicted white people, to the theory that it inspired creative genius, to its influence on Victorian beauty standards. (I didn’t know about those last two… or the Stetson hats.) If you’re familiar with John’s work, this approach won’t surprise you. He has a gift for getting people to care about things they might not think are “for me,” whether that’s poetry, astrophysics, or infectious disease.
John ends Everything Is Tuberculosis with a stirring call to action. He makes the case that saving lives from TB isn’t really a scientific challenge anymore; it’s a moral one. I largely agree. But I also think there are more reasons for hope than the book lets on.
While John is clear-eyed about the failures of the past and present—the slow pace of progress, the sky-high prices of new TB drugs, the inequality that determines who gets treated and who doesn’t—he doesn’t spend much time on what comes next. Having spent the last two-and-a-half decades investing in the science behind TB care through the Gates Foundation, I’ve seen a different side of the story. I know what’s in the pipeline, and I know what’s possible.
Today, we’re closer than ever to breakthroughs that could change everything about how we treat and even prevent TB: shorter drug regimens, better diagnostics, and even vaccines. These tools will only make a difference if they’re affordable enough to reach kids like Henry. But I think it’s important to recognize that the companies often criticized for pricing are also, ironically, the only ones that have been willing to invest in TB at all. We need to keep working with them as partners, keep the innovation coming, and keep bringing costs down.
If we do, we can make Henry’s story of survival the norm, not the exception—and make tuberculosis a disease of the past, not the future.
Such great heights
This heroic nurse climbs 1000-foot ladders to save lives
Agnes Nambozo goes to extraordinary lengths to vaccinate children in Uganda.

How do you get to work? Some people roll out of bed and move 10 feet to their desk. Others walk to the office or take public transit. I usually drive a car.
No matter how you get there, I guarantee that your commute isn’t as wild as Agnes Nambozo’s: She regularly climbs a rickety ladder that is nearly 1,000 feet tall—or 300 meters—before she can start work for the day.
Agnes is a nurse based in Buluganya, located in the shadow of Mount Elgon in eastern Uganda. Like many nurses in rural communities across sub-Saharan Africa, she wears a lot of different hats. She might spend one day delivering babies and treating wounds and the next as a health educator, promoting good nutrition and sanitation in her community. The days Agnes believes she makes the biggest difference, though, are the ones when she treks deep into the Ugandan countryside to vaccinate children.
Uganda has done an amazing job of reducing childhood mortality over the last 25 years. In 2000, about 145 children died per every thousand live births. By 2023, that figure had dropped to fewer than 40 deaths per 1,000 births. A lot of that progress can be attributed to vaccines and vaccinators like Agnes.
Eastern Uganda is a gorgeous place, but parts of it are incredibly difficult to cross. Many of the communities Agnes visits are high in the mountains. Some are only accessible by ladders, which act as links between communities. Older children can climb down them to go to school, but they are too steep for the little ones. Mothers can’t safely carry their babies down the ladders to the health clinic, so Agnes comes to them.
When Agnes was a little girl, she wanted to be a police officer—until her mom convinced her the job was too dangerous. Instead, she took a nursing course. She fell in love with the profession, even though it ended up being a much riskier job than her mom ever imagined. She travels to the villages to vaccinate kids in all kinds of weather. It’s often rainy in the mountains, and the ladders become slippery. “The ladders are risky because you might miss a step,” she says. “If you are lucky, you can get a fracture. If you’re not lucky, you can lose your life.”
On the days when she heads into the field to vaccinate children, Agnes leaves her house by 6:00 am. She takes a taxi from where she lives in Sironko to Buyaga, a town closer to where the health clinic is located. Cars can’t drive on the road to the clinic, so she takes a motorbike for the last stretch.
She arrives at the clinic around 8:00 am and starts packing for the day. Rural vaccinators like Agnes must carry their supplies on their backs, and there’s an art to making sure everything is loaded properly. The vaccines must be kept cold so she wears a heavy insulated backpack stuffed with ice packs.
Agnes then hops on another motorbike to a staging location before heading off on foot to the ladders. By the time she reaches the village and starts setting up to immunize the community, it’s usually around 10:30—more than four hours after she left her house for the day.
She comes in with a plan for how many people she’ll vaccinate, but Agnes always brings a couple extra doses just in case. A typical day usually means around 50 patients. Most are children under 5, who get vaccinated against deadly diseases like polio, measles, tetanus, and pneumonia. The latter is especially important in a region as rainy as this one, where the damp weather makes people more susceptible to respiratory diseases.
Agnes and her colleagues are often the only health workers who visit the most remote communities in the mountains, so they also provide general nursing care while they’re there. Agnes regularly gives kids deworming treatments and key supplements like vitamin A. She answers questions from the adults and offers them health guidance, including advice on planning a family.
After she wraps up for the day, Agnes makes the long trek back home. It’s exhausting, difficult work, but she is proud to help so many people. “Our motto for nurses in Uganda is ‘To love and serve,’” she says. “And to me, love is not just a word. It’s a verb.”
Unfortunately, Agnes’s job recently became a lot more difficult. Many of her colleagues at the health clinic in Buluganya were supported by USAID, and they lost their jobs when funding was cut. Some of the positions that were eliminated supported new and expectant mothers. Others worked on HIV and tuberculosis, distributing medication and testing high-risk individuals to prevent further spread.
Agnes and the others who are left are doing their best to ensure communities still receive care, but they can only do so much. “Our community is suffering a lot,” she says. She is worried about burnout if funding isn’t restored.
Still, Agnes won’t rest until she has helped as many people as she can. Thanks to the support of the Rotary Club of Kampala, she recently went back to school and is working towards a degree in nursing. She hopes to learn new skills that will save even more lives.
“My dream is to make people feel good, to make them happy, and to give my service to the people,” says Agnes. “When you have positivity, nothing is impossible.”

Everyday miracles
A perilous time for the world’s poorest children
My latest speech about why we need to keep funding vaccines.

I’ve been giving speeches about vaccines for 25 years. After so much time, it could have become routine for me. But it never has.
One reason is that the impact of vaccines—a single dose can protect a child from deadly diseases forever—is like a miracle to me, and who gets tired of talking about miracles?
The other reason is tied to this particular moment. There’s never been a point in the past 25 years when more lives hung in the balance. In all likelihood, 2025 will be the first year since the turn of the century when the number of children dying will go up instead of down.
Why? Governments are cutting health aid—including funds for Gavi, the vaccine organization that the Gates Foundation helped start. As a result, Gavi will likely not have all the money it needs to fund its next five years of work.
So when I spoke this week at a summit in Brussels where donors committed a new round of funding for Gavi, I focused on why it’s so important to keep the money flowing and maintain our momentum on vaccines. You can read my remarks below.
Remarks as delivered
June 25, 2025
Global Summit: Health & Prosperity through Immunisation
Brussels, Belgium
Good evening, and thank you to everyone joining us here tonight—and for all your support for one of the most transformative efforts in the world.
I want to particularly thank President von der Leyen and President Costa, and the European Union, for co-hosting this summit. President von der Leyen has long been an incredible champion for health and development, and the EU has been one of the Gavi's biggest supporters since the very beginning—support that's more crucial now than ever.
This chart is one that I think about a lot. It's really my most favorite chart. And I consider it almost kind of a report card for humanity. Because over the last 25 years, the reduction of under-five deaths has been far faster than any time in history. We've gone from over 9 million to now half as many deaths taking place by children. This is an unbelievable result.
And it doesn't fully state the benefit of these vaccines. The vaccines leave a lot of kids far more healthy, and so their ability to achieve their potential is increased.
Gavi prioritizes saving lives, and it's done with incredible scientific rigor. We're constantly improving vaccines. We're constantly looking at the safety, and I'm very proud of the work that's done to make sure that these vaccines are incredibly safe.
The founding of Gavi actually goes back to about the time the Gates Foundation was first started. And after 25 years, I can still say that it's at the top of the list of things that I'm very, very proud of. At that time, kids were not getting access to vaccines. They were too expensive. They hadn't been formulated properly. And I was stunned to learn that so many kids were dying from a disease like rotavirus because the vaccine wasn't getting out to all the children of the world.
So Gavi was created to not only help finance vaccines, but work with countries to adopt these new vaccines.
We've done an amazing job of getting these prices down. A good example is the pneumococcal vaccine, PCV. This vaccine became available in high-income countries the year that Gavi was founded. And it does a fantastic job of protecting kids against pneumonia, which was the single most deadly childhood infection. But it was very expensive.
And so Gavi and its partners incentivized vaccine manufacturers to develop a new, much cheaper PCV, which was introduced in 2017. Today, the manufacturers make PCV vaccines available to low-and middle-income countries for just $2 a dose.
And of course, we've seen similar reductions across all of the different vaccines, allowing us to add new vaccines to save even more children.
Since the founding of Gavi, the overall cost of fully vaccinating a child has been cut in more than half.
And we have a pipeline of new vaccines coming along, vaccines to address new diseases and that bring down costs even further.
A good example of this is the HPV vaccine. Cervical cancer, which HPV prevents, is the fourth most common cancer in women around the world. And this vaccine can prevent over 90% of these cases.
But countries were slow to adopt this vaccine, in part because it was hard to deliver: initially, it required three doses spread across six months.
Scientists believed that perhaps it could be done with fewer doses. And so the Gates Foundation funded a trial to see whether a single dose was essentially fully protective. And after seeing the incredible results, the WHO approved a single dose schedule in 2022.
Now, we have 75 countries around the world that have moved to this single dose approach.
And because the single dose is cheaper and easier to deliver, it's now getting to far more girls around the world. For example, after Nigeria introduced the single-dose vaccine, it was able to vaccinate more than 12 million girls in less than a year. That's really incredible.
Across Gavi countries, HPV vaccine coverage has increased dramatically. The year after this single-dose approval, we doubled the number of girls getting the vaccine. And [the next year] we doubled it again, and this year we'll double it again.
There's more than just making vaccines available. We have to work with our partner countries on helping improve their health systems. So the Gavi Alliance has spent a lot of its resources and a lot of its technical support in helping improve those primary health care systems, which are so vital. We've helped countries understand where they're missing kids and how to invest in raising those coverage levels.
As you've heard, over this 25-year period, that means over a billion children have been vaccinated—resulting in the saving of over 19 million lives.
Nineteen million is a big number. It's almost easier to understand if I just say: okay, here's a child whose life was saved. But you have to take your reaction to how valuable that is and multiply it by this absolutely gigantic number.
The total cost to save those lives was about $22 billion. And that means that Gavi saved children's lives for only about $1,000 per life saved.
And in addition, the kids who these vaccines have kept healthy not only go to school; they do well in school. They join the economy. They contribute to their country. And really, this is why improving health through vaccines is part of the formula for helping countries be self-sufficient.
Gavi's vaccination has generated $250 billion in economic benefits in the countries it supports. In fact, Gavi has had such an extraordinary economic benefit that over 19 countries that were Gavi recipients have now graduated, meaning they now fully fund their own immunization programs.
A great example is Indonesia. Since partnering with Gavi, it’s doubled the number of vaccines offered through its routine immunization program—and it’s seen childhood deaths fall to a quarter of what they were before. And now, Indonesia is not only transitioning to be fully self-supportive—it’s also become a Gavi donor.
Of course, this is a challenging time. All the progress we’ve made is at risk. Budgets are tight, and we all have to show our priorities when there’s tough trade-offs to be made.
There’s no denying: this is a global health crisis. Between the U.S. cuts and other funding cuts, in total, aid in total has gone down by 30 billion this year alone. It reinforces the incredible values being shown by the people who are showing up here today and being incredibly generous.
But with the cut in health resources, along with the financial situation a lot of these low-income countries are in, we are going to have a few years where things will go backwards.
As we think about this, think of a mother who will bring a baby wheezing for breath to a help center, and because the vaccines aren't available, that baby will not survive.
Think of a health worker trying to deal with a measles outbreak who, because there's less resources for that primary health care system or vaccines, that measles epidemic will continue.
This is agonizing. I mean, we have to put ourselves in the position of the parents who lose these children and how tough it must be for them to realize that the life could have been saved by a vaccine that costs just 30 cents.
So though our trend lines will briefly go into reverse, I believe that we can come back. I believe that we will resume that incredible progress that you saw.
I don't know if it'll be in two years or four years or six years, but I do know that as we bring these resources back, and we take advantage of an incredible pipeline of innovation, new drugs, new vaccines—lots of amazing things to help with these diseases—we will resume progress.
So everyone here, I'd say, is recommitting themselves, just like the Gates Foundation, to doubling down and staying committed.
You know, I'm not pessimistic. In fact, we have things like polio eradication that we are, as we say, this close to elimination. That'll be a mind-blowing thing. Likewise, malaria: we have tools, a variety of tools that brought together will give us a chance in the next 20 years to completely eradicate that as a disease, just like we're doing with polio.
This is all why the Gates Foundation is pledging $1. 6 billion to Gavi for this next five-year period. Thank you.
And it's why we'll invest billions in making sure that pipeline of new and lower-cost vaccines continues to make Gavi even more effective.
In closing, I think we can reflect on what Nelson Mandela once said: “There can be no keener revelation of a society's soul than the way it treats its children.”
In the last 25 years, Gavi has helped over a billion children live better, healthier lives—thanks to the extraordinary support of partners like you.
If we get this right, this trajectory of progress will continue for decades to come.
Thank you.
The last chapter
My new deadline: 20 years to give away virtually all my wealth
During the first 25 years of the Gates Foundation, we gave away more than $100 billion. Over the next two decades, we will double our giving.

When I first began thinking about how to give away my wealth, I did what I always do when I start a new project: I read a lot of books. I read books about great philanthropists and their foundations to inform my decisions about how exactly to give back. And I read books about global health to help me better understand the problems I wanted to solve.
One of the best things I read was an 1889 essay by Andrew Carnegie called The Gospel of Wealth. It makes the case that the wealthy have a responsibility to return their resources to society, a radical idea at the time that laid the groundwork for philanthropy as we know it today.
In the essay’s most famous line, Carnegie argues that “the man who dies thus rich dies disgraced.” I have spent a lot of time thinking about that quote lately. People will say a lot of things about me when I die, but I am determined that "he died rich" will not be one of them. There are too many urgent problems to solve for me to hold onto resources that could be used to help people.
That is why I have decided to give my money back to society much faster than I had originally planned. I will give away virtually all my wealth through the Gates Foundation over the next 20 years to the cause of saving and improving lives around the world. And on December 31, 2045, the foundation will close its doors permanently.
This is a change from our original plans. When Melinda and I started the Gates Foundation in 2000, we included a clause in the foundation’s very first charter: The organization would sunset several decades after our deaths. A few years ago, I began to rethink that approach. More recently, with the input from our board, I now believe we can achieve the foundation’s goals on a shorter timeline, especially if we double down on key investments and provide more certainty to our partners.
During the first 25 years of the Gates Foundation—powered in part by the generosity of Warren Buffett—we gave away more than $100 billion. Over the next two decades, we will double our giving. The exact amount will depend on the markets and inflation, but I expect the foundation will spend more than $200 billion between now and 2045. This figure includes the balance of the endowment and my future contributions.
This decision comes at a moment of reflection for me. In addition to celebrating the foundation’s 25th anniversary, this year also marks several other milestones: It would have been the year my dad, who helped me start the foundation, turned 100; Microsoft is turning 50; and I turn 70 in October.
This means that I have officially reached an age when many people are retired. While I respect anyone’s decision to spend their days playing pickleball, that life isn’t quite for me—at least not full time. I’m lucky to wake up every day energized to go to work. And I look forward to filling my days with strategy reviews, meetings with partners, and learning trips for as long as I can.
The Gates Foundation’s mission remains rooted in the idea that where you are born should not determine your opportunities. I am excited to see how our next chapter continues to move the world closer to a future where everyone everywhere has the chance to live a healthy and productive life.
Planning for the next 20 years
I am deeply proud of what we have accomplished in our first 25 years.
We were central to the creation of Gavi and the Global Fund, both of which transformed the way the world procures and delivers lifesaving tools like vaccines and anti-retrovirals. Together, these two groups have saved more than 80 million lives so far. Along with Rotary International, we have been a key partner in reviving the effort to eradicate polio. We supported the creation of a new vaccine for rotavirus that has helped reduce the number of children who die from diarrhea each year by 75 percent. Every step of the way, we brought together other foundations, non-profits, governments, multilateral agencies, and the private sector as partners to solve big problems—as we will continue to do for the next twenty years.
Over the next twenty years, the Gates Foundation will aim to save and improve as many lives as possible. By accelerating our giving, my hope is we can put the world on a path to ending preventable deaths of moms and babies and lifting millions of people out of poverty. I believe we can leave the next generation better off and better prepared to fight the next set of challenges.
The work of making the world better is and always has been a group effort. I am proud of everything the foundation accomplished during its first 25 years, but I also know that none of it would have been possible without fantastic partners.
Progress depends on so many people around the globe: Brilliant scientists who discover new breakthroughs. Private companies that step up to develop life-saving tools and medicines. Other philanthropists whose generosity fuels progress. Healthcare workers who make sure innovations get to the people who need them. Governments, nonprofits, and multilateral organizations that build new systems to bring solutions to scale. Each part plays an essential role in driving the world forward, and it is an honor to support their efforts.
Of course, although the Gates Foundation is by far the most significant piece of my giving, it is not the only way I give back. I have invested considerable time and money into both energy innovation and Alzheimer’s R&D. Today’s announcement does not change my approach to those areas.
Expanding access to affordable energy is essential to building a future where every person can both survive and thrive. The bulk of my spending in this area is through Breakthrough Energy, which invests in companies with promising ideas to generate more energy while reducing emissions. I also started a company called TerraPower to bring safe, clean, next-generation nuclear technology to life. Both of these ventures will earn profits if successful, and I will reinvest any money I make through them back in the foundation, as I already do today.
I support a number of efforts to fight Alzheimer’s disease and other related dementias. Alzheimer’s is a growing crisis here in the United States, and as life expectancies go up, it threatens to become a massive burden to both families and healthcare systems around the world. Fortunately, scientists are currently making amazing progress to slow and even stop the progress of this disease. I expect to keep supporting their efforts as long as it’s necessary.
The success in both areas will determine exactly how much money is given to the foundation since any profits they earn will be part of my overall gift.
What the Gates Foundation hopes to accomplish
Over the next twenty years, the foundation will work together with our partners to make as much progress towards our vision of a more equitable world as possible.
The truth is, there have never been more opportunities to help people live healthier, more prosperous lives. Advances in technology are happening faster than ever, especially with artificial intelligence on the rise. Even with all the challenges that the world faces, I’m optimistic about our ability to make progress—because each breakthrough is yet another chance to make someone’s life better.
Over the next twenty years, the foundation’s funding will be guided by three key aspirations:
In 1990, 12 million children under the age of 5 died. By 2019, that number had fallen to 5 million. I believe the world possesses the knowledge to cut that figure in half again and get even closer to ending all preventable child deaths.
We now understand the essential role nutrition—and especially the gut microbiome—plays in not only helping kids survive but thrive. We’ve made huge advances in maternal health, making sure that new and expectant mothers have the support they need to deliver healthy babies. We have new, life-saving vaccines and medicines, and we know how to get them to the people who need them most thanks to organizations like Gavi and the Global Fund. The innovation is there, the ability to measure progress is stronger than ever, and the world has the tools it needs to put all children on a good path.
Today, the list of human diseases the world has eradicated has just one entry: smallpox. Within the next couple years, I expect to add polio and Guinea worm to the list. (When we eradicate the latter, it will be a testament to the late President Jimmy Carter’s leadership.) I’m optimistic that, by the time the foundation shuts down, we can also add malaria and measles. Malaria is particularly tricky, but we’ve got lots of new tools in the pipeline, including ways of reducing mosquito populations. That is probably the key tool that, as it gets perfected and approved and rolled out, gives us a chance to eradicate malaria.
In 2000, the year that we started the foundation, 1.8 million people died from HIV/AIDS. By 2023, advances in treatment and preventatives cut that number to 630,000. I believe that figure will be reduced dramatically in the decades ahead, thanks to incredible new innovations in the pipeline—including a single-shot gene therapy that could reduce the amount of virus in your body so much that it effectively cures you. This would be massively beneficial to anybody who has HIV, including in the rich world. The same technology is also being used to treat sickle cell disease, an excruciating and deadly illness.
We’re also making huge progress on tuberculosis, which still kills more people than malaria and HIV/AIDS combined. Last year, a historic phase 3 trial began that could be the first new TB vaccine in over 100 years.
The key to maximizing the impacts of these innovations will be lowering their costs to make them affordable everywhere, and I expect the Gates Foundation will play a big role in making that happen. Health inequities are the reason the Gates Foundation exists. And the true test of our success will be whether we can ensure these life-saving interventions reach the people who need them most—particularly in Africa, South Asia, and across the Global South.
To reach their full potential, people need access to opportunity. That’s why our foundation focuses on more than just health.
Education is key. Frustratingly, progress in education is less dramatic than in health—there is no vaccine to improve the school system—but improving education remains our foundation’s top priority in the United States. Our focus is on helping public schools ensure that all students can get ahead—especially those who typically face the greatest barriers, including Black and Latino students, and children from low-income backgrounds. At the K-12 level, that means boosting math instruction and ensuring teachers have the training and support they need—including access to new AI tools that allow them to focus on what matters most in the classroom. Given the importance of a post-secondary degree or credential for success nowadays, we’re funding initiatives to increase graduation rates, too.
As I mentioned, having access to a high-quality nutrition source is key to keeping kids’ development on track. Smallholder farmers form the backbones of local economies and food supplies, and they play a key role in making that happen. One of the main ways the foundation helps farmers is through the development of new, more resilient seeds that yield more crops even under difficult conditions. This work is even more important in a warming world, since no one suffers more from climate change than farmers who live near the equator. Despite that, I’m hopeful that we can help make smallholder farmers more productive than ever over the next two decades. Some of the crops our partners are developing even contain more nutrients—a win-win for both climate adaptation and preventing malnutrition.
We’ll also continue supporting digital public infrastructure, so more people have access to the financial and social services that foster inclusive economies and open, competitive markets. And we’ll continue supporting new uses of artificial intelligence, which can accelerate the quality and reach of services from health to education to agriculture.
Underpinning all our work—on health, agriculture, education, and beyond—is a focus on gender equality. Half the world’s smallholder farmers are women, and women stand to gain the most when they have access to education, health care, and financial services. Left to their own devices, systems often leave women behind. But done right, they can help women lift up their families and their communities.
The United States, United Kingdom, France, and other countries around the world are cutting their aid budgets by tens of billions of dollars. And no philanthropic organization—even one the size of the Gates Foundation—can make up the gulf in funding that’s emerging right now. The reality is, we will not eradicate polio without funding from the United States.
While it's been amazing to see African governments step up, it’s still not enough, especially at a moment when many African countries are spending so much money servicing their debts that they cannot invest in the health of their own people—a vicious cycle that makes economic growth impossible.
It's unclear whether the world’s richest countries will continue to stand up for its poorest people. But the one thing we can guarantee is that, in all of our work, the Gates Foundation will support efforts to help people and countries pull themselves out of poverty. There are just too many opportunities to lift people up for us not to take them.
The last chapter of my career
Next week, I will participate in the foundation’s annual employee meeting, which is always one of my favorite days of the year. Although it’s been many years since I left Microsoft, I am still a CEO at heart, and I don’t make any decisions about my money without considering the impact.
I feel confident putting the remainder of my wealth into the Gates Foundation, because I know how brilliant and dedicated the people responsible for using that money are—and I can’t wait to celebrate them.
I'm inspired by my colleagues at the foundation, many of whom have foregone more lucrative careers in the private sector to use their talents for the greater good. They possess what Andrew Carnegie called “precious generosity,” and the world is better off for it.
I am lucky to have been surrounded by many generous people throughout my life. As I wrote in my memoir Source Code, my parents were my first and biggest influences. My mom introduced me to the idea of giving back. She was a big believer in the idea of “to whom much is given much is expected,” and she taught me that I was just a steward of any wealth I gained.
Dad was a giant in every sense of the word, and he, more than anyone else, shaped the values of the foundation as its first leader. He was collaborative, judicious, and serious about learning—three qualities that shape our approach to everything we do. Every year, the most important internal recognition we hand out is called the Bill Sr. Award, which goes to the staff member who most exemplifies the values that he stood for. Everything we have accomplished—and will accomplish—is a testament to his vision of a better world.
As an adult, one of my biggest influences has been Warren Buffett, who remains the ultimate model of generosity. He was the first one who introduced me to the idea of giving everything away, and he’s been incredibly generous to the foundation over the decades. Chuck Feeney remains a big hero of mine, and his philosophy of “giving while living” has shaped how I think about philanthropy.
I hope other wealthy people consider how much they can accelerate progress for the world’s poorest if they increased the pace and scale of their giving, because it is such a profoundly impactful way to give back to society. I feel fulfilled every day I go to work at the foundation. It forces me to learn new things, and I get to work with incredible people out in the field who really understand how to maximize the impact of new tools.
Today’s announcement almost certainly marks the beginning of the last chapter of my career, and I’m okay with that. I have come a long way since I was just a kid starting a software company with my friend from middle school. As Microsoft turns 50 years old, it feels right that I celebrate the milestone by committing to give away the resources I earned through the company.
A lot can happen over the course of twenty years. I want to make sure the world moves forward during that time. The clock starts now—and I can’t wait to make the most of it.
Field notes
The world needs more Nick Kristofs
I loved this journalist’s story of chasing hard problems and holding onto hope.

If you’re a big reader, you can probably point to a book or two that changed the course of your life. For me, it was a 1997 New York Times column by Nicholas Kristof about diarrhea, which was killing three million kids a year.
At the time, I had wealth—and knew I planned to give it away—but no clear mission. Nick’s article gave me one. I faxed it to my dad with a note: “Maybe we can do something about this.”
That ended up setting the direction for what became the Gates Foundation. It didn’t just give us a what—it gave us a how. Nick’s reporting showed us that the biggest challenge in global health isn’t always discovering new breakthroughs. Often, it’s making sure the tools we already have—vaccines, medicines, bed nets, or oral rehydration therapies for rotavirus—reach every child, no matter where they’re born.
Reading Nick’s new memoir, Chasing Hope, brought me back to that moment and showed me how it fit into the bigger story of his life. The book is a deeply personal account of a life spent documenting injustice and refusing to look away, whether it’s genocide in Darfur, refugee camps in Sudan, or the streets of his hometown in rural Oregon.
Nick’s impulse to go where the suffering is, and to make people care, has defined his career. He’s reported from more than 150 countries, covering war, poverty, health, and human rights. He and his longtime collaborator and wife, Sheryl WuDunn, won a Pulitzer Prize for their work. Together and individually, they’ve brought injustices around the world into view for millions of readers.
But Chasing Hope isn’t just a greatest-hits collection of his past reporting. It’s the story of how someone becomes Nick Kristof. He writes about growing up on a sheep and cherry farm in Oregon, driving tractors as a teenager, and nearly becoming a lawyer before deciding on journalism. He also reflects on the toll his career has taken on him, his family, and his capacity for hope.
I’ve known Nick for many years now, and I’ve admired his work since that 1997 rotavirus column. On paper, we don’t seem all that similar. He’s a journalist, I’m a technologist; he tells stories, I talk numbers. But reading Chasing Hope, I was struck by what we have in common: growing up in the Pacific Northwest, learning about the value of service from our parents, thinking globally.
We both attended Harvard and left early—me because I dropped out, him because he graduated in three years before heading to Oxford as a Rhodes Scholar. But neither of us ever stopped learning. I think we both believe the world’s pretty interesting if you remain a student.
Nick’s curiosity didn’t come out of nowhere, and neither did his sense of purpose. His mother was an art history professor and a civic leader who helped influence local politics. His father, a political science professor who fled both Nazism and communism, believed deeply in education and the responsibilities that come with freedom. That kind of upbringing left a mark on him and shaped the kind of journalist he became.
Over decades, he’s built a career reporting on crises that are often ignored because they happen in far-off places, far from centers of power. In Chasing Hope, he recounts his experiences chronicling river blindness in Ethiopia, maternal mortality in Cameroon, and malaria in Cambodia. Through the foundation, I mobilize science, data, and funding to address many of the same global challenges Nick reports on. Our approaches are different, but the underlying questions we ask (and try to answer) are the same: Why are some lives valued less than others? And how can we use the tools we have—information, resources, attention—to close that gap?
Nick has an admirable commitment to nuance, especially when it comes to hard subjects like China. Nick lived there for years, speaks Mandarin, and understands the country in a way most Western commentators don’t. I’ve always appreciated his ability to go beyond the headlines—and focus not just on what’s going wrong, but on what’s changing and why it matters.
Nick is also an optimist, which might sound strange given the kinds of suffering he writes about. But his work is grounded in a belief I share: The right data—or the right story—can move people to act. As Nick puts it, “A central job of a journalist is to get people to care about some problem that may seem remote.” People, when given the chance, want to make things better. Progress, while never guaranteed, is possible.
That optimism feels especially important, if increasingly difficult, right now. Isolationism is on the rise around the world, and governments are cutting back on foreign aid at the very moment when we should be doing more, not less. Millions of lives are at stake. Nick’s work reminds us what’s possible when we care about people beyond our own borders—and what happens when we don’t.
Chasing Hope made me think a lot about what kind of person chooses to run toward the hardest problems—and keep going back until they’re solved. It also made me think the world would be a much better place if there were more Nick Kristofs. In the meantime, we’re lucky to have this one.
Back for the future
I’m heading back to India
This trip will give me the chance to see what’s working, what’s changing, and what’s next—for India and the Gates Foundation.

In a few days, I’ll be traveling to India—my third visit in three years. India is a place where big challenges meet even bigger ambitions, and where innovation is transforming lives at an incredible scale. Every time I’m there, I see firsthand how much progress is being made in public health, agriculture, and technology. And I come away with new ideas, because India is full of smart, ambitious people tackling some of the world’s hardest problems in creative ways.
This visit will also be significant because—as we mark our 25th anniversary—the Gates Foundation’s Board of Trustees is meeting in the Global South for the first time. India is the right place for this milestone. The foundation has been working in the country for more than two decades, partnering with the government, researchers, and entrepreneurs to improve health and development. Today, India is home to some of the most impactful programs we’ve contributed to, from disease eradication and sanitation to women’s empowerment and digital financial services. This trip will give me a chance to see what’s working, what’s changing, and what’s next—for India and the foundation.
India’s track record in public health shows what’s possible. When I visited in 2011, it was one of the last places in the world still fighting polio. But that year, after relentless effort, India recorded its last case—and it’s remained polio-free ever since. Avahan, the HIV prevention program launched by the Gates Foundation two decades ago, is another success story. It pioneered a community-led approach to reduce infection rates that complemented the government’s efforts in high-prevalence states; eventually, management of the program transitioned to the Indian government, becoming part of the country’s broader health strategy.
That same model—leveraging local leadership, innovative solutions and data-driven insights—is now driving India’s fight against tuberculosis. The country has the world’s highest TB burden, but its investment in new diagnostics, AI-powered detection tools, and improved treatment strategies is accelerating progress toward elimination.
India’s success in childhood immunization is another reason I’m eager to return and learn more. Over the past several years, the country has scaled up routine vaccination programs, ensuring every major childhood vaccine is available. It has also used digital dashboards to track vaccine coverage, monitor cold storage, and improve maternal and child healthcare. These efforts have helped drive down mortality rates and create a stronger health system that can respond to new challenges.
India’s global health leadership is also transforming how the country approaches diagnostics and treatment for infectious diseases. As a result, it’s become a leader in low-cost vaccine manufacturing, ensuring that life-saving vaccines are available around the world. Indian companies are also tackling another critical challenge: making diagnostics more affordable. One effort I’m following closely is the push to make a saliva-based TB test for under $2, which could help millions of people in India and globally detect the disease earlier and get treatment faster.
Beyond health, India is also at the forefront of digital transformation. I’ve written before about how digital public infrastructure (DPI)—like Aadhaar and India’s digital payments system—has made it easier for millions of people to access banking, healthcare, and government services. Now, India is using AI-powered DPI tools to help rural health workers improve early disease detection, optimize pregnancy care, and manage patient data more effectively.
AI is also transforming agriculture across the country. When I was in Odisha last year, I saw farmers using AI-powered tools to predict weather patterns, choose crops, and reduce disease risks. I’m looking forward to seeing how much better those tools have gotten in the short time since.
What makes India’s progress so transformative, though, is that it doesn’t just benefit India. During India’s G20 Presidency in 2023, Prime Minister Modi declared his intent to make Indian innovations and know-how available to solve development problems globally. And that’s exactly what is happening. The solutions being developed there, from vaccine manufacturing to AI-powered diagnostics, are being shared with the world. Indian companies are making TB tests that could be game-changing across Africa. They’re developing AI models that could help farmers across Asia. And they’re proving that digital technology can make healthcare work better for everyone, especially the most vulnerable.
At the Gates Foundation, we tackle tough problems by working in close partnership with the people and governments most affected by them. India has been an incredible partner in this work because of the country’s deep expertise and willingness to develop and scale new ideas. The challenges remain: eliminating TB, improving nutrition, expanding access to AI-driven health and development services. But India has shown time and again that progress happens when innovation, local leadership, and investment come together.
That’s why I’m so excited for this trip. I’ll be meeting with government leaders, scientists, and philanthropists who are shaping the future of health and development in India. I’ll be visiting innovators who are working on solutions that could help people in India and around the world. And I’ll get to see how the foundation’s work fits into this bigger story—and how we can continue to support Indian-led efforts to improve lives.
I always leave India inspired. I know this trip will be no different.
The sky’s the limit
The Drone Didis are taking flight
Drones are helping rural women boost their income and India’s agricultural productivity.

I was excited to get a drone for my birthday last year. I couldn’t wait to get it into the air and see what my backyard looked like from the sky. But, as anyone who has used one can tell you, I quickly learned a harsh truth: Flying a drone isn’t easy. It takes a lot of practice and skill.
Maybe it’s time to pull the drone back out, because I was lucky to get a lesson from the experts last month in India. During my visit to Delhi, I met with Sangita Devi, Sumintra Devi, and Kajol Kumari—three Drone Didis from Bihar who are taking India’s agricultural productivity to new heights.
The women I met are part of the Indian government’s Namo Drone Didi program. (Didi is the Hindi word for “sister.”) It was launched in 2023 to help rural women boost their income and boost India’s agricultural productivity—and although the program is still in its early days, I’m already impressed by its results.
Right now, the Drone Didis primarily use their flying skills to fertilize crops. Applying fertilizer via drone has a lot of benefits over doing it by hand. Since you can spray farther away from the plant, the liquid fertilizer becomes more atomized—which means that it turns into finer droplets that cover more area. This benefits both farmers and the environment, because you need significantly less fertilizer and less water to help distribute it. Plus, it’s faster. One Drone Didi can cover as much as five acres in the same time it would take five people to cover half an acre.
I cannot wait to see how the program expands in the years ahead. The Indian government has plans to equip the drones with advanced sensors and imaging technology. This will allow Drone Didis to use real-time data to deliver targeted interventions to improve the quality and quantity of farmers’ crops. They will be able to detect diseases and pests, assess soil moisture levels, monitor crop growth, and more.
I’m equally excited to track how the Drone Didi program continues to empower women across India. Every Didi is affiliated with a self-help group, or SHG. The plan is to provide nearly 15,000 drones to SHGs across India by the end of next year.
In the United States, where I live, self-help groups are usually associated with mental health. In India, they’re a form of mutual aid. Each SHG is small—most are around 12 people, although some are as big as 25—and brings together women to support each other socially and financially. They pool their savings, access microloans at lower interest rates, and solve problems in areas like health and education.
The Didis I met with were longtime members of SHGs organized by JEEViKA, an organization in Bihar that works to lift people from rural areas out of poverty. During our time together in Delhi, Kajol told me about how JEEViKA helped her open her own shop three years ago, where she sells seeds and fertilizers. She loves being an entrepreneur, and when she was approached about becoming a Drone Didi, she knew it would do wonders for her business.
Each Didi attends a training program in Hyderabad or Noida, where they are taught how to pilot the drone and apply fertilizer effectively. (I was surprised to hear that learning to fly is apparently easier and takes less time than learning to fertilize!) Other women in their SHGs are trained as drone technicians, ready to repair the machines if any problems arise.
In the less than two years, the Drone Didi program is already transforming the lives of its pilots. Kajol is using the extra income she’s earned to expand her shop offerings and build a warehouse to store her stock. She also plans to send her children to a better school. Sangita’s family couldn’t afford a bicycle before she became a Drone Didi—today, she is the proud owner of an auto rickshaw.
Sumintra hopes that, when people see someone like her flying a huge drone, it changes their perception of what women are capable of. Like many women in her area, she married very young and was expected to stay home with her children. Today, her kids call her “Pilot Mummy” and dream about her flying airplanes one day.
I hope you think of the Didis the next time you hear the buzz of a drone above you at a wedding or a park. It’s remarkable how one piece of technology can reshape what is possible in a community. Kajol told me that people sometimes look at her and say, “She’s flying too high! What will she do next?”
Her response? “This is just the beginning. Wait and see what’s coming.”

Ancient gains
Could a grain older than the wheel be the future of food?
Lost crops like fonio could help us fight climate change and malnutrition.

What grain did your family grow up eating? I’m from the United States, where wheat and corn are king. But if I had been born in East Asia, I probably would’ve eaten a lot more rice as a kid.
If you grew up in West Africa, you might have eaten an ancient grain called fonio. Fonio has been feeding families in West Africa for more than 5,000 years, longer than any other cultivated grain on the continent. That makes it older than toilets, the wheel, and even writing. It’s a super small grain with a texture that reminds me a bit of couscous when cooked in hot water. Its nutty taste is delicious on its own but is also good when ground into flour.
Fonio is just one part of a much bigger family of remarkable ancient grains: the millets. Perhaps you’ve heard of finger millet. It’s a staple in Uganda and parts of Kenya and Tanzania, and it’s beloved in India where it is called ragi. Or maybe you’ve heard of teff, a longtime favorite in Ethiopia where it’s used to make injera.
Millets have been around for centuries, but they’re currently experiencing a resurgence—both for consumers who enjoy their taste and for farmers who appreciate how reliable they are to grow.
Fonio, in particular, is like farming on easy mode. You wait until a good rain comes, lightly till the soil to loosen it up, and then scatter the seeds on the ground. Two months later, you harvest the grain.

Farm work
On Africa’s farms, the forecast calls for adaptation and innovation
In Kenya, I visited with a smallholder farmer using new tools and practices to fight back against climate change.

I planted drought-tolerant seeds, fed and weighed chickens, and used a mobile phone to monitor weather forecasts and local crop prices.
These were a few of the chores I was given during my visit with Mary Mathuli, a smallholder farmer in rural Kenya.
I stopped at her home in Makueni County, south-east of Nairobi, during my recent trip to Kenya to better understand how farmers like Mary are faring in the face of climate change.
I arrived expecting to hear her talk about the record droughts and smaller harvests many farmers are experiencing throughout Africa.
Instead, to my surprise, she led me out to her fields to show off the innovations that are allowing her to continue to grow crops and earn an income to support her family, despite the drastic changes in rainfall and weather patterns.
A natural teacher, Mary encouraged me to learn by doing. She put me to work so I could understand how these new agricultural inputs and practices can make a big difference in their lives.
This experience taught me a couple important lessons.
First, my farming skills—like holding a chicken and swinging a hoe—need some work.
Second, and more importantly, I got a personal reminder of how resourceful and resilient African smallholder farmers like Mary are. Battered by years of drought and other extreme weather patterns, they are developing new skills and embracing new technologies to adapt to some of the toughest conditions for growing crops and raising livestock.
To be clear, African farmers face huge challenges due to climate change. Although sub-Saharan Africa accounts for only about four percent of the world’s carbon emissions, the continent is bearing the brunt of climate change impacts. Climate-related losses on many African farms are more than double those seen globally. In Makueni County, where Mary farms, yields of maize have been falling since 1994, largely due to changes in the weather.
While more innovation is needed to help Africa’s smallholder farmers keep pace with the threats posed by climate change, Mary and other farmers in Kenya are adopting some incredible new tools and practices that can limit crop losses and help their farms thrive even in extreme weather:
As farms go, Mary’s farm is quite small. Just about 4 acres, which is typical for farms in Africa. Still, she packs a lot of activities in this space, growing commercial and subsistence food crops and rearing poultry and livestock. In sub-Saharan Africa, more than half of the population works in agriculture. Together, they produce about 80 percent of the continent’s food supply. And most of the people doing the backbreaking farm work—like the chores I performed—are women.
I was impressed by Mary’s entrepreneurial spirit and her optimism. She appeared to seize every opportunity to try out new technologies and agricultural practices. It’s one of the reasons why she was trained as a model farmer and Village Based Advisor by the Cereal Growers Association, an organization that works with smallholder farmers to help improve their productivity. In this role, Mary provides guidance to several hundred farmers in her community, showing them how to use drought-tolerant seeds, raise chickens, and adopt other climate adaptation agricultural strategies.
She is clearly doing a good job in this role because more than 90 percent of farmers in her area have embraced one of the new adaptation practices.
I look forward to hearing how the seeds I planted with Mary are doing, despite the disappointing rains in recent months. I can’t imagine them in better hands than hers.
Thanks so much for the visit, Mary!
Food for thought
What it will really take to feed the world
In his latest book, one of my favorite authors argues that solving hunger requires more than producing more food.

In the introduction to his latest book, How to Feed the World, Vaclav Smil writes that “numbers are the antidote to wishful thinking.” That one line captures why I’ve been such a devoted reader of this curmudgeonly Canada-based Czech academic for so many years. Across his decades of research and writing, Vaclav has tackled some of the biggest questions in energy, agriculture, and public health—not by making grand predictions, but by breaking down complex problems into measurable data.
Now, in How to Feed the World, Vaclav applies that same approach to one of the most pressing issues of our time: ensuring that everyone has enough nutritious food to eat. Many discussions about feeding the world focus on increasing agricultural productivity through improved seeds, healthier soils, better farming practices, and more productive livestock (all priorities for the Gates Foundation). Vaclav, however, insists we already produce more than enough food to feed the world. The real challenge, he says, is what happens after the food is grown.
This kind of argument is classic Vaclav—questioning assumptions, forcing us to rethink the way we frame problems, and turning conventional wisdom on its head. His analysis is never about the best- or worst-case scenarios; it’s about what the numbers actually tell us.
And the numbers tell a striking story: Some of the world’s biggest food producers have the highest rates of undernourishment. Globally, we produce around 3,000 calories per person per day—more than enough to feed everyone—but a staggering one-third of all food is wasted. (In some rich countries, that figure climbs to 45 percent.) Distribution systems fail, economic policies backfire, and food doesn’t always go where it’s needed.
I’ve seen this firsthand through the Gates Foundation’s work in sub-Saharan Africa, where food insecurity is driven by low agricultural productivity and weak infrastructure. Yields in the region remain far lower than in Asia or Latin America, in part because farmers rely on rain-fed agriculture rather than irrigation and have limited access to fertilizers, quality seeds, and digital farming tools. But even when food is grown, getting it to market is another challenge. Poor roads drive up transport costs, inadequate storage leads to food going bad, and weak trade networks make nutritious food unaffordable for many families.
And access is only part of the problem. Even when people get enough calories, they’re often missing the right nutrients. Malnutrition remains one of the most critical challenges the foundation works on—and it’s more complex than eating enough food. While severe hunger has declined globally, micronutrient deficiencies remain stubbornly common, even in wealthy countries. One of the most effective solutions has been around for nearly a century: food fortification. In the U.S., flour has been fortified with iron and vitamin B since the 1940s. This simple step has helped prevent conditions like anemia and neural tube defects and improve public health at scale—close to vaccines in terms of lives improved per dollar spent.
One of the most interesting parts of the book is Vaclav’s exploration of how human diets evolved. Across civilizations, people independently discovered that pairing grains with legumes created complete protein profiles—whether it was rice and soybeans in Asia, wheat and lentils in India, or corn and beans in the Americas. These solutions emerged from practical experience long before modern science could explain why they worked so well.
But just as past generations adapted their diets to available resources, we’re now facing new challenges that require us to adapt in different ways. Technology and innovation can help. They’ve already transformed the way we produce food, and they’ll continue to play a role. Take aquaculture: Once a tiny industry, it’s grown over the past 40 years to supply more seafood for the world than traditional fishing—a scalable way to meet global protein demands. The Green Revolution is another example. Beginning in the 1960s, innovations in higher-yielding crops, more effective fertilizers, and modern irrigation prevented widespread famine in India and Mexico. These changes were once seen as unlikely, too.
New breakthroughs could drive even more progress. CRISPR gene editing, for instance, could help develop crops that are more resilient to drought, disease, and pests—critical for farmers facing the pressures of climate change. Vaclav warns that we can’t count on technological miracles alone, and I agree. But I also believe that breakthroughs like CRISPR could be game-changing, just as the Green Revolution once was. The key is balancing long-term innovation with practical solutions we can implement immediately.
And some of these solutions aren’t about producing more food at all—they’re about wasting less of what we already have. Better storage and packaging, smarter supply chains, and flexible pricing models could significantly reduce spoilage and excess inventory. In a conversation we had about the book, Vaclav pointed out that Costco (which might seem like the pinnacle of U.S. consumption) stocks fewer than 4,000 items, compared to 40,000-plus in a typical North American supermarket.
That kind of efficiency—focusing on fewer, high-turnover products—reduces waste, lowers costs, and ultimately eases pressure on global food supply, helping make food more affordable where it is needed most.
How to Feed the World had a lot to teach me—and I’m sure it will teach you a lot, too. Like all of Vaclav’s best books, it challenges readers to think differently about a problem we thought we understood. Growing more and better food remains crucial—especially in places like sub-Saharan Africa, where there simply isn’t enough. But as the world’s population approaches 10 billion, increasing agricultural productivity alone won’t solve hunger and malnutrition. We also need to ensure that food is more accessible and affordable, less wasted, and just as nutritious as it is abundant.
After all, the goal isn’t to make more food for its own sake—it’s to feed more people.

Alphabet soup
You’ve probably never heard of CGIAR, but they are essential to feeding our future
No other institution has done as much to feed our world as CGIAR.

What’s for dinner?
It’s a question asked every day in homes around the world. No other organization has done as much to ensure families—especially the poorest—have an answer to that question as CGIAR, the world’s largest global agricultural research organization.
More than 50 years ago, CGIAR’s research into high-yielding, disease-resistant rice and wheat launched the Green Revolution, saving more than a billion people from starvation. In the years since then, their work on everything from livestock and potatoes to rice and maize has helped reduce poverty, increase food security, and improve nutrition.
Never heard of CGIAR? You’re not alone. It’s an organization that defies easy brand recognition. For starters, its name is often mistaken for “cigar,” suggesting a link to the tobacco industry. And it doesn’t help that CGIAR is not a single organization, but a network of 15 independent research centers, most referred to by their own confusing acronyms. The list includes CIFOR, ICARDA, CIAT, ICRISAT, IFPRI, IITA, ILRI, CIMMYT, CIP, IRRI, IWMI, and ICRAF, leaving the uninitiated feeling as if they’ve fallen into a bowl of alphabet soup.
It’s too bad that more people don’t know about CGIAR. Their work to feed our hungry planet is as important now as it’s ever been. By 2050, as the world’s population gets bigger and incomes increase (which causes dietary changes like eating more meat), global food demand is expected to increase by 60 percent. Meeting this challenge is made tougher by climate change, which is affecting food production in every corner of the globe. Farmers are under assault from shifting rainfall, more frequent and extreme droughts and floods, and severe pest and disease outbreaks among crops and livestock.
The people who are most affected by these changes today are the world’s smallholder farmers. About 500 million farming households, in South Asia and sub-Saharan Africa, earn their living by raising crops and livestock on small parcels of land. These families have the fewest resources to cope with the many impacts of a warming climate.
I’ve been writing a lot this year about why reducing emissions from all sectors of our economy, including agriculture and electricity generation, is critical in our fight against climate change. But it’s equally important for the world to stay focused on helping vulnerable populations, like smallholder farmers, prepare for the disruptive impacts of climate change. We owe it to them. The people who will suffer most from climate change, especially in sub-Saharan Africa, are the least responsible for emitting these greenhouse gases. According to an Africa Progress Panel report, an average Ethiopian would have to live for 240 years to equal the carbon footprint of the average American.
I’m now co-chairing the new Global Commission on Adaptation, which is playing a key role in building government and public support for efforts to reduce the impacts of climate change on communities most at risk. We will need CGIAR’s research to help supply farmers with a steady stream of climate-smart crop varieties.
A great example of a CGIAR innovation helping smallholder farmers adapt to climate change is its drought-tolerant maize program. More than 200 million households in sub-Saharan Africa depend on maize for their livelihoods. Maize productivity in Africa is already the lowest in the world. And as weather patterns have become more erratic, farmers are at greater risk of having smaller maize harvests, and sometimes no harvest at all.
In response to this challenge, CGIAR’s International Maize and Wheat Improvement Center or CIMMYT, with funding from our foundation, USAID and the Howard Buffett Foundation, developed more than 150 new maize varieties that could withstand drought conditions. Each variety is adapted to grow in specific regions of Africa. At first, many smallholder farmers were afraid of trying new crop varieties instead of more commonly planted ones. But as CIMMYT worked with local farmers and seed dealers to share the benefits of these new varieties, more and more farmers adopted drought tolerant maize. The results have been life changing for many farming families.
In Zimbabwe, for example, farmers in drought-stricken areas using drought-tolerant maize were able to harvest up to 600 kilograms more maize per hectare than farmers using conventional varieties. The additional harvest was enough to feed a family of six for 9 months. For farming families who chose to sell their harvests, it was worth $240 in extra income, giving them much-needed cash to send their children to school and meet other household needs.
CIMMYT, in partnership with another CGIAR center, the International Institute of Tropical Agriculture or IITA, has gone on to develop other maize varieties for farmers who are not only vulnerable to drought, but also poor soils, disease, pests, and weeds. These varieties are expected to give farmers up to 30 percent greater yields and help them fight malnutrition.
CGIAR’s team of more than 8,000 scientists and staff around the world are also developing other tools to help farmers adapt to unpredictable weather and diseases. They have created a smart phone app that allows farmers to use the camera on their phone to identify specific pests and disease attacking cassava, an important cash crop in Africa. There are also new programs to use drones and ground sensors to help wheat and sugarcane farmers determine how much water and fertilizer their crops need.
We will need many new ideas like these to help farmers be prepared to meet the challenges of our changing climate. If they are, we will all have an answer to the question “What’s for dinner?” for years to come.

Farm aid
A warmer world will hurt this group more than any other
We need to help the world’s poorest people adapt to climate change.

I’ve spent a lot of time over the last month talking about climate change. Whether it’s on my book tour, in media interviews, or just during conversations with colleagues, it’s been great to have so many thoughtful conversations with people about how we prevent the worst effects of climate change.
Most of the questions I’ve gotten are about how we get to zero greenhouse gas emissions. Mitigation is the biggest climate problem we need to solve, and it’s been great to see it get so much attention. But I’ve noticed there’s one key topic that people don’t ask about as much: how we can help the world adapt to climate change.
I understand why. I dedicated five chapters of the book to mitigation and only one to adaptation. (In retrospect, I wish I had written more about the subject.) But there’s a reason I named my book “How to Avoid a Climate Disaster” and not “How to Stop Climate Change:” Our climate is already changing.
You just need to look at last month’s freeze in Texas and last year’s wildfires in California to see that extreme weather events are becoming more common. The scary thing is that these events aren’t the only (or even the most devastating) way a warming world is making life more difficult for people. The biggest damage is happening too gradually to make headline news, mostly in places near the Equator—and no one is more at risk than the world’s poorest people.
About two-thirds of those living in poverty work in agriculture, often relying on the food they grow to feed their families. A warmer world will be problematic for relatively well-off farmers in America and Europe, but potentially deadly for low-income farmers in Africa and Asia.
The closer you live to the Equator, the worse the effects of climate change will be. Droughts and floods will become more frequent, wiping out harvests more often. Livestock will eat less and produce less meat and milk. The air and soil start to lose moisture, leaving less water available for plants; in South Asia and sub-Saharan Africa, tens of millions of acres of farmland will become substantially drier.
When you’re already living on the edge, any one of these changes could be disastrous. We’re likely going to see a situation for these farmers where, instead of your crop getting wiped out every ten years, it gets wiped out every four years. If you don’t have money saved up to buy imported food—which is the case for most smallholder farmers—your children will likely become malnourished and more susceptible to disease.
The worst impact of climate change in poor countries will be to make health worse—which is yet another reason why we need to help the poorest improve their health. This starts with raising the odds that malnourished children will survive by improving primary healthcare systems, doubling down on malaria prevention, and continuing to provide vaccines for conditions like diarrhea and pneumonia. We also need to ensure that fewer children are malnourished in the first place by helping poor farmers grow more food.
This is a problem we can help solve with innovation. We need better methods and tools to grow food, just like we need to find zero-carbon ways to move around and generate electricity. No other organization is in a better position to create the innovations that will help poor farmers adapt to climate change in the years ahead than CGIAR, a global partnership that helps make plants and animals more resilient and productive. (I’ve written about how amazing CGIAR is before.)
Our foundation first got involved with CGIAR more than a decade ago, when we supported their work to develop drought- and flood-tolerant varieties of staple crops like maize. We’re already seeing big improvements in places like Zimbabwe. Farmers in drought-stricken areas there who used drought-tolerant maize were able to harvest up to 500 more pounds per acre than farmers who used conventional varieties—producing enough to feed a family of six for nine months.
CGIAR and other organizations are also creating tools to help farmers adapt to unpredictable weather, like sensors that tell you when to plant seeds and phone apps that help identify pests. Poor farmers need more advances like these, but to provide them, we need to invest more money in agricultural R&D. Doubling CGIAR’s funding so it can reach more farmers is one of the main recommendations by the Global Commission on Adaptation, which I led along with former UN secretary-general Ban Ki-moon and former World Bank CEO Kristalina Georgieva. (Other recommendations include shoring up water infrastructure and building a stronger safety net to help farmers recover faster.)
If we don’t take steps now to help farmers adapt, we’re setting ourselves up for a humanitarian and geopolitical disaster. The U.S. military predicts that climate change will become a huge driver of global instability. When people can’t grow enough food to feed themselves, they often leave those areas for places that can better support their families. We’re going to see more “climate refugees” move to cooler regions as the world gets warmer. The Department of Defense is already thinking about where a warmer climate could cause conflicts that they would be asked to intervene in.
It’s deeply unfair that the people who contribute the least to climate change will suffer the worst from its effects. Extreme poverty has plummeted in the past quarter century, from 36 percent of the world’s population in 1990 to 10 percent in 2015 (although COVID-19 is a huge setback that is undoing a great deal of progress). Climate change could erase even more of these gains, increasing the number of people living in extreme poverty by 13 percent.
Rich and middle-income countries are causing the vast majority of climate change, and we need to be the ones to step up and invest more in adaptation. The world’s poorest deserve our help, and they need more of it than they’re getting.

Net gains
Planes, trains, and smartphones
The future of public infrastructure is digital, efficient, and for everyone.

Almost thirty years ago, I wrote a book called The Road Ahead, about the transformative potential of the internet and other new digital technologies. Back then, I envisioned a world where online payments and e-government would change how we interact with money, services, and each other. Today, much of that has become a reality, in part due to the development of digital public infrastructure. In my recent travels around the world, I’ve seen up close how DPI is revolutionizing the way entire nations serve their people, respond to crises, and grow their economies. And at the Gates Foundation, we see it as an important part of our efforts to help save lives and fight poverty in poor countries.
There are a few core components that constitute DPI: digital ID systems that securely prove who you are, payment systems that move money instantly and cheaply, and data exchange platforms that allow different services to work together seamlessly. These systems and platforms are to the digital world what roads, bridges, and power lines are to the physical one—an underlying structure that connects people, data, and money online. Strong DPI can propel a country forward by making it easier for people to access essential services, participate in the formal economy, and improve their lives. On the flip side, DPI that is poorly implemented (or simply non-existent) can slow a country’s development and perpetuate inefficiencies and inequities.
In the 21st century, digital public infrastructure is proving to be as important for progress as its brick-and-mortar predecessors—and the effects have been impressive around the world, wherever it’s been embraced.

Accounting for accounts
Digital tech is turning the unbanked into the banked
More people have accounts than ever. Here’s what we need to do next.

In the worst days of COVID-19, when people around the world were out of work and struggling to pay for food and housing, many national governments came to the same conclusion about the best way to offer immediate help: send people cash. More than 200 countries introduced emergency cash transfer programs or expanded existing ones; India, for example, transferred money to 300 million people, 200 million of whom were women, in the weeks after its first lockdown. Brazil reached 70 million people with emergency transfers.
Imagine the risk involved in making these payments with paper money during a pandemic. Government workers would have to physically deliver these payments, potentially exposing them and everyone they encountered to the virus. In addition, the whole process would be expensive and time-consuming at a time when people need help as quickly as possible.
Fortunately, most governments didn’t have to resort to in-person payment. They were able to deposit cash transfers directly into people’s accounts—allowing them to give crucial support without paper bills changing hands. And during the pandemic, even more users were brought into the digital fold. For example, after financial regulators in West Africa temporarily allowed people to open accounts by text or telephone, more than 8 million signed up for accounts while their countries were in lockdown.
Globally, transferring so much money without cash was possible thanks to more than a decade of painstaking work by governments, financial service providers, nonprofits, and other partners. Today, about three quarters of people worldwide have an account at a financial institution or through a mobile money provider. That’s a 50 percent increase in the past ten years, and the growth has not just been in higher-income countries. Developing countries have increased 71 percent in that time.
This growth is great news because it means that more low-income people—and especially low-income women—are being empowered to use products that let them make and receive payments, save and borrow money, and get insurance. Both research and experience show that this financial inclusion helps people exit and stay out of poverty. And using digital technology to do it is a low-cost way to build economic resilience and reduce extreme poverty, which is why it’s an essential part of the Gates Foundation’s strategy. We have granted several hundred million dollars to partners who are helping low- and middle-income countries build digital financial systems.
Whenever I talk to friends about this work, they’re surprised to learn that roughly 1.4 billion adults can’t or don’t use any type of formal financial account, and most of those unbanked people live in low- and middle-income countries. One reason is that analog banking requires buildings, piles of paperwork, security guards, and tellers, making the cost per transaction so high that it’s not economical for a company to serve people with low balances and small transactions. As a result, people create ingenious informal banking methods—doing things like pooling cash with family and neighbors or creating community savings groups. As creative as these solutions are, they don’t allow people to build assets or move money instantly. And they are often risky—cash stashed under a mattress can be stolen, for example.
Today, the proliferation of mobile phones means that you no longer need so much expensive infrastructure to provide modern financial services. With digital technology, costs are low enough that it makes economic sense for companies to serve more of the people whom the old system has ignored.
An early example was M-PESA in Kenya, which let people living in cities send money to their relatives in rural areas efficiently and inexpensively. As it caught on, it was eventually used to make payments in shops. Likewise, India’s Universal Payment Interface allows users to make instant digital payments to each other at extremely low cost; it now includes 323 financial service providers throughout the country and handles nearly 6 billion transactions each month. During the pandemic, more than 80 million adults in India made their first digital payment to a merchant.
Yet even the exemplar countries aren’t reaching everyone who needs digital banking. That’s why the World Bank (with support from the foundation) runs the Global Findex database, a comprehensive survey of how adults borrow, save, and send money and manage risks. The Findex has been updated periodically since 2011, and the latest version was just published earlier today. Using data gathered from 128,000 adults in 123 economies, it highlights steps that will expand formal banking to everyone in the world who wants it.
I eagerly read an early copy of the Findex report as soon as I had the chance, and I’m glad I did. I recommend the report to anyone, especially policymakers, who wants more people to benefit from financial inclusion. When the world knows more about where inclusion is growing and where it isn’t, we’re better equipped to make sure we’re reaching the people who are still left out.
One Findex finding that jumped out to me is the gender gap. Although the world has made progress in empowering women to use formal financial services as much as men do, there’s still work to do. In developing countries, the gap was 9 percent in 2017 and 6 percent in 2021. The world can do better. Leaders should focus even more directly on expanding account ownership and use among women.
Another section of the report looks at a crucial question: What prevents the people who are still unbanked from joining the formal system? Knowing the answer will make it easier to create services that will work for them.
To find out, the researchers behind the Findex did extensive surveys of the unbanked. Their top explanations: The accounts are still too expensive, a family member already has one, banks are too far away, or they don’t have enough money to use an account. So making the accounts even more affordable, accessible, and appealing needs to be a priority. Introducing digital payments via mobile phones is a great way to start: Between 2014 and 2021, the percentage of people in Ghana using formal banking services went up 28 points, and virtually all of the increase was driven by people signing up for mobile-enabled digital payments.
I’ve heard people argue that there’s a simple way to automatically expand financial inclusion: introduce digital currencies, and specifically cryptocurrencies. But that idea isn’t rooted in an understanding of what poor people require—the kind of understanding that the Findex provides.
In many areas where the unbanked live, many transactions are still done in cash, so even people with digital accounts need the ability to convert digital money into paper money quickly, and vice versa. But today, that’s extremely difficult to do with cryptocurrencies, particularly in rural areas. In addition, cryptocurrencies don’t solve the problem of identification; buyers and sellers would still need to be able to prove they are who they say they are.
When it comes to financial inclusion, the most important thing is to consider what poor people require. That means creating secure financial systems that identify who is making transactions, and that are interoperable, so that a person using one system can make transactions with someone on another system. It also means updating regulations so they protect consumers while encouraging innovation.
I’m excited about the great progress that’s documented in this year’s Findex. More people around the world, including more women and low-income people, have and use bank accounts than ever before. A lot of people are still excluded, but we have a roadmap that is feasible without billions of dollars of extra money to build systems that empower them. By following the roadmap, we can help them lift themselves out of poverty and make the world a fairer place.

Two countries, five days
Highlights of my trip to Nigeria and Ethiopia
A few photos from my latest visit to Africa.

I’ve just wrapped up a busy five-day trip to Ethiopia and Nigeria. It’s the kind of trip that’s both tiring and energizing at the same time. Even though I stay in touch with a lot of partners in both countries—the Gates Foundation has been funding work in them for more than 15 years—there’s nothing quite like visiting to see the work in action.
Whenever I get home from a trip like this, friends are curious to hear how it went. Here’s what I’m telling them. From 2000 to 2019 or so, Ethiopia and Nigeria led the way on dramatic improvements in health and poverty that rippled across Sub-Saharan Africa. Since then, the pandemic, extreme weather, and political and economic instability have set both countries back, along with much of the rest of the continent. But as I saw on this trip, there’s great work going on in both places that makes me optimistic about their future, and Africa’s.
I want to share a few photos from the week. Thanks to everyone who shared their time and insights with me, including Prime Minister Ahmed of Ethiopia, Nigerian health minister Muhammad Ali Pate, and a special guest who came along for the trip: the amazing musician Jon Batiste. The foundation will be working with African partners even more in the future, and based on what I saw this week, my next visit will be just as inspiring.

Production diary
Behind the scenes of my new Netflix series
I had a lot of fun filming What’s Next?, which you can watch now.

I've always thought of myself as a student trying to get to the bottom of things. A good day for me is one where I go to sleep with just a little bit more knowledge than I had when I woke up in the morning. So, when I am deciding how to spend my time these days, I usually ask myself three questions: Will I have fun? Will I make a difference? And will I learn something?
My new Netflix Series, What’s Next? The Future with Bill Gates, is out today. And when I think back on the process of working on it over the last two years, the answer to all three questions is a resounding “yes.”
I had an amazing time working with the super talented director, Morgan Neville. Morgan directed one my favorite documentaries, Best of Enemies, which is about Gore Vidal’s and William Buckley’s debates during the 1968 U.S. presidential election. Morgan also won an Oscar for his terrific film 20 Feet from Stardom.
As you might guess from the title, What’s Next? is a show about the future. I’m very fortunate to get to work on a number of interesting problems. Between fighting to reduce inequities through the Gates Foundation, leading Breakthrough Energy’s work on the climate crisis, and my continued engagement with Microsoft, I have a front seat to some of the biggest challenges facing us today.
I feel extremely grateful to have had the opportunity to work with and learn from some truly incredible people during the making of this show. (I’m hesitant to even use the word “work” because the process was so much fun!) My hope is that people watch What’s Next? and feel like they’re joining me on my learning journey.
Each episode focuses on a different challenge: artificial intelligence, climate change, misinformation, disease eradication, and income inequality. I sat down with some of the big thinkers and innovators who are pushing for progress. Some of them have different ideas than I do about how to tackle these challenges, and I loved getting to hear their perspectives. It was an eye-opening experience.
I got to have conversations on camera with familiar faces like Dr. Anthony Fauci, Open A.I. co-founder Greg Brockman, and the groundbreaking director James Cameron. And I made a lot of new friends as well—including an ingenious malaria researcher from Burkina Faso named Abdoulaye Diabaté, young climate activists who impressed me with their intelligence and passion, and an amazing group of people from across the Bay Area who overcame tremendous adversity in their path from poverty to stability.
There also were dozens of people who participated in the series with standalone interviews, like my friend Bono and the brilliant Mark Cuban—each of whom brings an inspiring and grounded view of the challenges we’re facing. My hope is that, together, we can combat the doomsday narratives that so often surround these issues.
It’s hard to pick which discussion I learned the most from. But three conversations will always stand out in my memory: the ones with Lady Gaga, Senator Bernie Sanders, and my younger daughter, Phoebe.
Going Gaga
I couldn’t help but feel a little nervous.
I was in Palm Desert, CA, preparing to have a filmed conversation with Lady Gaga for our episode about misinformation. Being around famous people doesn’t normally affect me. But I’m a big fan of A Star is Born—especially its music—and I was aware of her reputation as an outsized personality. I couldn’t wait to hear what she had to say.
Luckily, I had nothing to worry about. I was blown away by how thoughtful Gaga was. She made me laugh with the outrageous stories of how she’s been the subject of misinformation in the past—and inspired me with some of the ways she thinks about the topic.
In the early years of her career, one of the most persistent internet rumors about Gaga was that she was actually a man. It became so mainstream that reporters would ask about it during interviews. She refused to confirm or deny it. Instead, Gaga turned it back on the interviewer and asked, “Would it matter if I was?”
On the day of our Netflix conversation, I had been filming earlier with my two sisters, Kristi and Libby. So I asked them to come and watch the conversation between Lady Gaga and me.

Start spreading the news
Amazing stories I wish everyone knew
Meet some of the heroes who are fighting poverty and saving lives.

Have you ever heard a story that was so cool you couldn’t help telling everyone you met about it? Something you knew and wished that everyone else did too?
That’s how I feel about the people whose work I get to learn about through the Gates Foundation. Every day, around the world, they save lives and help people lift themselves out of poverty. Some are scientists. Others are educators, nurses, midwives, or advocates. Their work is so inspiring to me that I’ve committed virtually all of my wealth to supporting it.
When I see how much passion people like Josephine have for helping themselves and their neighbors, I’m inspired to help too. I hope these stories will be as inspiring for you as they are for me.
The worst tragedy
Why do children die?
The toughest question I’ve ever had to answer.

Twenty-five years ago, I encountered a question that I have thought about literally every day since: Why do children die?
Before I tell you what drew me to this mystery, I want to acknowledge that child mortality is not an easy subject to talk about. As a parent, I can’t imagine what it would be like to lose a child. It is shocking even to see the words “children” and “die” used in the same sentence.
But I think “why do children die?” is one of the most important questions ever. It is hard to think of a measure of how a society is doing that reveals more than whether it is protecting its children, and especially its most vulnerable children. And the better we understand why children die, the more we can do to save them.
The very good news is that the world has made phenomenal progress in this area over the past several decades. Since 1990, the number of children who die every year has fallen by more than half! If progress on child mortality is a good measure of the state of the world, then—despite the huge global setbacks of the past few years, including COVID-19—the state of the world has improved dramatically. And based on what I know about innovations that are still to come, we can look forward to even more progress in the years ahead.
My introduction to the subject came 25 years ago, when I read a New York Times article about the health problems caused by unsafe drinking water in low- and middle-income countries. I was shocked to learn that every year, 3.1 million people—nearly all of them children—died of diarrhea, often because they had drunk contaminated water. Diarrhea kills 3.1 million children?, I thought. That can’t be true, can it? But it was.
I had to know more. What other major inequities did I not know about?
I read everything about global health that I could find, and I spoke to as many experts as I could. I learned that researchers define child mortality as the death of anyone under the age of 5. They use that age because the first five years are the riskiest time of childhood, when kids are the most vulnerable.
Learning about the history of child mortality helped me put the statistics in context. In 1950, some 20 million children died. In 1990, it was down to 12 million children, even though more babies were being born. By 2000, the number had dropped to fewer than 10 million. By 2019, it was below 5 million. Virtually all of these deaths occur in low- and middle-income countries.
So the next question was, why were so many children dying?
Around 18 percent of the deaths were caused by non-communicable conditions, such as cancer and cardiovascular problems. The large majority—82 percent—of the deaths were caused by communicable diseases, such as diarrhea and malaria, and health problems that their mothers experienced—and exacerbated by risk factors including malnutrition. (This 18:82 ratio still holds true today.)
On one hand, this was heartbreaking. The worst killers were all things that people in rich countries considered just an unpleasant episode (such as diarrhea) or never experienced at all anymore (such as malaria). In other words, although it was obviously true that children were dying because of deadly diseases, that was only part of the explanation. They were also dying because of where they were born.
On the other hand, it was encouraging to learn that such a large share of the deaths was preventable. When I saw the breakdown of diseases, I thought: Here is our road map. This is what the Gates Foundation should be working on. With the right team, partners, and funding, we could help the world move through the list, systematically going after the worst killers. The solutions that already existed could be made more affordable and delivered to people in low-income countries. The ones that didn’t exist could be invented.
Here is the chart as it looks today:
As you can see, pneumonia is the top preventable cause, but the story here is one of real progress. In 2000, it took the lives of more than 1.5 million children, but by 2019, the number was around 670,000—still an awful number, but a reduction of more than 55 percent. The innovation related to pneumonia that’s going on today is so exciting that I made a separate post and video about it.
Diarrhea is another example of progress. In two decades, its death toll has dropped 58 percent. A key reason is the use of low-tech interventions like oral rehydration solution (sugar water, essentially), which replaces lost electrolytes. Governments also ran large-scale sanitation programs to cut down on the spread of bacteria. And scientists developed an affordable rotavirus vaccine, and the world came together to deliver it. Between 2010 and 2020, this vaccine prevented more than 200,000 deaths. By 2030, it will have prevented more than half a million deaths.
Even though the overall number of deaths has gone down by half, the relative positions of the top three killers have not changed. They are the same today as in 1990: neonatal disorders, pneumonia, and diarrheal diseases. As you can see in this graphic, the fourth slot is where there has been a huge shift. In 1990, it was occupied by measles, responsible for half a million deaths. Today, it’s malaria that is in the fourth slot—not because malaria deaths went up (they actually went down), but because measles deaths fell by a whopping 87 percent.
Why? Vaccines. Since 2000, Gavi, the Vaccine Alliance has provided measles vaccines to more than 500 million children—half a billion!—through routine immunization and special vaccination campaigns. (This is just one example of the magic of vaccines—although unfortunately vaccination rates have dropped because of the pandemic and other factors.) And malaria may not be #4 on that list for long, thanks to innovations like malaria vaccines, improved insecticide-treated bed nets, and sugar baits.
Many groups deserve credit for the decades of progress I’ve described in this post. Countries with high disease burdens have launched massive vaccination campaigns, strengthened their health systems, and shared best practices with each other. Wealthy countries generously give aid that supports these efforts. Pharmaceutical companies have contributed technical expertise and made products affordable for low- and middle-income countries. Foundations including the Gates Foundation have stepped up with additional funding for innovative ideas. (At the foundation, we have staff and partners dedicated to each slice of the pie you see above.)
Although it’s still true that too many children do not live to see their fifth birthday, the world is moving in the right direction. If everyone keeps doing their part, we can move even faster and save even more lives. Because of COVID and other setbacks, the United Nations’ goal to cut childhood deaths in half again to below 3 million by 2030 will be missed, but it can still be achieved the following decade.
At a time when war and pandemic are in the news every day, it is important to look for reasons to be hopeful. The world’s opportunity—and ability—to save children’s lives is surely one of those reasons.

Target acquired
The newest weapon against mosquitoes: computer vision
The tech behind self-driving cars is also helping fight malaria.

Can computers see? The answer is complicated. I've been following the field of computer vision for decades—ever since Paul Allen and I started dreaming about what you could do with a personal computer—and we're only now reaching the point where they can really understand visual inputs. We still have a long way to go, but the ability of computers to see things is already revolutionizing many parts of our lives. It makes autonomous vehicles possible. It’s used to read x-rays quickly and accurately, and it’s what allows a mobile phone to translate street signs from one language to another.
Lately I’ve been especially enthused about a different application (and one my teenage self never would’ve imagined caring about): scanning pictures of mosquitoes.
Mosquitoes are responsible for spreading malaria, which kills more than 600,000 people every year and is a major focus of the Gates Foundation’s health work. Although scientists have learned a lot about them in the past few decades, one challenge has been especially stubborn: telling one mosquito from another. There are around 3,500 different species of them, and many look alike. Even a highly trained entomologist has to examine one for several minutes under a microscope to identify it accurately.
Why do we care about mosquito species? Most importantly, because different species can carry different diseases, and some don’t carry any diseases at all. (The ones that carry malaria belong to the genus Anopheles.) There are other differences too: Some bite people indoors, while others feed outdoors. Some dine at dusk while others take their meals during the day. And only females bite—the blood gives them the energy needed to lay eggs.
All this variation means we need different tools for different mosquitoes. For example, indoor insecticides and bednets work well against species that primarily bite indoors. But for the ones that mainly live and feed outside, you’ll need to take other steps too, such as eliminating the outdoor spaces where they breed.
Fortunately, some novel uses of computer vision are supercharging the process of identification. They’re not only helping us know our opponent, they’re helping us target its weak spots, save more lives, and move even closer to eradicating malaria.
One of the most exciting innovations is called VectorCam—an app that lets someone with minimal training identify mosquito species in a matter of seconds.
VectorCam was developed by Dr. Soumya Acharya and his team of bioengineers at Johns Hopkins University, with support from Uganda’s malaria control program, Makerere University, and the Gates Foundation. Using a smartphone, the VectorCam app, and an inexpensive lens attached to the phone, you simply take a picture of a mosquito and get it identified right away. The app can distinguish among the different species that transmit malaria. It can also determine the sex of the mosquito and, if the insect is a female, whether it has recently fed on blood or developed eggs. And with further refinement, VectorCam could identify species that carry other diseases, like dengue and Zika.

The nose knows
Could perfume be our secret weapon in the war on mosquitoes?
Mosquitoes use their sense of smell to find new victims. A Swiss fragrance company is hoping to thwart them.

Are you a mosquito magnet? If you don’t seem to get your unfair share of mosquito bites every summer, chances are you know someone who does. Some people are just more attractive to the pests than others.
The reason why is probably how you smell. Mosquitoes rely on their sense of smell to find their targets, and they’re drawn to certain odors naturally produced by the human body. Although some people may be a little more attractive, the unfortunate truth is that we all smell like a delicious meal to mosquitoes. You can hide yourself for a while using a bug spray like DEET or treating your clothes with permethrin. But if you want sustained protection, you have to add another step to your routine, which not everyone has the time to do or can afford.
There’s good news on the horizon, though: A company called dsm-firmenich is working to make repelling mosquitoes as easy as washing up in the morning.
I actually visited dsm-firmenich’s lab in Geneva back in 2016, when I checked out their innovative work to improve sanitation for the world’s poorest by reducing toilet odors. The nutrition, beauty, and health company is one of the world’s largest manufacturers of flavors and fragrances. Most of their products are used to make our food taste better and our household products smell more appealing, but they also have a history of using their scent expertise to fight disease transmission. Their latest efforts are focused on stopping mosquitoes, because the diseases they carry kill hundreds of thousands of people each year, most of whom are children in low-income countries.
The team’s goal is simple: Incorporate scents that repel mosquitoes into everyday products. After doing extensive research into the household products used most frequently in places where mosquito-borne diseases are common, they decided to focus mostly on bar soap and powdered laundry detergent. (They’re also thinking about other things like body lotion and body cream.) These products are already scented with a fragrance—what if that fragrance also helped keep mosquitoes away?
The idea is that you gain an added halo of protection without having to add any new steps to your daily routine or buy any new products. No one at dsm-firmenich thinks this kind of protection will be a silver bullet, but their hope is that, when combined with other proven tools like bed nets, people can significantly and sustainably lower their risk of catching deadly diseases like malaria and dengue.
Making a bar soap that gives you all-day protection against mosquitoes is a lot more complex than just infusing it with citronella. The scientists in Geneva started by identifying a wide array of scent ingredients that keep the pests away and are commonly used to create perfumes. Some of these ingredients are true repellants, giving off a smell that causes mosquitoes to fly in the opposite direction. Others block receptors in the mosquito’s brain that usually perceive and draw them to humans.
As they were combining the ingredients to create new fragrances, the team knew they had to keep a human-centered design approach in mind. The best candidates wouldn’t necessarily be the most effective—they also had to smell clean and fresh. I love the smell of cheeseburgers, but I don’t think I’d want my laundry to smell like them every day even if they protected me from mosquitoes!
To test the most promising odors, researchers used a tool I know all too well: The arm-in-cage test, where a human puts their arm—which has been coated in the fragrance being studied—into an enclosed area filled with hundreds of mosquitoes. Sensors track how the mosquitoes respond and whether they’re biting the arm. The team considered any test with two mosquito bites a failure.
Behavioral tests like those being done in collaboration with the Swiss Tropical and Public Health Institute are still ongoing, but they’ve already revealed some surprising results. One of the most effective fragrances so far smells like lily-of-the-valley, a light floral scent that is commonly used in perfumery. It’s exactly the kind of fresh scent that people like in their soaps and laundry detergents. The team’s early results indicate that some lily-of-the-valley odors could be as effective as DEET when used at certain doses.
The next step is the most difficult, and it remains to be seen whether it will succeed. The mosquito experts at dsm-firmenich have handed off the best scent candidates to the company’s product formulation experts and perfumers, who are now looking for ways to make them last all day in consumer products.
It’s a tall order. Scent ingredients are fragile, and activities like scrubbing your hands or washing your clothes cause them to vanish quickly. (Think about how quickly that freshly laundered smell can fade from your clothes.) A perfume that protects you from mosquitoes all day will likely end up being the result of a whole lot of innovation and a complex combination of different scents, rather than one single ingredient. And, of course, the final result has to smell good enough that people are willing to use it every day.
Still, I’m optimistic the scent wizards in Geneva will find a way. The Gates Foundation is supporting their research with the hope that, one day, people in high-risk areas will gain more mosquito protection without having to do any extra work or spend any extra money. When the world gives children and families more tools to protect themselves, we save lives—and take the bite out of the world’s deadliest animal.

Sweet dreams
Sugar Fix
Mosquitoes love blood, but did you know they have an even bigger sweet tooth?

Everyone knows mosquitoes have a taste for blood, but did you know they have an even bigger sweet tooth?
Mosquitoes love sugar.
Just as humans are drawn to the sweet smell of a chocolate shop or bakery, mosquitoes find the smell of sugar irresistible.
All mosquitoes need sugar to survive. Female mosquitoes consume blood to lay eggs, but both male and female mosquitoes require sugar for energy. In fact, even though mosquitoes buzzing in your ears may appear single-minded about biting you, they need sugar more often than they need blood.
Exploiting this craving, researchers have developed a lethal new tool to kill mosquitoes and protect people living in areas at high risk for malaria and other mosquito-borne diseases.
Here’s how it works: In nature, mosquitoes get sugar from flower nectar and plants. But scientists have developed a tempting bait that lures mosquitoes with a highly attractive fruit scent. When they land on it to get their sugar fix, the mosquitoes begin feasting on a sweet meal laced with insecticide. Not long after, they drop dead, reducing mosquito populations and, researchers hope, the spread of malaria in the communities where the traps are used.
While other insects, like bees and butterflies, may also be drawn to the bait’s sweet scent, the bait is just lethal for mosquitoes. A protective membrane, only accessible to mosquitoes, covers the bait and prevents other insects from feasting on the deadly meal inside.
This new mosquito control tool, called Attractive Targeted Sugar Baits or ATSBs, developed by Westham Co., is simple to use, affordable, and has the potential to be a game changer in the effort to eradicate malaria.
And it couldn’t arrive soon enough.
Over the past two decades, the world has dramatically reduced the global burden of malaria, preventing 1.7 billion cases and saving 10.6 million lives. This progress has been attributed, in large part, to the widescale use of long-lasting insecticide-treated bed nets, which protect people from bites while they sleep, and indoor residual spraying, which kills mosquitoes that land on insecticide-treated walls and ceilings in homes.
As effective as these tools have been, both mosquitoes and the malaria parasite are constantly evolving, sometimes making these interventions less effective. We’ve seen this again and again with resistance to insecticides and malaria drugs. And that’s why it’s critical that the world continues to innovate with new ways to prevent the spread of malaria.
In response to the widespread use of bed nets and indoor insecticide spraying, mosquitoes have changed their behaviors, according to some researchers. In some areas, instead of seeking their blood meals only inside homes after bedtime, malaria-carrying mosquitoes are now biting outside homes, and earlier in the evening, when people will often cook and socialize.
And this is how the sugar baits fit in.
By attracting mosquitoes outside, sugar baits offer a highly effective mosquito control tool for households. About the size of a sheet of notebook paper, sugar baits can be easily installed with a hammer and a nail. Two baits hung on the adjacent outside walls of a home are enough to offer months of protection.
In studies conducted in Mali in 2016 and 2017 researchers found that the sugar baits dramatically reduced mosquito populations and malaria cases in the communities where they were used.
A more recent modeling analysis predicted that sugar baits, when used to complement long-lasting insecticide-treated bed nets and indoor spraying, could reduce malaria cases by 30 percent in areas with high malaria burdens.
In 2020, there were an estimated 241 million malaria cases. A 30 percent reduction in malaria cases would be a huge breakthrough and save many lives.
That’s why our foundation has been supporting the development of sugar baits, including sponsoring a large-scale field trial currently underway in Kenya, Mali, and Zambia. So far, the results have confirmed the effectiveness of the bait stations.
If all goes well with the trials, sugar baits could be available for widespread use as soon as next year.
No need to sugarcoat it. For the millions of people at risk of malaria around the world, that would be welcome news.

Benin in front
Full coverage: Bed nets for Benin
Its bed net distribution system will help save lives from malaria and other diseases too.

If you’ve ever traveled to a part of the world where there’s a risk of malaria or other mosquito-borne disease, you probably slept under a mosquito net.
The gauzy fabric creates a physical barrier that protects you from mosquitoes. At the same time, you serve as bait in a deadly trap. Treated with potent insecticides, the net kills mosquitoes that land on it during their futile efforts to bite you.
It’s a remarkably simple tool, but it’s proven to be one of the most effective weapons we have against malaria. Increased bed net use is largely responsible for the more than 50 percent drop in malaria deaths worldwide since 2000.
Still, more needs to be done to ensure that communities at highest risk of malaria have access to them.
That’s why I’m excited that the government of Benin this year launched a new, innovative approach to distributing bed nets to their population.
Using smartphones, real time data collection, satellite mapping and other surveillance techniques, Benin’s distribution program will give health officials the data they need to provide full bed net coverage to the country.
Benin is faced with one of the highest burdens of malaria in the world. The West African country of nearly 12 million people has about 2 million cases each year. If successful, this new bed net distribution effort will save thousands of lives and serve as a blueprint for other high burden malaria countries to follow.
As you might imagine, distributing bed nets to every household is a massive logistical effort involving thousands of people—from truck drivers to health workers. And the job is made even harder in Benin where exact population numbers are uncertain.
For many years, Benin’s distribution campaigns were run with pencil and paper systems. Health officials used thick ledgers to keep track of the names and addresses of residents and how many beds nets they needed. It was time-consuming and often inaccurate. No one knew exactly how many nets would be needed or if they reached their intended destinations. As a result, many families were missed during the distribution, putting them at higher risk of malaria because they lacked the protection of a bed net.
But this year’s distribution is different. In partnership with Catholic Relief Services and our foundation, Benin’s national malaria program created a new, digitized distribution system that is more accurate and efficient in getting bed nets into the homes of all households in the country.
In many ways, this effort is based on the lessons the global health community has learned in the fight against polio. As vaccinators sought to immunize every child against polio in India and Nigeria, they would sometimes miss households, especially in remote areas. But with satellite mapping and better data collection, health workers were able to quickly identify gaps in vaccination coverage and reach every home.
Benin’s new bed net distribution operates in much the same way. Walking door to door, health workers make home visits throughout the country and perform a brief census: the number of people living there, including number of children and pregnant women, number of bed nets needed, etc. Using cell phones, they enter this information into a database. They also give each household a uniquely coded voucher to redeem at a nearby distribution center where they can collect their bed nets.
On the distribution day, people come to collect their nets and get lessons on the proper way to set up and care for them. As people arrive to redeem their vouchers for the nets, the malaria team has real time data on which households have received their nets and which ones have not. This data—which can be reviewed on a digital map—allows the malaria team to quickly identify any problems with their delivery system. It also gives health workers detailed information about which households need to be targeted for follow up to ensure they all have nets.
I admit none of what I’ve just described may sound that revolutionary. But in global health, I’ve learned again and again that saving lives is the result of getting the smallest details—from the temperature of a vaccine to the address of a beneficiary—right. And Benin’s new digitized bed net distribution program does just that by giving the government a powerful tool to manage a complex job.
And with this new digital distribution system in place, Benin can use it as a platform to manage other big health campaigns—like vaccinating against meningitis and door-to-door efforts to eliminate neglected tropical diseases.
I’m looking forward to hearing more about Benin’s progress in the fight against malaria and other diseases because of this new system—and I hope other countries will learn from their success.
The big picture
On the road in Nigeria and Niger
These were some of my favorite moments from the last week in West Africa.

Have you ever visited a place you haven’t been in a while, and it somehow manages to feel both new and familiar? That’s how I feel every time I go back to Nigeria.
It was amazing to return to Lagos and Abuja this week. I’ve been fortunate to spend a lot of time in Nigeria over the last two-plus decades, but it’s been nearly five years since my last visit due to the pandemic. Nigeria—and especially Lagos—is one of the most dynamic, vibrant places in the world, and I am always blown away by how much it's changed. At the same time, I loved getting to catch up with old friends and reconnect in person with longtime partners. (Remote meetings are great, but it’s nice to meet face-to-face on occasion.)
This week also marked my first-ever trip to Niger. Our foundation has been working with talented Nigeriens for years to help ensure children's health and prevent the spread of polio, and it was exciting to see the country for myself and talk about the future of that work.
It was a great week. These were some of my favorite moments:

Back in China
I’m visiting the country after four years away
I’m seeing first-hand some of the innovations that could contribute to global progress.

I want to share a few impressions from my time in China. I just had a meeting with President Xi, in which we discussed the importance of addressing global health and development challenges, like health inequity and climate change, and how China can play a role in achieving progress for people everywhere.
As part of my work with the Gates Foundation, I’ve tried to visit China, India, countries in Africa and Europe, and Washington D.C. each year. On these trips, I’d talk to researchers, government leaders, advocates, and other experts who are working on inequities in health and development. I’d always learn a lot, returning inspired by what I saw and heard.
It’s great to be able to resume these regular visits. This was my first trip to China in four years, and immediately after this trip, I’m headed to West Africa for the first time in five years. And I went to India in March.
On each trip this year, I have a key message: Over the past two decades, the world made significant strides in reducing poverty and improving health outcomes, but COVID was a big setback and even reversed progress on some global goals like reducing poverty and fighting TB and malaria. Many African countries, for example, are particularly impacted by overlapping challenges, including the effects of climate change, high food prices, escalating poverty rates, surging infectious diseases, and significant debt pressures.
Even though the challenges facing many African countries are complex, I’m optimistic that innovation in health, agriculture, digital finance, and energy will help improve lives there. I’m looking forward to meeting leaders and young people helping to accelerate progress when I visit West Africa.
Solving these problems requires innovation—both new tools and new ways of doing things. China has eliminated diseases, including polio and malaria, within its borders, developed drugs like artemisinin that have saved millions of lives around the world from malaria, made great strides in poverty reduction, and has made significant investments in clean energy and climate adaptation. So I was looking forward to seeing what’s changed since my last visit four years ago.
One highlight was my visit to the Global Health Drug Discovery Institute, an organization our foundation helped establish six years ago in partnership with the Beijing Municipal Government and Tsinghua University. GHDDI represents a productive way for public and private partners to work together on discovering new medicines for diseases that disproportionately impact the world’s most vulnerable populations but have applications for the world. I spoke about the institute’s work on TB and malaria yesterday, and we also extended our partnership over the next five years.
I also got to visit the National Crop Genebank of China. This facility is a prominent crop research center and also serves as a long-term preservation storage space for seeds so that scientists around the world have access to important genetic data. During my visit, I met with agricultural scientists who are working with their counterparts worldwide, particularly in Africa, on new rice varieties that help farmers increase their productivity and minimize the need for fertilizers, pesticides, and irrigation.
The benefits of their work have reached millions of farming households across Asia and Africa. The continued investment in technology and innovation within the agricultural sector has played a significant role in the increase in agricultural productivity throughout China. What excites me even more is China’s commitment to share their expertise and innovative practices with low-income countries. By assisting farmers in adapting to climate change, increasing their income, and combating food crises, they are making a substantial contribution to global food security.
The genebank and GHDDI are just two examples of the promising work the foundation has seen in China in the more than 15 years we’ve been partnering here. And there will be more opportunities for China and others to step up later this year, including a summit on development financing in Paris, a meeting of the G20 in New Delhi, and the COP28 climate conference in Dubai.
I’m convinced that if the world works together to address climate change, health inequity, and food security we can make extraordinary progress. And I’m looking forward to exploring new opportunities for collaboration and innovation that will make a better future for everyone.

Across the finish line
Makoy Samuel Yibi won’t stop until the world eradicates its next disease
Guinea worm once infected 3.5 million people every year. Thanks to heroes like Makoy, that number dropped to 13 last year.

When you see someone suffering from a terrible disease, it’s hard not to imagine a world where no one has to feel this way ever again. But the problem with eradication is that it’s really, really hard. The fewer cases remain, the more difficult it is to find them. That’s why, in all of human history, we’ve only eradicated two diseases: smallpox and the cattle disease rinderpest.
That might change soon.
The world is close to eradicating Guinea worm disease, a debilitating and painful condition that once devastated an estimated 3.5 million people in Africa and South Asia every year. Thanks to heroes like Makoy Samuel Yibi, that number dropped to 13 people in 2023.
As the national director of the South Sudan Ministry of Health’s Guinea Worm Eradication Program, Makoy helped reduce the number of cases in his country last year to just two. That’s a remarkable accomplishment by any standard, but it’s truly impressive when you consider the circumstances he and his team have faced: civil wars, the COVID-19 pandemic, the political changes brought by South Sudan’s decision to become an independent country in 2011, and the fact that the nation was once home to 90 percent of the world’s Guinea worm cases.
I recently caught up with Makoy at the COP climate conference in Dubai, where we both participated in an event focused on ending neglected tropical diseases, or NTDs, like Guinea worm. When you meet him in person, it’s hard to imagine a better person for the job. Makoy is passionate, brilliant, and laser-focused on making life better for the people of South Sudan. So I was surprised to learn that, as a young man, he never imagined a career in health.
Makoy was born in Terekeka County, a rural area located on the shores of the West Nile in southern Sudan. When he was a young man, Makoy had one primary focus: avoiding military service, which could be extremely dangerous. A chance meeting with a general from Terekeka resulted in a position with the national health department. A measles outbreak was ravaging parts of Sudan at the time, and Makoy’s first assignment was to travel from village to village providing care.
“What struck me,” he recalls, “was that, in every household we went to, we found at least half of the household was down with Guinea worm.”
The Guinea worm is a particularly nasty parasite. It’s unlikely to kill you, but the disease it causes—which is also called dracunculiasis, or “afflicted with little dragons”—can incapacitate you for months at a time and leave you permanently disabled. That can have devastating consequences if your family counts on you to grow the food you eat and sell it to make a living, as many people in South Sudan do.
The way the disease works is horrifying. If a person drinks water contaminated with Guinea worm larvae, the larvae enter the digestive system and mate. The impregnated female worm grows, undetected by the body’s immune system. Around a year later, the infected person will start to feel an itch somewhere on their body (usually the lower leg or foot). After a couple days, a painful blister appears and eventually bursts. The worm—which is now about one meter long—slowly starts to emerge from the wound.
This can take weeks or even months, and the pain it causes is excruciating. The wound can get infected, which could result in permanent disfigurement or even require amputation. And people often endure multiple worms emerging at the same time. Makoy has seen patients with as many as 40 worms.
And here’s the most insidious part: One of the few ways to relieve the pain of the blister is by soaking it in cold water, like a pond or a puddle. But that’s exactly what the worm wants. As soon as it touches water, it releases its larvae, starting the cycle anew. The Guinea worm is scarier and more efficient than any monster in a horror movie.
Makoy has seen countless times how devastating Guinea worm can be. “This is a situation where you see serious disruption of the livelihood of the community,” he says. “You see people going through a cycle of hunger because they don’t have enough. They have lost the window of cultivation. They’re not able to tend to their cattle, and there’s nothing they can do.”
There is no cure or treatment for Guinea worm, and yet, the world is on the doorstep of eradicating it. How? Through a series of highly effective interventions and a network of incredibly dedicated health workers.
Makoy’s team has built a network of volunteers in virtually every village in the country, who report rumors of Guinea worm cases. They spend every day searching for cases, getting the word out, and building trust in a country where more than 60 languages are spoken.
Makoy and his colleagues investigate every single rumor, no matter how remote. During the rainy season when the majority of cases happen, he often spends days hiking through the Sudd or up a mountain with all of his supplies on his back just to reach his destination. Last year, in a country the size of France with less than 100 miles of paved road, the team responded to nearly all of the 50,000 rumors they received within 24 hours.
Once the team finds a confirmed case, they make the patient as comfortable as possible and do what is called “controlled immersion.” This means soaking the affected area in a bucket of water and encouraging the worm to come out.
Makoy also spends a lot of time preventing people from getting Guinea worm in the first place. His team distributes free water filters and educates communities about safe water practices. The system they’ve built to support this work has strengthened health systems across the country, providing a platform for delivering other health services like childhood vaccination.
Makoy’s team has had a tremendous partner in all of this work: former U.S. President Jimmy Carter and the Carter Center. In 1995, when Makoy was first starting his public health journey, President Carter negotiated what remains the longest humanitarian ceasefire in history when he helped convince both sides of the Second Sudanese Civil War to lay down their arms and allow health workers access to treat Guinea worm and other diseases, like polio and river blindness. Today, the Carter Center continues to lead the global eradication campaign’s march to zero. The Gates Foundation is proud to support the Carter Center as part of our overall efforts to tackle NTDs. (You can learn more about Makoy’s partnership with the Carter Center in a new film called The President and the Dragon that is coming out later this year.)
Eradication is now within sight, although it won’t be easy to eliminate the last few cases. South Sudan previously reported no Guinea worm in 2018, but cases were subsequently discovered after a peace agreement was reached in the South Sudanese Civil War. And Guinea worm has recently been detected in dogs and other animals, mainly in Chad. Eradication will require stopping all transmission, both human and animal.
But Makoy Samuel Yibi is optimistic we can get there—and so am I. His determination to root out every last case makes me hopeful that we will someday soon celebrate the end of Guinea worm disease.
“In the places where Guinea worm has been eliminated,” he says, “you can actually see how communities have been energized. They are more active, and they are productive. The communities are now empowered to be more self-sufficient, because they don’t have to worry about Guinea worm.”

Ick!
What’s gross and better to see on an empty stomach? This museum in Tokyo
Welcome to the bizarre, creepy, and endlessly fascinating exhibits at the world’s foremost parasite museum.

You may want to skip lunch—and probably avoid sushi for dinner—when visiting the world’s foremost museum of parasites in Tokyo.
At the quirky and endlessly fascinating Meguro Parasitological Museum, which I toured during my trip to Japan in August, you’ll find hundreds of stomach-turning displays featuring creepy parasite specimens.
Some of the strangest-looking ones have resided inside the bodies of fish, turtles, pigs, and other animals. But by far the most horrific specimens are the parasites that have chosen humans as their hosts.
What steals the show is the world’s longest tapeworm. In 1986, this garden-hose length parasite was discovered living in the small intestine of a Japanese man. He had dined on a piece of raw salmon that was infected with a tapeworm egg smaller than a grain of rice. Over the next three months it grew and grew until it reached 29 feet long! (If you’re a follower on my Instagram account, you may have gotten a glimpse of this impressive specimen.)
The man who recovered the tapeworm from this unfortunate patient was Dr. Satoru Kamegai, the founder of Meguro Parasitological Museum. A physician, Dr. Kamegai started practicing medicine after World War II. At the time the country’s water and sanitation systems were in ruins and many people throughout Japan suffered from parasitic diseases. Dr. Kamegai became fascinated by the strange world of parasites and started collecting them from his patients. In 1953, he opened a small museum to display his findings and raise awareness of these creatures. Dr. Kamegai passed away in 2002, but the museum has continued to operate as a private research and educational facility.
Today, the museum has a collection of 60,000 different parasites, about 300 of which are on display in the two-story collection. Entrance to the museum is free and it draws a steady stream of visitors. It even has a gift shop with parasite-themed t-shirts, pens, and jewelry. (I picked up a t-shirt with the famous tapeworm on it.)
While I had a busy trip to Japan, I took time to stop at this museum because of our foundation’s efforts to reduce the burden of so-called neglected tropical diseases, many of them caused by parasites. More than 1 billion people suffer from these overlooked diseases with often difficult to pronounce names, including dracunculiasis (Guinea worm disease), human African trypanosomiasis (sleeping sickness), visceral leishmaniasis (black fever), onchocerciasis (river blindness), and schistosomiasis (snail fever).
These diseases can cause anemia and blindness, stunt children’s growth, lead to cognitive impairments, complicate pregnancies, and result in thousands of deaths each year. And it’s not uncommon for people living in extreme poverty to suffer from more than one of these diseases at the same time, affecting their ability to go to school or make a living.
Our foundation works with partners on the treatment and control of these diseases. One of the most successful efforts has been mass drug administration, which seeks to treat everyone against a disease—even if they are not actually infected or show any symptoms. I observed this incredible work in Tanzania, where I joined a group of health workers going from house to house to distribute medicine to wipe out lymphatic filariasis, one of the world’s most painful and debilitating diseases.
The good news is that there’s been a lot of progress in reducing parasitic diseases around the world. But there’s still more work to be done. That makes this museum a great place for people to learn about where these diseases still exist and the incredible work that’s going on to wipe them out.
If you happen to be in Tokyo, I encourage you to visit.
Neglected no more
A massive success
How to stop disease by treating everyone—even healthy people.

Health workers have an unusual tool for fighting disease that turns our old thinking about treatment on its head. I saw it at work recently in a remote hilltop village in Tanzania, where I joined a group of health workers going from house to house to distribute medicine to wipe out lymphatic filariasis, one of the world’s most painful and debilitating diseases.
At each home, one health worker told the family about the swollen limbs, disfigurements, and other symptoms of the parasitic disease. Another carried a tall stick to measure the height of each family member to determine the correct dosage. Then, if they were willing to be treated, the parents and children took their pills and washed them down with a cup of water before our team moved on to the next house.
What was surprising about this effort is that none of the people who took the medicine were sick.
The village I visited was participating in what’s known as a mass drug administration campaign, which seeks to treat everyone against a disease—even if they are not actually infected or show any symptoms. Typically, of course, the sick are the ones who get treated, not the people who are healthy. But when it comes to combating some diseases, like lymphatic filariasis, it’s critical for health workers to try to treat the entire at-risk population to break the cycle of transmission. If not, the disease could continue to be spread by those who are not aware they are infected.
Ten countries have successfully eliminated lymphatic filariasis in this way, including Togo, which this year became the first country in sub-Saharan Africa to wipe out the disease. Still, more than 800 million people in 52 countries worldwide remain threatened by lymphatic filariasis.
Mass drug administration is not only effective against lymphatic filariasis, but also other neglected tropical diseases, including schistosomiasis, onchocerciasis, trachoma, and soil-transmitted helminths. These diseases go by names that are largely unknown and often difficult to pronounce. But it should be easy to understand why we should all care about them. They afflict people living in the poorest countries and cause untold suffering.
Lymphatic filariasis is one of the worst of these diseases. It’s caused by a parasite that’s spread by mosquitoes, and in the severest cases people may develop swollen limbs, a thickening of the skin known as elephantiasis, or other severe disfigurements. Beyond the pain and disabilities they experience, people affected by the disease are often ostracized by their communities and are unable to work, sinking them deeper into poverty.
To combat lymphatic filariasis, health officials could test everyone and then treat only those people who are infected. But testing the population for these diseases would be expensive and slow. The medicines used for treatment (ivermectin and albendazole), however, are inexpensive and have no side effects, making mass treatment a more effective approach to protect people from the disease. (And thanks to the generosity of the many pharmaceutical companies, billions of doses of these and other medicines combating neglected tropical diseases are being donated for free.)
Like many countries running mass drug administration programs, Tanzania’s biggest challenge is treating enough of its population at risk of the disease. To break the cycle of transmission, health workers must treat at least 65 percent of the population every year for 5 to 10 years. As you might imagine, meeting this target year after year is not easy.
Health officials must have strong public awareness campaigns, thousands of trained health workers, a well-organized supply chain to distribute medicines to the remotest corners of the country, and regular disease surveying to track their progress. At the same time, the program provides treatment and care for people who are suffering from the debilitating symptoms of the diseases.
Walking from door to door in the village with the health workers, I was struck that perhaps the most important element of the program is trust. Taking the medicine is strictly voluntary, making it important that the health workers distributing it earn the confidence of the community. The health workers I met certainly had. They were knowledgeable, passionate about their work, and clearly cared about the community they were serving. At each home, they took the time to explain the goal of the program and address any of the villagers’ questions or concerns. Thanks to their hard work the latest survey of lymphatic filariasis in their district showed that the cycle of transmission had been broken. For the first time, the village was not at risk of the disease.
By 2020, Tanzania hopes to eliminate lymphatic filariasis entirely within its borders. Based on what I saw in this village, I’m optimistic they will.
24:00:00
Record-breaking generosity
On January 30, 2017, a group combatting neglected diseases did something extraordinary. Guinness World Records took notice.

Page through the Guinness Book of World Records and you’ll learn that a lot can happen in 24 hours.
On February 14, 2004, Dan Meyer of Davis, California, set the record for the longest paperclip chain by an individual in 24 hours. Length: 5,340 feet. Total number of paper clips: 54,030.
On June 4, 2011, Nabi Salehi, a barber in London, set the record for giving the most consecutive haircuts in 24 hours. Total haircuts: 526.
And on January 30, 2017, another achievement—one that will improve millions of lives—was added to the Guinness World Record list. A group fighting neglected tropical diseases—including Guinea worm, river blindness, and elephantiasis—set the record for most drugs donated in a 24-hour period. Total number of drugs: 207,169,292!
This week in Geneva, I was excited to participate in the ceremony to celebrate the group that achieved this incredible feat, Uniting to Combat Neglected Tropical Diseases, a coalition of drug companies, governments, health organizations, charities, and other partners who work to reduce the burden of tropical diseases that impact the world’s poorest.
On January 30th, they organized drug manufacturers, warehouse workers, delivery drivers, government officials, and health workers to deliver this historic number of donated drugs on four continents for distribution to people living in the remotest parts of the world.
What’s truly amazing is that the 207 million drugs donated on January 30th represent just a small amount of this group’s generosity. Since 2012, when United to Combat Neglected Tropical Diseases signed a declaration to control or eliminate 10 of the worst neglected diseases, they have donated 7 billion treatments. I’m grateful to the pharmaceutical companies that have been making these donations year after year: Bayer, Eisai, Gilead, GSK, Johnson & Johnson, MSD, Merck KGaA, Novartis, Pfizer, and Sanofi.
Thanks to the efforts of these drug companies and their partners millions of people are receiving the medicines they need to cure and protect them from these diseases. These diseases are in retreat and the world is moving closer to the day when they will be eliminated altogether.
Of course, all world records get challenged. And I for one will be thrilled for the day when this record for drug donations gets broken. So will the millions of families around the world who need them.
Warning!
Neglected no more
These diseases may be difficult to pronounce, but it should be easy to see why everyone should care about them.

Warning: you may find what I’m about to write disturbing.
Imagine a fly infected with parasites bites you. First you get a fever, then headaches, joint pains, and itching. Eventually, when the parasites cross the blood-brain barrier, you lose your mind, you can’t control your muscles, and then you lose your life.
Now, imagine you drink a glass of water. The water contains tiny fleas containing even tinier larvae. The larvae mate and grow in your body. One year later, a painful blister forms on your foot. The head of a worm pokes out. It’s 3-feet-long and takes weeks to remove.
Finally, imagine a mosquito bites you. It’s infected with tiny larvae. They set up camp in one of your lymph nodes, where they mate and nest, causing your leg to eventually swell to 10 times its size.
Sound horrific? Well, I haven’t told you the most disturbing part. I’m not making up these diseases (Human African trypanosomiasis, Dracunculiasis, and Lymphatic filariasis). They are just three of more than a dozen tropical diseases that afflict some of the poorest people in the world. As I write this, more than a billion people suffer from at least one of them.
These diseases go by names that are largely unknown and often difficult to pronounce.
Still, it should be easy to understand why we should all care about them. Spread by worms and insects, they disfigure and disable people living in the remotest areas of the world, keeping children out of school and parents from being able to work. In the worst cases, they kill. And all of them can be prevented—if the world continues to work together to end them.
I am in Geneva, Switzerland this week for a meeting to raise awareness and continue support for the fight against these overlooked diseases. Collectively, they’ve been dubbed “Neglected Tropical Diseases,” but lately they’ve been getting some of the attention they deserve.
Five years ago, Uniting to Combat Neglected Tropical Diseases, a group of pharmaceutical companies, governments, health organizations, charities, and other partners, came together to treat and prevent these diseases. They set a goal to control or eliminate at least 10 of them by 2020. Today, there’s a lot of progress to celebrate. Fewer people are suffering from them, and many countries are on their way to eliminating them altogether.
Here are some examples of the progress that’s been made.
Dracunculiasis (also known as Guinea worm), the parasitic disease I described above in which a large worm grows inside its victims, is nearing its end. In 1985, the disease afflicted an estimated 3.5 million people in 21 countries in Africa and Asia. Last year, thanks to the work of Uniting to Combat NTDs, The Carter Center, and other partners the number of Guinea worm cases has been reduced by more than 99 percent to 25 cases.
Lymphatic filariasis, also known as elephantiasis, is thepainful, disfiguring disease spread by mosquitoes. Five years ago, 1.5 billion people needed preventive drug treatment to protect them from the disease. Since then, it has been eliminated in six countries and reduced in 18 others.
Human African trypanosomiasis (HAT), commonly known as sleeping sickness, is also in retreat. Cases have declined by more than 90 percent, from 26,000 cases in 2000 to 2,733 in 2015.
What’s driving this progress? It’s been the result of drug donations by pharmaceutical companies and generous commitments by donors and governments. More than one billion people were reached with NTD treatments in 2015 alone—across nearly 150 countries.
New innovations for testing and treatment have also made a big difference. For example, the diagnostic test for sleeping sickness used to require electricity, bulky equipment, and refrigeration, making it difficult to deliver to remotest areas of the world. Now, a simple finger-prick blood test allows health workers to test for the diseases. And new smartphone-based mapping tools could make it easier to map these diseases so health workers can target their treatment efforts in real time down to the household level.
Still, there’s a lot of work to be done. We need continued support from donor governments to finish the job. We need more research on improved drugs and tests to help make it easier to treat people quickly. And we must support the frontline health workers who have the tough job of delivering the drugs in the hardest to reach regions of the world.
If the world keeps up the fight against these diseases, we can improve the lives of millions of the poorest families. They won’t be neglected anymore.
Take Action
Help us eliminate these debilitating diseases that afflict the world’s poorest by supporting The END Fund. The END Fund is a GiveWell Top Charity.
Endgame
Let’s make this the last pandemic
My new book is all about how we eliminate the pandemic as a threat to humanity.

The great epidemiologist Larry Brilliant once said that “outbreaks are inevitable, but pandemics are optional.” I thought about this quote and what it reveals about the COVID-19 pandemic often while I was working on my new book.
On the one hand, it’s disheartening to imagine how much loss and suffering could’ve been avoided if we’d only made better choices. We are now more than two years into the pandemic. The world did not prioritize global health until it was too late, and the result has been catastrophic. Countries failed to prepare for pandemics, rich countries reduced funding for R&D, and most governments failed to strengthen their health systems. Although we’re finally reaching the light at the end of the tunnel, COVID still kills several thousand people every day.
On the other hand, Dr. Brilliant’s quote makes me feel hopeful. No one wants to live through this again—and we don’t have to. Outbreaks are inevitable, but pandemics are optional. The world doesn’t need to live in fear of the next pandemic. If we make key investments that benefit everyone, COVID-19 could be the last pandemic ever.
This idea is what my book, How to Prevent the Next Pandemic , is all about. I’ve been part of the effort to stop COVID since the early days of the outbreak, working together with experts from inside and out of the Gates Foundation who have been fighting infectious diseases for decades. I’m excited to share what I've learned along the way, because our experience with COVID gives us a clear pathway for how to be ready next time.
So, how do we do it? In my book, I explain the steps we need to take to get ready. Together, they add up to a plan for eliminating the pandemic as a threat to humanity. These steps—alongside the remarkable progress we’ve already made over the last two years in creating new tools and understanding infectious diseases—will reduce the chance that anyone has to live through another COVID.
Imagine a scenario like this: A concerning outbreak is rapidly identified by local public health agencies, which function effectively in even the world’s poorest countries. Anything out of the ordinary is shared with scientists for study, and the information is uploaded to a global database monitored by a dedicated team.
If a threat is detected, governments sound the alarm and initiate public recommendations for travel, social distancing, and emergency planning. They start using the blunt tools that are already on hand, such as quarantines, antivirals that protect against almost any strain, and tests that can be performed anywhere.
If this isn’t sufficient, then the world’s innovators immediately get to work developing new tests, treatments, and vaccines. Diagnostics in particular ramp up extremely fast so that large numbers of people can be tested in a short time. New drugs and vaccines are approved quickly, because we’ve agreed ahead of time on how to run trials safely and share the results. Once they’re ready to go into production, manufacturing gears up right away because factories are already in place and approved.
No one gets left behind, because we’ve already worked out how to rapidly make enough vaccines for everyone. Everything gets where it’s supposed to, when it’s supposed to, because we’ve set up systems to get products delivered all the way to the patient. Communications about the situation are clear and avoid panic.
And this all happens quickly. The goal is to contain outbreaks within the first 100 days before they ever have the chance to spread around the world. If we had stopped the COVID pandemic before 100 days, we could’ve saved over 98 percent of the lives lost.
I hope people who read the book come away with a sense that ending the threat of pandemics forever is a realistic, achievable, and essential goal. I believe this is something that everyone—whether you’re an epidemiologist, a policymaker, or just someone who’s exhausted from the last two years–should care about.
The best part is we have an opportunity to not just stop things from getting worse but to make them better. Even when we’re not facing an active outbreak, the steps we can take to prevent the next pandemic will also make people healthier, save lives, and shrink the health gap between the rich and the poor. The tools that stop an outbreak can also help us find and treat more HIV cases. They can protect more children from deadly diseases like malaria, and they can give more people around the world access to high quality care.
Shrinking the health gap was the life’s work of my friend Paul Farmer, who tragically died in his sleep in February. That’s why I’m dedicating my proceeds from this book to his organization Partners in Health, which provides amazing health care to people in some of the poorest countries in the world. I will miss Paul deeply, but I am comforted by the knowledge that his influence will be felt for decades to come.
If there’s one thing the world has learned over the last two years, it’s that we can’t keep living with the threat of another variant—or another pathogen—hanging over our heads. This is a pivotal moment. There is more momentum than ever before to stop pandemics forever. No one who lived through COVID will ever forget it. Just like a war can change the way a generation looks at the world, COVID has changed the way we see the world.
Although it may not always feel like it, we have made tremendous progress over the last two years. New tools will let us respond faster next time, and new capabilities have made us better prepared to fight deadly pathogens. The world wasn’t ready for COVID, but we can choose to be ready next time.
Exemplars
We’re finally learning why countries excel at saving lives
A new program is spreading the word about the most successful approaches to health.

Ever since I was a teenager, I’ve tackled every big new problem the same way: by starting off with two questions. I used this technique at Microsoft, and I still use it today. I ask these questions literally every week about COVID-19.
Here they are: Who has dealt with this problem well? And what can we learn from them?
They seem like obvious questions, but sometimes it's surprisingly hard to find the answers—especially when it comes to global health. There are low- and middle-income countries that have made huge leaps in, for example, delivering vaccines or ending malnutrition. But anyone who wants to identify those countries, find out how they did it, and apply the lessons in their own country would have their work cut out for them.
In sports, every coach is able to study the most successful teams and figure out what they’re doing well. There’s no reason that things should be any different when the goal is preventing childhood deaths instead of scoring touchdowns.
That’s why I was eager to be part of a global effort to fill the gap. Over the past three years, health experts and organizations from countries at every income level (including the Gates Foundation) have come together to find out who has made the most progress on certain health problems, identify what made them so successful, and help others put these lessons into action.
The result of all this effort—the Exemplars in Global Health program—launched earlier this year. If you want to know which countries have made the most progress with limited resources, Exemplars is a great place to start.
For now, Exemplars focuses on five areas: under-five mortality; vaccine delivery; the role of community health workers; epidemic preparedness and response; and childhood stunting (the reduction in physical and mental development caused by poor nutrition). The team will be adding other areas, including newborn and maternal mortality, family planning, maternal anemia, and primary health care systems.
The Exemplars team has scoured the world for the best performers and worked with experts in those countries to find out what worked so well. For example, they identified seven countries that have excelled at reducing the number of children who die before their fifth birthday: Bangladesh, Cambodia, Ethiopia, Nepal, Peru, Rwanda, and Senegal. The Exemplars website has a profile of each country, detailing insights from its work that other countries could learn from.
Bangladesh—whose childhood mortality rate dropped 56 percent between 2000 and 2015—used data, research, and testing especially well, and empowered women to make decisions about their children’s health. Peru, which achieved roughly the same decline as Bangladesh, conducted local studies to identify interventions that might suit specific communities. All seven countries built up strong community health systems and made specific efforts to close the equity gap by reaching the poorest people.
Of course, not all lessons can be applied in the same way everywhere. What works in one country may not work exactly the same way in another. And it is not always obvious how to implement big changes in national health systems, which are very complex and require a lot of coordination among the government, the private sector, and non-profits.
Recognizing these challenges, the Exemplars program is much more than a website. There is also a community of global and in-country experts ready to help countries make the case for investing in the most effective programs and figure out how to adapt the lessons to their particular needs. We’re not interested in simply getting the information out there—we want to help drive change.
Our hope is to connect with decisionmakers: people who work in the governments of low- and middle-income countries, at development agencies like America’s USAID and the World Bank, and at organizations that implement health programs. Exemplars is all about figuring out how to improve health care based on evidence of what works. It will help governments use time and money more efficiently—and with the COVID-19 pandemic, there has never been a greater need to get the most impact out of every dollar spent.
I’m grateful to all the people in governments, academia, and non-profits who made the Exemplars program possible. We all started out with one goal in mind: to accelerate the progress in improving health, so that the poorest countries don't have 20 times the childhood death rate of the richest ones. I think Exemplars is a great resource that will spread success stories so even countries with very little money can benefit. And that will, ultimately, save lives.
Innovation vs. the coronavirus
The first modern pandemic (short read)
The scientific advances we need to defeat COVID-19.

This post originally appeared as an opinion piece in the Washington Post. It’s adapted from a longer article, which you can read here.
It’s entirely understandable that the national conversation has turned to a single question: “When can we get back to normal?” The shutdown has caused immeasurable pain in jobs lost, people isolated, and worsening inequity. People are ready to get going again.
Unfortunately, although we have the will, we don’t have the way—not yet. Before the United States and other countries can return to business and life as usual, we will need some innovative new tools that help us detect, treat, and prevent COVID-19.
It begins with testing. We can’t defeat an enemy if we don’t know where it is. To reopen the economy, we need to be testing enough people that we can quickly detect emerging hotspots and intervene early. We don’t want to wait until the hospitals start to fill up and more people die.
Innovation can help us get the numbers up. The current coronavirus tests require that health-care workers perform nasal swabs, which means they have to change their protective gear before every test. But our foundation supported research showing that having patients do the swab themselves produces results that are just as accurate. This self-swab approach is faster and safer, since regulators should be able to approve swabbing at home or in other locations rather than having people risk additional contact.
Another diagnostic test under development would work much like an at-home pregnancy test. You would swab your nose, but instead of sending it into a processing center, you’d put it in a liquid and then pour that liquid onto a strip of paper, which would change color if the virus was present. This test may be available in a few months.
We need one other advance in testing, but it’s social, not technical: consistent standards about who can get tested. If the country doesn’t test the right people—essential workers, people who are symptomatic, and those who have been in contact with someone who tested positive—then we’re wasting a precious resource and potentially missing big reserves of the virus. Asymptomatic people who aren’t in one of those three groups should not be tested until there are enough tests for everyone else.
The second area where we need innovation is contact tracing. Once someone tests positive, public-health officials need to know who else that person might have infected.
For now, the United States can follow Germany’s example: interview everyone who tests positive and use a database to make sure someone follows up with all their contacts. This approach is far from perfect, because it relies on the infected person to report their contacts accurately and requires a lot of staff to follow up with everyone in person. But it would be an improvement over the sporadic way that contact tracing is being done across the United States now.
An even better solution would be the broad, voluntary adoption of digital tools. For example, there are apps that will help you remember where you have been; if you ever test positive, you can review the history or choose to share it with whoever comes to interview you about your contacts. And some people have proposed allowing phones to detect other phones that are near them by using Bluetooth and emitting sounds that humans can’t hear. If someone tested positive, their phone would send a message to the other phones, and their owners could get tested. If most people chose to install this kind of application, it would probably help some.
Naturally, anyone who tests positive will immediately want to know about treatment options. Yet, right now, there is no treatment for COVID-19. Hydroxychloroquine, which works by changing the way the human body reacts to a virus, has received a lot of attention. Our foundation is funding a clinical trial that will give an indication whether it works on COVID-19 by the end of May, and it appears the benefits will be modest at best.
But several more-promising candidates are on the horizon. One involves drawing blood from patients who have recovered from COVID-19, making sure it is free of the coronavirus and other infections, and giving the plasma (and the antibodies it contains) to sick people. Several major companies are working together to see whether this succeeds.
Another type of drug candidate involves identifying the antibodies that are most effective against the novel coronavirus, and then manufacturing them in a lab. If this works, it is not yet clear how many doses could be produced; it depends on how much antibody material is needed per dose. In 2021, manufacturers may be able to make as few as 100,000 treatments or many millions.
If, a year from now, people are going to big public events—such as games or concerts in a stadium—it will be because researchers have discovered an extremely effective treatment that makes everyone feel safe to go out again. Unfortunately, based on the evidence I’ve seen, they’ll likely find a good treatment, but not one that virtually guarantees you’ll recover.
That’s why we need to invest in a fourth area of innovation: making a vaccine. Every additional month that it takes to produce a vaccine is a month in which the economy cannot completely return to normal.
The new approach I’m most excited about is known as an RNA vaccine. (The first COVID-19 vaccine to start human trials is an RNA vaccine.) Unlike a flu shot, which contains fragments of the influenza virus so your immune system can learn to attack them, an RNA vaccine gives your body the genetic code needed to produce viral fragments on its own. When the immune system sees these fragments, it learns how to attack them. An RNA vaccine essentially turns your body into its own vaccine manufacturing unit.
There are at least five other efforts that look promising. But because no one knows which approach will work, a number of them need to be funded so they can all advance at full speed simultaneously.
Even before there’s a safe, effective vaccine, governments need to work out how to distribute it. The countries that provide the funding, the countries where the trials are run, and the ones that are hardest-hit will all have a good case that they should receive priority. Ideally, there would be global agreement about who should get the vaccine first, but given how many competing interests there are, this is unlikely to happen. Whoever solves this problem equitably will have made a major breakthrough.
World War II was the defining moment of my parents’ generation. Similarly, the coronavirus pandemic—the first in a century—will define this era. But there is one big difference between a world war and a pandemic: All of humanity can work together to learn about the disease and develop the capacity to fight it. With the right tools in hand, and smart implementation, we will eventually be able to declare an end to this pandemic—and turn our attention to how to prevent and contain the next one.

Talking dirt
Why I ♥ fertilizer
I visited a warehouse in Tanzania that was filled with a magical innovation that can lift millions out of poverty.

I’ve never been shy about my passion for fertilizer. It’s a magical innovation that’s responsible for saving millions of lives from hunger and lifting millions more out of poverty by boosting agricultural productivity.
So, you can imagine my delight when I recently stepped into a warehouse in Tanzania and got a glimpse of thousands of tons of fertilizer piled as high as snow drifts. The warehouse in Dar es Salaam is part of a new fertilizer distribution center, the largest of its kind in East Africa. Watching workers fill bags with the tiny white pellets containing nitrogen, phosphorous, and other plant nutrients was a powerful reminder of how every ounce of fertilizer has the potential to transform lives in Africa.
But that potential is only realized when it reaches the hands of the world’s poorest farmers—a challenge that’s proven difficult in Africa, where fertilizer use is very low, and, as a result, agricultural productivity is too. (Farmers’ yields in many parts of Africa are just a fifth of those of U.S. farmers.)
The warehouse I visited is one critical piece of the solution for improving both the supply and demand for fertilizer in Africa.
There are many reasons fertilizer use has not caught on in Africa. Cost is one of the biggest problems. Poor roads and other weak infrastructure make transporting fertilizer expensive, driving up its price for many African farmers by about 25 percent compared to their counterparts in other parts of the world. Then, there’s the issue of supply, which is not always dependable because of weak distribution systems in many parts of the continent. Limited access to credit prevents farmers from purchasing fertilizer even if it is available. And a lack of agricultural training means that farmers may not see the value of investing in it or understand how to use it properly.
So how can a warehouse solve these challenges? Let’s start with the warehouse itself. With room for 350,000 metric tons of fertilizer—in 2016, Tanzania used a total of 277,000 metric tons—the warehouse built by Yara, a Norwegian agricultural company, can hold an ample supply to prevent shortages.
At the same time, Yara is working with the government of Tanzania and dozens of other businesses and nonprofit organizations to stimulate demand for fertilizer by providing training to smallholder farmers on how to use it to boost crop yields.
Around 80 percent of Tanzania’s workforce is engaged in farming and related industries. Growing more food through greater fertilizer use would have a huge impact on the country’s prosperity.
What I saw at work in Tanzania is part of a broader effort underway in Africa to use agricultural as an engine to power economic growth across the continent. New innovations in farming—from better fertilizer and crops that are more productive, nutritious and drought and disease resistant—will make it possible for African farmers to increase their yields in the years ahead. With greater productivity, farming families will be able to sell their surpluses to supplement their family's diet with vegetables, eggs, milk, and meat.
We’ve seen the impact of helping farmers grow more food before with the “Green Revolution,” a historic transformation of agriculture in Latin America and South and Southeast Asia during the 1960s, which doubled food production and staved off widespread famine. The increase in agriculture production was made possible by improved seeds and fertilizer use.
As Africa experiences its own agricultural revolution, however, the world must be sure to learn from the past. One of the consequences of the Green Revolution was excessive fertilizer use, leading to water pollution and other environmental impacts. That’s why our foundation continues to work with partners to help train farmers how to apply fertilizer in the proper amounts that will increase yields while also promoting environmental sustainability. We’re also working on digital soil mapping and soil testing to provide farmers with valuable insights into how to improve the health of their soil so they can remain productive for generations to come.
My visit to the warehouse was a highlight of my trip to Tanzania. Just before wrapping up my tour, I paused briefly to watch workers stack bags of fertilizer onto flatbed trucks for their long journey to farms hundreds of miles away. It was exciting to think about the farmers who would use them and the positive impact the fertilizer would have on their next harvests and their country’s future.

Light meals
Tuning up photosynthesis to feed the world
Fixing flaws in photosynthesis could help boost productivity of our most important crops.

At some point in school, you probably learned about photosynthesis—how plants use energy from sunlight to convert carbon dioxide and water into food. This remarkable process is responsible for virtually all life on Earth, providing us with the energy we need and the oxygen we breathe.
But you might not have heard that photosynthesis has some flaws.
It turns out that plants are quite inefficient when it comes to using the sun’s energy. Just a fraction of the sunlight shining on a plant ends up fueling its growth, which means our crops are producing far less food than they could be.
An international group of researchers is aiming to fix that by giving photosynthesis a tune up. If successful, their research is expected to double the productivity of some of our most important crops—like rice, maize, cowpea, soybeans, and cassava.
That would be a much-needed breakthrough because the world is facing a crisis at the dinner table. With a growing population and changes in diets—like a greater demand for more meat as people earn higher incomes—we’ll need to produce 60 to 70 percent more food by 2050. At the same time, climate change is putting additional stresses on our food supply because of erratic rainfall, severe droughts, and the spread of pests and crop diseases.
Those who are at greatest risk of hunger in the years ahead are the world’s poorest people. They live in regions with high population growth and often rely on farming both to feed their families and to earn an income.
No single solution will solve this global food crisis. We’ll need to develop innovations in all areas of agriculture to increase productivity. Improved seed varieties for crops that are resistant to drought, flood, pests, and disease. Better data to help farmers manage their crops and livestock more efficiently. And some game-changing discoveries that will lead to bigger harvests.
That’s why our foundation along with the U.S. Foundation for Food and Agriculture Research and the U.K. Government's Department for International Development is investing in the global effort to make photosynthesis more efficient. This research program, known as Realizing Increased Photosynthetic Efficiency or RIPE, is being led by the University of Illinois.
RIPE scientists began their research by modeling the entire 170-step chemical process of turning sunlight into energy. Using computer simulations, they explored which changes might lead to the biggest increases in productivity—in the same way an efficiency expert might make improvements to a car production line to maximize output.
One promising area of research involves making plants absorb sunlight more effectively. While light is essential for a plant’s survival, too much high-intensity light can cause damage to the plant. To protect themselves, plants have developed mechanisms to siphon off some of the sun’s energy as heat when they are in direct sunlight. But this creates a problem when the sun goes behind a cloud and the plant is in the shade. The plant’s protective mechanism doesn’t adjust quickly to the reduced light, inhibiting the process of photosynthesis for minutes or sometimes hours. RIPE researchers discovered a way to speed up this transition, allowing the plant to continue with photosynthesis even with light fluctuations.
Another critical area of research involves an enzyme known as Rubisco, which captures carbon dioxide and turns it into sugars for the plant. Some researchers are working to speed up Rubisco activity in the plant, which would result in higher crop productivity.
Other researchers are trying to fix an inefficiency created by Rubisco: It has a hard time distinguishing carbon dioxide from oxygen. So, about 20 percent of the time Rubisco accidently grabs an oxygen molecule instead of a carbon dioxide molecule. This results in the creation of a compound that must be recycled by the plant through a process known as photorespiration. Photorespiration is long and complicated, costing a plant energy and resources that it could use for growth. To solve this, researchers have engineered an alternative pathway to drastically shorten the photorespiration process and save energy. When tested in the lab, this fix boosted plant growth by up to 40 percent.
Much of the field testing of these improvements to photosynthesis has been done using tobacco plants. While tobacco plants are not food crops, they are a convenient proof-of-concept crop because they are easy to transform genetically and they produce a large amount of seed, shortening testing cycles. In the next phase of research, scientists are working to transfer these new genetic traits to food crops, including cowpea, cassava, and soybeans.
Still, these high yielding crops are years away from being grown on farms around the world. And they would need to pass safety tests to gain consumer acceptance. I’m excited about the progress made by the RIPE team and I look forward to hearing more about their discoveries in the future.

A fruitful partnership
How I cemented my friendship with Aliko Dangote
My friend Aliko Dangote and I are working together to fight malnutrition.

Have you ever met someone new and immediately felt like you could talk to them for hours?
That happened the first time I met Aliko Dangote. A couple years ago, he and I ended up going to the same event in New York. A mutual friend suggested that I meet him because he knew we were both super interested in global health. So we made sure to sit next to each other at dinner.
As soon as we shook hands, it was clear we had a ton in common. We both started successful businesses in the late 1970s. For our second act in life, we both chose to start foundations aimed at improving health and education. (Today, the Dangote Foundation is the largest such organization in sub-Saharan Africa.)
More importantly, we both love to geek out over things that make some people’s eyes glaze over, like cement, fertilizer, and iodized salt. Check out this video of Aliko’s recent visit to our foundation’s office in Seattle for proof:
That first meeting sparked the beginning of a fruitful friendship. In 2016, our foundations announced a joint, five-year $100 million commitment to reducing malnutrition in Nigeria.
Malnutrition is the greatest health inequity in the world. It’s responsible for nearly half of all under 5 deaths in Nigeria (and around the world). Even if you survive to adulthood, your chances of dying are much higher, and your quality of life is greatly reduced.
One of the ways our foundations are working together to fight malnutrition is through food fortification. Kids often become malnourished when they don’t get enough micronutrients—vitamins and minerals—to digest their food properly. One way to correct this is by adding micronutrients to the food that families—especially those from low-income households—are purchasing every day.
When you go to a grocery store in the U.S., a lot of food already has this fortification. Think iodized salt, or milk that comes with extra vitamin D and calcium. By introducing additional micronutrients to the food people are already eating, you can improve health without changing any habits. Our foundations are now working together to find other staple foods and condiments that could be used to deliver more micronutrients to more people in Nigeria, like fortified bouillon cubes.
Improving health in Nigeria is critical to making progress in sub-Saharan Africa. The country is home to nearly a quarter of all people living in sub-Saharan Africa, and that population is only going to grow in the future. By solving problems in Nigeria, you can have a huge impact on all of Africa.
Aliko Dangote understands this, and that’s why he’s committed to making progress in his home country. Melinda and I are lucky to have him as a partner (and friend!) in improving health.
Meet the X-shredder
Test-tube mosquitoes might help us beat malaria
Genetic editing might help us wipe out the disease.

It’s Mosquito Week again on the Gates Notes. This year I’m exploring some of the science behind malaria and other mosquito-borne diseases. You can read below about how gene editing could play a key role in eradicating malaria. I’ve also written about amazing advances in tracking the disease and how the parasite is a deadly shapeshifter.
Humans have spent thousands of years inventing new ways to kill mosquitoes. The Romans did it by draining swamps. Today you might have a bug zapper in your back yard. In low- and middle-income countries, it’s common to see people spraying insecticides or setting up sticky traps baited with sugar.
But evolution is smart. It is one-upping us by creating mosquitoes that are harder to kill. In sub-Saharan Africa and parts of South America and southeast Asia, we are seeing an alarming number of mosquitoes that can withstand insecticides.
This is especially problematic for the fight against mosquito-borne diseases like malaria. To eradicate these diseases, we need new tools to complement the ones we already have.
Our foundation is backing a lot of different advances. One that I’m especially excited about is a set of techniques for genetically modifying mosquitoes that could dramatically reduce the number of disease-carrying insects in certain areas.
What is cool about these genetic techniques is how precise they can be. Precision matters because out of more than 3,000 species of mosquitoes, only five are responsible for causing most cases of malaria. Of those, only females spread the disease, because they’re the only ones that bite humans. (They do it when they need extra protein for reproduction. Experts call it “taking a blood meal.”) The males just drink nectar.
The promise of gene editing is that, instead of killing a bunch of mosquitoes indiscriminately, we could eliminate only the dangerous ones in a particular area. That would buy us time to cure all the people there of malaria. Then we could let the mosquito population return without the parasite.
One exciting gene-editing technique is called gene drive. The term covers several different approaches, but the basic idea is to use the CRISPR method to rewrite the usual rules of inheritance. Normally, for any given gene, there’s a 50 percent chance that a parent with that gene will pass it on to a child. (It is competing with one from the other parent, and only one of the two can win.) With gene drive, the odds go up to 100 percent. You give a few mosquitoes an edited gene that inserts—or drives—itself into all their offspring. When those mosquitoes mate with wild mosquitoes, all their children will have the edited gene, and over time it will make its way through the entire population.
Imagine if blue-eyed mosquitoes had only blue-eyed children, no matter what color their partners’ eyes were. Eventually, every mosquito in that population would have blue eyes.
This chart shows you how gene drive eventually spreads a gene throughout an entire population:
There’s no reason to think gene drive is even feasible in humans, let alone advisable. There are also serious questions surrounding the use of this technology on insects, which I will get to in a moment. But first I want to give you two examples of how it works.
One is the colorfully named X-shredder. As you might remember from biology class, the sex of a mosquito is determined partly by the sex chromosomes it inherits from its parents. Females got one X chromosome from each parent; males got an X from their mother and a Y from their father.
In 2014, scientists at Imperial College London and the Fred Hutchinson center here in Seattle were able to edit a protein in male mosquitoes so that it shreds the X chromosomes in their sperm. As a result, the males pass along mostly Y chromosomes, so most of their offspring will be males. Thanks to gene drive, those offspring will also have the edited protein, so most of their children will be males.
Within a few generations, the male/female ratio gets out of whack, and eventually the species dies off in that area.
Another example involves the doublesex gene, which in mosquitoes works along with the sex chromosome to determine whether an insect turns out male or female. Last year, researchers at Imperial College London found that females with edited doublesex genes develop a mix of male and female organs, including male genitalia and a proboscis that is too flimsy to break human skin. They can’t reproduce, so the population shrinks; and they can’t take a blood meal, so they won’t spread the parasite.
The doublesex edit doesn’t affect males, although thanks to gene drive, they will pass it to their offspring, which is how it keeps spreading through the population.
We know gene-drive technology works in the lab. When the Imperial College researchers put 150 males carrying a copy of the doublesex edit in a small cage with 450 wild-type mosquitoes, the population died off within a few months (about 10 generations). The sex bias edit produced similar results.
The next step is to run tests in larger cages and, eventually, get permission from governments to do them outdoors. We need to understand things like: What’s the impact on the food chain if a certain species of mosquito starts dying off? How many altered insects would we need to introduce? How long do we need the mosquitoes to be gone? Last year, the government of Burkina-Faso agreed to allow the release of sterile, non-gene-drive mosquitoes in the wild so researchers could begin to study some of these questions.
As I mentioned, social and regulatory issues also come into play. For example, because mosquitoes don’t exactly respect national boundaries, neighboring countries will probably need to agree on the rules surrounding the use of gene-editing technology. Policymakers and scientists have been debating these questions in forums like the World Health Organization and the African Union’s development agency, and they are moving toward a consensus.
I think we can have the regulatory approvals in place by 2024 and the first gene-drive mosquitoes ready for use by 2026. Although this technique will never replace the other tools we have for fighting malaria, I’m optimistic that it could become one more important weapon in eradicating the disease.
The Youngest Continent
Giving the Mandela Lecture
Africa could change faster in the next generation than any continent ever has.

I was 9 years old when Nelson Mandela was sent to prison on Robben Island. As a boy, I learned about him in school, and I remember seeing reports about the anti-Apartheid movement on the evening news. Decades later, I got to meet him and work with him. In person he was even more inspiring than I had imagined. His humility and courage left an impression that I will never forget.
So it was a special honor to be invited to give the Nelson Mandela Lecture in Pretoria, South Africa. I eagerly accepted the invitation and quickly began working on my remarks.
I decided to share my optimism about Africa’s future—to explain why I think the continent has the potential to change faster in the next generation than any continent ever has.
It’s because Africa is the world’s youngest continent, and youth can go hand in hand with a special dynamism. I was 20 years old when Paul Allen and I started Microsoft. The entrepreneurs driving startup booms in Johannesburg, Lagos, and Nairobi are just as young, and the thousands of businesses they’re creating are already changing lives across the continent. The potential will only grow as the digital revolution brings more advances in artificial intelligence and robotics.
But positive change across Africa won’t happen automatically. The real returns will come only if Africans can unleash this talent for innovation in all of the continent’s growing population. That depends on whether all of its young people are given the opportunity to thrive.
It is still an open question, and it is the crux of my speech, which I gave today at the University of Pretoria. It was an honor to give this lecture, and I’m grateful to the Nelson Mandela Foundation and the university for inviting me. You can read my full speech below the video.
Remarks as delivered
Nelson Mandela Annual Lecture
University of Pretoria, South Africa
July 17, 2016
BILL GATES:
Well, thank you. Good evening, ladies and gentlemen. Graça Machel, Professor Ndebele, Vice Chancellor de la Rey, members of the Mamelodi families, friends and dignitaries.
I can’t think of a greater honor than giving a lecture named after Nelson Mandela.
I’m also thrilled that the theme of this lecture this year is “living together.”
It’s truly fitting because in many ways, “living together” was also the theme of Nelson Mandela’s life.
The system he fought against was based on the opposite idea—that people should be kept apart, that our superficial differences are more important than our common humanity.
Today, South Africans are still striving to “live together” in the fullest sense. But you are so much closer to that ideal because Nelson Mandela and so many others believed in the promise of one South Africa.
I was only nine years old when Nelson Mandela was sent to Robben Island. As a boy, I learned about him in school. I remembered seeing reports about the anti-Apartheid movements regularly on the evening news.
The first time I got to speak to him was in 1994 when he called me to help fund South Africa’s election.
I was running Microsoft, and largely focused on software most of the time, but I admired him so much, and I knew the election was historic. So I did what I could to help.
My first trip to Africa had been just the year before that in 1993 when my wife Melinda and I had traveled to East Africa.
The landscape was beautiful, the people were friendly, but the poverty there, which we were seeing for the first time, disturbed us. It also energized us.
Obviously, we knew parts of Africa were poor, but being on the continent turned what had been an abstraction into an injustice we couldn’t ignore.
Melinda and I had always known that we’d give our wealth to philanthropy eventually. But when we were confronted with such glaring inequity, we started thinking about how to take action sooner.
This sense of urgency was further spurred on by another trip in 1997 when I came to Johannesburg for the first time as a representative of Microsoft.
I spent most of the time in the richer part of the city in business meetings, but I also went to the community center in Soweto where Microsoft was donating computers.
My visit to Soweto, which was quite different then than it is now, taught me how much I had to learn about the world outside the comfortable bubble I’d lived in all my life.
As I walked into the community center, I noticed there weren’t any electrical connections. To keep the computer on, the one I was donating, they had rigged up an extension cord connected to a diesel generator outside. I realized the minute I left, the generator would get moved to something more important.
So as I read my remarks about the importance of the technology gap, I knew that it was only a small part of the story. Computers could help people do very important things, and in fact, they are part of how life on the continent can be revolutionized. But computers alone can’t feed disease or cure children. And if they can’t be turned on, they can’t do much at all.
So after that, Melinda and I moved to start our foundation because the cost of waiting had become clear.
Our work is based on the simple idea that every person, no matter where they live, should have the opportunity to lead a healthy and productive life.
We’ve spent the past 15 years learning about the issues and looking for the leverage points where we can do the most to help people seize their opportunity.
It was when I started coming to Africa regularly for the foundation that I got to know Nelson Mandela personally. AIDS was one of the first issues our foundation worked on, and Nelson Mandela was both an advisor and an inspiration.
One thing we talked about was the stigma around AIDS. So I remember 2005 very clearly when his own son died of AIDS. Rather than stay silent about the cause of his son’s death, Nelson Mandela announced it publicly because he knew that stopping the disease required breaking down the walls of fear and shame that surrounded it.
It is important to recall Nelson Mandela’s legacy, and I’m grateful for the opportunity to do so.
But Nelson Mandela was concerned about the future. He believed people could make the future better than the past. And so that’s what I want to focus on for the remainder of my talk.
What can South Africa become? What can Africa become? What can the world become? And what must we do to make it that way?
The Millennium Development Goals adopted by the United Nations in 2000 laid a foundation that enabled the world, including Africa, to achieve extraordinary progress over the last 15 years.
And the Sustainable Development Goals that recently replaced them set even more ambitious targets for creating the better world we all want.
When I talk about progress, I always start with child survival because whether children are living or dying is such a basic indicator of a society’s values.
Since 1990, child mortality in sub-Saharan Africa has been reduced by 54 percent. That means one million fewer children dying each year compared to 25 years ago.
Ten African countries achieved the very ambitious MDG target of reducing child mortality by over two-thirds.
At the same time, the incidence of poverty and malnutrition is down. And though economic growth has slowed in the past few years, it’s been very robust in many African countries for more than a decade.
This is real progress, but the Africa Rising narrative doesn’t tell the whole story about the life on the continent.
First, the progress have been uneven. You know this very well here in South Africa.
In last year’s Nelson Mandela Annual Lecture, the French economist, Thomas Piketty, pointed out that income inequality in South Africa is, quote, “higher than pretty much anywhere else in the world.”
In general, African countries tend to have higher rates of inequality than countries on other continents.And despite healthy average GDP growth in the region, many countries have not yet shared in it. Inequalities exist within countries and between countries.
So until progress belongs to all people everywhere, the real promise of living together will remain elusive.
Second, even with the great progress Africa has made, it still lags behind the rest of the world in most indicators. In sub-Saharan Africa, one in 12 children still die before they turn five. Now, that’s a vast improvement compared to 25 years ago, but African children are still 12 times more likely to die than the average child in the world.
And because rates of poverty and malnutrition aren’t shrinking as fast as the population is growing, the number of people who are poor or malnourished has actually gone up since 1990.
Finally, the progress is fragile. The continent’s two largest economies, here in South Africa and in Nigeria, are facing serious economic challenges. And new threats require attention. The Ebola crisis pointed out weaknesses in many national health systems. The effects of climate change are already being felt among farmers in many countries.
In short, to meet the ambitious goals of the Sustainable Development Goals, Africa needs to do more, do it faster, and make sure everybody benefits. It won’t be easy, but I believe it can be done.
The successes and failures of the past 15 years have generated examples and lessons we can follow. Phenomenal advances in science and technology are expanding the range of solutions available to solve development challenges. And then there is the ingenuity of the African people.
One topic that Nelson Mandela came back to over and over again was the power of youth. He knew what he was talking about because he started his career as a member of the African National Congress Youth League when he was still in his 20s.
Later on, he understood that highlighting the oppression of young people was a powerful way to explain why things must change. There is a universal appeal to the conviction that youth deserve a chance.
I agree with Mandela about young people, and that is one reason I am optimistic about the future of this continent. Demographically, Africa is the world’s youngest continent. And its youth can be the source of a special dynamism.
In the next 35 years, two billion babies will be born in Africa. By 2050, 40 percent of the entire world’s children will live on this continent.
Economists talk about a demographic dividend. When you have more people of working age and fewer dependents for them to take care of, you can generate phenomenal economic growth. Rapid economic growth in East Asia in the 1970s and 1980s was partly driven by the large number of young people moving into their workforce.
But, for me, the most important thing about young people is the way their minds work. Young people are better than old people at driving innovation because they’re not locked in by the limits of the past.
When I started Microsoft at the age of 19, computer science was a young field. We didn’t feel beholden to old notions about what computers could or should do. We dreamed about the next big thing and we scoured the world around us for the ideas and tools that would help us create it.
But it wasn’t just Microsoft. Steve Jobs was 21 when he started Apple. Mark Zuckerberg was only 19 when he started Facebook.
The African entrepreneurs driving startup booms in the Silicon Savannahs from Johannesburg and Cape Town to Lagos and Nairobi are just as young in chronological age, but also in their outlook. The thousands of businesses they’re creating are already changing daily life across the continent.
In a few days, I’ll be meeting with some of these young innovators. People like the 21-year-old who founded Kenya’s first software coding school to provide other young people with computer programming skills. And like the 23-year-old social entrepreneur here in South Africa who manufactures school bags from recycled plastic shopping bags. Besides being highly visible to protect children as they’re walking to school, these school bags sport a small solar panel that charges a lantern during the journey to and from school, providing illumination so students can study at home.
The full returns will come if we can multiply this talent for innovation by the whole of Africa’s growing youth population. That depends on whether Africa’s young people—all of Africa’s young people—are given the opportunity to thrive.
Nelson Mandela said, “Poverty is not natural, it is man made and it can be overcome and eradicated by the actions of human beings.”
We are the human beings that must take action. And we have to decide now because this unique moment won’t last. We must clear away the obstacles that are standing in young people’s way so that they can seize all of their potential.
If young people are sick and malnourished, their bodies and brains will never fully develop. If they are not educated well, their minds will lie dormant. If they do not have access to economic opportunities, they will not be able to achieve their goals.
But if we invest in the right things, if we make sure the basic needs of Africa’s young people are taken care of, then they will have the physical, cognitive, and emotional resources they need to change the future. Life on this continent will improve faster than it ever has. And the inequities that have kept people apart will be erased by broad-based progress that is the very meaning of the words “living together.”
When Melinda and I started our foundation 15 years ago, we asked ourselves: What are the areas of greatest impact? It was clear to us that investing in health was high on the list. When people aren’t healthy, they can’t turn their attention to other priorities. But when health improves, life improves by every measure.
Over the last 15 years, our foundation has invested more than $9 billion in Africa. And we are committed to keep on investing to help Africa.
In the next five years, we will invest another $5 billion.
Some of this money has gone into discovering and developing new and better vaccines and drugs to help prevent infectious disease. We’ve also invested in global partnerships that work closely with countries across the continent to get these solutions to the people who need them most.
We’ve been fortunate to work with amazing partners, and together we’ve seen incredible progress.
For example, the entire continent of Africa has been polio free for two years, which puts us within reach of wiping polio out from the face of the earth forever.
The newest vaccines that protect children from two of the most devastating diseases—pneumonia and diarrhea—are reaching children across Africa at the same time they’re available for children in wealthier countries.
Countries that invest in strong, community-based primary healthcare systems—including Malawi, Ethiopia, and Rwanda—are making great progress reducing child mortality.
Malaria infections and deaths are down significantly thanks to better treatment and prevention tools.
And efforts like the Ouagadougou Partnership in West Africa are helping millions of women get access to contraceptives, which make it easier for them to care for their families.
HIV/AIDS is another area where there’s been good progress. Though it’s a complicated story, and there are still big challenges ahead.
In a few days, I’ll be speaking at the International AIDS Conference in Durban. When the global AIDS community last met there in 2000, only a few thousand Africans were receiving antiretroviral drugs. Today, more than 12 million Africans are on treatment, more than a quarter of them living here in South Africa.
So this is a huge achievement, and millions of lives have been saved. But the rate of new infections remains high. In sub-Saharan Africa, more than 2,000 young people under the age of 24 are infected every single day. The number of young people dying from HIV has increased fourfold since 1990.
We need to get people to get diagnosed, we need people to seek treatment, and people who are on treatment need to be fully adherent.
Along with HIV, we have high rates of tuberculosis, including here in South Africa where TB/HIV co-infection continues to wage a devastating toll.
So we need more creative ways to make testing and treatment accessible and easier to use.
We need to get much more out of existing prevention methods like condoms, voluntary medical male circumcision, and oral anti-HIV medicine.
And we’re going to have to invent new and better preventative solutions like medicines you only have to take once a month or an effective vaccine.
If we don’t act both on today’s treatment and create these tools, the hard-earned gains made against HIV in sub-Saharan Africa over the last 15 years could actually be reversed. Because of the population growth, just doing what we are today is not enough. We need to do more.
Nutrition is another critical area of focus for Africa. Nearly one-third of the continent’s children suffer from malnutrition that stunts their growth and robs them of their physical and cognitive potential. Millions more suffer from micronutrient deficiencies. These are impacts that last a lifetime and impact whole generations of African youth.
African Development Bank President Akin Adesina put it best when he said recently that the greatest contributor to Africa’s economic growth is not physical infrastructure, but gray matter infrastructure, people’s brainpower. The best way to build that infrastructure includes proper nutrition.
Without eliminating malnutrition, we won’t get the great potential that’s there.
We know that when mothers and infants get good nutrition, that breast feeding is a key part of that. We know that certain vitamins and minerals are essential for children.
We have a number of ways to intervene to help nutrition, things like fortified cooking oil, sugar fortified with vitamin A, and sugar and flour enriched with iron, zinc, and vitamin B.
One of the most exciting advances is the breeding of crops so they are naturally more nutritious. For example, when adolescents eat high-iron pearl millet, their likelihood of iron deficiency is reduced six-fold. And just half a cup of biofortified orange sweet potato is all it takes to meet a child’s daily vitamin A needs.
The toll of micronutrient deficiency is huge, but the costs of fighting it are not.
Recent estimates done in Nigeria and Uganda indicate that every dollar invested to reduce stunting returns $17 in greater earning capacity in the workplace.
When children’s bodies and brains are healthy, the next step is an education that helps them develop the knowledge and skills to become productive contributors to society.
Improving education is hard work. I’ve learned this first hand through our foundation’s efforts to create better learning outcomes for primary, secondary, and university students in the United States.
But this hard work is incredibly important. A good education is the best lever we have for giving every young person a chance to make the most of their lives.
In Africa, as in the United States, we need new thinking and new educational tools to make sure that a high-quality education is available to every child.
In Uganda, young innovators at the NGO called Educate! are helping high schools prepare young people for the workplace by teaching students how to start their own business.
And with the high level of mobile phone penetration in Africa, technology using mobile phones to connect to the Internet have the potential to help students build foundational skills while giving teachers better feedback and support.
Globally, the educational technology sector is innovating and growing rapidly and it’s exciting to see new models and tools emerging to meet the needs of educators and students who are not connected to current systems.
At the university level, we need not only to broaden access, we have to also ensure that we have high-quality public universities that will launch the next generation of scientists, entrepreneurs, educators, and government leaders.
South Africa is blessed with some of the best universities in Africa, like the one we’re at today.
For our foundation, we partner with these universities to do our work in health and agricultural research. Maintaining the quality of this country’s higher-education system, while expanding access to more students will not be easy, but it is critical to South Africa’s future.
Other countries in the region will do well to follow South Africa’s example and provide the highest-level university education to the largest number of qualified students.
Healthy, educated young people are eager to make their way in the world. But Africa’s youth must have economic opportunity to channel their energy into progress.
Some of those youths will work in agriculture, where still over half of the workforce toils today.
We need advances to make agriculture far more productive. Today, the seeds that are used are unproductive, the soils are not very good, and so many farmers grow just enough to feed their family.
With climate change leading to more severe weather, doing more of the same will not be good enough.
The key to this is a series of innovation at every step along the way from farm to market.
First, farmers need better tools to avoid disasters and grow surplus. Things like seeds that can tolerate drought, floods, pests, and disease; affordable fertilizers that have the right mix of nutrients to replenish the soil; and easy-to-administer livestock vaccines that can help prevent flocks and herds from being wiped out.
Next, farmers need to be connected to a market where they can buy these inputs at a good price, and sell their surplus, and earn a profit that they can invest not only in their family’s basic needs, but also back into the farm.
This, in turn, will provide employment opportunities both on and off the farm as more prosperous farmers begin to support a range of agribusinesses like seed dealers, trucking companies, and processing plants.
I recently met with a group of young crop breeders, one from Ethiopia, one from Kenya, one from Nigeria, one from Uganda. I really love talking about the science of plant productivity. And in this case, I was amazed at the expertise all of these scientists brought to their work on cassava, a staple crop that provides more than one-third of the calories in many African diets.
Some had ways of improving the nutritional content of cassava. Others were breeding a variety that can resist both of the devastating diseases that are threatening to wipe out the cassava crop.
Our foundation is also working with a young computer scientist from Makerere University who designed a mobile phone app that lets farmers upload a picture of their cassava plants to find out whether it’s infected or not.
These are examples of the kind of innovators who can drive an agricultural transformation across the continent if they have the support they need. For many decades, agriculture has suffered from dramatic underinvestment. Many governments didn’t see the link between their farmers and economic growth.
Now, however, this misconception is gone. And through the Comprehensive African Agricultural Development Program, countries have a framework for transforming agriculture. The investment needs to follow so that young Africans have the means to create the thriving agriculture they envision.
With Africa’s farms as a base, the next step in economic growth is to promote job creation in other sectors. Doing this will require investment in infrastructure including energy.
Seven in 10 Africans lack access to power, which makes it harder to do everything. Harder to get healthcare in a dark clinic. Harder to learn in school when it’s boiling hot. Harder to be productive when you can’t use labor-saving machinery.
Ultimately, a shortage of power, like many African countries—including South Africa—have experienced, is also a drag on economic growth.
Businesses will not invest fully in places where they can’t operate efficiently.
A recent report projected that 500 million Africans won’t have electricity even in 2040. We need to change that.
What Africa needs is what the whole world needs: An energy advance that provides cheap, clean energy for everyone.
I’ve spent a lot of my time in the last two years working on this issue because it’s such an important advance. I’m involved with a group of business people who are collaborating with governments to not only increase energy R&D, but also to vastly increase the private investment in this area.
I get angry when I see that Africa is suffering the worst effects of climate change, although Africans had almost nothing to do with causing this.
The rich countries need to follow through on their commitment to double their energy R&D budgets so that we get the breakthroughs that are applicable globally, and we need to do that urgently.
Africa needs power now. And so there are many pragmatic steps we need to take even in advance of these new inventions.
In parts of Africa, there’s hydro and geothermal sources which are both reliable and renewable that can be exploited. There’s been a lot of work on small-scale grids and the use if micro solar. This approach can provide individuals with electricity for basic purposes, but we also need large-scale power including well-managed electrical grids.
It means organizing the power system so that it’s economic, so that the electronic bills are paid for, and so that the network is reliable 100 percent of the time.
Once we get economic viability for these utilities, then it bootstraps the economy. It allows investments that are job creating.
So there are many challenges that I’ve laid out here: Challenges in health, education, agricultural productivity, energy, and creating enough job opportunities.
These advances only happen in the context of governments that function well enough to enable them. I applaud initiatives like Mo Ibrahim’s Annual Index of African Governments, which looks objectively at multiple measures of government performance in each country on the continent.
Citizens in other regions would be well served by this kind of comprehensive effort to spotlight and spread effective governance.
A lot can be accomplished by focusing on fiscal governance and accountability. Here in South Africa, the government gets strong marks for the budget information it provides to the public.
The International Budget Partnership, an independent monitoring organization, also ranks South Africa highly for its oversight of government spending.
In some countries, individual citizens are leading the way. In Nigeria, 30-year-old Oluseun Onigbinde gave up a career in banking years ago to devote himself full time to pulling back the curtain on the Nigerian federal expenditure.
With savvy use of data and social media, he founded BudgetIT Nigeria, which provides facts and figures the average Nigerian can understand. No doubt, he’s a thorn in the side of some of Nigeria’s elite, but to me he’s an example of what one person can do to make a difference.
Governments have an opportunity not only to learn from what’s been done in the past, but to do things in new ways. One of the exciting prospects is the role they can play in accelerating use of digital technology to leapfrog traditional models and costly infrastructure associated with banking and delivery of government services.
By using mobile phones, tens of millions of people are already storing money digitally and using their phones to make purchases as if they were debit cards.
A good example of this is M-PESA in Kenya. These services don’t just give people a better way to move money around, they give people a place to save cash to fund a startup of a micro enterprise or pay a child’s school fee. They create informal insurance networks of friends and families who can help with unexpected shocks. And they increase the profitability of small businesses by lowering transaction costs, making it easy to order products and supplies, and having greater security of financial assets.
A digital financial connection can also help governments deliver services more efficiently. Studies from India show the government able to save tens of billions a year by connecting households to a digital payment system and automating all government payments.
The early evidence suggests that similar programs in Africa can also yield substantial benefits. For example, recent research in Uganda showed that providing people with digital cash transfers rather than direct food subsidies not only saved the cost of delivery, it also improved nutrition because recipients used the money to purchase a greater diversity of foods and to space out meals as needed.
Governments can accelerate this digital transformation by implementing policies that encourage commercial investment, innovation, and healthy competition.
Countries like Kenya, Tanzania, and Nigeria are already investing in the building blocks of this new digital financial platform. And I believe they’ll see substantial positive returns.
If there’s one thing I’m sure of, it’s this: Africa can achieve the future it aspires to.
That future depends on the people of Africa working together across economic and social strata and across national borders to lay a foundation so that Africa’s young people have the opportunities they deserve.
Recently, I had a meeting with students at Addis Ababa University. I started asking them the kinds of questions you would ask college students in the United States like, “What do you want to do after you graduate? What fields are you thinking of going into?”
They looked at me like I was kind of crazy for asking those questions. Each of them had a plan for their future. They felt their parents had sacrificed for decades so they could go to this university. They weren’t weighing their options, they had come to the university to get specific training, and they were eager to take that training and use it to make their country more prosperous.
They saw themselves as part of a large community with great needs.And they were going to dedicate themselves to serving that community by meeting those needs.
I see that sense of purpose when I come to Africa, and especially when I talk to young Africans. I think it’s a unique asset that people see the need to change and that they want to give back.
The students here believe not only in themselves, they also believe in their countries and the future of the continent. Our priority is to make sure they have the opportunity to turn those beliefs into action because young people with this sense of purpose can make the difference between stagnation and faster progress.
Nelson Mandela said, “Young people are capable, when aroused, of bringing down the towers of oppression and raising the banners of freedom.” But our duty is not merely to arouse, our duty is to invest in these young people, to put in place the basic building blocks so they can build the future.
And our duty is to do it now because the innovations of tomorrow depend on the opportunities available to children today.
I’m sure it’s clear to everyone that these are big and complicated challenges. But it’s just as clear that people with bravery, energy, intellect, passion, and stamina can face big, complicated challenges and overcome them.
There is so much more work to be done to create a future in which we can all live together, but there are also so many people who are eager to get to work.
Let’s do everything within our power right now to help build the future that Nelson Mandela dreamed of and the future that we will achieve together.
Thank you.
Coop Dreams
Why I would raise chickens
I’m excited about the poverty-fighting power of poultry.

If you were living on $2 a day, what would you do to improve your life?
That’s a real question for the nearly 1 billion people living in extreme poverty today. There’s no single right answer, of course, and poverty looks different in different places. But through my work with the foundation, I’ve met many people in poor countries who raise chickens, and I have learned a lot about the ins and outs of owning these birds. (As a city boy from Seattle, I had a lot to learn!) It’s pretty clear to me that just about anyone who’s living in extreme poverty is better off if they have chickens.
In fact, if I were in their shoes, that’s what I would do—I would raise chickens.
Here’s why:
- They are easy and inexpensive to take care of. Many breeds can eat whatever they find on the ground (although it’s better if you can feed them, because they’ll grow faster). Hens need some kind of shelter where they can nest, and as your flock grows, you might want some wood and wire to make a coop. Finally, chickens need a few vaccines. The one that prevents the deadly Newcastle disease costs less than 20 cents.
- They’re a good investment. Suppose a new farmer starts with five hens. One of her neighbors owns a rooster to fertilize the hens’ eggs. After three months, she can have a flock of 40 chicks. Eventually, with a sale price of $5 per chicken—which is typical in West Africa—she can earn more than $1,000 a year, versus the extreme-poverty line of about $700 a year.
- They help keep children healthy. Malnutrition kills more than 3.1 million children a year. Although eating more eggs—which are rich in protein and other nutrients—can help fight malnutrition, many farmers with small flocks find that it’s more economical to let the eggs hatch, sell the chicks, and use the money to buy nutritious food. But if a farmer’s flock is big enough to give her extra eggs, or if she ends up with a few broken ones, she may decide to cook them for her family.
- They empower women. Because chickens are small and typically stay close to home, many cultures regard them as a woman’s animal, in contrast to larger livestock like goats or cows. Women who sell chickens are likely to reinvest the profits in their families. Read more about women and chickens in Melinda’s blog post.
Dr. Batamaka Somé, an anthropologist from Burkina Faso who has worked with our foundation, has spent much of his career studying the economic impact of raising chickens in his home country. In this video he explains why he is so passionate about poultry.
A big bet on chickens
Our foundation is betting on chickens. Alongside partners throughout sub-Saharan Africa, we are working to create sustainable market systems for poultry. It’s especially important for these systems to make sure farmers can buy birds that have been properly vaccinated and are well suited to the local growing conditions. Our goal: to eventually help 30 percent of the rural families in sub-Saharan Africa raise improved breeds of vaccinated chickens, up from just 5 percent now.
When I was growing up, chickens weren’t something you studied, they were something you made silly jokes about. It has been eye-opening for me to learn what a difference they can make in the fight against poverty. It sounds funny, but I mean it when I say that I am excited about chickens.
Ring the alarm
The next epidemic is coming. Here’s how we can make sure we’re ready.
I was honored to be asked to give this year’s Shattuck Lecture.

Four years ago, the world was stunned by the Ebola outbreak in West Africa. Panic broke out all over the globe. Governments scrambled to contain the infection. By the time the last patient tested negative for the disease, the outbreak claimed thousands of lives and caused billions of dollars in economic losses.
The 2014 Ebola outbreak was a stark reminder of how vulnerable our society is to epidemics of infectious diseases. We weren’t ready then, and we’re still not ready now—but we can be. We don’t know when the next epidemic will strike, but I believe we can protect ourselves if we invest in better tools, a more effective early detection system, and a more robust global response system.
When the Massachusetts Medical Society asked me to deliver this year’s Shattuck Lecture, I knew I wanted to talk about epidemic preparedness. I was honored to address their annual meeting earlier today. Here is the full text of my prepared remarks:
BILL GATES:
Thank you, Dr. Drazen, for that kind introduction. It’s an honor to be invited to deliver the Shattuck Lecture.
Most of the speeches I give on global health are about the incredible progress and exciting new tools that are helping the world reduce child mortality and tackle infectious diseases. Thanks to better immunization and other interventions, child mortality has been reduced by more than 50 percent since 1990. We are on the verge of eradicating polio. HIV is no longer a certain death sentence. And half the world is now malaria-free.
So usually, I’m the super-optimist, pointing out that life keeps getting better for most people in the world.
There is one area, though, where the world isn’t making much progress, and that’s pandemic preparedness. This should concern us all, because if history has taught us anything, it’s that there will be another deadly global pandemic.
We can’t predict when. But given the continual emergence of new pathogens, the increasing risk of a bioterror attack, and how connected our world is through air travel, there is a significant probability of a large and lethal, modern-day pandemic occurring in our lifetimes.
Watching Hollywood thrillers, you’d think the world was pretty good at protecting the public from deadly microorganisms. We like to believe that somewhere out there, there is a team ready to spring into action – equipped with the latest and best technologies.
Government agents like Jack Bauer in 24. Harvard professors like Robert Langdon in Inferno. And WHO epidemiologists like Dr. Leonora Orantes in Contagion – who even risked getting kidnapped as she pursued “Patient Zero.”
In the real world, though, the health infrastructure we have for normal times breaks down very rapidly during major infectious disease outbreaks. This is especially true in poor countries. But even in the U.S., our response to a pandemic or widespread bioterror attack would be insufficient.
Several things in the last decade have made me pay closer attention to the risk of future pandemics. One was the outbreak of Swine Flu in 2009. While H1N1 wasn’t as lethal as people initially feared, it showed our inability to track the spread of disease and develop new tools for public health emergencies.
The Ebola epidemic in West Africa four years ago was another wake-up call. As confirmed cases climbed, the death toll mounted, and local health systems collapsed. Again, the world was much too slow to respond.
And, as biological weapons of mass destruction become easier to create in the lab, there is an increasing risk of a bioterror attack.
What the world needs – and what our safety, if not survival, demands – is a coordinated global approach. Specifically, we need better tools, an early detection system, and a global response system.
Today, I’d like to speak with you about some of the advances in tools – vaccines, drugs, and diagnostics – that make me optimistic we can get a leg up on the next pandemic. And I’ll talk about some of the gaps we must address in preparedness and response.
Interestingly, the first Shattuck Lecture – given back in 1890 – focused on a pandemic . . . the Russian flu that struck Massachusetts the previous year. The Russian flu was not especially deadly. But it was the first flu pandemic to spread across continents connected by rail travel – and between continents connected by fast ocean liners. The virus circled the globe in just four months.
But the world was soon in for much worse. Less than 30 years later, the Boston area was one of the first places in the U.S. to feel the deadly effects of the 1918 flu. Military personnel getting off and on ships at the Commonwealth Pier – near where we are meeting today – helped carry the pathogen across the U.S. and back to the battlefields of World War I.
This animation shows how quickly the virus spread across the United States. It took five weeks and killed 675,000 people.
The death toll was so great that average life expectancy in the U.S. for that period dropped by 12 years.
Worldwide, the 1918 flu killed an estimated 50 million people, perhaps more.
We have better tools today than we did a century ago. We have a seasonal flu vaccine, although it’s not always effective, you have to get one every year, and most people in the world never get the shot. We also have antibiotics for secondary infections of bacterial pneumonia.
Despite these advances, this animated simulation by the Institute for Disease Modeling shows what would happen if a highly contagious and lethal airborne pathogen – like the 1918 flu – were to occur today.
Nearly 33 million people worldwide would die in just six months.
That’s the sobering news. The good news is that scientific advances and growing interest on the federal level, in the private sector, and among philanthropic funders makes development of a universal flu vaccine more feasible now than 10 or 20 years ago.
Our foundation is involved in a variety of research partnerships, including a collaboration between the Icahn School of Medicine at Mount Sinai, GlaxoSmithKline, and PATH.
Their work focuses on several vaccine candidates that did well in animal trials and which are now in human trials.
We are also supporting efforts by others, including the National Institute of Allergy and Infectious Diseases, whose vaccine candidate is expected to advance to human safety trials in about a year.
To broaden efforts even further, today we are launching a $12 million Grand Challenge in partnership with the Page family to accelerate the development of a universal flu vaccine. The goal is to encourage bold thinking by the world’s best scientists across disciplines, including those new to the field.
Lucy and Larry Page are also supporting efforts by the Sabin Vaccine Institute to encourage innovative approaches that eliminate the threat of a deadly flu pandemic.
However, the next threat may not be a flu at all. More than likely, it will be an unknown pathogen that we see for the first time during an outbreak, as was the case with SARS, MERS, and other recently-discovered infectious diseases.
The world took an important step last year to begin addressing this risk with the launch of a public-private partnership called the Coalition for Epidemic Preparedness Innovations (CEPI).
With funding commitments of more than $630 million, CEPI’s first order of business is advancing the development of vaccines for three of the priority diseases on the WHO list for public health R&D: Lassa fever, Nipah virus, and Middle East Respiratory Syndrome.
CEPI is also working on rapid-response platforms to produce safe, effective vaccines for a range of infectious diseases – almost as quickly as new threats emerge. Later this year, CEPI will announce grants to several companies working with a variety of technologies – including nucleic acid vaccines, viral vectors, and other innovative approaches. The goal is to be able to develop, test, and release new vaccines in a matter of weeks or months, rather than years.
I’m a big fan of vaccines, but they may not be the answer when we have to respond immediately to rapidly spreading infectious disease pandemics. Not only do vaccines take time to develop and deploy; they also take at least a couple of weeks after the vaccination to generate protective immunity. So, we need to invest in other approaches like antiviral drugs and antibody therapies that can be stockpiled or rapidly manufactured to stop the spread of pandemic diseases or treat people who have been exposed.
Earlier this year, the Shionogi pharmaceutical company received approval in Japan for a new influenza anti-viral, Xofluza This single-dose drug stops flu in its tracks by inhibiting an enzyme that the virus needs to multiply.
And PrEP Biopharm, a development stage biopharmaceutical company, has demonstrated in human challenge studies that pre-activating the innate immune response through intranasal delivery of a double-stranded viral RNA “mimic” can prevent both influenza and rhinovirus.
Since the host’s innate immune response is non-virus specific, such an approach has the potential to offer protection against other types of respiratory viruses as well.
Monoclonal antibody therapies have also made incredible advances in the last couple of decades, leading to several products for cancer and autoimmune diseases. During the Ebola outbreak in West Africa several years ago, researchers were able to identify and test a promising combination of monoclonal antibodies to treat infected patients.
And a growing pipeline of broadly neutralizing antibodies are being discovered in some individuals exposed to infectious diseases. For example, a small percentage of people infected with HIV develop antibodies with high potency and breadth of coverage sufficient to protect against many strains of the virus. The same is true for some people infected with the flu.
Different sets or cocktails of these exceptional antibodies may protect against a pandemic strain of a virus even if it has genetically evolved. It is conceivable that we could create libraries of these antibodies, produce manufacturable seed stocks, and have them ready for immediate use in an outbreak—or ready to scale up manufacturing if a pandemic ensues. If we can learn how to use RNA or DNA gene delivery effectively, we may not need to make the antibodies at all.
Rapid diagnosis is also critical, especially at the beginning of an outbreak when quarantine, treatment, and other public health measures are most effective. To that end, researchers at the Broad Institute and at UC-Berkeley have developed a highly-sensitive point-of-care diagnostic test that harnesses the powerful genetic engineering technology known as CRISPR.
But instead of using CRISPR to edit DNA, they have programmed an associated protein called Cas13 to hunt for specific pieces of RNA. When Cas13 locates the relevant genetic sequence, it releases a signal molecule that indicates the presence or absence of the target.
In a paper published yesterday in the journal, Science, the Broad researchers highlighted the field-use potential of this new diagnostic. Using paper strips similar to a pregnancy test – and with minimal sample processing – the diagnostic can check a patient’s blood, saliva, or urine for evidence of a pathogen.
What’s more, it can test for multiple pathogens at once. It could, for example, identify if someone is infected with Zika or dengue virus, which have similar symptoms.
There are also some interesting advances that leverage the power of computing to help predict where pandemics are likely to emerge and model different approaches to preventing or containing them.
Over the last few years, researchers at the Institute for Health Metrics and Evaluation at the University of Washington have developed a sophisticated computer model that combines data from dozens of sources with geospatial mapping to predict the pandemic risk of infectious diseases.
They recently looked at the pandemic potential of four viral hemorrhagic fevers in Africa – including Ebola. Their analysis confirmed that Guéckédouprefecture in Guinea – where the West African Ebola outbreak originated – was indeed one of the most likely places where an individual Ebola case could lead to a widespread epidemic.
The research also pinpointed dozens of other African communities that are at high risk of outbreaks of hemorrhagic fevers.
Meanwhile, researchers at the Institute for Disease Modeling are pushing the boundaries of computational epidemiology to provide a deeper understanding of both the spread of infectious diseases and the effectiveness of different control and eradication strategies.
In the effort to eliminate malaria, for example, IDM is combining surveillance data with computational modeling to tailor antimalarial efforts to unique local conditions. They are also using quantitative analysis and modeling to evaluate various control strategies for HIV, TB, and to eradicate polio. This kind of research could provide valuable information to help predict disease transmission and identify prevention measures and intervention tactics for epidemics and pandemics.
At the Munich Security Conference last year, I asked world leaders to imagine that somewhere in the world, there is a weapon that exists – or that could emerge – that is capable of killing millions of people, bringing economies to a standstill, and casting nations into chaos.
If this were a military threat, the response – of course – would be that we should do everything possible to develop countermeasures. In the case of biological threats, that sense of urgency is lacking.
The world needs to prepare for pandemics the way the military prepares for war. This includes simulations and other preparedness exercises so we can better understand how diseases will spread and how to deal with things like quarantine and communications to minimize panic.
We need better coordination with military forces to ensure we can draw on their mobilization capacity to transport people, equipment, and supplies on a mass scale.
We need a reserve corps of trained personnel and volunteers, ready to go at a moment’s notice. And we need manufacturing and indemnification agreements in place with pharmaceutical companies –with expedited review processes for government approval of new treatments.
Last month, Congress directed the administration to come up with a comprehensive plan to strengthen global health security – here and abroad. This could be an important first step if the White House and Congress use the opportunity to articulate and embrace a leadership role for the U.S. in global health security.
No other country has the depth of scientific or technical expertise that we do – drawing on the resources of institutions like the NIH, the CDC, and advanced research organizations like DARPA and BARDA.
Our biopharmaceutical industry is the global leader in biomedical innovation. And, on the world stage, the U.S. is an influential member of international forums like the UN, the WHO, the G7, and the G20.
The point is that the U.S. can and should play a leadership role in creating the kind of pandemic preparedness and response system the world needs.
As I said at the start, I’m fundamentally an optimist, and that gives me hope that we can get prepared for the next big pandemic.
The global community eradicated smallpox, a disease that killed an estimated 300 million people in the 20th century alone.
We are on the verge of eradicating polio, a disease that 30 years ago was endemic in 125 countries and that paralyzed or killed 350,000 people a year.
And today, nearly 21 million people are receiving life-saving HIV treatment, thanks primarily to the support of the world community.
America’s global HIV initiative, PEPFAR, was the catalyst for world action on the AIDS crisis. It’s an example of the kind of leadership we need from the U.S. on a broader effort to make the world safer from other infectious disease threats. With strong bipartisan support, PEPFAR has saved millions of lives and shown that national governments can work together to address pandemics.
Somewhere in the history of these collective efforts is a roadmap to create a comprehensive pandemic preparedness and response system.
We must find it and follow it because lives – in numbers too great to comprehend – depend on it.
Thank you for the opportunity to address you today.
Buzz Kill
Could this be the first country in sub-Saharan Africa to defeat malaria?
Swaziland’s success fighting malaria can teach the world valuable lessons.

In the tiny African kingdom of Swaziland*, one of the most effective tools in the fight against malaria is a telephone number: 977.
When someone tests positive for the mosquito-borne disease at a Swazi clinic, a nurse immediately dials those three digits to report the case to the country’s national emergency response center. The call triggers a text message to the national malaria program team, which dispatches investigators—armed with computer tablets that have built-in satellite maps and GPS software—to interview the patient and test all people living within a one-kilometer radius of their home. A separate team is called in to reapply insecticide to the walls of homes in the community to help protect other families from infection.
Such vigilance is one of the reasons why Swaziland may become the first malaria-free country in sub-Saharan Africa, where most malaria deaths occur.
Swaziland’s well-coordinated malaria program—including a robust surveillance and control system—has helped reduce the number of cases in the country by more than 90 percent since 2002. Now, Swaziland aims to eliminate malaria entirely within its borders by 2020.
Swaziland’s bold goal is evidence of the incredible progress the world has made against malaria. Between 2000 and 2015, the combination of increased donor investment, strengthened political commitment, and new tools (including artemisinin combination therapies, rapid diagnostic tests, indoor residual spraying, and insecticide-treated bed nets), led to a 60 percent decline in malaria deaths.
At the same time, the difficulties Swaziland has experienced trying to become malaria free are a sobering reminder of the challenges the world faces to reach its goal of eradicating the disease. While the number of malaria cases in Swaziland has fallen to just a few hundred cases each year, tackling those final cases is more difficult than anyone imagined. Swaziland thought it would eliminate the disease by the end of 2015, and again by the end of 2017, but each time fell short of its goal. Last year, Swaziland saw its number of malaria cases rise sharply.
Globally, progress in the malaria fight has stalled. Further progress is in peril given the plateauing funding levels which make it impossible to fill remaining gaps in prevention and treatment of malaria and address the challenges of drug and insecticide resistance. After years of dramatic declines in malaria cases and deaths, the world is starting to lose ground. In 2017, the World Malaria Report showed that for the first time in years the number of malaria cases went up.
These setbacks should not lead to despair. They should serve as a wake-up call. As I told health officials at the Malaria Summit in London last week, the world needs a new strategy to meet the challenges ahead. That means developing innovations that will keep driving down malaria cases and malaria deaths, while tailoring interventions to address the specific needs of a country or region.
Swaziland is a good example of how countries can adapt their malaria control strategies to meet their unique circumstances. One of Swaziland’s biggest challenges is the cross-border movement of people infected with the disease from outside the country. Mozambique, Swaziland’s next-door neighbor, has one of the highest malaria burdens in the world. Workers from Mozambique may come into Swaziland with malaria. And when Swazis go to Mozambique, they sometimes return with the disease, which can then be passed on to their neighbors. Unpredictable weather also poses a challenge. The sudden spike of new cases last year was driven by heavier rainfall in the region, resulting in more mosquito breeding.
Swaziland and Mozambique are part of the Elimination 8 regional malaria elimination effort, which aims to wipe out malaria from eight countries in southern Africa. Last year, as part of that effort, Swaziland and Mozambique set up malaria posts along their border. As people go back and forth between the two countries, they are offered malaria tests and treatment to help prevent the importation of new cases. Since the posts were set up last year, thousands of people have been tested and treated and the national malaria program is optimistic that the number of cases will fall this year as a result.
At the same time, Swaziland remains committed to the painstaking work of investigating every new malaria case and responding swiftly to reduce the chance the disease will spread. The country also organized intensive media campaigns to warn residents and travelers of the danger of malaria and teach them how to protect themselves. Malaria diagnosis and treatment are free to everyone in private and public clinics.
I look forward to hearing more about Swaziland’s progress in the months ahead. If successful eliminating malaria within its borders, Swaziland can achieve a major milestone toward a goal once thought impossible—making Africa malaria free. I hope to see many more countries follow its lead.
* Just before I posted this, King Mswati III of Swaziland announced that the name of the country was changing to the Kingdom of eSwatini. In order to avoid confusion, I’ve used Swaziland in this post.
Out for blood
This animal kills more people in a day than sharks do in a century
I’m bringing back Mosquito Week on the Gates Notes.

Mosquitoes keep me up at night.
If you ask someone about what things scare people the most, there’s a list of usual suspects: shark attacks, heights, enclosed spaces, etc. Mosquitoes usually don’t make the cut—but they frighten me more than almost anything else.
This fear might be a bit irrational in Seattle, where I live. Our climate is too mild for the types of mosquitoes that harbor serious diseases. In other parts of the world, however, families have good reason to be afraid. Mosquitoes and the diseases they carry kill more than half a million people every year. Consider this mind-blowing statistic:
Of all the illnesses mosquitoes spread, malaria is the worst by far. More than 200 million people suffer from it every year, and a child dies from malaria every other minute of every day. If you survive, it can leave you vulnerable to other debilitating diseases and chronic anemia. It’s an awful, painful disease (I wrote about what it feels like to have malaria a couple years ago).
Melinda and I encounter a lot of suffering through our work, but one of the worst things I’ve ever seen is a child having seizures from cerebral malaria in Tanzania. I will never forget watching his small body twist in agony, as his parents waited to find out if he would survive. I wouldn’t wish that experience on anyone.
So why exactly are people more afraid of sharks than mosquitoes? The late Hans Rosling would argue that humans are hardwired to fear things that cause us physical harm. This instinct is practical if you live in poverty (on level 1 or 2), where an animal attack is more likely to kill you. But if you can afford life-saving healthcare, it can distort your perception of how significant a threat really is.
Even if you know that you’re 50,000 times more likely to get killed by a mosquito than a shark, human instinct wins out. A photo of a shark attack victim on the evening news evokes a visceral reaction, because the threat is obvious. A picture of a malaria victim in a hospital ward doesn’t trigger our fear instinct in the same way.
Despite this, I’m determined to spread the word about mosquitoes—which is why I’m bringing back Mosquito Week here on Gates Notes.
Everything I’m posting this week is dedicated to my least favorite pest. You can read some good news about a country that hopes to eliminate malaria by 2020. You can see how the bed nets the Mozambique Ministry of Health and World Vision distributed last year on behalf of the Gates Notes Insider community are making a difference. I’m going to be talking about mosquitoes on my social channels all week, and I hope you’ll join the conversation.
As long as Hollywood keeps making blockbusters about sharks, I’ll keep talking about why everyone should be more scared of a tiny bug than a 3,000-pound carnivore. Jaws is nothing compared with the flying terror that is a mosquito.
Covered
Net impact
Learn how a new, long-lasting mosquito net is helping save lives in the southern African country of Mozambique.

The world is making incredible progress against malaria. New innovations—including more effective drugs for treatment, rapid diagnostic tests, and better insecticides—have helped prevent more than 600 million cases of malaria and saved 6.8 million lives between 2000 and 2015. One new tool that helps protect families in Africa is a long-lasting type of bed net. Learn more about the impact these bed nets are having in the southern African country of Mozambique.
Fourteen-month-old Judite Luis battles malaria (and complications from malnutrition) at Chicuque Rural Hospital in Inhambane, Mozambique with her mother, Adozinda Augusta, at her side. Malaria is the leading cause of death among children under 5 in Mozambique. Judite died the day after this photo was taken.
A boy points out the holes in an old mosquito net used in his home. While the older generation of bed nets helped protect families from malaria in Mozambique, they had some downsides. They needed to be soaked in insecticide every six months and didn’t stand up to repeated washings when they got dirty, leading to tears that mosquitoes could fly through.
In November, thousands of families in Inhambane, Mozambique lined up to receive long-lasting insecticidal mosquito nets from the Mozambique Ministry of Health’s National Malaria Control Program and World Vision partnership. The nets protect people from mosquitoes for three years and can even be washed when they get dirty. (The bed net donation was made possible, in part, by the participation of Gates Notes readers in a bed net giveaway campaign last year. Thanks for your help!)
Clayton Pedro Albert, age 6, and his 11-month-old sister, Sharmila, go to bed under one of the long-lasting insecticidal nets. “There is no malaria in this house this year. Last year, it was so many times,” said Carolina Alberto, their mother. Across Mozambique, World Vision, in partnership with the Ministry of Health, has distributed more than 21 million bed nets. Ensuring families use their new bed nets is critical for controlling malaria. World Vision follows up with households to show families how to hang and care for their nets and remind them of the importance of sleeping under them every night.
Silvina Jorge Mahoche and her daughter, Celineza Mahoche, share their new insecticidal net. The Mahoche family has had malaria more times than they can remember. What they don’t forget are the painful symptoms: “A fever, chills, joint pain, headaches, and vomiting,” Silvina said. Since receiving the net last year, no one in the family has been sick from malaria.
Villagers return home after receiving new mosquito nets. Ensuring communities have universal coverage of nets and follow up to ensure appropriate use is critical to achieving malaria control and elimination. Some mosquitoes are now developing resistance to the pyrethroid insecticides used in bed nets—so researchers are working on next generation nets that use combinations of insecticides and appear effective against all mosquitoes, including insecticide-resistant ones. Much more work needs to be done to eliminate malaria in Africa, but continued innovation in bed nets and other tools will ensure that the world will continue to make progress against this deadly disease.

Beans & rice
Lunchtime in Africa
More than a meal: The humblest of school lunches can transform lives and entire nations.

Could a plate of beans and rice help change the world?
Last month, I squeezed into a child’s-size desk to have lunch with a class of primary school students in Tanzania. I was there to join them for the launch of their new school lunch program. On the menu: red beans cooked with tomatoes and onions served over rice.
You can join us in this video. (We’ve saved a plate for you.)
Lunch was delicious. More than that, it filled me with hope. Watching my 67 lunchmates—most of them 8-year-olds—dig into their piles of rice and beans, I was reminded that even the humblest of meals can have a far-reaching impact not just for individuals, but entire nations.
Here’s why: This month, as children around the globe begin another school year, millions of students in the poorest countries (and even some in wealthy countries) will turn up for classes on an empty stomach, making it difficult for them to learn and continue their schooling. According to the World Food Program, 66 million primary school-age children attend classes hungry across the developing world, with 23 million in Africa alone.
A school lunch program, however, can make a world of difference. It encourages kids to come to school, gives them energy to learn, and improves their overall health. The benefits don’t stop at the classroom door. Economic modelling shows that every US$1 invested in school meals programs brings a US$3-10 economic return from improved health, education and productivity. And a new research paper by the World Food Program found that school meals can contribute to help achieving the Global Goals, including ending hunger, quality education, and gender equality and indirectly to reducing poverty, contributing to the economy, and helping to reduce inequality.
Not too bad for a plate of beans and rice.
Stay tuned for more stories from my trip to Tanzania in the months ahead.
Bug zappers
Mosquito wars
The progress we’ve made to reduce malaria deaths is one of the most remarkable global health stories in recent years.

We’ve come a long way since the days of blaming the stars.
Malaria has terrorized humankind for thousands of years, but for most of that time, we had no idea what caused it. The ancient Greeks thought Sirius the dog star might be responsible. A Chinese medical text from 270 BCE speculated that three demons spread the disease. As recently as the mid-1800s, doctors believed malaria was caused by the stinky fumes that wafted into cities from nearby swamps (the word malaria means “bad air” in Italian).
Today, we know exactly who our enemy is: the mosquito. Doctors no longer subject malaria sufferers to unpleasant (and pointless) treatments like blood-letting and chewing tree bark. Most importantly, we’ve made massive progress in fighting a disease that as recently as 2000 killed nearly 870,000 people in a single year.
This progress is one of the most remarkable global health stories in recent years. Malaria claimed more than 429,000 lives last year, mostly in Africa and Southeast Asia. While that figure is still way too high, it represents a 50 percent reduction overall from the disease’s peak in the early 2000s. I don’t throw the word “miracle” around lightly, but that number is nothing short of miraculous.
How did we get here? I give credit to an unprecedented scale-up in global commitment and cooperation—malaria funding rose by 1,000 percent from 2000 to 2015. This money fueled a number of amazing scientific breakthroughs, enabled us to deliver them at scale, and focused more brainpower on improving both control and treatment efforts.
This October marks a decade since Melinda and I first called for eradicating malaria. It was a controversial move at the time, but the progress made since then has convinced many that this is a realistic goal (although some are still skeptical).
If I had known back in 2007 how much progress we would make in ten years, I would’ve been thrilled by how much we’ve cut the death rate. I’d also be impressed by how many insecticidal bed nets are now in use, how new treatments are helping people with the most severe cases of malaria, and how rapid diagnostic tests have made it easier to find and treat people. But it wouldn’t all be good news.
In 2007, I thought we’d have a long-lasting malaria vaccine by now. The WHO plans to begin pilot demonstration projects of a first-generation malaria vaccine in sub-Saharan Africa next year, although without a booster dose it only protects a child for less than six months. I’m hopeful that researchers will develop a next generation vaccine that offers much longer protection within the next 10 years, but a decade ago I was overly optimistic about where we’d be today.
There are still plenty of reasons to believe we can eradicate malaria, though. In the war against malaria and the mosquitoes who carry it, we’re already fighting on every front. Consider the wide array of innovations in development right now:
- New Insecticide-Treated Bed Nets: The older generation of bed nets needed to be soaked in a special insecticide solution every six months. The long-lasting nets we will distribute in Mozambique through our giveaway protect people from mosquitoes for three years and can even be washed when they get dirty. Unfortunately, some mosquitoes are now developing resistance to the pyrethroid insecticides used in these nets—so researchers are working on next generation bed nets that use combinations of insecticides and appear effective against all mosquitoes, including insecticide-resistant ones.
- Tackling Drug Resistance: In Southeast Asia, we’ve seen some types of the malaria parasite develop resistance to the drug combinations we use to cure and prevent the disease. If this drug resistance spread to Africa, it’d be a disaster. Fortunately, we have partners on the front lines finding ways to fight back. Watch this video about the amazing work one team of researchers is doing to combat drug resistance in Thailand:
- Disease Mapping: We know more today about where malaria is occurring than we have at any other point in history. Public health experts are combining anonymous data from mobile phone records with data on malaria incidence to track the movements of infected mosquitoes. That's super valuable, because it helps countries use their limited resources in places that have the highest disease burden.
- Eave Tubes: Many houses in hot climates have a gap between the roof and the walls to keep the inside cool. By sealing these gaps and inserting special tubes just below the roofline, air still flows into the house but keeps mosquitoes out with a mesh filter. Since the tubes are too high for children to reach them, the mesh can be coated with a high enough dose of insecticide to kill even insecticide-resistant mosquitoes.
- Genome Editing: Our foundation has invested a lot of money into editing the genetic code of mosquitoes. We’re still in the very early stages of development, but scientists are exploring whether this technique could one day render a small number of key mosquito species infertile or unable to carry the malaria parasite.
- Attractive Targeted Sugar Baits: Only female mosquitoes bite people, and they only do it when they’re breeding. The rest of the time, they rely on sugar for energy. These calendar-sized traps hang on the outside of homes and contain a minimum risk toxin that kills more than 95 percent of the mosquitoes that flock to their sweet scent without affecting pollinators. Trials are underway in Mali.
I think we will see an end to malaria in my lifetime. It’s a preventable and curable disease, and the public health community has already demonstrated that it’s possible to shrink the map and save lives. These new tools in the development pipeline will play a huge role in reaching our goal. While we’re still decades away from wiping malaria off the map for good, one thing is clear: the mosquito has met its match.
Loaf actually
The bread lab in my backyard
These Washington state researchers are doing cool things with baked goods.

I’ve been to lots of labs, but until recently I had never seen one that was centered on a full working kitchen. Last month I got my chance when I visited the Bread Lab, located a couple hours north of my hometown Seattle. It brings together local farmers, expert plant breeders, and world-class bakers with the goal of producing wheat for baked goods that are both delicious and good for you.
I could smell the baking bread the minute I walked in the door. Canisters of flour from different types of wheat lined the walls. Bakers were pulling warm rolls out of large commercial ovens. In the corner there was a farinograph, a machine that measures the strength of dough.
It was all very impressive. But deep down, I was a little skeptical: How would the breads actually taste? The Bread Lab emphasizes using whole grains, and not just wheat—lab director Steve Jones loves buckwheat because it’s unusually high in lysine and other nutrients. Although eating whole-grain bread might make me feel virtuous, in my experience it just never seems to taste as good as white bread.
But I got to sample lots of their baked goods, and I’m happy to report that everything I ate was delicious—even the croissants, which are especially hard to get right when you’re using whole grains.
The lab is part of Washington State University, and although most of their work is with rich-world companies including Clif Bar, La Brea Bakery, and Chipotle, they are also applying their expertise to the problem of malnutrition in poorer countries. For example, I met a Pakistani Ph.D. student, Farah Ahmad, who’s looking at ways to make chapatis, cookies, and other foods from her home country using approaches developed by the Bread Lab.
Here’s a video from my visit:
Beasts of the southern tropics
What cowboys can teach us about feeding the world
Could a cattle ranch in Australia improve food security in Africa?

Beyond breeding, Wylarah Station uses technology to ensure that their herds receive proper nutrition. I was surprised to see their ranch hands use smart watches to track how much the cows are drinking.
In the past someone had to manually inspect all of the water troughs scattered across the ranch, driving hundreds of kilometers every day. Now they receive a notification on their watch when a sensor detects that a tank needs attention. The whole operation was a far cry from the John Wayne cowboy movies I used to watch as a kid.
Not all of AACo’s innovative approaches could work in the poor world. It’s unlikely that every farmer in Africa will be wearing a smart watch anytime soon (if ever). But as smartphone usage continues to grow across the continent, it’s easy to imagine a future where Africans might use an app to order the perfect bull DNA or make sure their cattle are eating enough—something that an African ICT company called iCow is promoting in Kenya, Ethiopia, and Tanzania with help from our foundation.
Farmers across sub-Saharan Africa are already raising cattle—beef and dairy—in massive numbers. Ethiopia, Sudan, and Tanzania are among the world’s top 15 cattle producing countries. While there are legitimate questions about whether the world can meet its appetite for animal products without destroying the environment, it’s a fact that many poor people rely on cattle for both nutrition and income. I believe they should be able to raise cattle as efficiently as farmers in rich countries do.
I’m optimistic that technology can improve the quality of African cattle. A typical dairy cow in the United States produces nearly 30 liters of milk every day. Compare that to your average cow in Ethiopia, which produces just 1.69 liters of milk a day. If you want to increase milk yield, you can’t just take a high-producing Holstein cow from Wisconsin and drop it into the tropical savannah. Unlike indigenous breeds, temperate cattle have no natural resistance to tropical diseases—like trypanosomiasis, or sleeping sickness—and they struggle to get enough nutrition from local food sources.
Instead, you could breed cattle that will flourish in the local climate. That means using artificial insemination—like the process they use at Wylarah Station—to crossbreed a native female cow (with her built-in resilience to tropical heat and diseases) with a bull from a genetic line that produces lots of milk.
Our foundation is already tackling this, but AACo’s technology could make the process much more precise than it is today. One of the things that amazed me most during my visit was how much they know about the ancestry of their cattle. The animals on their ranch have a more detailed family history than most people do. If farmers in Africa were equipped with the same level of knowledge, they could handpick the best possible cow parents and breed a better calf. But that leads us to another problem.
Because they lack adequate storage, most African farmers rely on artificial insemination stations (yes, that’s what they’re really called) to provide sperm samples. Depending on how far a farmer lives from a station, the sample can sometimes heat up too much and effectively die before it is delivered. Many farmers decide not to take the risk. Instead they get their cows pregnant the old-fashioned way, which makes it harder to control genetic integrity and can lead to calves that are less resilient or produce less milk.
AACo is looking into methods that extend the viability of sperm samples. Similar technology is currently used in Europe to improve the success rate of fertilization, but it hasn’t been tried yet with tropical cattle. If successful, it could double the amount of time a sample can survive outside of storage and make it easier for more farmers across Africa to use artificial insemination.
Beyond breeding, Wylarah Station uses technology to ensure that their herds receive proper nutrition. I was surprised to see their ranch hands use smart watches to track how much the cows are drinking.
In the past someone had to manually inspect all of the water troughs scattered across the ranch, driving hundreds of kilometers every day. Now they receive a notification on their watch when a sensor detects that a tank needs attention. The whole operation was a far cry from the John Wayne cowboy movies I used to watch as a kid.
Not all of AACo’s innovative approaches could work in the poor world. It’s unlikely that every farmer in Africa will be wearing a smart watch anytime soon (if ever). But as smartphone usage continues to grow across the continent, it’s easy to imagine a future where Africans might use an app to order the perfect bull DNA or make sure their cattle are eating enough—something that an African ICT company called iCow is promoting in Kenya, Ethiopia, and Tanzania with help from our foundation.
There’s a lot we can learn from Wylarah Ranch about how to more efficiently raise cattle, but I can’t ignore the big question: should we rely on animals for food at all? Eating too much meat contributes to higher levels of obesity and heart disease, and raising animals contributes to climate change. That’s why I’ve invested in companies working on meat substitutes, which could one day eliminate the need to raise and slaughters animals entirely.
Although it might be possible to get people in richer countries to eat less, we can’t expect people in low income countries to follow suit. When I went vegetarian for a year in my late 20s, all I had to do to get my daily serving of protein was buy a can of beans or a container of tofu at the grocery store. It’s not so easy for families in poor communities to get the nutrition they need.
For them, meat and dairy are a great source of high-quality proteins that help children fully develop mentally and physically. Just 20 grams of animal protein a day can combat malnutrition, which is why our foundation’s nutrition strategy wants to get more meat, dairy, and eggs into the diets of children in Africa. Cattle are also a huge economic driver in some parts of Africa. In Ethiopia alone, cattle account for 45 percent of their agricultural GDP. In addition, livestock can actually contribute to ecosystems by stimulating pasture growth, enhancing biodiversity, and recycling energy and nutrients.
As more people in poor countries move into the middle class, they will likely eat more beef and drink more milk. But we can mitigate the impact of that growth on the environment by increasing production from the cows they already have. The cowboys of Wylarah Ranch have mastered the art of raising tropical cattle. I don’t know yet how African farmers can benefit from their expertise—our foundation is just starting to dig into this—but I’m excited about the possibilities.
Safety first
Foreign aid keeps Americans safe
The strategic case for fighting disease and poverty abroad.

You may have seen in the news that elected officials in Washington, D.C., are working on next year’s federal budget. One of the ideas that has been floated is to make deep cuts in foreign aid—the investments that America makes to help other countries fight poverty and disease.
That would be a big mistake.
For one thing, these programs amount to less than 1 percent of the federal budget. For anyone worried about the budget deficit, cutting 1 percent will not make a dent.
More importantly, these programs give American taxpayers a phenomenal return on investment, one of the best anywhere in government. They do this in three ways:
- Making Americans safer and the world more stable
- Creating jobs at home and promote trading partners that will buy American goods
- Saving lives and building up health systems so other countries can take better care of their people
Together these three points make what you might call the strategic case for aid—the argument that aid helps the countries that give it as well as those that receive it.
To be honest, the strategic case is not what prompted Melinda and me to get involved in this work more than 17 years ago. We were moved by what you could call the moral case: the idea that it is terribly unjust that people in poor countries—especially children—die of diseases that can be prevented. That is still the main thing that drives us today. But over the years we have come to see the compelling strategic case too. And we have found that people often support aid who aren’t convinced by the moral argument but are by the strategic one.
In this post I want to focus on point #1 above. I’ll come back to #2 and #3 in subsequent posts.
Let’s look at how promoting health and development keeps Americans safe.
Preparing for the next epidemicYou may remember the Ebola epidemic of 2014–16. It killed more than 11,000 people in three West African countries. Each of those deaths was a tragedy, but the epidemic could have been far worse. If it had spread to neighboring Nigeria, home to more than 180 million people and a busy international travel hub with daily flights to the world’s capitals, it would have been very hard to contain. It could have easily jumped the Atlantic and infected Americans, and spread throughout Europe or Asia.
Why didn’t that happen? One key reason is that a number of health workers were stationed in Nigeria as part of the global campaign to stamp out polio. As the Ebola epidemic took hold, they were quickly reassigned from polio to Ebola. They already had a system in place for identifying possible cases, tracking them, and reporting the data to people organizing the response. They helped contain the disease and keep it from spreading farther than it did.
The polio eradication program helped stop Ebola and saved countless people, including Americans. Its biggest public funder? The United States government.
In addition, Ebola may have been only a preview of what is to come. The next epidemic—say, a virulent flu as bad as the Spanish Flu of 1918—could be far worse. Epidemiologists estimate it could kill 30 million people, more than three times the population of New York City.
Funding from the U.S. government helps keep that from happening. It helps other countries strengthen their health systems so they can identify dangerous diseases and contain them before they get out of control.
It is no accident that the Ebola epidemic hit hardest in three countries—Guinea, Sierra Leone, and Liberia—with especially weak health systems. Helping them improve makes it more likely that we can prevent a worldwide epidemic that destabilizes entire regions of the world and kills tens of millions of people.
Stabilizing vulnerable countriesPreventing pandemics is one specific way that U.S. funding makes Americans safer. There is also a broader point here: by fighting poverty and disease, we make the world a more stable place.
For example, both evidence and common sense tell us that when people don’t have reliable food supplies, they will pick up and move someplace else—becoming migrants or refugees—and that leads to more instability. Look at the countries with the least reliable food supplies in the world: Sudan, South Sudan, Eritrea, Burundi. Each of them is either at war or recently emerged from conflict.
Syria is another tragic example. In 2007, the country suffered the worst drought in its history. More than 1 million people fled rural areas for the cities, where they hoped to find food. This migration stoked political tensions and created the foundation for the horrific civil war that continues today. Of course that war has many causes, and not every drought-stricken country will become another Syria. But it is clear that the world is not a safer place when more people are going hungry—and that when we strengthen food and farming systems, we tackle some of the root causes of migration and instability.
Improving health is another way to make countries more secure. One of my favorite all-time examples is PEPFAR, the program America launched in 2003 to stop the spread of AIDS. Today it provides life-saving medicine for more than 11 million people living with HIV in some of the world’s poorest countries. Those 11 million people are teachers, health-care workers, and police officers—people who build strong, self-sufficient societies. So it should not be surprising that in countries where PEPFAR has a presence, political instability fell by 40 percent between 2004 and 2013. In non-PEPFAR countries, it dropped only 3 percent. And the PEPFAR countries grew three times faster.
Shoring up national securityAmerican military leaders understand that fighting poverty and disease is part of a smart national-security strategy. It was true after World War II, when the United States invented modern development assistance to combat instability in Europe and prevent a third World War, and it’s true today. The more stable poor countries are, the lower the odds that America will need to intervene in them.
More than 120 retired generals and admirals recently wrote a letter to Congress arguing that U.S. aid programs “are critical to preventing conflict and reducing the need to put our men and women in uniform in harm’s way.” While he was the head of U.S. Central Command, overseeing American operations in Syria, Pakistan, Afghanistan, and elsewhere, Secretary of Defense James Mattis said: “If you don’t fully fund the State Department”—which houses many aid programs—“then I need to buy more ammunition.”
Aid is an important part of our broad diplomatic and security relationships. Out of 135 countries that receive some health or development aid from the United States, we have bilateral defense agreements with 131 of them.
These are some of the arguments I have been making in Washington on behalf of American aid. In future posts I will explain how aid not only keeps Americans safe, but also creates jobs in the United States and helps other countries become more self-sufficient. All reasons why I believe this money is well-spent and ought to be maintained.
Progress 360
Strong coffee, stronger women
How Ethiopia’s 38,000 health workers have helped save children’s lives and improved the health of their nation.

Of all the charts I’ve seen, this one is the most beautiful:
Why?
First, that descending red line captures one of the most amazing stories of human progress: It shows how the number of deaths of children under 5 per year has been cut in half since 1990.
Second, hidden along that line are millions of stories of the incredible work being done by health officials, governments, donors, and parents around the world to help save all those lives.
Here’s one of those stories. It begins with some remarkable women I met in Ethiopia. They are part of an innovative program that’s improved the health of millions of children in their country.
You can meet them yourself (and join us for a cup of coffee) in this video.
Back in 1990, Ethiopia had one of the highest rates of child mortality in the world. One in five children were dying before their 5th birthdays. With few doctors and most of its population living in rural areas, Ethiopia struggled to provide basic health services to the country. Most women in rural areas gave birth at home.
Then in 2000, the Ethiopian government made a commitment to improve its healthcare system. Ethiopia signed on to the United Nations’ Millennium Development Goals, which focused the world’s attention on fighting disease and ending poverty by using data to measure progress on health and development progress. As part of the goals, Ethiopia pledged to reduce under-five death rates by at least two-thirds by 2015.
To achieve it, Ethiopia needed to find an effective way to deliver healthcare to the remotest corners of the country. But training thousands of new doctors to staff them would take years and would be extremely costly. Instead, Ethiopia created a community health worker program. They selected thousands of people, primarily young women with at least a 10th grade education, and trained them in a set of basic health skills—including how to deliver babies, administer immunizations, and provide family planning support—that are proven to save lives. Most of the health workers were recruited from the communities they served, helping to quickly build public trust in the new effort.
In 2012, I made my first trip to Ethiopia to see the program in action for myself. I was amazed. I visited a remote health post south of Addis Ababa run by two health workers, Yetagesu Alemu and Betula Shemesie. They spent many of their days walking from door to door in their village caring for pregnant women and families with newborns. Their health post didn’t have electricity or any high tech medical equipment. Still, their efforts had made an impact on the health of the families in their community.
What was exciting to see was how this success was being repeated in villages across the country. Despite being one of the poorest countries in the world, Ethiopia managed to dramatically reduce the rate of child mortality. By 2012, Ethiopia had met the target for the Millennium Development Goal on child survival, with under-five death rates dropping by 66 percent since 1990.
One of the key reasons the program has been so effective is that the health workers are dedicated to measuring their progress. Covering nearly every square inch of the walls of the health post I visited were large charts, where the health workers would track births, immunizations, malaria cases, and other indicators. Each indicator helped them understand how well they were performing and which areas demanded more attention.
Today, Ethiopia has more than 15,000 health posts delivering primary health care to the farthest reaches of this rural country of 100 million people. The health posts are staffed by 38,000 health workers like Betula and Yetagesu.
Last summer, I had a chance to visit Ethiopia again. I caught up with Yetagesu and Betula over coffee and to learn more about how the health worker program was going. They told me how women who once delivered their babies at home were now choosing to give birth at health centers. Their communities also had access to ambulances that would pick up any woman who is ready to give birth. Yetagesu and Betula were also proud to report that they had received additional medical training to sharpen their health skills.
To be sure, there’s a lot more work to be done to improve health services in rural Ethiopia. Their communities need more ambulances. Just one vehicle serves 17 health posts, Yetagesu said. They also hoped the country would hire more health workers so they would have the time to provide families with more comprehensive services. And as Melinda and I discussed in this year’s annual letter, one of the biggest challenge in child survival is newborn deaths. In Ethiopia, about 44 percent of all childhood deaths occur within the first 28 days of life. We need to find innovative ways to solve this challenge.
Still, I’m confident that Ethiopia will continue to make progress in child survival. And what’s most exciting is that Ethiopia’s health program has been so successful that it now serves as a model for other countries to follow. Sharing lifesaving innovations like Ethiopia’s ensures that in the years ahead the most beautiful chart in the world will become even more beautiful.
A real bargain
How foreign aid helps Americans
It makes the country more secure, prevents epidemics, and saves lives.

Foreign aid is often in the hot seat, but today the heat is cranked up especially high. The United States government, one of the world’s most influential donors, is considering dramatic cuts to health and development programs around the world. I understand why some Americans watch their tax dollars going overseas and wonder why we’re not spending them at home. Here’s my answer: These projects keep Americans safe. And by promoting health, security, and economic opportunity, they stabilize vulnerable parts of the world.
This is a lesson I’ve learned myself. When I first got involved in health and development more than 15 years ago, the main motivation was to save and improve people’s lives around the world. That’s still true today, but over the years I have come to see the tangible ways in which American aid benefits Americans too.
For one thing, it helps prevent epidemics. The most recent Ebola outbreak in West Africa killed more than 11,000 people, but the death toll would have been much worse if the disease had spread widely in neighboring Nigeria, an international travel hub that’s home to 180 million people. What contained it? Among other things, a group of health workers who were stationed there for an anti-polio campaign. They were quickly reassigned to the Ebola fight, and their efforts helped stop the disease—and keep it from crossing the Atlantic to the United States.
The biggest public funder of anti-polio work has been the U.S. government, and for good reason. It is protecting Americans and helping us get ready for the next epidemic, which could be orders of magnitude deadlier than Ebola. To stop emerging diseases, we need the infrastructure built by consistent funding of well-run health programs.
Another example is America’s global HIV/AIDS effort, known as PEPFAR, which began under President George W. Bush and works with some of the world’s poorest countries. PEPFAR is an undeniable success. There are 11 million people with HIV who are alive today because of the medicines that it provides. Many more never got the virus in the first place because of prevention efforts supported by PEPFAR.
This is not simply a humanitarian accomplishment. For those countries it means more teachers, entrepreneurs, police officers, and health-care workers contributing to strong, stable societies. According to one bipartisan study, political instability and violent activity in African countries with PEPFAR programs dropped 40 percent between 2004 and 2015. Where there was no PEPFAR program, the decline was just 3 percent.
Better health puts nations on the path to self-sufficiency. How? When health improves, people decide to have fewer children, because they’re confident that the children they do have will survive into adulthood. As family size drops, it gets easier for countries to feed, educate, and provide opportunity for their people—and that is one of the best ways to stabilize any vulnerable region.
A more stable world is good for everyone. But there are other ways that aid benefits Americans in particular. It strengthens markets for U.S. goods: of our top 15 trade partners, 11 are former aid recipients. It is also visible proof of America’s global leadership. Popular support for the U.S. is high in Africa, where aid has such a dramatic impact. When you help a mother save her child’s life, she never forgets. Withdrawing now would not only cost lives, it would create a leadership vacuum that others would happily fill.
Syria is a tragic example of what can happen when the key ingredients of stability don’t come together. Beginning in 2007, the country experienced the worst drought in its history, driving more than a million people from rural areas into the cities, stoking political tension, and laying the foundation for the horrific civil war that continues today. Of course there were many causes of that war, and not every country that has a severe drought collapses as badly as Syria did. But the world will not be a safer place if the U.S. stops helping other countries meet their people’s needs.
None of this is lost on our military leaders. More than 120 retired generals and admirals recently wrote a letter to Congress arguing that U.S. programs “are critical to preventing conflict and reducing the need to put our men and women in uniform in harm’s way.” Secretary of Defense James Mattis famously said, back when he was commander of U.S. forces in Afghanistan, Pakistan, and other hotspots: “If you don’t fully fund the State Department”—which runs many of America’s key programs—“then I need to buy more ammunition.”
Protecting Americans, preventing epidemics, strengthening markets, saving lives: aid delivers phenomenal benefits, and for a bargain. It represents less than 1 percent of the federal budget, not even a penny out of every dollar. It is some of the best return on investment anywhere in government. This money is well spent, it has an enormous impact, and it ought to be maintained.
This post originally appeared on time.com.
Future investment
Preparing for the next epidemic: a first step
A new organization will help accelerate the development of vaccines we’ll need to contain future outbreaks.

At a time when world leaders are understandably focused on terrorism and other security threats, another enemy is being largely overlooked—the next epidemic.
We don’t know when the next pathogen will emerge, what it will be, how it will spread, or who will be affected, but we do know that the world is not prepared to deal with it. That was the tough lesson that Ebola (and the Zika outbreak since) taught us. Ebola claimed thousands of lives, caused billions of dollars in economic losses, and showed how vulnerable our society is to epidemics of infectious diseases. As I’ve written about before, the world lacks an effective system to detect, respond to, or prevent the next outbreak.
That’s why I’m excited this week, at the World Economic Forum in Davos, to participate in the launch of a new organization that will help the world get ready for future epidemics. Backed by the governments of Norway, India, Japan, and Germany, along with the Wellcome Trust and our foundation, the Coalition for Epidemic Preparedness Innovations (CEPI) will invest in innovations to accelerate the development of vaccines we’ll need to contain outbreaks.
CEPI’s focus on vaccine development is a critical part of getting prepared for whatever pathogens threaten us next. We know from the world’s defeat of smallpox and its successful fights against polio, measles, and other diseases that vaccines are incredibly effective tools for preventing disease and saving lives. Now, this alliance of governments, philanthropies, vaccine manufacturers, academia, NGOs, and other partners needs to work together to develop new vaccines to make the world safe from future epidemics.
Traditional approaches to making new vaccines are too slow to respond to a sudden disease outbreak. Currently, the development of a new vaccine, including testing and deployment, is a process that can typically take more than 10 years. Fast-moving epidemics don’t allow us to be that patient. In 1918, an extremely infectious and deadly strain of the flu infected about one-fifth of the world’s population and killed at least 30 million people in less than two years. Ebola and Zika were also both frightening viruses, but the way they are transmitted—through bodily fluids and mosquitoes—helped limit their spread globally. A highly-contagious airborne disease would pose a far greater threat. It would thrive in densely populated urban areas and could easily cross national borders and oceans by air travel.
My great hope for CEPI is that it will help enable the world to produce safe, effective vaccines as quickly as a new threat like this emerges. With $460 million in initial funding, CEPI will work to bring together the most advanced vaccine technologies and resources from the private and public sector that can help lead to new breakthroughs in vaccine development. CEPI’s vaccine development strategy includes two areas of focus: “just in time” vaccines for those currently unknown pathogens that will emerge, and “just in case” vaccines for pathogens that we know are at high risk of causing another outbreak, like Ebola and Middle East respiratory syndrome or MERS.
One promising area of vaccine development research is using advances in genomics to map the DNA and RNA of pathogens and make vaccines. The vaccines can be decoded by human cells to make their own vaccines and antibodies inside the body. If successful, this technology could dramatically reduce the development timeline from years to possibly months or weeks.
What’s exciting about these new technologies is that they wouldn’t just protect us from future epidemics. They also would help us to develop vaccines for existing health threats to hundreds of millions of people around the world, including HIV, malaria, and TB.
At the same time, CEPI will work to minimize regulatory hurdles that further delay the deployment of vaccines. CEPI will fund studies to evaluate these newly-developed vaccines and build vaccine stockpiles before epidemics begin, so countries can move swiftly to full vaccine efficacy trials and emergency deployment during an outbreak.
As pleased as I am to see CEPI’s work get underway, it’s important for everyone to understand that this effort is just the first step toward getting us prepared for the next epidemic. It’s an important step, but CEPI alone won’t be enough to protect us. We have a lot more work to do.
We need a global warning and response system for outbreaks. It begins with strengthening local health systems in poor countries, which have gotten hit the hardest during recent epidemics. The thousands of remote health clinics around the world will be the backbone of our global effort to defeat future epidemics. They must have trained health workers who can provide primary health care, deliver vaccines, and monitor the health of their communities.
We must have a better disease surveillance system, which includes a global database so countries can share information on cases. We also need trained medical personnel ready to mount a rapid response to an outbreak.
Last, we need to continue to invest in health research to develop not just vaccines, but also new drugs and diagnostic tests that will strengthen our ability to respond quickly and effectively to the next epidemic.
Still, we’ll never know exactly when a new disease outbreak will emerge. It could arrive tomorrow, next month, next decade, or next century. But that uncertainty shouldn’t be an excuse for inaction. I hope that today’s announcement marks the first of many steps the world will take to get prepared for the next epidemic. All of our futures depend on it.
HIV’s Deadly Partner
Let’s make TB history
By investing in R&D, I know it will be possible to discover new innovations that will make TB a disease of the past.

I visited South Africa earlier this year to learn more about the progress the country is making in the fight against HIV. I toured health clinics, met with doctors and researchers, and listened to the stories of people living with HIV. Again and again, our conversations turned to an often forgotten disease which is HIV’s lethal partner: tuberculosis.
Tuberculosis, or TB, is an infection of the lungs that kills about 1.8 million every year, including 400,000 people with HIV and TB. Historically, TB was dubbed “consumption” because it caused such severe weight loss that the disease appeared to “consume” its patients.
Together, HIV and TB form a deadly duo. HIV weakens the immune system, which makes it susceptible to TB infection and much harder for the body to fight the disease. Last year, about one-third of people living with HIV were also infected with TB bacteria, and about 35 percent of deaths among HIV-positive people were due to TB. Worldwide, South Africa has the largest number of people infected with TB and HIV.
Since 2000, better testing and treatment programs have helped drive down TB deaths by more than 20 percent, saving tens of millions of lives. But a new World Health Organization report found that the TB epidemic is larger than previously estimated. New surveillance and survey data revealed hundreds of thousands of new cases, the bulk of them in India. In 2015, there were an estimated 10.4 million new TB cases worldwide, up from 9.6 million cases in 2014. The WHO report also found that of the 10.4 million people with TB, 4.3 million of them did not receive quality care because of significant gaps in testing, treatment, and reporting of TB by health providers. TB deaths climbed to 1.8 million, up from 1.6 million in 2014.
One of the key concerns among health officials fighting TB is the rising threat of drug resistance, something I learned about during a previous visit to South Africa. New strains of the disease have emerged that do not respond to the most commonly used drug treatments available. Treating people with drug-resistant TB is complicated and costly. It also places incredible hardships on the patients who must undergo months of treatment using drugs which are toxic and have serious side-effects.
Last year, Simbongile, a young mother living outside of Cape Town, learned she was infected with drug-resistant TB and started the difficult road to recovery. Her story is heartbreaking, but she is among the lucky ones. In 2015, nearly 600,00 people fell ill from drug resistant TB treatment worldwide. Just 1 in 5 received treatment.
While the impact of drug-resistant TB is a serious problem, the vast majority of TB cases are drug sensitive, meaning they can be cured effectively with medicines so long as they are taken properly. Drug resistance emerges because of incorrect prescriptions by health providers, low-quality drugs, and patients stopping treatment prematurely. That’s why the best way to prevent drug resistance is to improve TB testing and treatment programs for drug-sensitive cases.
TB, like so many other diseases, primarily impacts the world’s poorest people. If you live in a wealthy country, it might be easy to think, as many people do, that TB is a disease of the past. That fact is reflected in the lack of funding for TB programs around the world. In 2016, global support for TB care and prevention fell $2 billion short of the $8.3 billion needed.
Stories like Simbongile’s, however, are a powerful reminder that TB is still an active threat and the world is in dire need for new innovations to prevent and treat it. By investing more in research and development, I know it will be possible to create a new generation of TB drugs and develop a new and effective TB vaccine.
TB is not a disease of the past, but if the world works together to fight it, I have no doubt it can be.
So Long, Sucker
Mapping the end of malaria
Defeating the world’s deadliest creature and the terrible disease it carries is one of the greatest success stories in global health.

A few years ago, I pulled off a purposeful prank. While I was giving a TED Talk on malaria to a room full of influential people, I opened a canister and let loose a small swarm of mosquitoes. “There’s no reason that only poor people should have the experience,” I said. I let the audience squirm in their seats for about half a minute before I let on that the mosquitoes were not infected with malaria. My gimmick worked. A distant problem suddenly got very close to home.
Today, gimmicks are no longer necessary for convincing Americans of the danger of mosquito-borne diseases. The spread of Zika virus in south Florida, Puerto Rico, and other parts of the U.S. has given millions of Americans a direct understanding what it’s like to live with the fear of mosquitoes and the harm they can do, especially to pregnant women and children.
The world must focus serious attention and resources on ending the Zika epidemic. At the same time, we should keep in mind that the overwhelming toll of mosquito-related illness and death comes from malaria. Malaria is the key reason mosquitoes are the deadliest animal in the world.
Over the years, I have been in hospitals in several African countries when malaria is at its peak. I’ve seen beds out in the corridors and two children to a bed. There’s nothing more painful to see than a child experiencing cerebral malaria, when the parasite is attacking the brain and causing horrible seizures. As a parent, these memories will stay with me for life.
That’s why it gives me great joy to share a new report published todayin The New England Journal of Medicine. Rigorous new data show that the malaria death rate in sub-Saharan Africa has declined by a stunning 57% since 2000. With almost 500,000 children still dying of malaria every year, we obviously have a long way to go. But cutting the death rate by more than half is a miracle. It’s one of the greatest success stories in the history of global health.
We’ve known for some time that malaria deaths have been declining steeply. The significance of this new study, which was produced by the Institute for Health Metrics and Evaluation, is that we now have the strongest evidence ever of just how steep the decline has been.
This progress on malaria is no accident. It’s the result of an unprecedented increase in focus and commitment by rich and poor countries alike. The amount of money available to pay for bed nets, effective medications, and malaria research rose by 1,000 percent from 2000 to 2015, fueling massive new prevention and control efforts in countries hit hard by malaria.
In Tanzania, a country that has led the way with a major scale-up, the mortality rate fell more than 80 percent from 2000 to 2015. I remember visiting Tanzania years ago during the rainy season and seeing overflowing hospitals. When I went back years later, there were almost no children in the wards.
Tanzanian health authorities have launched major campaigns to distribute insecticide-treated bed nets and encourage people—especially children—to sleep under them every night. They’ve done widespread spraying of insecticides inside homes and in urban ponds, puddles, and marshes where mosquitoes breed. And they’ve used great medications that contain a drug called artemisinin, which earned its discoverer, Youyou Tu, the 2015 Nobel Prize in Medicine. If you take three days’ worth of these pills, you can get rid of the malaria parasites in your bloodstream, which helps you and also stops you from being the source of malaria spreading back to other people.
And now we have an awesome new tool in our arsenal: precision malaria maps. In the same New England Journal article I mentioned above, the authors report on cutting-edge mapping efforts that have given us an ability to see at a very high degree of granularity (5 km by 5 km) the burden of malaria in sub-Saharan Africa. That’s super valuable for short-term interventions, like helping a country determine where to deploy health staff. It’s just as valuable for long-term efforts to reduce the rate of transmission and shrink the malaria map.
When you zoom in with these high-definition maps, you can quickly home in on the hot spots where malaria is hitting hard and yet existing tools like bed nets are not being used widely enough. These maps show that in most countries it’s actually a very small percentage of the country where the disease burden is high and you need to focus your interventions.
And here’s more good news: After years of investment, we now have better diagnostics for detecting infections in people who show no physical symptoms (because people who are infected with malaria parasites but don’t show signs of illness are a big part of the chain of transmission). We have helped private-sector companies develop new, safe insecticides that will allow us to preserve the gains we have made against malaria. We have also helped bring to market simple technologies to protect families from mosquitoes, such as “eave tubes” that kill mosquitoes trying to enter homes and new traps which exploit mosquitoes’ attraction to sugar to kill them outdoors.
As a result of all this progress, I am confident that we can pursue the end goal of not just shrinking the malaria map but wiping malaria off the map altogether. Last year, Ray Chambers, the UN Secretary General’s special envoy for malaria, and I put forward a concrete plan for eradicating the disease by 2040. The potential upside is enormous: 11 million lives and $2 trillion dollars of economic impact. And the alternative to eradication—controlling the disease forever without eliminating it—is biologically and politically untenable. It would require endless investment in the development of new drugs and insecticides just to stay one step ahead of disease resistance. I also believe it would be impossible to maintain strong political commitment to fighting malaria unless we can define a clear end point. History has shown that unless countries rid themselves of malaria altogether, they eventually see the disease come roaring back on a massive scale.
To achieve eradication by 2040, we’ll need several other key innovations under development to come to fruition.
First, we’ll need new classes of drugs that completely clear malaria parasites from the body with just one dose. We should have these new cures in about a decade.
Second, we need new tools that can prevent malaria transmission. This can either be done with an effective malaria vaccine or by reducing mosquito populations. We will soon have a first-generation vaccine, but it protects a child for less than six months without a booster dose. I’m betting that within the next 10 years, researchers can produce a vaccine that provides much longer protection.
We have another potential game-changer in the works. Our foundation is supporting scientists who are using a powerful new tool called “genome editing” to introduce genetic changes in the Anopheles gambiae species of mosquito, one of the most effective transmitters of malaria in Africa. These genetic edits cause females to produce mostly male, sterile offspring. In theory, scientists could drive this trait throughout entire populations of mosquitoes in much of Africa, dramatically reducing malaria transmission in a very short time. While I’m excited about the potential of this technology, I know that changing the mosquito genome in a permanent way is something that should be done only with incredible caution and care. My hope is that it will be possible to deploy some version of this technique in a safe manner within 10-12 years.
In 1999, Melinda and I made our first major investment in malaria—a grant to establish the Malaria Vaccine Initiative. Funding for malaria research was so diminished at the time that we nearly doubled the resources with that one single grant. That blew my mind.
Today, this is no longer a lonely fight. More than 50 countries have joined together to mobilize billions of dollars through The Global Fund. And these resources are coming not just from wealthy countries. African countries such as Benin, Côte d’Ivoire, Kenya, Namibia, Nigeria, Senegal, South Africa, Togo, and Zimbabwe are contributing as well. In fact, African countries are now, for the first time ever, mobilizing more of their own resources for malaria than they’re receiving from donors.
So the next time you hear skeptics charging that foreign aid doesn’t work, point to malaria. Foreign assistance has not chased away local resources. On the contrary, it’s encouraged African nations to step up their own health efforts. And the results have been nothing short of remarkable.
360⁰ of Connection
South Africa: Virtually There
Travel with me to South Africa to see how the country is hoping to win the fight against AIDS.

If you could shuffle all of the homes in the world like a deck of cards so that people in wealthy countries lived side by side with people from poor countries, it would transform the world’s fight against poverty, hunger, and disease. It would be impossible for people to look away, impossible for them not to help.
I was naïve about the deep poverty in the world until I took my first trip to Africa with Melinda in 1993. Seeing the disparities with our own eyes made all the difference and inspired us to start our foundation.
Since then, I’ve continued to travel regularly to Africa, India, and other parts of the developing world. I always return from my trips humbled and inspired. My one disappointment is that I wish everyone could have seen what I did. I have no doubt it would help more people become aware of the challenges the world’s poorest people face. It would also leave them as optimistic as I am about the incredible progress the world is making in health and development.
During my trip to South Africa in July, I tried something new that I hope will allow people to experience what I have. I had highlights of my visit recorded in virtual reality. It’s still an emerging technology but what excites me about it is that it allows viewers to immerse themselves in another world. You can look up and down. Turn right or left. Listen to sounds all around you. I used to think there was no substitute to being there and seeing things for yourself. But virtual reality is a close second. It fulfills my dream of allowing people to see what I’m seeing and, perhaps, feel what I’m feeling, too.
In this video, you will hear the stories of young women living with HIV. Sit beside me as I drive from the leafy suburbs of Johannesburg to the dusty township of Soweto. Feel what it’s like to be in the center of a stomping gumboot dancing troupe. And be inspired by the power of South Africa’s youth, who will drive the next generation of innovations to create a future free of AIDS.
If you want to know more about my trip to South Africa, you can read about my visit here and here. I also encourage you to learn more about The Global Fund, which has helped provide lifesaving treatment to millions of people living with HIV.
Thanks for watching and look out for more virtual reality videos in the months ahead.

Status Check
We Haven’t Turned the Corner on AIDS
Why we need to invest more in the fight.

Next week I’ll be traveling to Durban, South Africa, to attend the International AIDS Conference. It’s an important opportunity for members of the AIDS community to discuss our ongoing efforts to fight the disease. I’ll be there to listen and learn. But I’ll also be delivering my own message.
The good news is that the fight against AIDS has seen many successes. The infection rate declined for several years and millions of people have been put on treatment, allowing them to live full, productive lives.
But we have not turned the corner. The infection rate has essentially stopped declining. That’s a particular problem in sub-Saharan Africa, which has a growing population of young people, who are most susceptible to the disease. If the infection rate stays the same while the at-risk population rises, then the number of people in sub-Saharan Africa who contract HIV each year could start going up instead of down.
One reason the infection rate has stagnated is that AIDS funding has stagnated. Another reason is that the current prevention tools have not had as much impact as any of us had hoped. Voluntary medical male circumcision is a very effective prevention approach, but the programs offering the procedure have not been scaled up sufficiently to reach all those who would benefit. The newest tool, using AIDS treatment as a way to prevent HIV infection among healthy people, has not been rolled out fast enough, and asking people to take a pill every day for prevention presents its own challenges.
There is the idea of “treatment as prevention”: Treating people who have HIV not only saves their life, it also makes them much less likely to pass the virus along to others. This is a promising approach and certainly we should treat as many people as possible so we can save their lives. But it is not yet clear to me that it is financially feasible to treat enough people to get a large prevention effect. I hope to learn more about this question at the conference next week.
For all these reasons, we need to invest more in both delivering the best prevention tools we have and developing new ones that are even more effective. For example, researchers are working on prevention and treatment tools that last for several months after a single dose, which would make it easier for people to stick to the regimes. I am also optimistic that within a decade we will have an AIDS vaccine that provides an acceptable level of protection.
In this video, I explain what it will take to make the most of these opportunities and ensure that AIDS cases keep going down:
17 Million Saved
Let’s preserve this lifesaver
Why we need to keep supporting the Global Fund.

Let me cut to the chase. There’s a program that has helped save the lives of 17 million people in poor countries since 2002. It’s called the Global Fund to Fight AIDS, TB, and Malaria. It’s poised to do even more good in the years ahead, but to continue its work, it needs donors to make new funding pledges.
I just got back from Europe, which is starting to think through many tough decisions surrounding Brexit. Despite that challenge, the governments of France and Italy became the latest to make commitments to the Global Fund, building on recent pledges from Japan, Canada, the United States, and the European Commission. When I was in London, a senior member of the British government confirmed to Parliament that they remain committed to the Global Fund’s success. Although I’m confident the Global Fund will raise the money it needs—donors have consistently recognized that it’s an effective and low-cost way to save lives—we are not there yet.
Since the Global Fund started, Melinda and I have committed $1.6 billion to it. Here are four reasons why we are such big believers:
- Saving lives. In countries where the Global Fund operates, deaths from HIV, TB, and malaria have dropped by a third since 2002. Certainly the Fund doesn’t deserve sole credit for that phenomenal progress, but it has played an irreplaceable role. And its work is far from finished: Three million people still die every year from these diseases.
- Getting rid of diseases so we never have to fight them again. In my lifetime I expect to see the end of malaria, which kills nearly half a million children every year. When you eradicate a disease, you not only save lives, you free up billions of dollars and many hours of effort. One reason I’m so optimistic about ending malaria is the work of the Global Fund, which has slowed the spread of the disease and saved lives by distributing hundreds of millions of bed nets.
- Helping poor countries become more self-sufficient. If you ever hear people say “poor countries just keep getting foreign aid forever,” tell them about the Global Fund. It helps the countries it works with improve their health systems so they can take better care of their people. They also devote an increasing share of their own budgets to health (they have promised to spend 50 percent more between 2015 and 2017 than they did in the previous three years). That translates into less spending by rich governments.
- Using aid efficiently. The Fund has a done a great job keeping costs low and streamlining its work. Its operating costs are just over 2 percent of all the grants it gives out. That means the vast majority of the money that flows through the Global Fund is reaching the people who need it most.
The Global Fund raises money in three-year batches; the current batch will cover the years 2017-19. They’re asking for $13 billion, which will go toward delivering lifesaving drugs and bed nets as well as developing new tools like better diagnostics and next-generation prevention techniques. To put that number in context, it’s about 3 percent of the total foreign aid that rich countries give over three years. And consider the payoff: By one estimate, the $13 billion raised by the Global Fund will generate about $300 billion in economic benefits.
It is never easy to raise large sums of money like this, and it certainly isn’t easy now, with the refugee crisis in Europe compounding an already difficult global economy. Although I don’t think anyone would argue that fighting disease will directly end wars or stop the flow of refugees, improving health certainly makes countries more stable and more prosperous—and less likely to spread disease and instability to their neighbors.
If you want to save and improve lives, health is one of the most effective investments you can make. And if you want to improve health, the Global Fund is one of the most effective investments you can make. It is one of the kindest things people have ever done for one another, and I am inspired by the countries and leaders who are stepping up to support it.
Innovation Nation
America’s secret weapon
By investing in R&D, the U.S. creates jobs at home and helps people around the world.

This presidential election has the country captivated. As many commentators have pointed out, the primaries are more focused on personalities than policy. While the parties focus on who is going to represent them in the fall, I want to make the case for something that I hope every candidate will agree on in November: America’s unparalleled capacity for innovation. When the United States invests in innovation, it creates companies and jobs at home, makes Americans healthier and safer, and saves lives and fights poverty in the world’s poorest countries. It offers the next president a tremendous opportunity to help people in America and around the world.
Of course, America’s capacity for innovation is nothing new. We have been inventing for more than two centuries: think of Benjamin Franklin, Margaret Knight, Thomas Edison. By the end of World War II, the United States led the world in automobiles, aerospace, electronics, medicine, and other areas. Nor is the formula for success complicated: Government funding for our world-class research institutions produces the new technologies that American entrepreneurs take to market.
What is new is that more countries than ever are competing for global leadership, and they know the value of innovation. Since 2000, South Korea’s R&D spending (measured as a percentage of GDP) has gone up 90 percent. China’s has doubled. The United States’ has essentially flatlined. It’s great that the rest of the world is committing more, but if the U.S. is going to maintain its leading role, it needs to up its game.
I have seen first-hand the impact that this type of research can have. I was lucky enough to be a student when computers came along in the 1960s. At first they were very expensive, so it was hard to get access to them. But the microchip revolution, made possible by U.S. government research, completely changed that. Among other things it enabled Microsoft, the company I co-founded, to write software that made computers an invaluable tool for productivity. Later, the Internet—another product of federal research—changed the game again. It is no accident that today most of the top tech companies are still based in the United States, and their advances will have a massive impact in every area of human activity.
My favorite example is health. America’s investment in this area creates high-paying jobs at universities, biotech companies, and government labs. It leads to new treatments for disease, such as cancer therapies. It helps contain deadly epidemics like Ebola and Zika. And it saves lives in poor countries. Since 1990, the fraction of children who die before age 5 has fallen by more than half. I think that’s the greatest statistic of all time, and the United States deserves a lot of credit for making it happen.
The next few years could bring even more progress. With a little luck we could eradicate polio, a goal that is within reach because of vaccines developed by U.S. scientists. (Polio would be the second disease ever eradicated, after smallpox in 1979—in which the U.S. also played an irreplaceable role.) There is also exciting progress on malaria: The number of deaths dropped more than 40 percent from 2000 to 2012, thanks in part to America’s support for breakthrough tools like drugs and bed nets. But to make the most of these opportunities, we need to invest more in basic health research and specific areas like vaccines.
Energy is another great example. American-funded research defines the state of the art in energy production. Early advances in wind and solar technology were developed with federal money. And this research offers a strong return on investment. Between 1978 and 2000, the Department of Energy spent $17.5 billion (in today’s dollars) on research on efficiency and fossil fuels, yielding $41 billion in economic benefits. Yet until this year, the DOE’s research budget hadn’t seen a real increase since the Reagan administration.
If we step up these investments, we can create new jobs in the energy sector and develop the technologies that will power the world—while also fighting climate change, promoting energy independence, and providing affordable energy for the 1.3 billion poor people who don’t have it today. Some of the more promising areas include making fuel from solar energy, much the way plants do; making nuclear energy safer and more affordable; capturing and storing carbon; and creating new ways to store energy that let us make the most of renewables.
There’s a lot of momentum right now on clean energy research. Last year the leaders of 20 countries, including the United States, committed to double federal investments in this area. Complementing that crucial effort, I helped launch the Breakthrough Energy Coalition, a group of private investors who will back promising clean-energy companies. The next president will have a chance to accelerate this momentum.
Investing in R&D isn’t about the government picking winners and losers. The markets will do that. It’s about doing what we know works: making limited and targeted investments to lay a foundation for America’s entrepreneurs. This approach has been fundamental to U.S. leadership for decades, and it will become only more important in the years ahead.
By the end of this summer, the political parties will have chosen their leaders and will start looking ahead to the November election. The nominees will lay out their vision for America and their agenda for achieving it. These visions will probably have more differences than similarities. But I hope we can all agree that, no matter how you see America’s future, there will always be an essential role for innovation.
This article was originally published by Reuters News Agency.
Lessons From Ebola
We’re not ready for the next epidemic
We’re not ready for it. But we can get there.

I am in Vancouver this week attending the TED conference. I just gave a brief talk on a subject that I’ve been learning a lot about lately—epidemics.
The Ebola outbreak in West Africa is a tragedy—as I write this, more than 10,000 people have died. I’ve been getting regular updates on the case counts through the same system we use to track new cases of polio. Also, last month I was lucky enough to have an in-depth discussion with Tom Frieden and his team at the Centers for Disease Control and Prevention in Atlanta.
What I’ve learned is very sobering. As awful as this epidemic has been, the next one could be much worse. The world is simply not prepared to deal with a disease—an especially virulent flu, for example—that infects large numbers of people very quickly. Of all the things that could kill 10 million people or more, by far the most likely is an epidemic.
But I believe we can prevent such a catastrophe by building a global warning and response system for epidemics. It would apply the kind of planning that goes into national defense—systems for recruiting, training, and equipping health workers; investments in new tools; etc.—to the effort to prevent and contain outbreaks.
This is what my TED talk was about. You can watch it here:
The more I learn about what it takes to respond to an epidemic, the more impressed I am by the health workers who have been risking their lives to care for the sick. Just putting on a protective suit is huge undertaking. Once it’s on, it’s hard to hear what anyone else is saying, and you start to sweat after just a few minutes.
Here’s a short photo essay about one attempt to solve this problem that I was involved with.
At TED we also put together an exhibit where attendees could try on a suit for themselves:
Finally, if you’re interested in learning more, you might want to check out this op-ed I wrote for the New York Times. And if you are willing to read a little more (okay, a lot more), here is a longer paper I wrote for the New England Journal of Medicine.
Melinda and I remain committed to improving the health of the poorest 2 billion. The good news is, many of the steps required to save lives in poor countries—such as strengthening health systems—also improve the world’s ability to deal with epidemics. So I’m optimistic that we can solve this problem. Making the right investments now could save millions of lives.
An Anti-Viral Campaign
Hard questions about the next epidemic
I hit the road to talk about preventing epidemics. Here’s what I heard.

Normally when I post here on TGN, give a speech, or write an op-ed, I’m out to share good news about how the world is getting better. But last month I made an exception. In a TED talk, an op-ed in the New York Times, and a longer paper in the New England Journal of Medicine, I wanted to highlight a sobering fact: The world is not prepared to handle a major epidemic. I shared a few thoughts about what it might take to get ready, based on lessons from the Ebola epidemic in West Africa.
I was curious to hear people’s feedback on my suggestions, so it was great to meet in Berlin with a group of health experts from governments, non-profits, and pharmaceutical companies, and then with U.S. senators in Washington, D.C. In this post, I want to share a few of the things I heard.
There is general agreement that this is a big challenge. Everyone I talked to, politicians and technical experts alike, felt strongly that the world isn’t doing enough to prepare. There is also broad agreement about what to do: we need to create a global alert and response system for epidemics.
As we got into the details, though, we ran into some tough issues.
For example, I argued that in a severe epidemic, the military has to play a role. It’s the only group that can quickly move large numbers of people and equipment in and out of an affected area. But in my conversations in D.C., it became clear that the U.S. military is not chartered for this work and doesn’t prepare for it, which meant that in West Africa they were learning on the fly.
In addition, what happens when there’s an outbreak in a region where people see the army—whether it’s domestic or foreign—as the bad guy? Some NGO leaders and health workers worry that being associated with armed forces could put them in harm’s way by making them a target.
This is one of the toughest issues that came up and it deserves more discussion. At a minimum I think we need a diverse set of military groups from different countries ready to help. And we can take steps to make it clear that troops are on a humanitarian mission, for example by running simulations in different countries so citizens can see what they’re up to.
Another big topic was drug trials. In an epidemic you want to develop and test new treatments very quickly. But how do you make that happen when the usual drug-approval process takes years? Should there be an emergency regulator who decides which drugs to test, how to test them quickly, and whether to deploy one? Should (and can) they indemnify whoever is producing the drug to protect them from lawsuits?
All these conversations raised a larger issue that is fascinating to me: How should the world get ready for rare, potentially cataclysmic events? When an epidemic strikes, we will want the best health and logistics experts ready to spring into action. But which group has the budget to maintain that kind of spare capacity? Even more importantly, how do we get brilliant people to sit around waiting for an event that has a small chance of occurring in any given year?
The closest analogy I can think of is the military, where troops might go years at a time without seeing combat. They use training exercises and war games to stay sharp. I think we should be doing something similar—germ games—for epidemics.
What happens next? Even though the experts mostly agree on the broad strokes of what should be done, I don’t know whether the world will choose to put meaningful resources into this effort. But I am hopeful that it will happen. The group I joined in Berlin is providing input to German Chancellor Angela Merkel and the G7 group of wealthy countries as they think about how they can help solve this problem. Creating a global plan would help more nations see how they can contribute and hopefully draw them in. The United Nations and WHO are also looking at various steps that could improve their ability to respond. And at the Gates Foundation we’re talking about how we might be able to assist.
It is great to see this issue rising up the global agenda. The world isn’t ready yet for a serious epidemic, but I think we have a good chance to make real progress in the next few months.
Well Suited
Arming doctors to fight Ebola
As I learned recently, it’s one thing to find a new tool that will help the people fighting this deadly disease. Getting it to them is another story.

Getting new tools into the hands of the people fighting Ebola is much harder than it needs to be. I have experience with one alarming example.
Health workers in protective suits get so hot that they have a hard time caring for their patients. (For example your goggles fog up and you sweat profusely.) I asked a team of experts who work on technology for keeping vaccines cold to refocus on keeping the medical workers cool.
Within days, the team had found an existing solution: a vest with pockets where you could insert cooling packs.
Doctors who had treated Ebola patients in West Africa helped test and improve these cooling vests. Here you see Dr. Colin Bucks of Stanford University testing a vest and suit at home while under quarantine after working in Liberia. He rode a stationary bike to simulate the heat of West Africa.
Unfortunately, there was no coordinated system for getting the vests to West Africa. The team had to create new distribution channels by working directly with treatment centers in the region. They eventually got the suits to over a thousand health workers.
Although this wasn’t a critical issue, it is just one example of the challenge of preparing for a highly infectious disease. We see similar breakdowns in detecting outbreaks early, training and deploying volunteers, coordinating with the military, and more. But I’m optimistic that if we start now and stay focused, we can get ready for the next epidemic.

Dino-Might
How dinosaurs could help us fight malnutrition
Research on ancient reptiles may help us understand how children grow.

Kids love dinosaurs. When you’re three feet tall and can’t have dinner unless somebody brings you food, the idea of enormous, powerful creatures that have fangs to defend themselves and claws to capture their own meals seems pretty great.
I loved dinosaurs as much as anyone, but eventually I grew tall enough to get my own dinner, and my interest in dinosaurs waned.
My friend Nathan Myhrvold, though, never stopped loving dinosaurs. Actually, there are a lot of things Nathan never stopped loving—he’s published best-selling cookbooks and essays on bioterrorism, among other things—but if you ask him about his longest-running obsession, he’ll tell you it’s dinosaurs. His office is full of dinosaur bones, some of which he dug up himself, along with a model of a dinosaur whose tail moved so fast it broke the sound barrier.
Because he’s so curious, Nathan can take what he knows about these great reptiles and apply it to fields that seem completely unrelated—fields like childhood nutrition, one of the most important and misunderstood areas in all of development.
Here’s a short video in which he explains the connection:
Dinosaur growth rates, it turns out, are hard to study. There may be only thirty fossils of a particular dinosaur species in the world, and none of them may be complete. So how do you know whether a bone is shaped a certain way because that’s how triceratops grew or whether your particular specimen just had a funny-looking head?
In poor countries, children’s physical development is also hard to study, though for different reasons. For one thing, measurements are notoriously inaccurate. If you’re measuring a crying, squirming baby who doesn’t want a cold tape measure pressed up against his body, you might not get the numbers exactly right. There’s also a host of reasons a child could be short. Is this girl short because she’s malnourished? Is she from a short family? Or has she just not hit her growth spurt yet?
What that means is that in both areas, dinosaur growth and childhood growth, you end up with problematic data; with children, it’s messy, and with dinosaurs, it’s sparse. In both cases, though, the problem is the same: looking at the data from the wrong angle gives you the wrong answers.
Nathan thinks he’s figured out a systematic way to look at the growth records from the right angle. Since we started working with him he’s shared some promising ideas about how to measure children’s growth accurately, analyze the trends, and take action on the analysis. For example, some researchers recently looked at the relationship between gross domestic product and childhood stunting and, to everyone’s surprise, they found no correlation—until Nathan pointed out that they were using the wrong statistical methods to analyze the information. The methods he suggested instead—based on his work on dinosaurs—showed that the relationship was actually even stronger than many people in the field had thought. And that could have a big impact on how policymakers and health-care workers approach the problem of childhood nutrition.
This is a great example of a trend I hope we’ll see a lot more of: taking scientific advances from lots of different fields and using them to solve problems in global health.
Ever since dinosaurs were discovered, kids have showered them with love. Thanks to this work, we may have found a way for dinosaurs to pay them back.
Spending Pennies, Saving Lives
The Miracle of Vaccines
Vaccines, one of the best investments you can make for improving health.

Imagine there’s an infectious disease spreading through your community. It leaves some people crippled; others die from it. Then someone comes along and says: “Here’s something that will protect you from this disease for the rest of your life. You and your family can have it, for free.” You would be very relieved, right?
This scenario may seem hypothetical (though perhaps less so given how much the Ebola virus has been in the news). But it is very real for millions of people in the world’s poorest countries. Vaccines that were once out of reach for them are being delivered in greater numbers every year. That means more parents are feeling the relief of knowing their families are protected.
I’ve been looking at some of the data on vaccines and thought I would share what I’m seeing. At a time when so many news headlines are grim, it is inspiring stuff.
I’ll start with polio. Cases are down more than 99 percent since 1988. Earlier this year, we celebrated a fantastic achievement: India was declared polio-free. And in Nigeria, the number of polio cases is at an all-time low, just 6 so far this year versus more than 50 by this time last year. It’s one of only three countries that have never been polio free (the others are Pakistan and Afghanistan).
Wherever we make progress on polio, it’s a testament to the amazing work of many people: political leaders who prioritize stopping the disease, donors who help fund the effort, and—most importantly—the health workers who doggedly go from house to house to deliver vaccines. Thanks to all this work (and with a little luck), 2015 could be the first time Nigeria goes a year without a case of wild poliovirus, and the first time all of Africa is polio-free. If we maintain this commitment, I’m quite optimistic that by 2018 we will get rid of this crippling disease, everywhere, forever.
There’s also fantastic progress in delivering basic immunizations for diseases like measles and pneumonia. The impact is phenomenal: By next year, the public-health group known as Gavi, the Vaccine Alliance will have helped prevent 3.9 million deaths. And expanding vaccine coverage over the next five years can save as many as 6 million lives and unlock more than $100 billion in economic benefit.
Along those lines, we hit a big milestone in September. With the addition of South Sudan, pentavalent vaccine—which protects against five debilitating diseases—has now been introduced in all 73 countries that get financial support from Gavi. Pentavalent replaced a vaccine that protected against only three diseases, which means kids are protected from more diseases without getting any extra shots. This would never have happened without Gavi: By negotiating with manufacturers and bringing in new suppliers, it drove down the cost of pentavalent vaccine from $30 per dose in rich countries to just $1.19 for poor countries.
Another big step has been the rollout of a vaccine for rotavirus, which causes severe diarrhea. Rotavirus is one of the reasons Melinda and I first got involved in global health; in the late 1990s, we were shocked by a newspaper article that said it killed 800,000 children a year—nearly all of them in poor countries—more than almost any other disease. After more research, we decided rotavirus should be a focus of our giving. We’re gratified to see that 65 countries are now rolling out rotavirus vaccines, and more are signing up. Manufacturers in India are working on a new vaccine and talking about exporting it to other countries, which would help save even more children.
We’re also getting closer to solving some big delivery problems, like the fact that many vaccines spoil if they get too warm. Researchers are field-testing a specially designed container that keeps vaccines cold for a month or more, using just a single batch of ice and no electricity. These trials are helping thousands of African children get immunized. I’m very hopeful that containers like this one will eventually help health workers reach far more people.
A Ripple Effect
Vaccines save lives, which is reason enough to make sure they get out there. But that’s not their only benefit. Healthy children spend more time in school, and they learn better while they’re there. When health improves, poor countries can spend more on schools, roads, and other investments that drive growth, which makes them less dependent on aid.
Vaccines deliver all this for, in some cases, just pennies per shot. That’s why I say that if you want to save and improve lives around the world, vaccines are a fantastic investment.
How You Can Help
One way you can help is to ask your political leaders to support Gavi next year, when donor governments need to renew their commitments. In the United States you can do that through Shot@Life, whose website makes it easy to send a message to your representatives.
You can also help by donating to Shot@Life. For $20, you can help protect a child from pneumonia, diarrhea, polio, and measles. And Shot@Life has teamed up with Walgreens for a “Get a shot. Give a shot” program: Get a vaccine at Walgreens and they will provide one for a child in a poor country.
This is flu season in the United States, so you may already be planning to get immunized. Why not help out someone else while you’re at it?
On the Front Lines of an Epidemic
“Your blood tested positive for Ebola. I am sorry.”
A Nigerian doctor’s harrowing account of outlasting the deadly virus.

Once in a while, you read something that’s so compelling, you want to share it with everyone you can. Dr. Ada Igonoh’s story had that effect on me.
Dr. Igonoh is a physician in Lagos, Nigeria, where she helped care for Patrick Sawyer, the patient who introduced Ebola into Nigeria in July. After coming down with the deadly virus herself, she spent two harrowing weeks getting treatment in isolation wards.
When I met her at a conference in New Orleans last week, Dr. Igonoh handed me a written account of her experience. Even knowing she was going to be okay, I couldn’t stop reading—I had to know what happened next. Her optimism was inspiring. Her story also gave me a deeper appreciation for all the health workers who are heroically caring for patients and trying to stop this epidemic. And it is a good reminder of the way uncertainty reigns in the early days of an epidemic. The world’s response since then has been remarkable, and Nigeria has now been certified free of Ebola.
I want to thank Dr. Igonoh for her courage, and for agreeing to let me share her story here. It is well worth your time to read it. — Bill Gates
On the night of Sunday July 20th, 2014, Patrick Sawyer was wheeled into the emergency room of the First Consultants Medical Centre, Obalende, Lagos, with complaints of fever and body weakness. The male doctor on call admitted him as a case of malaria, and took a full history.
Knowing that Mr. Sawyer had recently arrived from Liberia, the doctor asked if he had been in contact with an Ebola patient in the last couple of weeks, and Mr. Sawyer denied any such contact. He also denied attending any funeral ceremony recently. Blood samples were taken for full blood count, malaria parasites, liver function test, and other baseline investigations. He was admitted into a private room and started on antimalarial drugs and analgesics. That night, the blood count result came back as normal and not indicative of infection.
The following day, however, his condition worsened. He barely ate any of his meals. His liver function test result showed his liver enzymes were markedly elevated. We then took samples for HIV and hepatitis screening.
At about 5:00 p.m. he requested to see a doctor. I was the doctor on call that night, so I went in to see him. He was lying in bed with his intravenous (IV) fluid bag removed from its metal stand and placed beside him. He complained that he had stooled about five times that evening and that he wanted to use the bathroom again.
I picked up the IV bag from his bed and hung it back on the stand. I told him I would inform a nurse to come and disconnect the IV so he could conveniently go to the bathroom. I walked out of his room and went straight to the nurses' station where I told the nurse on duty to disconnect his IV. I then informed my consultant, Dr. Ameyo Adadevoh, about the patient's condition, and she asked that he be placed on some medications.
The following day, the results for HIV and hepatitis screening came out negative. As we were preparing for the early morning ward rounds, I was approached by an ECOWAS [Economic Community of West African States] official who informed me that Patrick Sawyer had to catch an 11 o'clock flight to Calabar for a retreat that morning. He wanted to know if it would be possible. I told him it wasn't, as he was acutely ill. Dr. Adadevoh also told him the patient could certainly not leave the hospital in his condition. She then instructed me to write very boldly on his chart that on no account should Patrick Sawyer be allowed out of the hospital premises without the permission of Dr. Ohiaeri, our Chief Medical Consultant. All nurses and doctors were duly informed.
During our early morning ward round with Dr. Adadevoh, we concluded that this was not malaria, and that the patient needed to be screened for Ebola Viral Disease. She immediately started calling laboratories to find out where the test could be carried out. She was eventually referred to Professor Omilabu of the LUTH Virology Reference Lab in Idi-Araba, whom she called immediately.
Prof. Omilabu told her to send blood and urine samples to LUTH straightaway. She tried to reach the Lagos State Commissioner for Health but was unable to contact him at the time. She also put calls across to officials of the Federal Ministry of Health and National Centre for Disease Control.
Dr. Adadevoh at this time was in a pensive mood. Patrick Sawyer was now a suspected case of Ebola, perhaps the first in the country. He was quarantined, and strict barrier nursing was applied with all the precautionary measures we could muster. Dr. Adadevoh went online, downloaded information on Ebola, and printed copies which were distributed to the nurses, doctors and ward maids. Blood and urine samples were sent to LUTH that morning. Protective gear, gloves, shoe covers and facemasks were provided for the staff. A wooden barricade was placed at the entrance of the door to keep visitors and unauthorized personnel away from the patient. Despite the medications prescribed earlier, the vomiting and diarrhea persisted. The fever escalated from 38°C to 40°C.
On the morning of Wednesday, 23rd July, the tests carried out in LUTH showed a signal for Ebola. Samples were then sent to Dakar, Senegal for a confirmatory test. Dr. Adadevoh went for several meetings with the Lagos State Ministry of Health. Thereafter, officials from the Lagos State came to inspect the hospital and the protective measures we had put in place.
The following day, Thursday 24th July, I was again on call. At about 10:00 p.m. Mr. Sawyer requested to see me. I went into the newly created dressing room, donned my protective gear and went in to see him. He had not been cooperating with the nurses and had refused any additional treatment. He sounded confused and said he received a call from Liberia asking for a detailed medical report to be sent to them. He also said he had to travel back to Liberia on a 5:00 a.m. flight the following morning and that he didn't want to miss his flight. I told him that I would inform Dr. Adadevoh. As I was leaving the room, I met Dr. Adadevoh dressed in her protective gear, along with a nurse and another doctor. They went into his room to have a discussion with him, and as I heard later to reset his IV line which he had deliberately removed after my visit to his room.
At 6:30 a.m., Friday 25th July, I got a call from the nurse that Patrick Sawyer was completely unresponsive. Again I put on the protective gear and headed to his room. I found him slumped in the bathroom. I examined him and observed that there was no respiratory movement. I felt for his pulse; it was absent. We had lost him.
It was I who certified Patrick Sawyer dead. I informed Dr. Adadevoh immediately and she instructed that no one was to be allowed to go into his room for any reason at all. Later that day, officials from WHO came and took his body away. The test in Dakar later came out positive for Zaire strain of the Ebola virus. We now had the first official case of Ebola virus disease in Nigeria.
It was a sobering day. We all began to go over all that happened in the last few days, wondering just how much physical contact we had individually made with Patrick Sawyer. Every patient on admission was discharged that day and decontamination began in the hospital. We were now managing a crisis situation.
The next day, Saturday 26th July, all staff of First Consultants attended a meeting with Prof. Nasidi of the National Centre for Disease Control, Prof. Omilabu of LUTH Virology Reference Lab, and some officials of WHO. They congratulated us on the actions we had taken and enlightened us further about the Ebola Virus Disease. They said we were going to be grouped into high risk and low risk categories based on our individual level of exposure to Patrick Sawyer, the "index" case. Each person would receive a temperature chart and a thermometer to record temperatures in the morning and night for the next 21 days. We were all officially under surveillance. We were asked to report to them at the first sign of a fever for further blood tests to be done. We were reassured that we would all be given adequate care. The anxiety in the air was palpable.
The frenetic pace of life in Lagos, coupled with the demanding nature of my job as a doctor, means that I occasionally need a change of environment. As such, one week before Patrick Sawyer died, I had gone to my parents' home for a retreat. I was still staying with them when I received my temperature chart and thermometer on Tuesday, 29th of July. I could not contain my anxiety. People were talking about Ebola everywhere—on television, online, everywhere.
I soon started experiencing joint and muscle aches and a sore throat, which I quickly attributed to stress and anxiety. I decided to take malaria tablets. I also started taking antibiotics for the sore throat. The first couple of temperature readings were normal. Every day I would attempt to recall the period Patrick Sawyer was on admission—just how much direct and indirect contact did I have with him? I reassured myself that the contact with him was quite minimal. I completed the anti-malarials but the aches and pains persisted. I had loss of appetite and felt very tired.
On Friday, 1st of August, my temperature read a high 38.7°C. As I type this, I recall the anxiety I felt that morning. I could not believe what I saw on the thermometer. I ran to my mother's room and told her. I did not go to work that day. I cautiously started using a separate set of utensils and cups from the ones my family member were using.
On Saturday, 2nd of August, the fever worsened. It was now at 39°C and would not be reduced by taking paracetamol. This was now my second day of fever. I couldn't eat. The sore throat was getting worse. That was when I called the helpline and an ambulance was sent with WHO doctors, who came and took a sample of my blood. Later that day, I started stooling and vomiting. I stayed away from my family. I started washing my plates and spoons myself. My parents, meanwhile, were convinced that I could not have Ebola.
The following day, Sunday, 3rd of August, I got a call from one of the doctors who came to take my sample the day before. He told me that the sample which they had taken was not confirmatory, and that they needed another sample. He did not sound very coherent and I became worried. They came with the ambulance that afternoon and told me that I had to go with them to Yaba. I was confused. Couldn't the second sample be taken in the ambulance like the previous one? He said a better-qualified person at the Yaba Centre would take the sample. I asked if they would bring me back. He said "yes." Even with my symptoms, I did not believe I had Ebola. After all, my contact with Sawyer was minimal. I only touched his IV fluid bag just that once without gloves. The only time I actually touched him was when I checked his pulse and confirmed him dead, and I wore double gloves and I felt adequately protected.
I told my parents I had to go with the officials to Yaba and that I would be back that evening. I wore a white top and a pair of jeans, and I put my iPad and phones in my bag.
A man opened the ambulance door for me and moved away from me rather swiftly. Strange behavior, I thought. They were friendly with me the day before, but that day, not so. No pleasantries, no smiles. I looked up and saw my mother watching through her bedroom window.
We soon got to Yaba. I really had no clue where I was. I knew it was a hospital. I was left alone in the back of the ambulance for over four hours. My mind was in a whirl. I didn't know what to think. I was offered food to eat but I could barely eat the rice.
The ambulance door opened and a Caucasian gentleman approached me but kept a little distance. He said to me, "I have to inform you that your blood tested positive for Ebola. I am sorry."
I had no reaction. I think I must have been in shock. He then told me to open my mouth and he looked at my tongue. He said it was typical Ebola tongue. I took out my mirror from my bag and took a look and was shocked at what I saw. My whole tongue had a white coating, looked furry, and had a long, deep ridge right in the middle. I then started to look at my whole body, searching for Ebola rashes and other signs, as we had been recently instructed. I called my mother immediately and said, "Mummy, they said I have Ebola, but don't worry, I will survive it. Please go and lock my room now; don't let anyone inside and don't touch anything." She was silent. I cut the line.
I was taken to the female ward. I was shocked at the environment. It looked like an abandoned building. I suspected it had not been in use for quite a while. As I walked in, I immediately recognized one of the ward maids from our hospital. She always had a smile for me but not this time. She was ill and looked it. She had been stooling a lot, too. I soon settled into the corner and looked around the room. It smelled of feces and vomit. It also had a characteristic Ebola smell to which I became accustomed. Dinner was served—rice and stew. The pepper stung my mouth and tongue. I dropped the spoon. No dinner that night.
Dr. David, the Caucasian man who had met me at the ambulance on my arrival, came in wearing his full protective hazmat suit and goggles. It was fascinating seeing one live. I had only seen them online. He brought bottles of water and ORS, the oral fluid therapy, which he dropped by my bedside. He told me that 90 percent of the treatment depended on me. He said I had to drink at least 4.5 litres of ORS daily to replace fluids lost in stooling and vomiting. I told him I had stooled three times earlier and taken Imodium tablets to stop the stooling. He said it was not advisable, as the virus would replicate the more inside of me. It was better, he said, to let it out. He said good night and left.
My parents called. My uncle called. My husband called crying. He could not believe the news. My parents had informed him, as I didn't even know how to break the news to him.
As I lay on my bed in that isolation ward, strangely, I did not fear for my life. I was confident that I would leave that ward some day. There was an inner sense of calm. I did not for a second think that I would be consumed by the disease.
That evening, the symptoms fully kicked in. I was stooling almost every two hours. The toilets did not flush, so I had to fetch water in a bucket from the bathroom each time I used the toilet. I then placed another bucket beneath my bed for the vomiting. On occasion, I would run to the toilet with a bottle of ORS, so that as I was stooling, I was drinking.
The next day, Monday, 4th of August, I began to notice red rashes on my skin, particularly on my arms. I had developed sores all over my mouth. My head was pounding so badly. The sore throat was so severe I could not eat. I could only drink ORS. I took paracetamol for the pain. The ward maid across from me wasn't doing so well. She had stopped speaking. I couldn't even brush my teeth; the sores in my mouth were so bad. This was a battle for my life but I was determined I would not die.
Every morning, I began the day with reading and meditating on Psalm 91. The sanitary condition in the ward left much to be desired. The whole Ebola thing had caught everyone by surprise. Lagos State Ministry of Health was doing its best to contain the situation but competent hands were few. The sheets were not changed for days. The floor was stained with greenish vomitus and excrement. Dr. David would come in once or twice a day and help clean up the ward after chatting with us. He was the only doctor who attended to us. There was no one else at that time. The matrons would leave our food outside the door. They hardly entered in the initial days. Everyone was being careful. This was all so new. I could understand, was this not how we ourselves had contracted the disease? Mosquitoes were in our room until they brought us mosquito nets.
Later that evening, Dr. David brought another lady into the ward. I recognized her immediately as Justina Ejelonu, a nurse who had started working at First Consultants on the 21st of July, a day after Patrick Sawyer was admitted. She was on duty on the day Patrick reported that he was stooling. While she was attending to him that night, he had yanked off his drip, letting his blood flow almost like a tap onto her hands. Justina was pregnant and was brought into our ward bleeding from a suspected miscarriage. She had been told she was there only on observation. The news that she had contacted Ebola was broken to her the following day after results of her blood test came out positive. Justina was devastated and wept profusely—she had contracted Ebola on her first day at work.
My husband started visiting but was not allowed to come close to me. He could only see me from a window at a distance. He visited so many times. It was he who brought me a change of clothes and toiletries and other things I needed because I had not even packed a bag. I was grateful I was not with him at home when I fell ill or he would most certainly have contracted the disease. My retreat at my parents' home turned out to be the instrumentality God used to shield and save him.
I drank the ORS fluid like my life depended on it. Then I got a call from my pastor. He had been informed about my predicament. He called me every single day, morning and night, and he would pray with me over the phone. He later sent me a CD player, CDs of messages on faith and healing, and Holy Communion packs through my husband. My pastor, who also happens to be a medical doctor, encouraged me to monitor how many times I had stooled and vomited each day and how many bottles of ORS I had consumed. We would then discuss the disease and pray together. He asked me to do my research on Ebola since I had my iPad with me, and told me that he was also doing his study. He wanted us to use all relevant information on Ebola to our advantage. So I researched and found out all I could about the strange disease that had been in existence for 38 years. My research, my faith, and my positive view of life, the extended times of prayer, study and listening to encouraging messages boosted my belief that I would survive the Ebola scourge.
There are five strains of the virus, and the deadliest of them is the Zaire strain, which was what I had. But that did not matter. I believed I would overcome even the deadliest of strains. Infected patients who succumb to the disease usually die between 6 to 16 days after the onset of the disease from multiple organ failure and shock caused by dehydration. I was counting the days and keeping myself well-hydrated. I didn't intend to die in that ward.
My research gave me ammunition. I read that as soon as the virus gets into the body, it begins to replicate really fast. It enters the blood cells, destroys them and uses those same blood cells to aggressively invade other organs where they further multiply. Ideally, the body's immune system should immediately mount up a response by producing antibodies to fight the virus. If the person is strong enough, and that strength is sustained long enough for the immune system to kill off the viruses, the patient is likely to survive. If the virus replicates faster than the antibodies can handle, however, further damage is done to the organs. Ebola can be likened to multi-level, multi-organ attack, but I had no intention of letting the deadly virus destroy my system. I drank more ORS. I remember saying to myself repeatedly, "I am a survivor, I am a survivor."
I also found out that a patient with Ebola cannot be re-infected and they cannot relapse back into the disease as there is some immunity conferred on survivors. My pastor and I would discuss these findings, interpret them as it related to my situation and pray together. I looked forward to his calls. They were times of encouragement and strengthening. I continued to meditate on the Word of God. It was my daily bread.
Shortly after Justina came into the ward, the ward maid, Mrs. Ukoh, passed on. The disease had gotten into her central nervous system. We stared at her lifeless body in shock. It was a whole 12 hours before officials of WHO came and took her body away. The ward had become the house of death. The whole area surrounding her bed was disinfected with bleach. Her mattress was taken and burned.
To contain the frequent diarrhea, I had started wearing adult diapers, as running to the toilet was no longer convenient for me. The indignity was quite overwhelming, but I did not have a choice. My faith was being severely tested. The situation was desperate enough to break anyone psychologically. Dr. Ohiaeri also called us day and night, enquiring about our health and the progress we were making. He sent provisions, extra drugs, vitamins, Lucozade, towels, tissue paper; everything we needed to be more comfortable in that dark hole we found ourselves. Some of my male colleagues also had been admitted to the male ward two rooms away, but there was no interaction with them. We were saddened by the news that Jato, the ECOWAS protocol officer to Patrick Sawyer, who had also tested positive, had passed on days after he was admitted.
Two more females joined us in the ward; a nurse from our hospital and a patient from another hospital. The mood in the ward was solemn. There were times we would be awakened by the sudden, loud cry from one of the women. It was either from fear, pain mixed with the distress, or just the sheer oppression of the isolation.
I kept encouraging myself. This could not be the end for me. Five days after I was admitted, the vomiting stopped. A day after that, the diarrhea ceased. I was overwhelmed with joy. It happened at a time I thought I could no longer stand the ORS. Drinking that fluid had stretched my endurance greatly.
I knew countless numbers of people were praying for me. Prayer meetings were being held on my behalf. My family was praying day and night. Text messages of prayers flooded my phone from family members and friends. I was encouraged to press on. With the encouragement I was receiving, I began to encourage the others in the ward. We decided to speak life and focus on the positive.
I then graduated from drinking only the ORS fluid to eating only bananas, to drinking pap and then bland foods. Just when I thought I had the victory, I suddenly developed a severe fever. The initial fever had subsided four days after I was admitted, and then suddenly it showed up again. I thought it was the Ebola. I enquired from Dr. David, who said fever was sometimes the last thing to go, but he expressed surprise that it had stopped only to come back on again. I was perplexed.
I discussed it with my pastor, who said it could be a separate pathology and possibly a symptom of malaria. He promised he would research if indeed this was Ebola or something else. That night as I stared at the dirty ceiling, I felt a strong impression that the new fever I had developed was not as a result of Ebola but malaria. I was relieved. The following morning, Dr. Ohiaeri sent me an antimalarial medication, which I took for three days. Before the end of the treatment, the fever had disappeared.
I began to think about my mother. She was under surveillance along with my other family members. I was worried. She had touched my sweat. I couldn't get the thought off my mind. I came across a tweet by WHO saying that the sweat of an Ebola patient cannot transmit the virus at the early stage of the infection. The sweat could only transmit it at the late stage.
That settled it for me. It calmed the storms that were raging with me concerning my parents. I knew right away it was divine guidance that caused me to see that tweet. I could cope with having Ebola, but I was not prepared to deal with a member of my family contracting it from me.
Soon, volunteer doctors started coming to help Dr. David take care of us. They had learned how to protect themselves. Among the volunteer doctors was Dr. Badmus, my consultant in LUTH during my housemanship days. It was good to see a familiar face among the care-givers. I soon understood the important role these brave volunteers were playing. As they increased in number, so did the number of shifts increase and subsequently the number of times the patients could access a doctor in one day. That allowed for more frequent patient monitoring and treatment. It also reduced care-giver fatigue. It was clear that Lagos State was working hard to contain the crisis.
Sadly, Justina succumbed to the disease on the 12th of August. It was a great blow and my faith was greatly shaken as a result. I commenced daily Bible study with the other two female patients and we would encourage one another to stay positive in our outlook, though in the natural it was grim and very depressing. My communion sessions with the other women were very special moments for us all.
On the 10th day in the ward, the doctors having noted that I had stopped vomiting and stooling and was no longer running a fever, decided it was time to take my blood sample to test if the virus had cleared from my system. They took the sample and told me that I shouldn't be worried if it comes out positive as the virus takes a while before it is cleared completely. I prayed that I didn't want any more samples collected from me. I wanted that to be the first and last sample to be tested for the absence of the virus in my system. I called my pastor. He encouraged me and we prayed again about the test.
On the evening of the day Justina passed on, we were moved to the new isolation centre. We felt like we were leaving hell and going to heaven. We were conveyed to the new place in an ambulance. It was just behind the old building. Time would not permit me to recount the drama involved with the dynamics of our relocation. It was like a script from a science fiction movie. The new building was cleaner and much better than the old building. Towels and nightwear were provided on each bed. The environment was serene.
The following night, Dr. Adadevoh was moved to our isolation ward from her private room where she had previously been receiving treatment. She had also tested positive for Ebola and was now in a coma. She was receiving IV fluids and oxygen support and was being monitored closely by the WHO doctors. We all hoped and prayed that she would come out of it. It was so difficult seeing her in that state. I could not bear it. She was my consultant and my mentor. She was the imperial lady of First Consultants, full of passion, energy and competence. I imagined she would wake up soon and see that she was surrounded by her First Consultants family but sadly it was not to be.
I continued listening to my healing messages. They gave me life. I literally played them hours on end. Two days later, on Saturday the 16th of August, the WHO doctors came with some papers. I was informed that the result of my blood test was negative for the Ebola virus. If I could somersault, I would have, but my joints were still slightly painful. I was free to go home after being in isolation for exactly 14 days. I was so full of thanks and praise to God. I called my mother to get fresh clothes and slippers and come pick me up. My husband couldn't stop shouting when I called him. He was completely overwhelmed with joy.
I was told however that I could not leave the ward with anything I came in with. I glanced one last time at my CD player, my valuable messages, my research assistant, a.k.a my iPad, my phones and other items. I remember saying to myself, "I have life; I can always replace these items."
I went for a chlorine bath, which was necessary to disinfect my skin from my head to my toes. It felt like I was being baptized into a new life as Dr. Carolina, a WHO doctor from Argentina poured the bucket of chlorinated water all over me. I wore a new set of clothes, following the strict instructions that no part of the clothes must touch the floor and the walls. Dr. Carolina looked on, making sure I did as instructed.
I was led out of the bathroom and straight to the lawn to be united with my family, but first I had to cut the red ribbon that served as a barrier. It was a symbolic expression of my freedom. Everyone cheered and clapped. It was a little but very important ceremony for me. I was free from Ebola! I hugged my family as one who had been liberated after many years of incarceration. I was like someone who had fought death face to face and come back to the land of the living.
We had to pass through several stations of disinfection before we reached the car. Bleach and chlorinated water were sprayed on everyone's legs at each station. As we made our way to the car, we walked past the old isolation building. I could hardly recognize it. I could not believe I slept in that building for 10 days. I was free! Free of Ebola. Free to live again. Free to interact with humanity again. Free from the sentence of death.
My parents and two brothers were under surveillance for 21 days and they completed the surveillance successfully. None of them came down with a fever. The house had been disinfected by Lagos State Ministry of Health soon after I was taken to the isolation centre. I thank God for shielding them from the plague.
My recovery after discharge has been gradual but progressive. I thank God for the support of family and friends. I remember my colleagues who we lost in this battle. Dr. Adadevoh my boss, Nurse Justina Ejelonu, and the ward maid, Mrs. Ukoh were heroines who lost their lives in the cause to protect Nigeria. They will never be forgotten.
I commend the dedication of the WHO doctors, Dr. David from Virginia, USA, who tried several times to convince me to specialize in infectious diseases, Dr. Carolina from Argentina who spoke so calmly and encouragingly, Mr. Mauricio from Italy who always offered me apples and gave us novels to read. I especially thank the volunteer Nigerian doctors, matrons and cleaners who risked their lives to take care of us. I must also commend the Lagos State government, and the state and federal ministries of health for their swift efforts to contain the virus.
To all those who prayed for me, I cannot thank you enough. And to my First Consultants family, I say a heartfelt thank you for your dedication and for your support throughout this very difficult period.
I still believe in miracles. None of us in the isolation ward was given any experimental drugs or so-called immune boosters. I was full of faith, yet pragmatic enough to consume as much ORS as I could, even when I wanted to give up and throw the bottles away. I researched on the disease extensively and read accounts of the survivors. I believed that even if the mortality rate was 99 percent, I would be part of the 1 percent who would survive.
Early detection and reporting to hospital is key to patient survival. Please do not hide yourself if you have been in contact with an Ebola patient and have developed the symptoms. Regardless of any grim stories one may have heard about the treatment of patients in the isolation centre, it is still better to be in the isolation ward with specialist care, than at home where you and others will be at risk.
I read that Dr. Kent Brantly, the American doctor who contracted Ebola in Liberia and was flown out to the United States for treatment was being criticized for attributing his healing to God when he was given the experimental drug, Zmapp. I don't claim to have all the answers to the nagging questions of life. Why do some die and some survive? Why do bad things happen to good people? Where is God in the midst of pain and suffering? Where does science end and God begin? These are issues we may never fully comprehend on this side of eternity. All I know is that I walked through the valley of the shadow of death and came out unscathed.
Breaking a Fever
We can eradicate malaria—within a generation
New tools and a new strategy mean we can eradicate it in a generation.

I’m in New Orleans, where I just had the honor of speaking at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). As you can imagine, given that this is a gathering of experts on infectious diseases in poor countries, Ebola is on everyone’s mind.
Even though I am confident that the U.S. and other countries with strong public health systems will contain the cases that are popping up within their borders, it’s devastating to see what this virus is doing to entire families in West Africa. At times like this, it’s easy for organizations like ASTMH to make the public case that global health matters to all of us in our increasingly interconnected world. I hope that will help strengthen the public will to do more to help poor countries lift the burden of disease—not just from emerging killers like Ebola but also from pathogens that have held back human potential for thousands of years.
That’s why, in my remarks at the conference, I addressed the Ebola crisis but devoted the bulk of my time to another killer disease: malaria. Based on the progress I’m seeing in the lab and on the ground, I believe we’re now in a position to eradicate malaria—that is, wipe it out completely in every country—within a generation. This is one of the greatest opportunities the global health world has ever had. Melinda and I are so optimistic about it that we recently decided to increase our foundation’s malaria budget by 30 percent.
Melinda and I first called for eradication back in 2007 along with Margaret Chan, who runs the World Health Organization. Melinda was eloquent and passionate in her call to action: “Any goal short of eradicating malaria is accepting malaria; it’s making peace with malaria; it’s rich countries saying: ‘We don’t need to eradicate malaria around the world as long as we’ve eliminated malaria in our own countries.’ That’s just unacceptable.”
Some people said then (and still say today) that we’re overly optimistic to be talking about eradication. After all, malaria is an enormously complex target and has defeated efforts to stamp it out in the past. They’re right that we shouldn’t promise the moon—you don’t get rid of a disease this complex overnight—but I am confident that the future will be different from the past.
Why? Because we’ve seen a huge scale-up in the resources and brainpower focused on this disease. Four countries have eliminated malaria since 2000, and two dozen more could do it in the next decade. Mortality rates worldwide have gone down by a remarkable 42 percent in that time—a good-news story that ought to make critics wary of trumpeting claims that foreign aid doesn’t work. More than 3.3 million people who would have died of malaria are alive today.
And we have tools today we’ve never had before—not everything we will need to achieve eradication, but more than we’ve ever had. Here are two of the recent innovations that fuel my optimism:
- Diagnostics: Malaria is not only treatable but also curable, thanks to a class of drugs derived from a flowering plant called Artemesia annua, or sweet wormwood. But until recently, there was no good way for most people who came down with a fever to find out whether they had malaria. In 2010, we got a great new tool, called the RDT (rapid diagnostic test). Armed with this 50-cent test, community health workers with little training can determine in minutes with 99 percent accuracy whether someone has malaria or not. Last year, we deployed 200 million of them in Africa alone.
- Modeling Systems: The digital revolution has produced fantastic new tools for tracking the disease. Public health experts are combining anonymous data from mobile phone records with data on malaria incidence to identify the key migration hotspots—allowing countries to target their resources in the most cost-effective and strategic ways. In Kenya, for example, these maps helped experts target large-scale tea plantations in the country’s Lake Zone. Comprehensive efforts at the plantations could make it possible to eliminate malaria from large swaths of the country’s highlands without even having to run elimination efforts there.
Just as important as any specific innovation, our team has converged on an eradication strategy that will make the whole greater than the sum of the parts. That strategy has three components: Complete Detection, Complete Cure, and Complete Prevention.
Complete Detection is a departure from current approaches, which focus on finding and treating only those people who have active malaria cases. To achieve eradication, health workers need to find all people who have the parasite in their blood, regardless of whether they’re showing symptoms. (I wrote about this work earlier this year, after Melinda and I saw it in action in Cambodia.) We’re supporting many efforts to develop and bring to market a new generation of diagnostic tools that are even more sensitive than the RDTs now in use and can identify the presence of malaria parasites in all infected individuals.
Complete Cure means using treatments that clear all malaria parasites from the body. Our best anti-malaria treatment today, known as ACT, generally cures the patient clinically but does not eliminate all forms of the parasites that are responsible for continued transmission. So we are trying to supercharge efforts to develop long-lasting, single-dose treatments for malaria that can completely clear malaria parasites from the body and provide a period of protection following the treatment. We believe that our largest partner in this effort, the Medicines for Malaria Venture, could bring these complete-cure drugs to market within five years.
Complete Prevention means reducing opportunities for mosquitoes to pass the parasite on to humans, and preventing the emergence of strains that resist drugs and insecticides. We’ll need next-generation vaccines that block transmission for six months to a year, so that once an area is cleared of the parasite, it stays clear. We’ll also need new insecticides to offset the widespread emergence of mosquito resistance to the chemical compounds we use most frequently today. We may even need cutting-edge approaches, like introducing special fungi into mosquito populations to kill them off or introducing modified genes that can stop mosquitoes from reproducing.
I believe it’s not only possible to eradicate malaria; I believe it’s necessary. Ultimately, the cost of controlling it endlessly is not sustainable. The only way to stop this disease is to end it forever.
If you want to join the fight, please consider donating to our partner Malaria No More.
Beyond the Plow
4 innovations for poor farmers
Four new tools that are helping poor farmers grow more food.

Whenever I visit small farmers in a poor country, I’m struck by how many are laboring with hoes, plows, and other implements that haven’t changed in generations. Yet farmers in wealthier countries have benefited from wave after wave of technological improvements. This gap is one big reason why some farmers produce much more food than others.
Thankfully, some of the brightest minds in Africa, India, and elsewhere are creating new tools to close the gap.
Here are four especially promising innovations…
For many years, so little agriculture research was being done in Africa that we knew less about the soil there than we did about the surface of Mars. Now that’s changing, thanks to an initiative to map the continent’s soil. The Africa Soil Information Service is creating digital maps that help farmers make informed decisions about which seeds to plant, which fertilizers to use, and how to raise their crop yields. They’re available free to anyone with a cell phone or Internet connection.
In Africa, half a billion people depend on cassava as a staple crop. But breeding more-nutritious, disease-resistant varieties of the root takes a long time—a decade or more. Now scientists with the Next Generation Cassava Breeding (NEXTGEN) project have cut that time in half, using computer modeling techniques and a treasure trove of new information on the plant’s genome. They have also improved the breeding cycle, so they can zero in on the most desirable traits earlier in the process.
How do you cheaply spread good information about farming? The Indian nonprofit Digital Green is having success with simple YouTube videos. They’ve shot thousands of videos featuring farmers sharing best practices. (See for yourself.) Farmers, they’ve found, are much more likely to listen to peers who look and sound like them. The idea isn’t limited to farming either: The UK’s development agency is now helping Digital Green use its platform to spread health messages.
Being a dairy farmer has risks. As I learned on a trip to Kenya, milk can spill or spoil on its way from the cow to the chilling station. So I asked the team at Global Good to study the problem. Working with Heifer International, they made a jug that’s easy to clean and won’t spill. Partners in Kenya and Ethiopia will make and sell them for about $5 each, versus up to $30 for other jugs. This modest step could help dairy farmers earn more money—and create new manufacturing and sales jobs too.
Cornell’s Corn
The love life of plants
Studying the love life of plants could help millions escape poverty.

Of all the things I did when I visited Cornell University recently, I probably had the most fun brushing up on how plants have sex.
Cornell is one of the world’s top universities for research on improving crops. Their work involves a lot of plant breeding. During one meeting, I got to try my hand at cross-pollinating wheat, which is a surprisingly delicate procedure. It gave me even more respect for the people who do it every day.
Cornell’s work on crop improvement also involves a lot of cutting-edge genetics. You might see the words “crop improvement” and “genetics” in the same sentence and think I’m talking about GMOs. Although Melinda and I do support research in that area—we don’t think poor farmers should be denied the choice to use any tools that might benefit them—the work I saw at Cornell is different. It’s focused on how the science of genetics can improve agriculture in other ways. And the advances are really exciting.
I got interested in crop breeding through my work with the Gates Foundation. Because most of the world’s poor people are farmers, helping farmers grow more food is one of the most powerful levers we have for fighting poverty. The faster we can improve crops—making them more nutritious or drought-tolerant, for instance—the faster we can help farmers become more productive.
My main guide was Dr. Ed Buckler, a scientist in his mid 40s who works at Cornell for the U.S. Department of Agriculture (USDA). Over the four hours we spent together I asked Ed dozens of questions (I’ve learned a lot about agriculture, but I’m still a city boy at heart), and he was always quick with an answer. Yet Ed and his colleagues aren’t just experts in their field—they’re also deeply passionate about their work. I can see why: The advances they’re working on will change people’s lives by dramatically accelerating a process that is now slow and laborious.
Here’s how it works today. Suppose you want a variety of corn with a natural resistance to a certain pest. You start by planting as much corn as you can. You wait 8 to 12 weeks for it to grow, and then you take pollen from some of the plants that aren’t infested and use it to pollinate others. If the offspring of those plants is pest-resistant, you’re in luck—your plant won the genetic lottery. If not, you have to start over. Because you’re limited by the growing season, the process can take seven to ten years.
Genetics research will cut that time in half.
Getting there takes three steps. One is to understand the crop’s genetic makeup. Ed took me on a short tour of a lab where machines called sequencers were analyzing DNA from thousands of plants. They were mapping the genes that give each plant its physical traits: its height, color, etc.
The second step is to go into the field and record those physical traits for each individual plant whose genes you’re studying. Cornell researchers are growing hundreds of acres of corn and other crops not far from campus, and they make regular treks out there to collect data. Unfortunately, I didn’t have time for a field trip on this visit.
Finally, you build a computer model that puts the two together—the genetic maps of individual plants, along with the data about their physical traits. Once you have that model, you no longer need to cross two plants and just hope for the best. You can ask the computer, “Out of all the plants I have in my field, which two should I breed in order to produce one that is pest-resistant?” Think of it as a highly sophisticated Match.com for plants.
Cornell and the USDA have already built such a model for some traits in corn; because people in rich countries eat corn, there’s a big market for better varieties. Meanwhile, crops that are eaten mostly by the poor have largely been ignored by scientists. But that’s starting to change.
With support from the British government, our foundation, and others, researchers at Cornell and the USDA are now working on a model for cassava, a root vegetable that’s a staple crop in many tropical regions. Partners in Uganda and Nigeria are growing lots of plants, recording their traits, and sending genetic samples to Cornell for sequencing. When the cassava model is finished, it will help breeders develop new varieties faster than ever. (Incidentally, I’m fascinated by cassava—and you may not know that it is responsible for the fun factor in bubble tea.)
During my visit, I learned about one trait that I had never thought about before: poundability. Over lunch with several graduate students, a Ugandan researcher named Paula Iragaba told me that women in her country do most of the work to turn cassava into flour, and they wish it were easier to process. “Women’s preferences have to be taken into account,” she said. I couldn’t agree more.
Keep in mind, none of the genetics research I saw changes the basics of plant sex. Breeders in the field still have to move pollen from one plant to another, as they have for ages. We’re just getting a lot smarter about helping them pick the best partners. And the result will be phenomenal—a much faster path to more-productive crops so that millions of people can eat better food, earn more money, and improve their lives.
Africa’s Table
Why does hunger still exist in Africa?
Not starving, but still hungry in Africa.

When I first started traveling to Africa, I would often meet children in the villages I was visiting and try to guess their ages. I was shocked to find out how often I guessed wrong. Kids I thought were 7 or 8 years old based on how tall they were—would tell me that they were actually 12 or 13 years old.
What I was witnessing was the terrible impact of malnutrition in Africa. These children were suffering from a condition known as stunting. They were not starving, but they were not getting enough to eat, leaving them years behind in their development—and it was hard to see how they could ever catch up.
Stunting not only affects a child’s height. It also has an impact on brain development. Stunted children are more likely to fall behind at school, miss key milestones in reading and math, and go on to live in poverty. When stunted children don’t reach their potential, neither do their countries. Malnutrition saps a country’s strength, lowering productivity and keeping the entire nation trapped in poverty.
Worldwide, one in four children is stunted. Three-quarters of them live in South Asia and sub-Saharan Africa. However, while stunting has declined by more than a third in South Asia since 1990, in sub-Saharan Africa, the number of stunted children is still on the rise, up 12 million since 1990 to 56 million. Forty percent of all children in sub-Saharan Africa are stunted.
I run into a lot of people from rich countries who still think of Africa as a continent of starvation. The fact is, that’s an outdated picture (to the extent that it was ever accurate at all). Thanks to economic growth and smart policies, the extreme hunger and starvation that once defined the continent are now rare. As I saw when I was back in Africa last month with best-selling author John Green, today the issue isn’t quantity of food as much as it is quality—whether kids are getting enough protein and other nutrients to fully develop.
As Melinda and I have grown aware of the scale of this challenge, we’ve made improving nutrition a bigger priority for our foundation. One thing we’ve quickly come to appreciate is the problem’s complexity. There’s no vaccine to prevent stunting. Proper nutrition involves eating enough food, and the right kinds, every day of your life. While the global health community is still working to understand all of the causes and solutions to malnutrition, we do know a lot about how to ensure children get the nutrition they need for a healthy start to life.
We know that getting children the right nutrition in the first 1000 days—from the start of a woman’s pregnancy until her child’s 2nd birthday – is the best down payment on their future, giving them the opportunity to grow and develop physically and mentally. We also know that exclusive breastfeeding in the first six months of a child’s life is the single most effective intervention to help the brain develop and protect against life-threatening diseases. That’s why we continue to research the best ways to address cultural beliefs and other barriers that have kept almost half of all women from using optimal breastfeeding practices.
We know kids have a hard time getting the nutrients they need when fruits, meats, and vegetables are in short supply—so fortifying staple foods like cooking oil, flour, and salt with essential vitamins and minerals can fill the gap. We’re also beginning to develop new crops that are more-nutritious--including a sweet potato that’s enriched with vitamin A—and also produce a higher yield. Not only does this help smallholder farmers earn more income that can be used to diversify their family’s diet, it also puts more nutritious food directly on their table.
Providing better health care can make a difference too. Children who receive the rotavirus vaccine, for example, have fewer bouts of diarrhea, which can drain kids of vital nutrients and make them more susceptible to infection. Likewise, clean water and sanitation play a role in improving nutrition by reducing illness and disease.
We have many great interventions on our side, but with so many factors at play it can be difficult to measure which interventions have the most impact on improving nutrition and why. If I could have one wish, I would want the world to have a better understanding of malnutrition and how to solve it.
We have much more research to do in this area and we will continue to make progress. But what’s not in doubt is the importance of giving all children the nutrition they need for a healthy start to life. Their future depends on it. So does Africa’s.
Mosquito Week
What It Feels Like to Have Malaria
How the disease saps human potential.

Search the Web for “what it feels like to have malaria” and you will find a lot of harrowing descriptions.
Here’s an especially gripping one:
I awoke to what felt like lightning going through my legs, and then spreading through my body and in my head. Probably the worst headache, body aches, and chills you could possibly imagine. It felt like I was being stung repeatedly by an electric shock gun and could barely control my movements. The pain was so intense; I actually believed I was dying, literally crying out in pain so bad that I was taken to a 24 hour clinic that night at 3am.
Imagine feeling like that and trying to go to school, work, or take care of your family. It would be impossible.
It’s no surprise that economic growth in countries with severe malaria is significantly lower than in countries without it, even after accounting for other factors. As the economists Jeffrey Sachs and John Luke Gallup have written, “The only parts of Africa free of malaria are the northern and southern extremes, which have the richest countries on the continent.” Malaria is far from the only cause of poverty—but it is a significant one.
Whenever someone asks me why we should fight malaria, I have a simple answer: Because it kills so many people (more than 600,000 every year), and it leaves so many more people too sick to function, which holds back the world’s poorest from making the most of their lives. Malaria is gone from the United States and Europe. But where it is still a problem, few diseases do more to limit human potential.
This may all sound hopeless, but I’m actually optimistic that we can eventually eradicate malaria. I wrote about why here. I hope you’ll take a look.
Tax-Day Blues?
A reason to smile on April 15
A reason to smile on April 15.

There can’t be many days that are less popular than April 15. But I want to remind you of a fact that might ease the pain: The income taxes you’re paying will save lives in poor countries.
If your family makes the U.S. median household income of roughly $51,000, together you will buy someone in a poor country about seven months’ worth of HIV treatment. Or provide a lifesaving vaccine for 48 children. Or buy eight bednets that will protect people from mosquitoes that cause malaria.
These numbers might make you wonder if a large portion of your income taxes goes to foreign aid. After all, seven months of AIDS treatment can’t be cheap. You wouldn’t be alone in wondering this: Polls show that Americans tend to think nearly a quarter of the budget goes to aid.
It turns out that foreign aid is just 1 percent of the federal budget, or about $30 billion a year. Another way to think about it is that just 1 percent of your income taxes goes to foreign aid.
Compare that to other items in the budget. Defense for example is 17 percent, or more than $1,500 out of the median household’s income tax bill.
I believe that if more people knew what a small share of the budget goes to these programs, and how effective these programs are at saving lives, they’d want to do even more.
April 15 will never be anyone’s idea of a fun day, but I hope it helps to remember how much good American aid is doing around the world.
Maintaining Aid
Why I high-fived a colleague in Paris
Why I high-fived a colleague in Paris.

I don’t generally do a lot of high-fives. But as I climbed into the car after meeting with President Hollande in Paris this week, I held up my hand and slapped palms with one of my fellow passengers.
We were both celebrating and feeling relieved. Just a few hours before, it had seemed unlikely that the meeting would happen at all. The president had just announced a major reorganization of his Cabinet, and I didn’t think he would have time to talk with me about French foreign aid, the subject of our meeting. And even if he did have time, I thought the president might tell me that there was no way his government could maintain its aid commitments in the years ahead. Although France has an amazing track record in this area (it’s the second-largest contributor to the Global Fund, for example), the federal budget is under a lot of pressure. They are facing cuts on the order of 50 billion euros over the next three years.
So I definitely appreciated it when the president decided to keep our meeting even with everything else he had going on. And I was quite encouraged when he told me, without being asked, that he’s going to do his best to preserve France’s commitments. Of course, neither of us is under any illusion about how tough the budget situation is. But it was great to hear the president talk about the impact of France’s support and pledge to try to maintain it.
Paris was the second of three stops on this trip. I had been to Stockholm the day before and would be taking a quick trip to London the next day. In each place I wanted to encourage political leaders and voters to maintain their commitments to foreign aid, even in tough economic times. I wanted to remind people of all the lives they are saving.
This is an important year for Sweden, with elections for the national government and the European Parliament coming up later this year. I was pleased to hear from leaders in the major parties that they want the country to keep playing a leading role in global health and development, no matter how the election turns out. I had an especially productive meeting with Finance Minister Anders Borg, who oversees Sweden’s aid-related programs. He’s so interested in the work that he travels to Africa to learn and see the impact first-hand. We discussed some innovative ideas about how Sweden could take a leading role in funding infrastructure projects, like roads, in Africa. Improving its infrastructure is one of the keys to the continent’s growth in the coming decades, so I hope donors step up with creative funding ideas.
In Stockholm I also had a great time at an event hosted by one of my favorite global health experts, Hans Rosling, and three of his colleagues. Hans is unmatched in his ability to get you excited about the topic while also teaching you something. While I was there we shot a video about vaccination rates that involves me pouring orange juice out of a pitcher. (It will make sense when you see it, I promise.)
In London I got to visit Deputy Prime Minister Nick Clegg and thank him and Prime Minister David Cameron for committing to spend 0.7 percent of the country’s GDP on foreign aid. The U.K. reached that milestone last year, and they’ve said they want to maintain this level. The impact is phenomenal. For example the U.K. supports the GAVI Alliance, which provides vaccines that prevent millions of children’s deaths each year.
I also met with the CEOs of major pharmaceutical companies. We’ve gotten together every year for the past five to talk about the work they’re doing on diseases that affect the poor; I especially want to hear about the obstacles they’re running into and how we can work together to overcome them. This week we marked exciting progress on much faster tests and treatments for sleeping sickness (a.k.a. human African trypanosomiasis), which threatens millions of people in sub-Saharan Africa—during epidemics, it has been known to overtake HIV/AIDS as a leading cause of death in some communities. These advances make it possible for the first time to imagine eliminating this terrible disease. In fact I helped announce $240 million in new funding to treat neglected tropical diseases, including sleeping sickness.
I’ll close by sharing this selfie I took in Paris with a few Youth Ambassadors from the ONE Campaign. They’re part of a program that ONE started in Germany and is now taking to other countries to help keep foreign aid on the agenda. It’s always energizing to meet young people who are so enthusiastic about saving lives. Even on a trip where I heard a lot of a good news, they left me feeling especially optimistic.
Toilet Talk
The next great market opportunity: sanitation for India’s poor
To address a health crisis, India, hosted a Reinvent the Toilet fair.

If you’re inclined to take your toilet for granted, consider this. Half of all patients in hospitals in developing countries are there because of problems with water and sanitation. It’s a staggering health crisis that demands new ideas and new approaches. Last week we saw an encouraging sign that the sanitation issue is starting to get the traction it deserves: Delhi, India, hosted its first Reinvent the Toilet fair.
One problem is that flush toilets are impractical for billions of people. They require vast amounts of water and connections to expensive infrastructure, like sewer systems. Unfortunately, the current-day toilet works just well enough for rich people that no one seems to see the market for a new-and-improved toilet. That’s why we have been working with innovators from dozens of countries to reinvent the toilet so that it works for poor people.
The Next Great Market Opportunity: Sanitation for India's Poor
Last year, I went to New Delhi to talk to government leaders about this toilet initiative. They were very interested. More Indians have access to cell phones than to toilets that are clean and private. One consequence is a terrible diarrhea epidemic, which contributes to India’s huge burden of malnutrition and 200,000 deaths every year.
The Department of Biotechnology and other government agencies worked with us to put on the fair and showcase next-generation sanitation solutions. Solutions like toilets that need no water and convert fecal waste into electricity—or waste processing plants not much bigger than a shipping container that can turn thousands of gallons of fecal sludge into fertilizer.
It’s great to see India at the cutting edge on sanitation. When I joined Prannoy Roy last year for a taping of his TV show, he said people laughed at him 20 years ago for saying that one of the most important things India could do to be a better country is provide better toilets for women. Nobody’s laughing anymore. According to a recent World Bank report, inadequate sanitation costs India nearly $54 billion a year – equivalent to 6.4% of India’s GDP. Some smart people are starting to realize that on the flip side of this economic penalty is a big economic opportunity. As the World Bank report notes, improving India’s sanitation infrastructure could be a $152 billion market.
Just like any other sector, there is a value chain in sanitation. And all across this value chain—from the design of next-generation toilets that don’t require a sewer connection to the development of new markets for the collection and treatment of waste—there is amazing business potential.
India is especially well-positioned to lead in sanitation innovation. It is a proven leader in addressing difficult health problems, like eliminating polio. The country has a well-educated workforce and a demonstrated capacity for technological innovation. And it has a ready market of 630 million people looking for affordable sanitation solutions.
At the Gates Foundation, we see a lot of market failures—situations where poor people’s needs are ignored because it’s impossible to make a profit meeting them. India’s sanitation crisis is different. There is a desperate need. There are also billions of dollars to be earned. The toilet fair demonstrated that there is finally a wealth of innovative thinking about solutions. It will be fascinating to watch this market develop in the next decade.
Global Health Hero
A visit to Haiti, and the biggest hellraiser I know
Last month we caught up with Paul Farmer, a hero of global health.

Last month, Melinda and I took the kids on a vacation during their mid-winter break—and managed to get in a quick visit to Haiti, where we caught up with one of the heroes of global health, Paul Farmer.
If I had to list ten amazing people I’ve had the honor of meeting, there’s no question Paul would be right up there (Nelson Mandela would be at the top). I don’t have enough space in this post to do justice to what a special person he is, so if you want the full story, I’d suggest the book Mountains Beyond Mountains, by Tracy Kidder, which tells the whole story. Paul co-founded Partners in Health (PIH), which helps run medical clinics at 12 sites in Haiti, providing phenomenal levels of care—dealing with everything from ophthalmology to women’s health to HIV and TB. They reach more than a million people and employ thousands of Haitians. PIH also runs clinics and hospitals in several other countries, including Rwanda and Russia.
I don’t know anyone who does a better job than Paul of calling attention to the cause of global health. He’s not a scold—he really draws people in and gets them excited about the work. He chose to work not only in Haiti, but in some of most remote regions within Haiti. The poorest places in one of the poorest countries anywhere. He’s driven by a strong sense of justice. As he says, “The idea that some lives matter less is the root of all that's wrong with the world.” Short of meeting Paul in person, you can get a good sense of his passion from his book To Repair the World, a collection of speeches where his moral vision really shines through. If you really want to dig in to the details, Reimagining Global Health: An Introduction is a good place to start—it’s based on a course he co-taught at Harvard.
Melinda and I have met Paul in various places, but we hadn’t visited him in Haiti for nine years. I had read a lot about the earthquake that devastated the country in 2010 and was eager to see how things had progressed. Plus, just being around Paul is an inspiration in itself.
We started our day in Cange, a town in the Central Plateau of Haiti where PIH has a clinic. When we arrived, a small student orchestra was performing a song that I later learned was from Pirates of the Caribbean. At least judging from what we saw, life in Cange has improved since the last time Melinda and I were there. The health clinic has a lot more space now, and the local school has expanded too. While it used to take four hours over bumpy roads to get there from Port-Au-Prince, you can now make the trip in less than 90 minutes, thanks to a road that the European Union helped pay for.
I’ve met a lot of doctors working in poor communities. Sometimes they’re reluctant to get too attached to their patients, because the emotional toll would be so high. But not Paul. As we made our way through the clinic, he seemed to draw more energy from everyone he met—stopping to offer clinical advice to a nurse or a word of encouragement to a patient. I got the feeling he would have been happy to spend the day just roaming the halls and caring for people.
After Cange, we drove about 15 minutes to see a factory that makes a kind of fortified peanut butter for undernourished children. Abbott Laboratories helped fund the factory, and it is quite fancy. They have huge propane tanks to run heaters and big generators to power the machines inside. The peanuts are grown by 200 local farmers who trained at the facility. We watched as the nuts were roasted, shelled, and ground, and then mixed up with other ingredients to make the paste. A machine pours it into big 1 kg jars that will be distributed to families. There’s even a lab with technicians who test the paste for contaminants.
Next we drove into the city of Mirebalais to see the new hospital run by PIH and the Haitian government. I was blown away. The hospital opened last summer and was built using money donated after the 2010 earthquake (people who were injured in the quake still need ongoing treatment). As you can see from the video here, they spared no expense to make it a first-class facility. There’s a machine for performing CAT scans. There’s a sophisticated system for keeping medical records. The staff can send digital images to Harvard and get input from specialists there. They have modern incubators for premature infants. The hospital gets electricity from an enormous solar array (plus a diesel generator at night).
As we pulled up to the hospital, I noticed a bunch of kiosks set up out front. They weren’t part of the hospital, but they were a natural outgrowth of it. Every day several hundred people come to the hospital for care, but the staff can’t deal with them all at once. Local entrepreneurs have created this impromptu market where they sell food and other items to the waiting patients.
Inside, we met some of the patients and staff. One of our daughters is thinking about becoming a doctor, so she peppered Paul with questions as we walked around. We all visited the ward for premature infants. Later, on the flight out of Haiti, the kids told me how moving it was. They had never seen anything like that before.
In another ward, Paul introduced me to one boy who had had cholera, and another whose appendix had burst. For a lot of Haitians, those conditions would almost certainly have killed them. But thanks to the great care they got here, both boys were well on their way to being cured.
Overall we had a great visit. I saw real evidence of progress. Of course, Haiti has a long way to go: It remains quite poor. And I worry about how the projects I saw will generate enough revenue and enough generosity from donors so they can maintain such great facilities. Operations and maintenance—whether for a CAT scanner or a peanut processor—takes funding and technical expertise. I left Haiti wanting to learn more about how countries at various levels of wealth are able to build strong health care systems, especially for primary care.
But even understanding all the challenges, I felt hopeful about the opportunity for more Haitians to improve their lives. You know you’ve had a good trip if you can visit a country as poor as Haiti and leave feeling optimistic about its future.
On the Right Track
What I Learned About Polio in Nigeria
In Nigeria I saw firsthand how work is progressing on polio eradication.

I had a great visit to Nigeria last month and was able to learn firsthand about how work is going on polio eradication and immunizing kids against preventable diseases. There’s a tremendous opportunity now for Nigeria to eradicate polio and it was exciting to meet with many of the government and traditional leaders who are making this progress possible. I was joined on the trip by Aliko Dangote, a Nigerian and one of Africa’s most successful business leaders and philanthropists. Having his point of view on Nigeria and our efforts was really helpful.
On my first day in Abuja, Aliko and I went to the Polio Emergency Operations Centre, where government and donors come together to analyze the latest polio data, and plan the polio vaccination campaigns that are at the heart of this effort. They reported the fewest number of polio cases in three years, down 56% from this time last year and restricted to only two areas of the country. It was great to see Nigerians and partners work together to grab this opportunity. The rest of Africa and the world are watching. It can be done. And I believe it must be done.
Later in the day, Aliko and I met with the Speaker of the National Assembly, Ministers for Finance and Agriculture, as well as a private meeting with Nigeria’s President Goodluck Jonathan. I’m excited about our broad range of investments in health, agriculture and digital money in Nigeria. By increasing agricultural productivity – in a sustainable way – and supporting widespread access to digital money services, we can reduce hunger and poverty, and help improve the health and prospects of millions of families. Science and technology offer amazing opportunities for innovative solutions to tackle tough challenges in Nigeria for those most in need.
We joined a meeting of the Presidential Task Force on Polio Eradication, and were happy to take part in a ceremony to recognize state Executive Governors who have improved vaccine coverage rates and reduced polio cases. We paid tribute to the all-important traditional leaders who are often at the front line of changing behavior and encouraging mothers to have their kids vaccinated. The spiritual head of Nigeria’s Muslims, His Eminence, the Sultan of Sokoto, gave me a traditional robe and hat.
At the same event, President Jonathan announced he was conferring on me the Commander of the Order of the Federal Republic. Both honors were very kind, and I appreciated both the tributes as well as the commitment of so many people in Nigeria who are working to improve public health and reduce poverty.
Aliko and I had private meetings with some of the Executive Governors on the front line in the fight against polio, and the huge push to get life-saving vaccines to more kids. I was really impressed by the courage and commitment of Governor Shettima of Borno. That state has more polio than anywhere else in the country and there are big security challenges to reach every child. We also met with Governor Kwankwaso and his team from Kano, which is the most populous state in the north and has the second highest number of polio cases. Both Governors are determined to improve the public health systems in their states.
Aliko and I joined the Minister of Health, the Sultan of Sokoto, and the House and Senate Chairmen on Health to launch Nigeria’s newest Routine Immunization Strategy. It includes plans for the introduction of new vaccines, sets out a multi-year budget and describes strategies for reaching all children. This is also the first time there has been a focused look at fixing accountability at every level of the program – from the release of funds at the Minister’s level, to the delivery of vaccines by health workers in the field. This is a tremendous milestone. I was encouraged by the increasing attention to measurement and using accurate data to diagnose problems and help health workers better manage their programs.
The next day Aliko and I were in Lagos to learn more about Nigeria’s efforts to improve its vaccine supply chain. We visited the Lagos State Cold Store where the staff showed us how they are now monitoring vaccine stocks at each district level to improve the availability of life saving supplies. We also learned more about their work to streamline vaccine distribution. Prior to the program, 43% of the facilities were running out of vaccines. Under the new delivery system, this has dropped to just one percent. Transforming health systems is not easy. But it’s exciting to see this kind of innovation taking root in Nigeria. It’s making a real difference.
Aliko and I got a lot accomplished in a short amount of time, and we met with some truly committed leaders and field workers. I left Lagos more convinced than ever that Nigeria is on the right track. Next, it was on to Berlin.
Unite Against AIDS
On World AIDS Day, a Call to Action
We can all take action against AIDS, by learning, acting, and giving.

The theme for World AIDS Day this year is "Working Together for an AIDS-Free Generation." This year is especially important because the world is making huge progress against HIV, but we still don’t have all the tools we need to end the epidemic. This is a time for everyone to learn the facts about AIDS and put knowledge into action.
When you look at the facts, you see there’s a very clear, cause-effect relationship between the world’s level of investment in HIV treatment and prevention and the number of lives saved. Providing women, men and children with access to low-cost treatment literally means the difference between life and death. Access to treatment is reviving entire communities by helping people live healthy and productive lives.
But we still have much more to do. The rate of new infections is going down, but the number of people who get infected every year is still double the number who gain access to treatment. We need to stay focused on developing new prevention methods, like long-lasting pills and injectables, that can provide people with sustained protection over time.
And we have to stay focused on finding an HIV vaccine. A lot of new discoveries have given us hope that we can produce a safe and effective vaccine to protect future generations.
The organization leading the international anti-AIDS effort is The Global Fund, which currently provides HIV treatment to nearly 4 million people in Africa and is also a key partner in efforts to end mother-to-child transmission of HIV. The Global Fund has a new executive director, Mark Dybul, the former U.S. global AIDS coordinator. And it recently adopted a new approach to funding grants by investing additional money in health programs that are poised to achieve the strongest impact.
I’m convinced that the right people and organizations are assembled to push toward beating this epidemic. What’s not yet in place are the necessary financial resources. The Global Fund relies on voluntary contributions. Many governments and private organizations, including our foundation, have invested significant amounts, but the donations received so far fall short of what is needed to expand affordable treatment to those who need it.
One of the best ways that people can support the fight against AIDS is to donate to the Global Fund. You can contribute through the UN Foundation or by buying great holiday gifts through Product Red.
Take a few minutes to learn more about World AIDS day from these sites: UNAIDS for global information and AIDS.gov for information about the state of HIV in the United States. Then consider helping with a contribution to the Global Fund.
A Very Good Year
Good news you might have missed in 2013
Looking back at 2013, I wanted to share a different kind of list.

You’re probably seeing a lot of people’s year-end lists right now, going through the best movies, books, YouTube clips, grumpy cat memes, etc.
I thought I would share a different kind of list: some of the good news you might have missed. I’ve limited my list to global health and development, where Melinda and I spend a lot of time, but even so, there’s a lot to report. If you measure progress by the number of children who die of preventable causes, or by the number of people who escape extreme poverty—as I do—then 2013 was definitely a good year.
For example:
We got smarter and faster at fighting polio. You may have heard about recent polio outbreaks in Syria, Kenya, and Somalia. What you may not know is just how rapid and effective the response has been. It looks like the outbreak in the Horn of Africa was controlled in 4 months, less than half the time it took to control an outbreak there in 2005. That speed is due in part to the work done at the Global Vaccine Summit held inAbu Dhabi this year. In the past, the world has had to make tough trade-offs between responding to outbreaks, improving routine immunization, and fighting the disease in the last three countries where polio is still circulating (Afghanistan, Pakistan, and Nigeria). There was no coordinated plan or long-term funding for doing all three at once. At the summit the world got both. We adopted a comprehensive plan for pursuing all three goals, including making the world polio-free by 2018. And more than 30 donors—including a number of very generous private individuals—backed the plan with a total of $4 billion in long-term funding. That means we won’t have to make those trade-offs anymore. It’s a huge step forward.
There’s also great news from India. In early 2014, India will have gone three years without a single polio case (assuming no new ones are reported between now and then). That’s a testament to the fantastic job they’ve done immunizing every child, even in the most remote parts of the country. Now they’re focused on keeping the disease from coming back.
Next door, in Pakistan, the political leaders are clearly resolved to get polio out of the country once and for all. When I met Prime Minister Nawaz Sharif this fall, he made it clear that he sees vaccinating children as a matter of justice. Despite the ongoing violence there and in Afghanistan—including horrifying reprisals against vaccine workers—the next couple of years are a good opportunity for us to make progress on this goal.
Child mortality went down—again. One of the yearly reports I keep an eye out for is “Levels and Trends in Child Mortality.” The title doesn’t sound especially uplifting, but the 2013 report shows amazing progress—for example, half as many children died in 2012 as in 1990. That’s the biggest decline ever recorded. And hardly anyone knows about it! If you want to learn more—and I’d urge you to—the report has a good at-a-glance summary on page 3.
The poverty rate went down—again. If you want to read just one article that explains the state of the world’s poor and the future of the fight against poverty, check out “Not Always With Us,” which the EconomistEconomist ran in June. It gives a short but thorough overview of the progress so far—the poverty rate has dropped by half since 1990—and the prospects for keeping it going. As the article says, the biggest factor in reducing poverty over the past few decades has been economic growth—growth that touches not just those who are already rich, but a broad range of people. We’ll need to maintain this growth in the coming decades to keep the poverty numbers coming down. That’s one reason I argue for stepping up our investments on health: Health may not cause growth directly, but it does help lay the foundation for it. I never miss an issue of the , and this might be the best piece they ran this year.
Rich countries re-committed to saving lives. Just this month, donors met in Washington, D.C., to renew their funding commitments to the Global Fund to Fight AIDS, TB, and Malaria. I was there and I got to meet Connie Mudenda, a Zambian woman living with HIV who started getting treatment in 2004 thanks to the Global Fund. The medicine she takes costs just 40 cents a day, and it helped her get healthy, go back to work, and support her family. Connie says that a decade ago, she’d often see people who were so sick with AIDS that they couldn’t even walk. A family member would push them down the street in a wheelbarrow. Today, though, 80 percent of Zambians with HIV have access to treatment, the country’s economy is growing, and Connie says the wheelbarrows have vanished.
There’s a terrible Catch-22 in global health: You need new tools to fight diseases, but if you can’t pay to deliver them, they don’t get made; and if they don’t get made, then no one gives money to deliver them. So it’s fantastic that donors are stepping up to avoid this problem by making big commitments to the Global Fund.
A fantastic Web site got launched. If you love data, and if you’re curious about what causes the most suffering around the world, you should check out the Global Burden of Disease Web site, which was launched early this year. (The foundation helped pay for it.) Personally I am a yes on both categories, which is why I have spent a lot of time on there. It lets you make beautiful charts that help you understand the impact of disease in different countries and even see how things change over time.
On a personal note, I should say how grateful I am to everyone who made time to meet with me, from world leaders to health workers in India, Nigeria, Pakistan, and around the globe. Some of these workers take great risks to help people, facing attacks from extremists in order to vaccinate children. They are true global-health heroes.
What’s Ahead in 2014
Next year I’m excited about the continued rollout of a vaccine called pentavalent (because it prevents five diseases). Next year it will be available in South Sudan, the last of the 73 poorest countries to introduce it. India just announced that they’ll start giving it to every child in the nation in 2014. If other countries follow India’s example, pentavalent could prevent 7 million deaths by 2020. Next up are new vaccines to prevent pneumonia and rotavirus (which causes diarrhea). And we’re seeing more middle-income countries like China and India develop the ability to manufacture vaccines, which drives the cost down.
Crucial to delivering all these vaccines is GAVI, an alliance that has helped 440 million children get immunized since 2000. (Go back and read that again: 440 million.) Next year GAVI will be asking donors to renew their commitments, just as the Global Fund did this year. It will be a challenge to raise more money, but I know from experience that people want to help kids get vaccinated when they see what a phenomenal impact it has. It’s hard to resist the thrill of helping to save the life of a single child, let alone millions.
One last note about 2014: I’ll be publishing my sixth annual letter in January. This time I’m planning to take a slightly different tack from years past—Melinda and I will be tackling some of the biggest myths we encounter in our work on health and poverty. It should be a fun one to write. If you’d like to get an e-mail notice when the letter is out, you can sign up here.
Meeting Problems with Solutions
Getting better all the time
Halfway through the first day of my India trip, TV personality Prannoy Roy told a story I think really highlights the progress of India’s long journey to better health.

Halfway through the first day of my India trip, TV personality Prannoy Roy told a story I think really highlights the progress of India’s long journey to better health.
We were filming a question-and-answer segment in front of a studio audience for his show on New Delhi Television, one of India’s largest news networks.Prannoy was asking me and Bollywood star Aamir Khan about philanthropy, health, and India’s development when he recounted a discussion he had about 20 years ago. A former prime minister asked him and a group of other people what India could do to be a better country. Prannoy said his answer – provide better toilets for women – was met with nothing but laughter.
Things have really changed. Just before seeing Prannoy, I had spent several hours in meetings with Indian parliamentarians and ministers. Our wide-ranging conversations about health and vaccines almost always returned to how to stop the spread of diseases through better sanitation and, specifically, toilets.
I was glad: the toilet is one of my favorite topics. At each meeting I got to talk about how flush toilets (ones that use water to clear the waste away through plumbing) won’t make it anytime soon to much of the world, including rural India where infrastructure is poor and water is scarce. Instead, we need to invent a better toilet, one that doesn’t use water yet eliminates harmful microbes and gets rid of any smell. Last year our foundation sponsored a “re-invent the toilet” fair where 14 universities submitted innovative answers to that problem. None were perfect but they all were a step in the right direction.
After several meetings it was clear there was strong interest in holding a similar “re-inventing the toilet” event in India early next year. We set some follow-up meetings to start figuring out how to make it happen. We agreed that applying India’s many creative minds to the sanitation problem could speed the path to a breakthrough.
In my post, “Why I’m Going to India,” I wrote that the country is an ideal place for understanding both the problems and the solutions in areas that our foundation focuses on. In my meetings yesterday, the sanitation discussions were just one example of the great optimism I felt from government leaders and health experts for overcoming the problems. I also heard about several new solutions.
A group of polio experts updated me on how India’s focus on ridding itself of that disease is paying dividends to broader health efforts. After a lot of hard work, India has been polio free since January 2011. India will be certified polio-free if there isn’t another case by next January. I’m confident we can get there. Yesterday the experts walked me through how they are using satellite mapping to not only see where they need to provide the polio vaccine but also to expand the country’s system of routine vaccinations (the vaccines children get in their early years). With satellites and cellphones we are getting far more detailed health data on hard-to-reach places. I’m convinced those tools, pioneered with polio, will be a game changer for expanding routine vaccination.
I also sat down with some of India’s top scientists, public health experts and pediatricians. This group was celebrating amazing progress of the phase 3 trial of Rotavac, India’s first home-grown vaccine for rotavirus, the world’s main cause of diarrheal disease—which, after pneumonia, is the second leading killer of children under age five. I touched on rotavirus in yesterday’s post but it’s worth emphasizing again. The work the group did to create the vaccine, and run a very high quality trial is nothing short of phenomenal. Rotavac is a rare global collaboration among the Indian government, vaccine manufacturer Bharat Biotech, and others including PATH, the U.S. Centers for Disease Control and Prevention and the National Institutes of Health. Our foundation provided grants to support the work.The next milestone is to get the vaccine licensed by Indian authorities.
Dr. M.K. “Raj” Bhan, former secretary of India’s Department of Biotechnology and a pediatrician who shepherded the vaccine’s creation, told me that he expects the vaccine to clear India’s regulators by the end of the year, an estimate the country’s minister of health echoed later in the day. That means that India could start introducing the vaccine next year and start saving tens of thousands of kids’ lives a year.
In answering the prime minister two decades ago, Prannoy, our TV interviewer, pointed to a health problem that India still hasn’t fixed. Yet things are absolutely getting better. Since that time, India’s child mortality has dropped 45%, better than 35% for the world as a whole. With every visit to the country I see how India will drop that further as it gradually solves its health issues. An official I met at India’s Planning Commission yesterday described how India is “slow and deliberate” and ultimately successful in working through challenges. “That’s what this country is all about: finding a way,” she told me.
Today I’ll see another example of how India is finding a way when I visit a research center using old and new technologies to help boost agriculture productivity andfight malnutrition.
First, Celebrate
Not Your Typical Vaccine Conference
This week I'm going to Abu Dhabi to attend the Global Vaccine Summit to celebrate the tremendous progress the world has made in ending polio and immunizing children.


This week I’m going to Abu Dhabi to attend the Global Vaccine Summit to celebrate the tremendous progress the world has made in ending polio and immunizing children.
This isn’t going to be typical conference. We aren’t going to have breakout sessions or canvas bags crammed with printed reports to take home. We’ll be there to do just two things: first, celebrate the progress we’ve made in the Decade of Vaccines to reach all kids, everywhere, with the vaccines they need; and second, to share best practices and have some frank discussions on what still needs to be done. As part of that, the Global Polio Eradication Initiative will roll out a new strategy to end polio once and for all. Global leaders will discuss their confidence in the plan and pledge political and financial commitments to help ensure its success.
Why Abu Dhabi? His Highness General Sheikh Mohamed bin Zayed bin Sultan Al Nahyan, Crown Prince of Abu Dhabi, is joining UN Secretary-General Ban Ki-moon and me to host the Summit, the first of its kind. The Crown Prince, an important partner of the foundation across several issues, represents to me the inspirational leadership we are seeing from the Middle Eastern and Islamic communities to improve child health worldwide.
In my talk, I’m going to share some of the numbers that impress me, such as the measurement systems that have allowed Ghana to build a strong immunization system. And I’ll share numbers that make me angry. For example, a child born in a low-income country is 18 times more likely to die before reaching the age of five compared to a child in a high-income country—largely due to preventable causes. That inequity is simply unacceptable and completely fixable.
I’m excited to meet some pretty amazing heroes while I’m there, too. World leaders like Jose Manuel Barroso and Kofi Annan will appear alongside Ade Adepitan, a British Paralympic medalist who contracted polio as a child in Nigeria, and Sikha Patra and Salim Shekh, two kids from India who organize polio immunizations for their community in Calcutta. I get to meet the two winners of my annual Gates Vaccine Innovation Award, too. Archie Panjabi will be our emcee. She appears on the American series The Good Wife and is using her celebrity to be a strong advocate for ending polio.
Thousands of people—scientists, investors, health experts, community leaders—share involved in the process of immunizing a child. We need to have the right vaccines, developed and manufactured at affordable prices, delivered to the hardest-to-reach children. It is crucial to build up strong routine immunization systems to protect our gains against polio and provide a platform for primary care. When the world comes together, we can set ambitious goals, we can measure our progress, and we can achieve even more. I’m counting on the Global Vaccine Summit to do just that.
Closing in on 1%
Turning the Corner on Polio in 2012
The Global Polio Eradication Initiative is making important changes.

Working to support the effort to rid the world of polio has taken me to some exotic places. But earlier this month, it took me to Washington, DC (I suppose you could argue this is also quite an unusual spot) to talk with policy makers about the historic opportunity we have to end polio forever.
My conversations with lawmakers gave me a chance to discuss some of the doubts people have expressed about whether we can really do this. But it also provided the opportunity to bring lawmakers up-to-speed on the results of important changes in the Global Polio Eradication Initiative’s (GPEI) approach—including cool new technology being used and the increased engagement on the part of governments in the countries where polio transmission continues.
In my opinion, the changes and progress in 2012 have made for the most convincing case yet that ending polio is possible—and is one of the most concrete accomplishments possible for global health.
For more than 10 years, we have been 99 percent of the way toward ridding the world of polio. Since then, every few years the global community would vow that year would be the year when polio transmission would stop.
However, 2012 is notably different from the earlier stagnation in progress. And while the global program hasn’t stopped transmission of the wild polio virus everywhere as some had predicted, it did close a big gap in that last one percent when India became polio-free early in the year after a long and hard battle to protect more than 172 million children under the age of five from polio. This was incredible tough terrain in which to run thousands, if not tens of thousands of vaccination campaigns. So, the lessons learned from India’s success are serving as a great guide for what’s needed in the remaining three countries where polio transmission persists—Nigeria, Pakistan and Afghanistan.
There’s no doubt that these countries aren’t easy places to get rid of the disease. There are a number of factors that need to be in place including improved campaign quality, meeting the program’s global funding needs, and anticipating political challenges.
I heard from U.S. lawmakers that the news regularly coming out of Afghanistan and Pakistan has led to reasonable concerns about the role insecurity plays in being able to reach children with vaccines. But in the last 11 months, incredible efforts are being made in these two countries by government officials, religious and community leaders and non-government organizations to negotiate access to children in hard-to-reach places.
And those efforts are paying off.
The polio program has been partnering with a number of NGOs to conduct negotiations to secure access to children, leading to breakthroughs in the past few months. In Afghanistan, the average number of inaccessible children in thirteen of the highest risk districts of the country has been reduced by more than half, from nine percent in June 2012 to 3.4 percent this November. And in the Terah Valley in Pakistan, where children hadn’t received vaccines in three years, approximately 30,000 children were reached with the polio and other critical vaccines during a vaccination campaign earlier this fall.
On the other front, in Nigeria, while cases have actually gone up this year, there is a full-scale effort to revamp the program, with many changes based on what vaccinators in India implemented to great success. Included in these changes are decreases in the size of vaccination teams and the addition of female vaccinators, tracking of nomadic populations, rigorous microplanning and scaling up of additional staff to help with all of these activities.
Another major innovation that is leading to early reports of impressive progress is the work on GIS mapping and GPS tracking to improve polio campaign planning and performance. (It’s a really ingenious use of the technology that you can learn more about here.) GPEI’s focus on using the polio program to increase routine immunization is ensuring that the polio program has an even broader long-term impact on the population.
The Independent Monitoring Board of the GPEI also notes the positive changes in a report released last week and their conclusion that the GPEI “has never been in a stronger position” reflects what I’m seeing too. Their assessment about what comes next for the history books is telling: “The time is momentous for public health history. A final concerted effort could indeed mean writing the story of polio’s last stand.”
I couldn’t agree more.
Join Us
World Polio Day: A Day to Learn, Act, Donate
Thanks to everyone working to end polio. Let's keep at it.

Today is World Polio Day, a day to celebrate the remarkable progress we’ve made in the fight against polio and to focus on the urgency of the work we still have to do. But equally important, it’s also a day to say “thank you” to the millions of people around the world who have generously given their time and money to this critical effort.
Ending polio is my top priority in my work at the foundation and I’m grateful for the opportunity to be part of this amazing public health campaign. Right now, the world has the opportunity to change history by ending polio forever.
In 1988, the year the global campaign against polio began, more than 350,000 children in 125 countries were paralyzed by the disease. Today, just three countries exist where polio transmission has never been stopped. And the number of new polio cases this year is down to 171 (compared to 467 cases this time last year). This number represents the fewest number of new cases in the fewest districts in the fewest countries in the world.
This is great progress.
And it kicked off this year with news that India—the second-most populous country—became polio-free in January and has been for more than 18 months. If we can rid India of polio, I’m optimistic we can do it anywhere. But we need to seize this opportunity and partners and donors need to act now.
For people who live in countries or regions that got rid of polio years or decades ago – like the U.S. and Europe – the disease might seem kind of abstract. But as long as there is a single case of polio anywhere in the world, no country is safe from the risk of reinfection. We have seen reinfection occur a number of times in recent years in countries that were previously polio-free. In a world of increased mobility, we all stand at risk until the job is done.
To ensure success, we need to fully fund polio campaigns and routine immunizations. We need continued leadership and accountability. And in regions where there are wars and conflicts, we need to ensure the security of vaccination teams so they can get to children - even in the most difficult areas.
I’m confident we can finish the job. We have an effective global polio program and real progress is being made.
We have a once-in-a-generation opportunity—now—to end polio forever and to leave in its place stronger health systems that can deliver life-saving vaccines to protect all children from vaccine-preventable diseases. You can be part of ending polio forever. It costs less than $1 to vaccinate a child against polio. Will you join this global effort? Here’s where you can learn more, act, or donate.
Someday we can retire World Polio Day. Let’s make that day come soon.
A Good Team
Partnering with Bono on foreign aid
For the past decade, we've teamed up to speak in support of aid.

This week, Bono and I met with European leaders to encourage them to renew their commitments to fund development assistance programs that help the world’s poorest. Bono is incredibly dedicated and it was great to partner with him on telling the aid story.
Giving in Tough Times
France committed to foreign aid
I'm thankful that France renewed its development commitment.

I was in Paris this week with Bono, talking about the importance and effectiveness of foreign aid with senior French officials, including France’s new President, Francois Hollande. I’m excited that France remains committed to development, even in these tough budgetary times.
“Last Mile” to Polio
Digital Mapping Technology Helps Polio Vaccinators Zero In
Health workers are using digital mapping to target polio in Nigeria.

One of the challenges getting from 99% to 100% on global polio eradication is making sure that all children are getting the multiple doses of the polio vaccine necessary to build up immunity.
To stop polio from circulating, you need to ensure that most children under the age of five receive several doses of the vaccine to build up their immunity. This is very difficult when there are hundreds of remote villages and hamlets that vaccinators don’t know about, nomadic tribes, and people in a castes or religious sects that don’t mix with the rest of the population.
Recently, public health officials began using GIS technology in Nigeria—one of the three remaining polio-endemic countries—to improve the quality of maps that tell vaccinators where to go. They are also using GPS technology to monitor the movement of vaccination teams. This kind of surveillance reduces the chances a team will miss an area that still harbors the disease.
The global health community has done an amazing job on polio, reducing the number of paralysis cases from 350,000 in 1988 to less than 200 so far this year. In 1988, more than 125 countries were endemic. Today, only three remain.
Yet, people sometimes ask me why we haven’t finished the job. It’s an understandable question since most countries got rid of polio a long time ago. One of the biggest reasons is that polio is a highly-contagious disease that travels quickly and easily. Another is the need to give each child multiple doses of the vaccine.
The use of digital mapping technology underlines the minute level of detail, planning, and organization required to completely eradicate polio. I’m optimistic that it will really help vaccinators cover the “last mile” in the delivery of polio vaccines.
Meanwhile, we can’t afford to ignore the other important pieces necessary to eradicate polio—sustaining political will and funding so vaccinators can reach children in every village, and ensuring accountability so the disease has nowhere else to go.
A Targeted Effort
GIS Mapping & GPS Tracking for Polio in Nigeria
A digital mapping system is being used in Nigeria to help health workers target specific areas for immunization efforts in the fight or eradicate polio.

In order to deliver vaccines, immunization teams go door-to-door throughout the country, including settlements in remote, rural regions.
Before going into the field, these teams use a process called “microplanning” to determine where they need to go in order to deliver the polio vaccine.
Before Geographic Information Systems (GIS) maps were made available through the mapping project, hand-drawn maps popularly known as “cartoon maps” were used to show the distribution of settlements. These maps were drawn from memory and not based on real geographical data.
GIS combines satellites, mobile device and mapping software capabilities to capture, analyze and present data as legible and informative maps.
The imagery of states is downloaded and organized for local government area (LGA) and ward map creation.
These maps make it possible to read distance and proximity with realistic placement of mapping features, to ensure that all settlements and hamlets are visited by vaccination teams, and the correct number and type of teams are deployed.
Phones are loaded with tracking software and the final settlement list before the vaccination teams are sent out in the field.
These vaccination teams are using tracking devices in the field. The phones collect geo-location readings through GPS.
The data from the phones is then processed in the GIS lab.
Detailed analytics report tracking results for each settlement.
These results make it easy to identify which settlements were missed and need to be revisited.
A Busy Day in NY
At the UN: Talking health and development
As the United Nations General Assembly convenes in New York this week, I’ve been asked to come and speak about the need for nations around the world to recommit to eradicating polio. Here are some notes from my first day at the UN.

UN Week is a crazy time in New York. Getting around can be tough with increased security, various protesters, and heads of state and other important visitors coming and going. But as I wrote yesterday, it’s also an incredible opportunity to see people, and to discuss issues of real importance to the world.
I got a chance to spend some time with UN Secretary General Ban Ki-moon this morning. He’s about the busiest guy in New York this week, so it was super nice of him to make the time. We got to talk about polio, and the important meeting he’s hosting tomorrow, which is the main reason I’m here. Having his voice continue to make the case for why we need to end this disease in the few places it remains is so important. As Secretary General, he’s called out five of the world’s major "killers" he wants to see eliminated during his second five-year term. Polio is on that list, along with malaria, pediatric HIV infections, maternal and neonatal tetanus, and measles.
In the morning I had the chance to meet the Prime Minister of Ethiopia, Hailemariam Desalegn, who was sworn into office just last week. I was really happy to get to meet him because Melinda and I both had a great working relationship with his predecessor, Meles Zenawi, who died in August of this year. It was a great loss for Ethiopia, and for Africa and the world. But I was impressed with the new Prime Minister, not only for his thoughtfulness and knowledge about the issues we work on as a foundation in Ethiopia, but also for his commitment to continuing the policies of Prime Minister Zenawi, which have made real progress in helping the people of Ethiopia. Some of the foundation’s most exciting projects are happening in Ethiopia, particularly our partnership with the government in improving agricultural output for small farmers. I was in Ethiopia earlier this year, and I told the Prime Minister I looked forward to getting back there sometime in the future.
One Year Polio-Free
Angola’s Re-Match Against Polio Underscores the Urgency of Global Eradication
Angola marks a full year without a new case of polio, evidence that with sustained focus we could end polio forever.

There have been many amazing success stories in the global campaign to eradicate polio. This past month adds another—Angola marked a full year without a new case of polio. Angola’s accomplishment is the latest evidence that we are extremely close to ending polio forever. Earlier this year, the World Health Organization (WHO) announced that India had gone a year without a new case of polio—a remarkable accomplishment considering its size and population. A sustained global public health effort over the last 24 years has led to more than a 99 percent reduction in polio cases and only 650 new cases in 2011.
Polio is a formidable foe and Angola is one of the world’s poorest nations with numerous health challenges to tackle, which makes Angola’s achievement especially noteworthy. After eliminating its own poliovirus over a decade ago, Angola persistently fought to stop transmission of polio virus imported on several occasions from outside the country. The last importation of the polio virus took several years and over 30 polio vaccination campaigns to stop the transmission.
Angola’s experience with polio is a stark reminder that countries that have eliminated polio within their borders are not safe from a new polio outbreak until the entire world is free of this vaccine-preventable disease. An impoverished country of 18 million in southwestern Africa, Angola originally defeated polio in 2001 despite decades of civil war, showing that polio can be eliminated under challenging circumstances. Angola remained free of the disease until 2005, when polio returned due to cross-border transmission. Porous borders and water and food contamination—key ways polio spreads—are especially big challenges in countries like Angola. But new outbreaks can occur in any country, including China and Tajikistan last year, and will continue to be a threat everywhere if the world does not ensure that we eradicate polio.
Angola’s leaders and citizens deserve a lot of credit for their determination to eliminate polio not just once, but twice. This is no easy or inexpensive feat, especially for poor countries like Angola, which must use limited resources for many other pressing health priorities to re-tackle polio. Angola, which now shoulders 90 percent of the operational costs of these campaigns, succeeded because of a deep commitment among government officials at all levels and the involvement of community and religious leaders, NGOs, and volunteers. Officials deployed huge vaccination campaigns involving thousands of health workers and volunteers going door-to-door, positioned on main streets, and canvassing markets. In Cazenga – one of the poorest municipalities – volunteers were each assigned to stay in contact with 10 families to ensure that they received regular checkups and vaccinations.
Like all 125 countries that have gotten rid of polio since 1988, Angola’s leaders and citizens also deserve the global resolve needed to ensure that no country ever has to go back and re-do the hard, expensive work that’s already been done to protect their children from polio. This will ensure that these countries can focus their resources on other pressing health priorities.The only way we can achieve this monumental goal is for all countries to take responsibility for making the world polio free. This means:
- We need to increase political will in existing and new donor countries to fill the Global Polio Eradication Initiative’s existing funding gap of almost $1 billion through 2013, and to commit to funding the GPEI for the long term until the job is done.
- Endemic countries—Afghanistan, Nigeria and Pakistan—where polio transmission has never been stopped must continue their strong political commitment to do everything they can to protect their children and the world’s children from polio.
- Countries such as Angola and India need to remain vigilant, continue dispensing the polio vaccine and improve routine immunization to ensure their children stay protected from vaccine-preventable diseases.
- Polio eradication partners such as the WHO and UNICEF must work on improving vaccination campaigns and protect every child with the polio vaccine.
We must not let go of the idea that we can ensure that all the world’s children will be safe from polio and on their way to protecting all children from vaccine-preventable diseases. I know I don’t.
WC: Winners' Circle
And the winners of the reinvent the toilet challenge awards are…?
Today I attended the Reinvent the Toilet Fair — a fascinating learning experience and an important step in providing safe sanitation for everyone in the world.

A year ago, the foundation launched an initiative to tackle the problem of sanitation in the developing world. We called it the Reinvent the Toilet Challenge. In this photo gallery you can learn more about each of the grantees and their sanitation solutions.
This week in Seattle, the foundation is holding a Reinvent the Toilet Fair. Today I awarded prizes to three universities who responded to our challenge a year ago to come up with solutions for capturing and processing human waste and transforming it into useful resources. The winners included: first place to California Institute of Technology in the United States for designing a solar-powered toilet that generates hydrogen and electricity, second place to Loughborough University in the United Kingdom for a toilet that produces biological charcoal, minerals, and clean water, and third place to University of Toronto in Canada for a toilet that sanitizes feces and urine and recovers resources and clean water. A special recognition was awarded to Eawag (Swiss Federal Institute of Aquatic Science and Technology) and EOOS for their outstanding design of a toilet user-interface.
A solar-powered toilet that generates hydrogen and electricity
California Institute of Technology, USA
A self-contained, solar-powered toilet and wastewater treatment system. A solar panel will produce enough power for an electrochemical reactor that is designed to break down water and human waste into hydrogen gas. The gas can then be stored for use in hydrogen fuel cells to provide a backup energy source for nighttime operation or use under low-sunlight conditions.
A sanitation system that converts human waste into biological charcoal
Participating organizations: Stanford University and the Climate Foundation, USA
A self-contained system that pyrolyzes (decomposes at high temperatures without oxygen) human waste into biological charcoal (biochar). After the fair, the system will be shipped to Nairobi to process two tons of human waste daily, at a facility located in the slums.
A toilet that converts human waste to fuel gas
Delft University of Technology, The Netherlands
A toilet system that applies microwave technology to transform human waste into electricity. The waste will be gasified using a microwave-induced plasma. This process will yield synthesis gas (syngas), a mixture of carbon monoxide and hydrogen. The syngas will then be fed to a solid oxide fuel-cell to generate electricity.
Diversion for safe sanitation
Participating organizations: Eawag: Swiss Federal Institute of Aquatic Science and Technology; EOOS, Switzerland
A functional model of a urine-diverting toilet that recovers water for flushing. The urine and feces will be safely transported to a decentralized processing center. The water used for cleaning will be recycled by a gravity-driven biological membrane.
A toilet that produces biological charcoal, minerals, and clean water
Loughborough University, United Kingdom
A toilet that transforms feces into a biological charcoal (biochar) through hydrothermal carbonization (decomposition at high temperatures without oxygen and in water) of fecal sludge. The proposed system will be powered from heat generated by combusting the produced biochar and will be designed to recover water and salts from feces and urine.
A urine-diverting combustion toilet
National University of Singapore, Singapore
A toilet that uses biological charcoal (biochar) to dry and combust feces. The heat generated will be used to extract water from urine by boiling it under pressure. The system can be fitted with activated carbon and exchange resin to recover highly purified water.
A community bathroom block that recovers clean water, nutrients, and energy
University of Kwazulu-Natal, South Africa
A toilet system that can safely dispose of pollutants and recover materials such as water and carbon dioxide from urine in community bathroom blocks. The system will separate the urine from the feces and extrude the feces into thin strands for faster drying and stabilization.
A toilet that sanitizes feces and urine to recover resources and energy
University of Toronto, Canada
A technology for treating solid waste streams through mechanical dehydration and smoldering (low-temperature, flameless combustion) that will sanitize feces within 24 hours. Urine will be passed through a sand filter and disinfected with ultra-violet light.
Meeting the People
The Urban Health Initiative in India
The Urban Health Initiative helps women in slums get contraception.

I always look forward to visiting India for the opportunity to meet people who are benefiting from projects we’re supporting in key health areas, like family planning, polio eradication, and HIV/AIDS.
On my recent trip, I spoke with several women in one of Lucknow’s urban slums who told me how grateful they are to have a choice of contraceptives. That hasn’t always been the case and there are still many poor women who don’t know about or have access to contraceptives. Efforts like the foundation-supported Urban Health Initiative are designed to change that by educating more women about contraceptive choices and practices like spacing births further apart.
This is a top health priority for the foundation because it directly affects the health (and often the survival) of poor women and their babies. And it offers them something that all mothers desire and deserve—the opportunity to provide their children with a high-quality education and the best chance of success growing up.
Reasons to Visit
Why India?
In this visit, I was interested to learn about India's progress in health.

I’ll soon be posting a full video about my recent trip to India. But first, a preview video and some thoughts about why I went. I go to India at least once a year to see the progress of the work our foundation is doing there. India is a fascinating, dynamic country, and I always learn so much from the people I meet.
We’ve been working in India for a long time, investing more than $1 billion in programs to fight disease and poverty. Originally we were focused mostly on preventing the spread of HIV/AIDS. That effort has become a great model for how to really scale up HIV/AIDS prevention, and it’s now transitioning to government sponsorship. This year’s trip was a chance for me to thank and congratulate everyone involved in the transition and in India’s progress against HIV/AIDS.
The trip also was a chance to celebrate the fact that India has now gone more than a year without recording a new case of polio. I also wanted to learn more about India’s progress as a developer and manufacturer of vaccines and other medicines that can help improve public health throughout the developing world.
Those are just some of the reasons why I went to India. The video on this page explains more, and I’ll share a lot more in the video that will be posted later this week.
Wash Your Hands
Can a simple, safe childbirth checklist save lives in developing countries?
I had the privilege recently of meeting Atul Gawande, a brilliant physician who’s using an amazingly simple concept—checklists for medical practitioners—to save lives and reduce health care costs. With support from our foundation, Gawande is investigating whether a safe childbirth checklist can increase the survival rate of mothers and newborns during childbirth in India and other developing countries.


It’s a well-known fact that hand washing and sterile instruments prevent the transmission of germs during medical procedures. Yet, many doctors and nurses frequently don’t follow these basic protocols.
It’s an especially big problem in developing countries—where many hospitals and clinics lack a basic standard of care.
Dr. Atul Gawande, a high-regarded U.S. surgeon and researcher, may have found the solution: a 1-page checklist that helps health workers avoid the major causes of maternal, newborn, and intrapartum (stillborn) deaths. Although it seems like a simple and obvious approach, no one has ever created a safe childbirth checklist. And until Gawande showed a few years ago that a simple checklist could save lives and avoid complications during surgery, there was no common checklist for that either. His work on developing and implementing checklists has had a dramatic impact on health care in the U.S. and around the world. Could we extend that insight to the developing world for childbirth?
I was a bit skeptical when I first heard about the power of a simple checklist. It sounded almost too good to be true. But Gawande’s research team tested the checklist idea with 8,000 patients undergoing surgery in eight cities around the world. On average, the checklist resulted in a 47% reduction in deaths and a 35% reduction in other complications.
At a time when most things about healthcare are getting more complex and costly, Gawande’s checklist is simplifying healthcare and saving money and lives. And the great thing is that it’s proving to be scalable without adding additional expense—a rare achievement in healthcare. So far, 4,000 hospitals worldwide are using the checklist approach to reduce errors during surgery.
In India, the safe childbirth checklist that Gawande’s research team developed in consultation with the World Health Organization is showing promising results. At the start of a pilot study at one childbirth center, health workers used only about one-third of the practices on the checklist—things like washing their hands before a vaginal exam, using a sterile blade to cut the umbilical cord, and introducing breastfeeding within an hour of birth. After the checklist was introduced—and with the coaching and guidance of the hospital administrator—compliance with best practices checklist shot up to 86%.
Our foundation is now funding a more extensive trial to see if the checklist can be scaled effectively to increase maternal and newborn survival in 120 hospitals in the Indian state of Uttar Pradesh. We focused on Uttar Pradesh because it is one of the poorest states in India. The mortality rate there for women giving birth is more than twice the rate elsewhere in India and over 30 times greater than in the U.S. So the potential impact in terms of saving lives is huge. And if the results are as positive as we hope, the childbirth checklist could be introduced in other developing countries.
One of the things that excites me about the checklist approach is that it focuses on improving health care by empowering the people working in local hospitals and clinics. And it doesn’t cost a lot of money. Getting the checklist right is critical, and not as easy as you might think. But once that’s done, Gawande’s approach is to train a handful of doctors or administrators and encourages them to coach their colleagues. We know that this kind of peer-to-peer coaching works well in other professions, such as teaching.
I first came across Gawande when I read one of his articles in The New Yorker, where he’s a staff writer (in addition to being a practicing surgeon, associate professor at Harvard, researcher, and book author). Gawande writes about his profession—and about his own experiences as a doctor—with an honesty and authenticity that is both refreshing and eye-opening.
I had the opportunity to meet him recently and he’s an impressive guy—one of a handful of people who’s really thinking creatively about how to improve the quality of health care and get costs under control. I’m optimistic there are other simple solutions that can similarly increase the quality of health care and lower costs at the same time. And if we can show their effectiveness in health care, we may discover they can be applied in other fields—such as education—where we also need to improve quality and make the most of limited resources.
Reaching High-Risk Groups
Avahan: Winning Against HIV/AIDS in India
One reason I was very excited to be visiting India recently was to get a chance to check on our foundation’s efforts to support the work of the government of India to halt the spread of HIV/AIDS. India is making good progress and learning lessons that could be helpful in other countries.

In 2003, we worked with Indian partners to launch a project called Avahan, which means “call to action” in Sanskrit, an ancient language of India. The project is a partnership with many Indian NGOs, state and local governments and the national government, which has increased funding for HIV/AIDS and established a national strategic plan that includes community-led HIV prevention.
Avahan’s efforts have been focused on reaching high-risk groups in six states of southern India, where the virus is most prevalent, and elsewhere along the nation’s major trucking routes, long-haul truckers being among those at high risk. Others we’re trying to reach include sex workers, their clients and partners, men who have sex with male partners, and injection drug users.
About 2.7 million people in India are infected with HIV, but that number is far below the dire forecasts that some experts predicted for India a decade ago. Avahan and India’s other efforts have contributed to a 50-percent reduction in HIV/AIDS incidence in the past six years, saving $100 million USD in averted health costs and, more importantly, saving many lives. One estimate puts the number of infections averted in the six states at more than 100,000.
Avahan is engaged in communities and at the street level, helping local groups deploy peer-to-peer counselors, distribute condoms and provide HIV testing, treatment and care. A big part of the effort is aimed at reducing the stigma that often prevents people from seeking HIV prevention and treatment services.
India has taken ownership of its national response to HIV/AIDS and is transitioning the Avahan program to state governments, facilitated by India’s National AIDS Control Programme. During my recent trip to India I was pleased to congratulate in person a number of the leaders who has been involved in transitioning Avahan and sustaining India’s HIV/AIDS prevention efforts.
In Bangalore, I got to spend time at a community center that’s part of Avahan. The center, known as Swathi’s Women's Group, was set up by sex workers to help prevent the spread of AIDS in their community. It’s been quite successful at that, and now it does lots more, like running a micro-finance bank and helping members defend their rights. It’s a great self-help success story.
The India program stands out as one of the best examples of effective national scale up of HIV prevention efforts, but those efforts will need sustained funding and government leadership. We’re hoping that what we learn in India will encourage and guide increased prevention efforts in other parts of the world.
In Bangalore
India: day three
My third day in India started with a visit to a community center that’s doing great work helping reduce HIV and providing support to sex workers. The day concluded with a meeting with a number of business leaders and philanthropists to talk about giving.

I started my last day in India at a Bangalore community center called Swathi’s House—a drop-in center for sex workers that’s part of a foundation-supported HIV prevention project called Avahan. The community members gave me a traditional Indian welcome, called an aarti. It was a day to celebrate, because the program is being handed off to the government for long-term support. But the real driver of success are the members themselves.
The center is run by a remarkable community-based organization called Swathi Mahila Sangha, which has approximately 8,500 members out of a population of about 19,000 sex workers in Bangalore. They provide counseling, medical help, HIV prevention training and a micro-finance bank. All of this is done with a cadre of peer educators and outreach workers. It’s a great model for self-help and empowerment.
I was touched by the community’s honesty and resolve—and their entrepreneurial spirit. Roughly half of the members now have savings accounts and their micro-finance bank has $800,000 USD in assets, with a recovery rate of nearly 100%. (I think most U.S. banks would be envious.) Thanks, in part, to their efforts, rates of HIV and sexually-transmitted diseases are down and the woman I talked with spoke of no longer feeling alone and helpless. They were proud of being able to keep their money, instead of remaining victims to “the thugs and the goons.”
Even though they are still a marginalized group, the sex workers are succeeding in advocating for their own rights and are enthusiastic about getting even more sex workers signed up and involved. There’s also been tremendous progress at the government level tackling the problem of HIV infection head-on, and Avahan and community centers like Swathi House are great examples.
I spent the last part of my trip at a gathering of a number of business leaders and philanthropists. I was the guest of two remarkable individuals. Azim Premji is the founder of Wipro and one of Asia’s biggest philanthropists. Ratan Tata is one of the country’s foremost business leaders and a member of the Tata family well known throughout Indian industry and philanthropy. They were nice enough to invite me to make a few remarks at the beginning, but mostly it was an opportunity to listen and learn about their perspectives on philanthropy in India.
While the circumstances for giving are unique in India, it was amazing just how much their discussion sounded like the conversations I’ve had with wealthy business people and philanthropists in the U.S. and elsewhere. A few common themes emerged. People agreed it was often easier to make the money than to give it away in a thoughtful way. There was a huge feeling of personal satisfaction in their philanthropic work, and a deep sense of societal obligation to give back. With so many problems to address, deciding where to engage and how to do it weighs heavily on their minds.
The group decided they wanted to get together again to learn from one another and talk through issues of common interest. That was fantastic. India is in a new phase of its long history of charitable giving, and I am certain many of these families are going to lead the way by doing remarkable things.
It’s been a very productive and moving three days. I’m grateful I had the chance to meet with so many amazing people in a short time. I’ll post some thoughts on the trip as a whole as well as some video the week of June 11. There’s a lot to reflect on.
Modeling Progress
Ethiopia: exciting innovations in agriculture and health
In Ethiopia, I saw advancements in farming and health services.

Ethiopia is one of the poorest countries in the world and has faced enormous challenges feeding its people and providing critical health services to mothers and their children. Yet, I returned from a recent visit excited about advances the country is making in agriculture and health.
If these innovations—which are a top priority for our foundation—succeed, they can be replicated in other African countries that also face big challenges in health and agriculture.
One factor in Ethiopia’s progress is Prime Minister Meles Zenawi and his leadership team, who have played a key role in reinventing the country’s agricultural and health systems. Making changes to either would be a big challenge in any country, so it’s even more impressive in Ethiopia, which has the second largest population of any country in Africa but a limited economic infrastructure.
Around 85 percent of the country’s population survives by growing crops on small plots of less than five acres. But frequent droughts and soils that have been depleted of nutrients often led to low crop yields and considerable food insecurity. More than half of the country’s population of 83 million is malnourished and more than 5 million households receive food aid each year.
Our foundation has been working with the Ministry of Agriculture, the county’s new Agricultural Transformation Agency, and other partners to help farmers plant higher-yielding, drought-tolerant seeds, improve soil health and fertility, and get higher prices for their crops by selling to global markets.
At the Melkassa Research Station, one of 13 government-run agricultural outposts, Dr. Markus Walsh, Sr. showed me a new, state-of-the-art technology called NIR spectroscopy that’s part of a digital revolution in agriculture. This portable device, which quickly and cheaply analyzes soil conditions, is a fantastic breakthrough that will help farmers everywhere. But it’s especially valuable in countries like Ethiopia, where farmers haven’t been able to afford laboratory tests but need to know how to amend soils to grow better crops. The spectroscopy is part of an even bigger agricultural digital information system that will provide a comprehensive and detailed map of soil properties across the country.
I also met with a number of farmers to talk about new varieties of sorghum (a grain) and beans they are growing. Beans are very important because they provide protein and people need a combination of protein and grain to have a reasonable diet.
Helping small farmers sell their crops in world markets is another important part of the work we’re supporting in Ethiopia. It’s currently a big challenge because poor farmers may not be growing the right crops for world markets and they often lack the roads, trucks, and other infrastructure necessary to enable exports. And getting foreign investors to help build this “value chain” can be difficult. But I visited one agricultural processing facility called ACOS, that is processing and shipping a variety of beans to European markets. It is jointly owned by an Italian company and Ethiopian investors and is a great example of private investment in developing countries.
What Ethiopia is doing in health is really a model system because it reaches everyone in the country. I visited the Germana Gale Health Post, where I talked to several of the more than 30,000 health extension workers who have been trained in recent years to deliver basic health education, prevention, and treatment. Most of the health workers are women, and those I met were energetic and well-trained.
These kinds of primary health services—giving vaccines, educating women about family health, and promoting hygiene and environmental sanitation—is the foundation for building good health systems in poor countries. Ethiopia’s health system also includes district health centers like the Dalocha Health Center I visited. There, they do a little bit of surgery and have more expertise and a wider variety of drugs. There are also primary hospitals that focus on higher level treatment and some emergency surgery, and general hospitals that deal with serious emergencies and high-risk and specialized care.
Ethiopia still faces some big problems. But the people I met and what I saw re-energized me and increased my optimism that the big investments we and other donors are making in health and agriculture will pay off for the people of Ethiopia and can serve as model activities in other African countries. Improving agricultural productivity and the quality of life through better health services is the key to unleashing the potential of Ethiopia and other poor countries and getting them on the road to self-sufficiency.
Science, Soil, and Seeds
Agriculture in Ethiopia
Most of the world’s poorest people are farmers, and so helping them improve their lives involves expertise in soil science, seed hybridization, and agricultural marketing. All of which are being used to end hunger and raise living standards in Ethiopia, as I observed during my recent visit.

Africa’s farmers get their food and income from farming small plots of land. They grow a variety of crops, which are often threatened by diseases, pests and drought.
One of the biggest challenges farmers face is unproductive soil. For Ethiopia, the Africa Soil Information Service is generating a digital soil map to diagnose local conditions and make targeted recommendations for improved crop production.
Soil samples are collected and analyzed using near-infrared spectroscopy, which is both portable and less expensive than traditional wet chemistry analysis. Samples are analyzed against a library of 500,000 entries.
The Ethiopian Institute of Agriculture Research has 13 stations that support technology development for sorghum, maize, common beans, and horticulture crops (onion, tomato, fruits). Bill visited the Melkassa Research Station in Nazaret, Ethiopia.
One of Ethiopia’s main crops is sorghum. It grows well in harsh conditions and is self-pollinating. There are many varieties, used for food and brewing.
Sorghum breeder Alemu Tirfessa shows Bill the diverse breeds, and describes hybrid seed production. The new hybrid seeds are more resistant to disease and drought.
The many varieties of beans grown in Ethiopia are grouped by market classes. Beans are a very important crop because they provide protein, which helps create a balanced diet when paired with grain.
Bill spoke with representatives from the Lume Adama Farmers’ Cooperative, which helps farmers set pricing, get credit, and gain access to improved seed. One farmer said that thanks to increased chickpea production, she’s doubled the number of oxen she owns and has earned enough money to send her four children to school.
In the Bowls of Millions
Ethiopia & sorghum
During my recent visit to Ethiopia, I learned about the nation’s ambitious efforts to fight poverty by increasing farm productivity. Those efforts are focused in part on a cereal crop that is almost unknown in the developed world, but that is a major lifeline for much of Africa and Asia.

Sorghum is the world’s fifth most important cereal in terms of the land used to grow it and the volume produced.
Sorghum is an especially important crop and diet staple in poor countries.
Other grains are unsuitable in areas that get little rainfall, that are subject to drought or where irrigation is not possible. That’s where sorghum is a lifesaver.
Sorghum is widely grown both for food and as a feed grain.
On my recent trip to Ethiopia, I learned about efforts to help poor farmers improve their crop yields. I got to attend a sorghum demonstration at the Melkassa Agricultural Research Station.
In Africa’s poorest regions, people still grind sorghum and other cereals by hand, much as their ancestors did.
Here a girl shakes a tray of sorghum to prepare it for use in making Injera, a sort of pancake. Consumed in many ways, sorghum and millets are a major source of calories and protein for millions of people in Africa and Asia.
Malting and brewing sorghum produce lager and stout, often referred to as clear beer, as opposed to traditional African opaque beer. Clear beer has been brewed commercially in Africa since the late 1980s.
Keeping the Pests Out
A simple advance in crop storage aids poor farmers in Africa
Reducing spoilage from weevils helps farmers store and sell more crops.

On a recent trip to Africa, I saw the incredible impact that simple innovations can have on the world’s poor. For years, farmers trying to eke out a living growing cowpeas—a protein-rich staple—would lose as much as half their crop to weevils. As I showed students during a recent talk at Stanford, a simple, inexpensive triple-layer bag invented by researchers at Purdue University enables farmers to protect their entire crop. This allows farmers to charge more for their crops and has increased their incomes by as much as 30 percent.
The People I Met
Photos from my trip to Ethiopia and Zambia
On my recent trip to Ethiopia and Zambia, I met with health workers, families, and farmers, and learned about the progress they are making in meeting healthcare and agricultural challenges.

On my recent trip to Ethiopia and Zambia, I met with health workers, families, and farmers, and learned about the progress they are making in meeting healthcare and agricultural challenges.
I visited the Germana Gale Health Post Site in Silte, Ethiopia, to meet with health extension workers and learn about the critical health issues they see, such as maternal and neonatal health risks, malaria, and pneumonia.
This health post offers several services, and also provides training to residents and community leaders to help spread information and educate the community at large about health issues and available treatments.
The health worker at this post is very active and experienced, providing family health services, and distributing supplies such as bed nets for malaria prevention.
This year, she has seen more than 200 children, most ages 2 weeks and older. On a tour of the delivery room, she explained that she is usually called to homes by family members for births.
She provides family planning services and counseling to new mothers, focusing on the importance of breastfeeding for the babies' health.
A large number of "family folders", individual family medical records, are kept at the health post. There are also many wall charts showing dates and numbers of services.
Each wall chart indicates annual and quarterly targets for each service (immunization, deliveries, preventive treatments).
I asked how closely they were meeting their targets, and learned how they captured the data.
The storage for vaccines includes a broken kerosene refrigerator and a cold box. The refrigerator broke after two years and has not been fixed.
Vaccine is delivered in a small cold box from the health center on the days they provide services.
An immunization clinic was being held on the porch of a side building, where a group of women were receiving tetanus vaccines and children were receiving Penta, polio, measles and PCV.
While most services are given at the health center, the health worker has two outreaches per month, the furthest being a three-hour walk away.
The clinic had a coffee ceremony for me, roasting the beans on the spot.
Coffee was served with popcorn.
I visited a household with a two week-old baby. The home was fairly large, with a fenced-off area for animals. The family has two other children – a 3 year-old and a 6 year-old.
The baby and the older children were all born at home with the help of the health worker, who taught their mother to begin breastfeeding immediately to help boost the baby's immune system with colostrum.
I visited the Melkassa Research Station in Nazaret, Ethiopia, one of 13 stations in the Ethiopian Institute of Agriculture Research that supports technology development for sorghum, maize, common bean and horticulture crops (onion, tomato, fruits).
Farmers are facing challenges in seed production with the current irrigation capacity. To address this, experimental hybrids are being formed under the Drought Tolerant Maize for Africa project.
In the last eight years, the agriculture sector in Ethiopia has been growing at the rate of 10 percent per year. The country also has a comprehensive food security program for drought-prone areas.
Currently, most farmers rely on seed they have saved themselves, which is subject to drought and losses caused by birds. Seed companies can produce hybrid seed, providing the best option increasing production of sorghum.
Workers sort and clean seed at a seed-processing facility.
At the legume seed storage facility, I saw the different market classes of beans (white pea, red kidney, small red, sugar, large kidney beans) as well as chickpea (desi and kabuli), and mungbean.
I visited the cold storage, which plays a critical role in preserving seed viability for legumes. They lose viability faster than cereals because of their high protein content.
Male circumcision can significantly reduce HIV transmission. At the Shang Ring Male Circumcision clinic, they are conducting a trial program where circumcision can be performed at a cost as low as $2 per device.
The Coptic Mission Hospital and Clinic in Lusaka, Zambia, has been a high-quality provider of HIV services.
I met Florence Daka, a cleaner at the hospital, who tested positive for HIV in 2008 and was successfully treated with an antiretroviral (ARV) drug. In 2010, Florence was able to conceive, and safely deliver an HIV-negative child, Stephen.
Some Pictures
Photos from my recent trip to Ethiopia and Zambia
On my recent trip to Africa, I met with many people and heard their interesting, inspiring stories about how aid works. This gallery has stories and photos from the trip.

On my recent trip to Africa, I met with many people and heard their interesting, inspiring stories about how aid works. This gallery is a preview of some of the stories and photos I'll share during a Livestream on April 4th.
In Silte, Ethiopia, we visited one of the nation’s many new “health posts” set up to improve public health, village by village. The staff members here are saving lives with their incredible work.
Bed nets are still one of our best tools against malaria. While in Zambia, we met with local health care officials to talk about their battle against the disease.
Africa is making significant progress toward the Millennium Development Goals of improving maternal and child health.
AIDS/HIV has taken a huge toll in Africa, but more people are getting the life-saving treatments they need, while education and outreach efforts are curbing the rate of new infections.
African farmers of cowpeas (also known as black-eyes peas) are benefitting from an inexpensive solution to weevil infestations that used to ravage their crops after harvest. Scientists from Purdue University developed airtight bags to protect cowpeas.
Now, farmers can store cowpeas for sale when prices are strong. That’s expected to raise farmers’ annual incomes by an average of $150 in West and Central Africa, where most live on about $2 per day.

A Good Effort
A report card on helping the world’s poor
I believe the global community deserves a solid B for progress meeting the UN’s Millennium Development Goals.

People sometimes say that the United Nations doesn’t do enough to solve the big problems of the world. I’ve never really agreed with that point of view, but if anyone is looking for evidence of the UN’s impact, a good place to start is the Millennium Development Goals (MDGs).
The MDGs are an ambitious set of goals for reducing poverty and child mortality rates, and fighting diseases that sap the socioeconomic potential of poor countries. They were agreed to in 2000 by all 193 UN member countries and 23 international organizations. Creating that kind of consensus is—by itself—a significant achievement.
The great thing about the MDGs is that they provide clear targets and indicators of progress in key areas, including ending poverty and hunger, ensuring universal education, gender equality, improving child and maternal health, combatting HIV/AIDS, environmental sustainability, and strengthening global development.
Although a number of countries won’t be able to achieve all of the goals by the target date of 2015, the MDGs have been helpful in getting everyone to really think about their part, the progress they’re making, and what they can learn from others. The goals have focused political attention in developing countries, encouraged UN groups to work together, and inspired wealthy and fast-growing donor countries to coordinate their efforts.
In February, the World Bank announced that the MDG goal of cutting extreme poverty by half had been achieved five years early. A week later, UNICEF and the World Health Organization announced that the goal of halving the number of people without access to safer drinking water was also reached five years early. These are noteworthy achievements though much work remains to be done. Other goals, such as reducing maternal mortality by three-quarters, simply won't be achievable by 2015, although the progress has been really good.
Already, people are talking about what the goals should be for 2030. That’s a great thing because there’s still a lot more work to do, especially in reducing diseases and maternal and childhood deaths. But I believe the global community deserves a solid B for its efforts so far and where there is progress, we should celebrate.
One of the things I’ve learned in my work at Microsoft and the foundation is that setting clear goals and honestly evaluating progress is critical when trying to tackle big challenges. The MDGs provide a report card on the progress the world is making to take care of those most in need.
Goal 1: Eradicate Extreme Poverty and Hunger
Goal 2: Achieve Universal Primary Education
Goal 3: Promote Gender Equality and Empower Women
Goal 4: Reduce Child Mortality
Goal 5: Improve Maternal Health
Goal 6: Combat HIV/AIDS, Malaria and Other Diseases
Goal 7: Ensure Environmental Sustainability
Goal 8: Develop a Global Partnership for Development
Beans
On my way to Africa
On my trip to Africa, I'm thinking about malaria, public health systems, farm productivity, and beans. Yes, beans.

This week I’m in Africa, a place I go a couple of times a year to see our foundation’s work in the field. The reason I go on these trips is to see for myself what’s happening and I come away with success stories, notes on things that we need to get smarter about, and a better understanding overall. This time I’m visiting Ethiopia and Zambia, which should be very interesting.
Eliminating malaria in Zambia
I’ll be looking at malaria intervention in Zambia, because that’s where we supported the first major efforts to distribute bed nets and get people to use them. After we began this work, the U.S. started the President's Malaria Initiative, which essentially expanded what we were doing in Zambia and replicated the program in other countries.
Malaria deaths are way down from their peak in Zambia. Bed nets have been very effective. But we’re still looking for answers to some questions about them. How much do they help long term? How quickly do they wear out? Despite them, do malaria deaths eventually rebound, as we’ve seen somewhat in Zambia (particularly in the north)? Why the increase - is it because people didn’t use the nets, because they’re torn, because mosquitoes adapted, or simply because mosquito numbers vary from year to year?
Nobody ever thought bed nets alone would drive malaria to zero. They’re a really good tool, but you'll need a couple other tools that you use in a deep way to ever get to eliminating malaria in a particular location or community. Everything we’re learning is equipping us to achieve our long-term goal, which is to eliminate malaria locally in a whole lot of communities, building to eventually emptying the malaria map.
New kind of government partnership in Ethiopia
We’ve been working in Ethiopia for more than a decade. In that time we’ve made over 125 grants to partner organizations that are doing health and development projects there. Our engagement deepened a few years ago when Prime Minister Melas Zenawi came to us and said he really wanted to improve agricultural productivity. Agriculture contributes about half of Ethiopia’s GDP and employs roughly 80 percent of the workforce.
But the Prime Minister said he wanted to try something different from the normal way donors come in and support particular projects. He wanted to step back and look at everything involved in farm yields – seed companies, farmer education, fertilizer costs, everything – and then figure out an overall plan. And then ask donors to support things that fit with the plan. So, about a year and a half ago, Ethiopia formed the Agricultural Transformation Agency.
This is exciting, because areas in the Horn of Africa are often on the edge of famine. The situation in Ethiopia is nowhere near as bad as in Somalia, but the eastern part of Ethiopia has had recurring food problems. Improving the amount of food farmers can raise would make a big difference in the lives of those families living there.
Now that ATA has new policies in place, donor money is going to support projects in line with an overall plan. A lot of the focus is on increasing the productivity of small farmers. Part of the plan involves using new types of seeds. I’ll get to see how that’s going.
Community health outreach
I’ll also get to see the results from Ethiopia really bulking up its community health outreach. About 20,000 young women have been trained and placed in newly built health posts, as they’re called. I’ll be interested to see how that’s going and what the challenges are. One surprise is that pregnant women aren’t coming into the health posts to deliver their babies, at least not as much as expected. What would it take to change that, since the health of the mother and the baby are so dramatically improved by delivering in a clinic? I’m also interested in getting a clearer idea of Ethiopia’s vaccination rates. There are conflicting data on that.
Legumes – beans, basically
I'm also visiting an agricultural research station in Ethiopia where they’re doing very interesting work with legumes – beans, basically. The project is developing new varieties and helping farmers learn how to process them for sale to urban markets, which small farmers weren’t getting to before.
Beans are interesting because they’re a staple for really poor people almost everywhere. The most basic or world diets consist of some kind of bean and some kind of grain: beans and rice, beans and wheat, beans and millet. That combination gives you the complete proteins you need to live. So, nearly everywhere, subsistence farmers grow beans. They’re not only a staple, but also a fertilizer for farmers’ other crops, because beans return nitrogen back into the soil, which most every other crop takes out. Coming up with even better varieties could help farmers and improve nutrition in many places.
As always, throughout this trip I’ll be meeting with local representatives of donor groups and leaders of aid projects. We get together and they talk openly about what’s working and what’s not. That’s always very helpful, hearing from people in the field.
When I come back from Africa I plan to share some of the stories and photos of what I’ve seen in the field so that others can have a glimpse of what’s going on in the poorer part of the world. And by providing that glimpse, I hope it draws people in to want to know about and care about these issues.
Innovation on Small Plots
Working together for small farmers
I urged leaders of the international agriculture community that they need to do better for small farmers.

If you care about poor people, you need to care about agriculture.
Most extremely poor people in the developing world get their food and income from farming small plots of land. Many others live in big cities and need access to inexpensive food to be healthy and productive. So helping small farmers grow more food sustainably is the best way to fight hunger and poverty over the long term.
History is on our side. In the past several decades, agricultural yields in many places have doubled, and hunger and poverty have been cut in half. Now it is time to continue and accelerate that progress.
This week, I am speaking to the leaders of the international agriculture community at a meeting at the International Fund for Agricultural Development. The audience will be made up of the key people working in developing countries, aid agencies in developed countries, and international groups like the World Food Program and the Food and Agriculture Organization—and my message is that they need to do better for small farmers.
I am urging them to get together to set a common productivity target and create a system of public scorecards to hold themselves accountable. If they take these steps, I believe it is possible to meet the world’s most aggressive goals for reducing hunger and poverty.
One of the most important priorities is connecting the poorest farmers in the world to breakthroughs in agricultural science and technology. Right now, a digital revolution is changing the way farming is done, but poor small farmers aren’t benefitting from it.
For example, we now have satellites that can identify instantly and precisely how much wheat there is in a field. However, many developing countries are still sending people out with a pad, pencil, and tape measure to estimate yields. As a result, we take more time and expense to get less accurate and incomplete data. Better data, collected in a timely way, means decision makers have better information to make policies that can help farmers. That is one examples of how a digital revolution can make a difference.
Innovation is the concept on which Melinda and I created the foundation. For years, we saw the impact that innovation in the computer industry had on the richest people in the world. But at the same time, the poorest half was hardly benefitting from innovation at all. We hope our foundation can work with partners to help change that.
The stakes could not be higher. The world’s ability to help small farmers be more sustainably productive will determine whether or not they remain in poverty or whether the hard work results in self-sufficiency for hundreds of millions of people.
Swatting Mosquitoes
Using Disease to Fight Disease
A novel approach to controlling mosquito populations

Most people probably wouldn’t want to visit a mosquito research lab on their family vacation, but Melinda and I were in Australia recently and were excited to see some amazing work in molecular biology that could lead to a breakthrough in controlling mosquito-borne diseases such as dengue fever.
Mosquitoes are a plague in much of the developing world, not just because they are a nuisance, but because they are transmission agents for some truly terrible diseases. The scientists we met with in Cairns have discovered a way to infect mosquitoes that are normally capable of carrying diseases like dengue and yellow fever with a bacterium called Wolbachia. Wolbachia is naturally present in many types of insects, but not in these mosquitoes. Although it is harmless to humans and most other animals, when placed in these mosquitoes Wolbachia shortens their lifespan by about 50 percent and inhibits the development of dengue virus and several other pathogens.
If mosquitoes with the Wolbachia strain can be successfully introduced into wild mosquito populations, it could greatly reduce the transmission of infectious diseases to humans because most mosquitoes would die off before the viruses that cause human disease could replicate in their body. Another plus for Wolbachia is that it alters the mosquitoes’ reproductive biology, so that when female mosquitoes that do not carry Wolbachia mate with male mosquitoes that do carry Wolbachia nearly all of their embryos die off. Since Wolbachia is passed through the mother mosquito to her offspring, this means that Wolbachia can spread very rapidly through a mosquito population.
Some of these discoveries were a surprise to scientists. If they can be proven in field trials, Wolbachia could create a cheap, natural, and self-sustaining method of control that dramatically reduces dengue fever and other major infectious diseases such as yellow fever and malaria.
The research, led by Professor Scott O’Neill of Monash University, has been funded since 2005 by the Foundation for the National Institutes of Health (FNIH) under the Grand Challenges in Global Health initiative, which encourages innovation to solve persistent health problems in the developing world. Diseases spread by mosquitoes are definitely at the top of that list.
O’Neill’s work is mainly focused on preventing mosquitoes from transmitting the virus that causes dengue fever, an infectious tropical disease that causes 22,000 deaths—mostly among children—and results in 500,000 cases of severe illness each year. Scientists are optimistic that this approach could also work with other insect-transmitted diseases such as malaria, which kills nearly 1 million people annually, mostly children under 5 years of age.
Historically, the battle against disease-carrying mosquitoes has relied on repellants, insecticides, bed nets and eliminating stagnant water breeding sites. More recently, scientists have been working on vaccines that would prevent people from getting infected with mosquito-borne diseases.
To do his current research, O’Neill has had to convince people in Cairns that releasing mosquitoes in their neighborhoods is a good thing. Melinda and I participated in one release of about 20 jars of mosquitoes—probably 1,000 mosquitoes in all. I was bitten by several dozen, but was safe from getting dengue fever because the mosquitoes being released were lab-reared and not infected with dengue. I have a lot of respect for the volunteers who go into mosquito cages and allow themselves to be bit in the name of science. The average number of bites they get is over 50!
It was fascinating to see the project first-hand. There’s a real possibility that this approach will get deployed broadly and could really help reduce a lot of disease transmission. But as exciting as it was for Melinda and me, our kids said they definitely didn’t mind not going along.
A Bunch of Reasons
Building better bananas
I'm sometimes asked why the foundation has made agricultural development a priority along with global health. Actually, the two are intertwined. One example comes from Australia and Uganda, where researchers are using advanced technology to try to improve the banana.

Our foundation’s work around the world gives me opportunities to meet really smart, visionary people who are doing pioneering work in fields that I might not get a chance to learn much about otherwise. For example, in December Melinda and I went to Cairns, Australia, where James Dale and his team from Queensland University of Technology are doing advanced research on bananas. As odd as that might sound, this research could make a big contribution to public health in a lot of Africa and Asia.
Before our visit, I didn’t know much about bananas. Dale, an agricultural scientist, is one of the world’s leading experts. He has been profiled in The New Yorker, in a fascinating article about the history of bananas as an export crop. As the article explains, a blight has spread among plantations in Asia and Australia in recent years, badly damaging production of the one type of banana that is grown for export, the Cavendish. This disease, a fungus, hasn’t spread to Latin America yet, but if it does, bananas could get a lot scarcer and more expensive in North America and elsewhere. Dale is working to develop new versions of the Cavendish that resist the fungus. He does this by inserting genetic material from other organisms into banana plants.
This work is separate from the research that our foundation supports, although some of the same techniques and scientific principles are involved, including transgenic experiments. Making banana plants less susceptible to diseases is a secondary goal for us. Our primary goal is to help Dale develop new types of banana that are more nutritious—specifically, much richer in Vitamin A and Iron that the body can absorb.
This is important because the diets of millions of people in Africa are deficient in both of these vital nutrients. While rare in the developed world, Vitamin A deficiency in developing countries causes hundreds of thousands of children to go blind each year. It also reduces the body’s ability to fight infection, which raises the fatality rates in poor countries from infectious diseases like measles. Iron deficiency is so serious and widespread that in Uganda, for example, more than 40 percent of young children have stunted growth and 73 percent are anemic.
Meanwhile, bananas are a primary staple of people’s diet in Uganda and many other African nations. (Our foundation also has supported research to enhance the micronutrient content of cassava, rice and sorghum, all staples for millions of the world’s poorest people.) An average Ugandan consumes about five times his or her weight in bananas each year. Fortunately, Ugandans have more varieties of banana to choose from than we usually do in the developed world. Some varieties are eaten raw, while others are cooked as part of a dish with other ingredients. The kind that are cooked are sometimes called plantains, but they’re all bananas. For dessert there’s the sweet Sukali Ndizi, which children especially love.
Unfortunately, the banana varieties grown in Uganda are low in essential micronutrients, particularly Vitamin A and Iron. To increase these levels, Dale and his team in Australia are collaborating closely with Ugandan scientists at that country’s National Agricultural Research Organization. The NARO team, led by Dr. Wilberforce Tushemereirwe, has made important contributions—developing research protocols, conducting field trials, and planning distribution of new, more nutritious banana varieties to Ugandan farmers. The NARO team’s involvement is a great example of young African scientists playing a major role as full partners in using state-of-the-art science for development of new products important to agriculture and health in their own country.
Our foundation has supported this work since 2005, initially as part of our Grand Challenges in Global Health initiative, which fosters early-stage research aimed at breakthroughs on the world’s most pressing health problems. If you had asked me at the time, I would have said the project was one of the more wild things we funded. Some of the original Grand Challenges projects, even some of the ones I thought were the most likely to succeed, have come to an end, but that’s scientific discovery.
Other funders have not been focused on the kind of work that Dale and NARO are doing, so our funding has been important, and the work is progressing well. New banana varieties have been developed that have as much as five times more Vitamin A than before. You have to get the levels just right, though, because too much makes the banana look orange, which consumers might not like. Boosting iron levels seems to be a tougher challenge.
It all takes a long time, though, for a few reasons. Not much was known before about how to work with banana cultures at the molecular level, so a lot of basic science had to be done first. Then, it takes two or three years to take a new banana culture from inception to the point where it produces fruit and you can see if it’s more nutritious. And there have been some unfortunate setbacks. In early 2011, Cyclone Yasi roared through Cairns and destroyed the fruit crop from field trials there. Luckily, the cyclone did not uproot the plants, but the trials were delayed at least nine months until a new crop of bananas could grow.
Once some clearly superior banana varieties are developed and proven, it will take time to do the research to show the health benefits, for regulators to approve them, and for farmers to begin planting them.
It’s great that we started back in 2005.
Fighting Crop Disease
Cassava: can science save a diet staple?
In Tanzania last year, I visited with farmers whose survival – like that of millions of other Africans – depends on the cassava, a diet staple threatened by disease. I also visited with African scientists on the forefront of efforts to protect the cassava and other vitally important crops.

In Tanzania last year, I visited with farmers whose survival—like that of millions of other Africans—depends on the cassava, a diet staple threatened by disease. I also visited with African scientists on the forefront of efforts to protect the cassava and other vitally important crops.
Cassava is a staple crop that provides a basic diet for more than 500 million people worldwide.
Cassava is a starchy root that must be processed before eating because it contains small traces of cyanide. It is often grated, dried, and roasted to make garri, a flour; the leaves are eaten as vegetables in a stew.
When dried to a powder, cassava is known as tapioca.
These cassava plants are infected with mosaic disease, making the cassava root much smaller and less nutritious.
Christina supports her family by farming cassava. In the past two years, Christina’s crop has been invaded by two cassava diseases. Because of these diseases, she is depleting her savings to buy cassava to feed her three children. For Christina and other small farmers getting food is the most pressing daily concern.(Mapinga Village, Tanzania)
When I was in Tanzania last year, I met Dr. Joseph Ndunguru, a plant scientist leading a project to fight the mosaic and brown streak diseases that attack cassava crops. Dr. Ndunguru is part of a new generation of African scientists building up the capacity to do innovative science in Africa.

One Year Polio-Free
India Marks a Milestone for Child Health
This Friday will mark a full year since the last case of wild poliovirus was detected in India. This is a huge milestone in the history of global health. But the fight against polio is not over.

Four years ago, I visited India and saw again what polio does to children. I was in a slum in East Delhi, when I met a 9-month-old girl named Hashmin—paralyzed by polio—cradled in her mother's arms. She will never be able to do many of the normal things kids do because she has polio. Watching her was the strongest of reminders of the imperative of ending this terrible scourge once and for all.
The following year, in 2009, India had more polio cases than any other country in the world. But much has changed since then, and this Friday will mark a full year since the last case of wild poliovirus was detected in India. This is a huge milestone in the history of global health.
With a huge and growing population, hard-to-reach migrant communities, and sanitation and health conditions that limit the effectiveness of polio vaccines, this remarkable achievement in India marks clear progress in the fight against polio.
India really stepped up to the challenge on polio. The government of India funded its own eradication program. Twice a year, 2 million volunteers prepare 800,000 vaccination booths around the country—at schools, hospitals, and community centers. They immunize more than 172 million children one by one. Working with partners like Rotary International, WHO, and UNICEF, they have built an impressive infrastructure for delivering health services to some of the most underprivileged children in the world.
India’s story is proof that major health problems can be solved in the toughest places in the world. But the fight against polio is not over and we are at a critical moment in time.
In 2011, there were still a handful of countries with polio outbreaks. We must sustain funding to ensure a comprehensive immunization effort in India and other countries—until there are no more cases. If we don’t, the virus can spread back into countries where it has been eliminated, as it did last year in Russia and China.
Eradicating polio is a top personal priority and of the greatest importance at the foundation. Last year, I visited India again to see how the country was able to make such phenomenal progress. I also visited Nigeria and Chad to understand the challenges that lie ahead. I’m optimistic that we can vanquish polio forever if other countries choose to learn from India’s success. Together, we can accomplish something amazing.
Keep Giving
A plan to assist the world’s poor
Advances in agriculture, education, health, and sanitation have led to a dramatic decline in child deaths over the last 50 years. But the global economic crisis is putting at risk the development aid so critical to continuing this progress. As Congress considers foreign aid in the coming weeks, I encourage policymakers to consider the remarkable impact of American aid, its benefits to the U.S., and the contributions of a growing number of donor countries.

Fifty years ago, almost 20 million children under the age of 5 died every year. In 2010, the figure was down to 7.6 million. This 60 percent decline in childhood deaths — reflecting advances in agriculture, education, health and sanitation — is compelling evidence of the increasing justice in our world.
But the global economic crisis is putting the long-term trend of progress at risk, as Congress’s debates about the foreign aid budget underscore.
I am giving a report Thursday to the heads of the Group of 20 governments, including President Obama, suggesting creative ways for the world to continue investing in development despite fiscal constraints. I hope three key ideas become part of congressional deliberations over the coming weeks.
First, programs funded by U.S. generosity have been a core component of this 50-year project of raising living standards around the world.
Aid is targeted to fill specific gaps in development. The most important of these gaps is innovation. When the private sector doesn’t have incentive, and poor governments don’t have the money, smart aid pays for breakthrough solutions. The green revolution that fed a billion people in the 1950s and ’60s never would have happened without advanced agricultural science funded by U.S. aid. In just the past 10 years, millions of children have been saved from diseases such as measles and whooping cough by vaccines that Americans paid for through their contribution to an organization called the GAVI Alliance. Immunization is a great example of how aid can be effective. Thirty-six cents worth of measles vaccine protects a child for a lifetime.
Second, development isn’t just good for people in poor countries; it’s good for all of us. It used to be that the world was, roughly speaking, one-third rich and two-thirds poor. Now, the number of dynamic, healthy, highly educated countries is much higher, which is a recipe for prosperity. Imagine the world economy without Brazil, China, India, Indonesia, South Korea, Mexico or Turkey.
If countries that are currently poor can feed, educate and employ their people, then over time they will contribute to the world economy. On the supply side, they’ll increase the production of key commodities such as food, keeping prices lower. On the demand side, as their citizens are more productive, they’ll become important markets for trade.
But if people don’t get access to basic necessities, continued suffering will lead to economic stagnation and instability. It is, for example, not only unconscionable but also a strategic mistake to allow famine to devastate the livelihoods of millions of people in the Horn of Africa.
Third, the United States is not doing development alone. We spend about 1 percent of our total budget on aid, as do dozens of donor countries.
And with only a few exceptions, the amount poor countries spend on their own development is much greater than the amount donors invest. Ethiopia, for example, has in the past five years built 15,000 rural health posts to provide improved services for its citizens.
There is also a group of rapidly growing countries — including Brazil, China and India — that combine recent experience with development and significant technical capacity, giving them the insight and the skill to have special impact. For instance, China is sequencing 10,000 varieties of rice to help small farmers cope with climate change. These efforts can make a big difference. For example, a new submergence-tolerant rice variety being used in flood-prone areas of Bangladesh and India can more than double farmers’ yields. We predict that 20 million farmers will be planting this variety in the next six years.
The private sector hasn’t always invested as much in development as it should because the market incentives haven’t always been clear, but there are ways to encourage involvement. In my report to the G-20, I’ll make half a dozen recommendations for mobilizing tens of billions of dollars annually from private sources. The African diaspora is sitting on $50 billion in savings that could fund development in their home countries if it were captured through diaspora bonds.
If the transaction costs on remittances worldwide were cut from an average of 10 percent to an average of 5 percent, it would unlock $15 billion a year in poor countries. In addition, there are trillions of dollars in sovereign wealth funds, and a portion could be reserved for key infrastructure projects in poor countries.
Sometimes Americans get the impression that we’re shouldering the whole burden of development and that, ultimately, our aid doesn’t make a big difference. I see it very differently. We’re providing strategic investments that link up with many other investments to systematically make a better, more prosperous and safer world. If we do it right, we can keep shrinking the number of countries where aid is needed to zero.
This was originally published on November 1, 2011 in the Washington Post.
Advancing the MDGs
Foreign aid advances millennium development goals
In this photo gallery, meet some of the people who are helping their countries move closer to meeting the U.N. Millennium Development Goals.

From a Kunwasi village in Ghana to a Maksoodpur village in India, development aid is saving children’s lives, improving health conditions, reducing poverty and hunger, and increasing economic growth and stability. In this photo gallery, meet some of the people who are helping their countries move closer to meeting the U.N. Millennium Development Goals.
Ethiopia
Lomitaa, a health extension worker in Ethiopia, makes a home visit in Mojo village. To reduce suffering from preventable and treatable diseases, the government trained more than 32,000 women as health extension workers, to teach rural families about disease prevention and healthy living. It also created “health outposts” to provide basic medical services and preventive care in rural areas. Since the program’s launch in 2006, there has been a 35 percent increase in immunizations for diphtheria, tetanus and pertussis, and a 50 percent reduction in malaria. Health extension workers often walk miles to reach families in the most remote areas.
Nicaragua
Nicaraguan horsemen Julio Mesa Zelodon and his son Santos delicately balance a fragile cargo of rotavirus vaccines, which must be transported in an insulated box to preserve the drug’s effectiveness. Rotavirus is a preventable and treatable diarrheal disease that causes 500,000 deaths each year among infants and young children. Since the vaccine’s introduction in 2006, Nicaragua has seen a 77 percent decrease in severe rotavirus cases. The vaccine is often transported by horse, donkey or boat to reach the country’s most remote areas.
Ethiopia
Since Ethiopia emerged from 16 years of civil war in 1991, the country has made significant progress in poverty reduction, food security, health, nutrition, and education. Education reforms aimed at increasing access, especially for girls and the rural poor, increased student enrollment by 500 percent. School fees were abolished and funding was provided for adult literacy programs, school construction, and to train and hire teachers.
Ghana
Staple crops like cassava and yams as well as cash crops like tomatoes and peppers are on sale at a street side market in Kumasi, Ghana. Through agricultural reforms, farmers are better able to cultivate staples and grow cash crops for additional income, reducing the country’s hunger rate by 75 percent and cutting poverty nearly in half.
Ghana
Andres Yemetey from the Ghana Infant Nutrition Action Network discusses the benefits and proper techniques of breastfeeding with Estherlyne Larkai as she feeds her daughter at the Osu Maternity Home in Accra.
In the past, many women in Ghana supplemented breast-feeding with water, sugar water, or herbal concoctions that caused diarrhea and other problems. As the result of government education efforts, many women now feed their babies only breast milk, and men are encouraged to provide support to make that possible.
Cote d'Ivoire
Kevin Kouassi, 36, who is HIV-positive, works at the NDA Health Center in Dimbokro, Cote d'Ivoire. His job is to encourage testing, counsel those who come to the clinic, and educate them about prevention and treatment. Today free testing for HIV/AIDS is readily available in Cote d'Ivoire and can be done in as little as 15 minutes, ensuring that patients will stay to receive their results. Here, he counsels 24-year-old Aya who is six months pregnant with her second child and has come to the clinic for testing.
Viet Nam
In the last two decades, Viet Nam has become a major exporter of rice and coffee, and its manufacturing sector has boomed. The government has tapped the country’s economic growth to improve health, education, and water and sanitation services. Incomes have risen and the poverty and infant mortality rates have fallen dramatically.
Egypt
Until recently, most births in Egypt were at home and unattended by skilled personnel. Through education and outreach efforts, couples like Saad and Madiha have learned about the value of prenatal visits, medically assisted childbirth, post-partum care, and family planning. Targeted villages have seen dramatic improvements in maternal and child health, including a 27 percent drop in underweight babies.
Bangladesh
A Bangladeshi mother, Shahinoor, gives her child, Santo, oral rehydration solution. Commonly made of ingredients that poor households can afford, such as salt and unrefined brown sugar, oral rehydration therapy has saved the lives of millions of children from death due to diarrhea. Its widespread use, in combination with immunization campaigns for childhood diseases, has significantly reduced child mortality and malnourishment in Bangladesh and worldwide.
India
In 1975, the Indian government started the Anganwadi program, one of the largest child health and development efforts in the world. Here, Anganwadi worker Pushpa Kumari vaccinates a child against polio in a house-to-house campaign in Maksoodpur village. Between 1999 and 2007, India’s under-five mortality rate fell from 117 to 72 per 1,000 children.
Malaria Forum
Charting a course to end malaria
With continuing innovation, we can eradicate malaria.

In the past 10 years, the number of people who die from malaria has declined 20 percent.
For the past three days, the global malaria community has been meeting in Seattle, talking about what it’s going to take to get rid of the other 80 percent. The eradication of malaria is an ambitious goal and a long-term goal—but a goal Melinda and I are 100 percent committed to.
People used to say eradication was impossible, but we remain optimistic because human beings have a spectacular ability to innovate.
The tool that’s most associated with the recent progress against malaria is the long-lasting bed net. Bed nets are a fantastic innovation. But we can do even better. We can invent new ways to control the mosquitoes that carry the malaria parasite.
One of the problems with nets is that they can be uncomfortable to sleep under, so people sometimes chose not to. Researchers are testing spatial repellents that drive mosquitoes away right now. A family could hang a small coil from the ceiling and be protected, without having to accept a terrible night’s sleep.
One innovation the malaria community has been pursuing for decades is a vaccine. We have never had a vaccine for a parasitic disease, and the scientific complexity is dizzying. But at this week’s meetings I was pleased to announce interim results from the final-phase of a trial for a vaccine candidate called RTS,S. Among five to 17-month-old children, the vaccine prevented clinical malaria (which was defined as the presence of fever and parasites in a child who was ill and brought to a health facility for care), in 56 percent of trial participants over a period of one year. We still need to analyze the complete data when it’s available, but this vaccine could be licensed and protecting children by 2015.
We’ll keep on innovating and improving on this vaccine, but these results are a huge milestone in the history of our fight against malaria.
The malaria parasite has been killing children and sapping the strength of whole populations for tens of thousands of years. It is impossible to calculate the harm malaria has done to the world. But we have the ability to make generation after generation of better tools, and we can chart a course to end malaria.
More Work to Do
Why we must outsmart mosquitoes
The decisions we make now will determine what happens to malaria in the future.

On October 18, at the foundation’s second annual Malaria Forum, I spoke about the progress being made in the war against the dreaded parasitic disease. But more needs to be done to control and eradicate it, including a higher level of preventive drug treatment for pregnant women, additional research on chemical repellants, and further investigation of vaccines and drugs to treat those who are infected.
Prepared Remarks by Bill Gates
Thank you, Melinda.
Melinda told you about some of the people we met in Tanzania recently. I was impressed by a man named Prosper Chaki, who runs a larviciding project in Dar es Salaam. He spends his days wading into the standing water where anopheles mosquitoes breed, so he can poison them. It’s not so surprising that he’s gotten malaria 20 times.
“Mosquitoes are smart,” Mr. Chaki said. Then he told us, “We have to be smarter.”
I believe we will be smarter. One reason is that you have come from all over the world to this forum—to challenge each other, to disagree with each other, and to learn from each other. When you leave tomorrow, our team at the foundation will move forward with the benefit of the most rigorous thinking in the world. We are grateful to you for that, and I hope each of you will take inspiration back with you as you continue your personal fight against malaria.
The other reason I believe we will be smarter is that human beings have a spectacular ability to innovate. Innovation is one of the most powerful forces in the world. It can make the impossible, possible.
Melinda talked about the innovations that have changed the course of malaria and saved a million lives in the past 10 years.
But innovations are only as good as our commitment to delivering them. We have to get better at using the innovative tools we have.
Intermittent preventive treatment with drugs during pregnancy and infancy are two proven methods of protecting those most at risk from malaria, but they’re not saving as many lives as they should be. For example, most countries in sub-Saharan Africa provide IPTp in less than 20 percent of pregnancies. That is not good enough.
We have to demonstrate the same level of commitment as new tools come online. I am very optimistic that Seasonal Malaria Chemoprevention will be available starting early next year, when the WHO’s approval process is complete. We must be aggressive in launching pilot studies to understand how this intervention should fit into control strategies, so we save as many lives as possible, as quickly as possible.
We also have to be thinking simultaneously about the next generation of tools. If we think big, bring more partners into the fold, and take smart risks, we will invent novel tools—powerful ways of fighting malaria that don’t exist now. This is the kind of innovation that will enable us to plan for the eventual eradication of malaria.
Eradication is an ambitious goal—and a long-term goal. It is also a goal to which we remain 100 percent committed.
We are committed to it for moral reasons. My children will not die from malaria, thank God. Since that is true, no child should die. It should never be too expensive or too inconvenient to give the poorest a chance to survive when the richest already have it. Equity is not yet a reality, but it is what we believe in and what we are striving for.
We are also committed to eradication for strategic reasons. The only alternative to charting a course to the end of malaria is an eternity of trying to stay just one step ahead of the parasite and the mosquito. If we have to fight in perpetuity, the cost in lives will be enormous. The opportunity cost of never being able to divert our attention to other challenges will be incalculable.
I know some people in the malaria community worry that focusing on the uncertain goal of eradication could distract us from control measures that are working today. I understand the desire to stay focused on saving lives. But I don’t see eradication and control as two separate approaches to the fight against malaria. Instead, they are two compatible parts of a single approach. To achieve elimination and eradication, we need to start with control, drive it up to high levels, and sustain it. But if we don’t target elimination and eradication, control will lapse, and malaria will continue taking lives.
It will take leadership and innovation and money to extend the recent success. It will also take leadership and innovation and money to plan for malaria’s eventual eradication. The conclusion is daunting, but inescapable: We will need enough leadership and innovation and money to do both. We do not have the luxury of choosing one or the other.
I am an optimist. I believe we are capable of setting our sights on an ambitious goal with a generation-long time horizon and multiple, shifting milestones along the way. But eradication will never happen as long as it remains a general aspiration. We must turn it into a specific plan, and our job now is to lead the constant search for new and better tools that will help us execute our plan, step by step.
The best tool we have now is bed nets. Nets are a fantastic innovation, but they’re not perfect and they won’t be sufficient. They are expensive, they are unpleasant to sleep under, and they don’t protect against outdoor- and daytime-biting mosquitoes. There is a clear need for cheaper, easier to use, and more powerful vector control methods.
I am enthusiastic about spatial repellants, chemicals that can keep mosquitoes away from treated areas. Repellants could be a big improvement over nets, because the people benefitting from them wouldn’t have to make the choice to sleep under them every single night. The likelihood of human error or human resistance would shrink by a lot. And spatial repellants would be effective against all types of mosquitoes, no matter when or where they bite.
Recent trials in China showed that mosquito coils containing a chemical repellent decreased people’s odds of contracting malaria by about 80 percent—and coils plus nets were much more effective than coils or nets alone. Right now, additional trials are taking place in Indonesia to confirm the impact of coils on transmission and to measure their impact on the mosquito population. We expect data from this critical proof of principle study in the middle of next year.
Researchers are also busy identifying potential active ingredients for spatial repellants. Larry Zwiebel of Vanderbilt University just isolated a compound that is 1,000 times more powerful than DEET. Other researchers are looking at other formulations, and results from these studies will be available in two or three years.
ACTs are the second tool that has changed the course of malaria control over the past several years. Obviously, they represent a vast improvement over the old drugs that weren’t effective, but, like nets, they are not ideal. Artemisinin is expensive, the course of treatment lasts several days, and resistance is already developing.
The Medicines for Malaria Venture currently has a drug candidate in phase II trials, OZ 439, that has the potential to be a single-dose cure. This could solve many of the problems with ACTs. It should be cheaper, since the total amount of drug needed for treatment will be lower. Adherence will be much higher, since people will have adhered completely as soon as they swallow the pill. This will decrease the risk of treatment failure and slow the development of resistance.
OZ 439 could be licensed as early as 2016, depending on the suitability of the quinolines currently being tested as partner drugs. In addition to finishing the trials, MMV is working to find a partner from the pharmaceutical sector to help it make and market OZ 439 when the time comes.
One of the most important innovations for the future of the fight against malaria will be a tool we don’t yet have: a vaccine. A vaccine is a wonderful thing. It’s the simplest, most cost-effective way to save lives. The smallpox vaccine, plus the innovative approach of ring vaccination, led to the eradication of smallpox. The polio vaccines have pushed the world to the threshold of eradicating polio. Vaccines have slashed the number of deaths caused by diphtheria, measles, tetanus, and a host of other diseases.
But the search for a malaria vaccine has been a long and frustrating process. There has never been a vaccine for a parasitic disease. The scientific complexity is dizzying.
Today, however, we are closer than ever before to tackling that complexity. Four years ago, I announced interim results from phase II trials of the RTS,S vaccine. Today, I am pleased to announce the interim results from the phase III trials. Among five to seventeen month old children, the vaccine prevented clinical malaria in 55.8 percent of trial participants over a period of one year. RTS,S prevented severe malaria in 47.3 percent of trial participants aged five to seventeen months. It prevented severe malaria in 34.8 percent of the entire study population, including infants.
These are only interim results. We need to study the data over a longer period of time to understand whether the effect of the vaccine diminishes. We also need to evaluate the impact of a booster dose. Leaders must have all this information before they can make decisions about how to use the vaccine if and when it’s approved.
Nevertheless, these results signal a huge milestone, and I want to congratulate the many partners that have been working on this project for decades. First, this is proof that it is possible to create a vaccine that is effective against malaria. For a long time, we didn’t know. Now, we know. Second, if RTS,S continues to show effectiveness of around 50 percent—above and beyond bed nets—it has the potential to protect millions of children and save thousands of lives.
And RTS,S is a first-generation vaccine. It is an early outcome of a long process of innovation that will ultimately yield more effective vaccines. Researchers are currently recruiting participants for the phase I trials of a second-generation RTS,S vaccine.
There are many vaccines that work according to completely different mechanisms in various stages of development. I am particularly excited by the potential of transmission blocking vaccines, vaccines that prevent mosquitoes from picking the infection up from human hosts. In the drive toward elimination and eradication, these vaccines will be invaluable.
But the fact is there are still many basic science questions about malaria that we need to answer to make the search for vaccines less challenging. We know there are mechanisms by which people become immune to malaria. We can even produce that immunity artificially, but we don’t understand it. If we get a better sense of what underlies immunity in those cases, we will have a much better chance of filling the vaccine pipeline with good products.
As we develop these new tools, we also have to develop a more sophisticated understanding of how to deploy them. When you have several ways to fight more than one species of parasite, carried by many species of vector, you can’t afford to guess about strategy. What is the smartest way to combine our interventions so they have the maximum effect? We need to be able to answer these questions with evidence.
I believe modeling can help generate that evidence. I want to walk you through some charts from one malaria model to give you a sense of the kinds of answers they can provide.
When our friend and mentor Warren Buffett made his gift to our foundation five years ago, he was clear about the purpose philanthropy should serve. One of his famous quotes about finance is, “I don’t look to jump over 7 foot bars. I look around for 1 foot bars that I can step over.” Philanthropy is the other way around, he tells us. We should be looking around for the 7 foot bars; that’s why we exist.
Malaria eradication is a high bar. To reach it, it will take a constant, concerted effort to innovate. But we can do it. We can drive down the number of cases, lower and lower. We can keep introducing new and better tools, until we interrupt transmission like we’ve done in dozens of countries already. And, eventually, with relentless focus, we can eradicate malaria. We’ve already shrunk the malaria map considerably. We can make it disappear.
It won’t happen in four years, or in eight years. But the decisions we make now will determine what happens to malaria in the future.
The parasite has been killing children and sapping the strength of whole populations for tens of thousands of years. It is impossible to calculate the harm malaria has done to us. Now, we can chart a course to end it.
Thank you.
In Africa
Visiting Tanzania: A Battleground in the Fight Against Malaria
On my most recent trip to Tanzania, Melinda and I spent time looking into how the foundation’s partnerships to reduce malaria are progressing.

On a recent trip to Tanzania with Melinda, we spent time focused on the foundation's efforts to reduce malaria. We were particularly interested in learning about the progress of research into a malaria vaccine.
Bagamoyo District Hospital
These children were waiting to see a doctor at the Bagamoyo District Hospital in Tanzania. They are among several thousand children participating in field trials of the vaccine, known as RTS,S. Just this week, interim results from the clinical trials were reported, and they prove that it’s possible to create a vaccine that’s effective against malaria. It was exciting to visit this clinic because it is so well run, they're offering lots of good health services, and people are coming from far away to participate in the vaccine trial.
Meeting with Health Officials
We met with health officials from the Bagamoyo District Hospital and the Ifakara Health Institute. There were a lot of visiting scientists from the Swiss Tropical and Public Health Institute, which has a close relationship with the IHI. We saw scientists who are working on ways of repelling mosquitoes so people don’t just have to rely on bed nets, which are only partly successful protection against malaria. It's great that the foundation’s support is helping with the vaccine, and that it is also helping train young scientists and building up a research infrastructure, which will have a lot of long-term benefits.
Ifakara Health Institute
Scientists at the Ifakara Health Institute were great at educating us about their work, including techniques for capturing mosquitos to help prevent malaria, what species of mosquito they were focused on, how they get the vaccine out into the field, and how they saw if the vaccine worked.
Meeting with Hospital Staff
We also met with staff at the local hospital to discuss progress treating and preventing malaria.
Mapinga Village Dispensary
We visited the Mapinga Village Dispensary, which is an example of how healthcare is delivered in Africa. These dispensaries are the first place people go for care in or near their villages. We saw how the dispensaries keep their vaccines, and we talked to people like Neema Malachi Najwale, the nurse in charge of the Mapinga Dispensary, about how they get mothers to come in for the vaccines. We also talked about how they can now use cell phones to send regular status reports on their inventory.
Meeting with Parents
We talked with some of the parents of children participating in the vaccine trials. Although Tanzania is quite poor and hasn't developed a very extensive infrastructure of roads and electricity, in the health area they've done pretty well. They have good vaccine coverage and are on track to meet a lot of the Millennium Development Goals. It’s a great example of the progress taking place in Africa.
Defeating Malaria
At the Mapinga Village Dispensary, we talked with the head nurse about a number of diseases they have to deal with besides malaria. But by far the biggest killer of children and adults in that area of Tanzania is malaria. So the enthusiasm among health officials for the new malaria work there is very high. I’m an optimist when it comes to defeating malaria. There is good progress with the vaccine, drugs to prevent and treat malaria, and other preventive measures. Eradicating malaria won’t happen overnight, but it’s a moral and economic imperative for Africa, and for the entire world.

A Childhood Terror
The history of polio in the U.S.
David Oshinsky remembers growing up in an America terrified by polio—a plague that put every child at risk until a vaccine was finally developed in the mid-1950s.

David Oshinsky, the author of Polio: An American Story reflects on the history of polio and the final push needed for eradication.
First Pledges
GAVI raises $4.3 billion at first pledging conference
Today we get to celebrate a significant milestone for global health equity.

The GAVI Alliance, an organization that helps make sure children in poor countries get the same vaccines that children in rich countries do, just met its fundraising target for the next four years. They did it despite the fact that donors everywhere are coping with budget crises.
This news comes on the heels of an announcement by several multinational and developing country vaccine manufacturers that they will be lowering the prices of some key vaccines. Together, these developments mean that we can save more than 4 million additional lives by 2015.
Vaccines are one of the best long-term investments to prevent disease and give children a healthy start in life. But for a long time, the healthiest children in the least danger were getting vaccines, and the children who needed vaccines the most weren’t getting them. In many cases, it took decades before vaccines made for developed-country markets were available in poor countries. Take the example of rotavirus, the leading causes of diarrheal disease. Only children in poor countries die from rotavirus, yet the vaccines for the disease was made available first in rich countries!
That’s why increasing access to vaccines for the world’s poorest countries is one of the top priorities of the Gates Foundation, and that’s why today we pledged an additional $1 billion to support the lifesaving work of the GAVI Alliance over the next five years. We were joined by many other donors who understand that buying vaccines saves lives, and who know it is an investment worth making, no matter how tight their budgets.
How We Fight Epidemics
Tackling TB Through Innovation
I explored innovation in testing and treating tuberculosis, as I spent World TB Day in India.

Many people think tuberculosis is a disease of the past, but this ancient epidemic remains a huge global problem. Each year there are 9 million new TB cases and 1.7 million deaths.
Yet there is a tremendous opportunity to turn this situation around. Most new TB cases are in major emerging economies like India, China and South Africa, which have a remarkable history of using innovation to address tough health challenges. They are adopting new TB strategies, and are poised to develop the next wave of innovations. This could change the way the world fights the epidemic.
The major problem is outdated tools. TB is preventable and treatable, but the most common TB test is more than 125 years old and misses half the cases. By the time most TB patients are correctly diagnosed and treated, they may have unknowingly infected many others – creating an endless cycle.
At the same time, today’s TB drugs are more than 40 years old and take six months to work. The combination of poor tests and outdated treatments is driving the spread of drug resistance, undercutting global efforts to stop the epidemic.
I witnessed this firsthand in 2009, when I visited the King George V TB hospital in Durban, South Africa. I met a woman with HIV who had been diagnosed with a highly drug-resistant type of TB. She told us about the despair she felt when she learned she had such a dangerous form of the disease.
Fortunately, there is a promising pipeline of new TB diagnostics, drugs and vaccines under development. And we are starting to see results. Just today, I saw how India is using these innovations. I marked World TB Day by visiting the state-of-the-art L.R.S. Institute of Tuberculosis and Respiratory Diseases in New Delhi with Dr. Ashok Kumar, head of India’s TB program. L.R.S. uses a new molecular test, GeneXpert, which can accurately determine whether a patient has TB in about two hours.
Molecular diagnostics could revolutionize TB care, and things will continue to improve as the price comes down and new tests are developed. This is where India could have global impact. India is a leader in developing low-cost health technologies, and the country could produce high-quality, inexpensive molecular TB diagnostics. This would increase access at home and across the globe.
Meanwhile, South Africa is stepping up its own efforts. The country will likely begin widespread use of GeneXpert soon. This could profoundly impact health in a country where thousands of lives are lost each year to TB/HIV co-infection.
India and South Africa’s leadership shows the extraordinary potential for high-burden countries to pioneer TB innovations. Their success could be a model for other countries—and save millions of lives in the process.
Not Letting Up
Going the last mile in India
Eastern India's Bihar state closes in on eradicating polio.

“The last mile is when people get most fatigued,” says Dr. Hemant Shukla, who leads polio eradication efforts in eastern India’s Bihar state. But having made major strides against polio, India now is closing in on it with vaccination programs for nomadic peoples and others who are hardest to reach.
Be Prepared
Annual Letter: A health emergency
I’m willing to be seen as a troublemaker by people who are happy with the status quo on global health.

Malaria: Progress on Multiple Fronts
The fight against malaria is making very good progress. The death toll, overwhelmingly of young children in Africa, went down from 985,000 in 2000 to 781,000 in 2009. Of the 99 countries with malaria, 43 have decreased cases of the disease by more than 50 percent. Turkmenistan and Morocco were recently declared malaria-free. For these communities the reduction in both death and sickness makes a huge difference. And it is possible only because of increased donor spending, which reached $1.5 billion in 2009.
The Roll Back Malaria group, with strong support from the WHO and our foundation, has set an aggressive goal to provide bed nets to almost every household that needs them in the next few years. As coverage goes up from its current level of 42 percent, it will have a dramatic impact. In Senegal, where 80 percent of households own a bed net, the number of malaria cases went down 41 percent in a single year. Many amazing grassroots groups are helping with the delivery of bed nets. The Nothing But Nets campaign, for example, has gotten hundreds of thousands of individual citizens and organizations like the United Methodist Church and the National Basketball Association involved in the fight against malaria.
We are also working on lowering the cost of the anti-malaria drugs containing artemisinin, which are expensive enough that people are still using less effective drugs instead. The approaches range from breeding the plant that provides artemisinin to have a higher yield, to using very advanced synthetic chemistry that can make artemisinin starting with simple sugars.
As is the case with all infectious diseases, the ultimate tool against malaria would be a low cost, highly effective vaccine. The RTS,S vaccine, developed in partnership with the pharmaceutical manufacturer GSK, is in its final phase-3 trial stage. Interim data will be available later this year, and we should have final results by 2015. A number of other vaccine candidates that might be even more effective or might be combined with RTS,S are also making progress, and several will start human trials this year.
Saving the Youngest Children
Of the 8.1 million deaths per year of children under the age of 5, over 40 percent happen in the first 28 days of life, or the neonatal period. The good news is that we are headed in the right direction. In 1995 there were an estimated 5.6 million neonatal deaths. The most recent estimates show the number down to around 3.6 million.
Unlike the deaths that take place after a child is 28 days old, almost all of which can be prevented by inventing and delivering vaccines, reducing these early deaths requires a range of approaches. Some require new tools such as an ointment for the baby’s skin that prevents infection and an antibiotic solution for cleaning the cut umbilical cord. However, many of the key interventions involve social and behavioral change. You can have a huge impact (on both newborn and maternal health) by increasing the number of births done by a skilled provider in a clinic. It’s also important to teach mothers to wash their hands before handling a baby, to have frequent skin-to-skin contact with their babies, and to breastfeed exclusively for the baby’s first six months. (Mother’s milk contains not only key nutrition but also antibodies that block infection until the baby’s immune system is ready to operate on its own.) Where all of these elements come together, neonatal deaths can be reduced by 50 percent or more, so it’s critical that we learn more about how to teach and motivate mothers effectively, especially at a large scale.
Melinda has been a strong leader on maternal and child health issues. She gave an especially powerful speech last year to the Women Deliver conference. The plight of mothers and their babies is something she feels deeply, and it’s something we talk about a lot.
When she came home from a trip to Malawi she shared the experience of seeing two babies in a hospital in the town of Lilongwe, lying side-by-side in the same incubator. They were born within hours of each other. Each had suffered the same condition—they were unable to breathe at birth. Sadly, it was clear that only one would survive. That baby’s mother had made it to the donor-funded hospital in time for her delivery and was able to get the care she needed. Her baby was immediately resuscitated, which saved his life. The other was not so fortunate. He was born on the way to the clinic, on the side of road, and was not resuscitated soon enough. I wish everyone had a chance to experience what Melinda did, so they could see how things are improving but also understand the urgent need to do more.
HIV/AIDS and the Need for Leadership
Progress continues in fighting the AIDS epidemic, but the pace is slow. The rate of HIV infection has been reduced by almost 20 percent over the last 10 years, to fewer than 2.7 million infections per year. The number of people dying from AIDS has gone down by more than 20 percent in the last five years, to fewer than 2 million annually. Given all the lives that are at stake, I am impatient enough about this that I am willing to be viewed as a troublemaker by people who are happy with the status quo.
The war against AIDS is being waged on two fronts—treating those who are already infected and preventing new infections. Treatment continues to be scaled up, with more than 5 million people receiving HIV drugs. This is a great success story. Rich country generosity has been crucial and the execution in poor countries has been strong. However, there will not be enough money to treat everyone who will become infected if we don’t halt the progress of HIV. Because we don’t have a cure for AIDS, treatment has to continue for a patient’s entire life. That means costs continue to increase as you put more and more people on treatment.
Even without including people who will become infected in the future, the cost of treating the 33 million people living with AIDS today would be over $40 billion per year at current costs—over four times as much as is provided in aid today. To minimize the funding gap we need to reduce per patient costs of treatment. Drug costs have already been reduced to less than 20 percent of treatment costs. Most of the future savings will have to come from treatment models that reduce personnel, laboratory, and overhead costs. The difficulty of funding treatment makes it clear how important it is to prevent new cases. The sooner we make progress the better. There needs to be a sense of urgency that doesn’t exist yet.
Prevention breaks down into several different areas. The easiest should be preventing mother-to-child transmission since it simply involves giving a mother drugs to prevent transmission to her child. There is a lot of focus on getting from the current number of over 300,000 infections per year to zero. Another prevention approach is counseling people to change their behavior, including avoiding risky acts and using condoms. Then we have prevention approaches that rely on new tools. We now have three tools that have shown significant impact. The first is male circumcision, which I discussed last year. Amazingly, teenagers in communities with high HIV incidence show a high willingness to be circumcised. Kenya is leading the way with over 200,000 circumcisions performed. However, there are over 10 million men in high-risk settings in Africa who would benefit from male circumcision, and we should be scaling up 10 times faster than we are.
Another new tool is a vaginal microbicide gel that a woman can use to protect herself. A recent trial showed a gel containing tenofovir protected women against infection. Now the question is how long it will take before the gel is rolled out on a large scale. As someone outside the field, I am surprised at the number of steps it takes. First the product has to be licensed, which requires approvals from regulatory groups in both the country where the product will be used and donor countries. Many of these approval steps happen serially rather than in parallel, and it is only when the entire approval process is complete that the product can be rolled out. Even then the process isn’t complete because a whole system for delivering the product needs to be put together, and again a lot of these steps proceed in a slow serial fashion.
Another new prevention tool, PrEP (Pre-Exposure Prophylaxis), involves someone without HIV taking an anti-HIV drug on a regular basis to block infection. A PrEP trial showed a strong prevention benefit for the participants who consistently used the drugs and a weaker impact when all the participants were included. With both microbicides and PrEP I think countries with large epidemics should figure out how to do large community trials as soon as possible. This would shorten the time before all patients have these lifesaving tools by many years.
If the United States had an epidemic where almost half the girls in large neighborhoods contracted a terrible disease, we would find a way to cut through all the complexity. With HIV it is more difficult since there are many countries involved. But we need to work creatively to shorten these delays.
The best tool would be a vaccine for HIV. The scientific progress on this has gone well. The positive results of the trial in Thailand were a turning point for the field, and blood samples from the volunteers are being studied in depth for lessons about why that vaccine worked but only to a limited degree.
There has also been an explosion in the discovery of antibodies that block HIV infection. Scientists don’t yet know how to make a vaccine that will cause patients to generate lots of these antibodies, but there are several approaches that look promising and will be ready to go to trials in the next few years.
In order to get a fully effective HIV vaccine we will almost certainly need several rounds of trials where we learn and improve the candidate vaccines. So to get a vaccine as soon as possible we need to minimize the length of the trials and the time between trials. So far each cycle has taken over five years. The field needs to look into how to shorten this so that progress matches the urgency of the problem.
We Have Proof
Real Lives. Real Progress.
Optimism is always in short supply, but it’s needed to sustain efforts to improve global health and support development. Fortunately, thanks to development aid, reasons for optimism abound. To help highlight them, and Melinda and I are actively involved in the Living Proof campaign.

Melinda and I are heading to London in a couple of days to thank the UK for its history of generosity and remarkable commitment to foreign aid. We want to share the proof that investments in global health and development are saving lives, improving livelihoods, and building prosperous societies.
In the last 50 years, child deaths in the developing world have been cut by more than 50 percent; polio cases have been reduced by 99 percent; measles deaths in Africa dropped by 92 percent between 2000 and 2008; and malaria cases have been reduced by 50 percent in 38 countries between 2000 and 2008. Through our work, especially our visits to the field, Melinda and I have been deeply touched by personal stories of lives changed for the better. We have seen clear evidence that targeted foreign investments are saving lives, preventing and curing disease, and helping people to lift themselves and their communities out of poverty.
Earlier this year, we transferred the Living Proof campaign to the ONE Campaign. Living Proof highlights the positive impact foreign aid is making. It aims to challenge stereotypes and misconceptions about development assistance, using a series of success stories that will galvanize support, energize activists and ultimately inspire action. With the message that effective aid in global health and development is working, the campaign will share the proof that smart aid is having a lasting impact on people’s lives and livelihoods and advancing real progress in developing countries.
ONE is expanding Living Proof to reach new audiences in more countries and to highlight the lasting impact of European investments. On October 18, the ONE Campaign is launching Living Proof in London. Both Melinda and I will be there to share stories about real lives and real progress being made around the world.
For us, these success stories have a profound impact on the way we look at our investments, and we believe that telling these stories to as many people as possible can help change the way they look at what we can achieve in the future. Together with ONE and our partners, we want to get these stories and facts out and inform the conversation around the opportunities in global health and development.
We are confident that spreading the word about what’s working is one of the most important things we can do to motivate governments and others to invest in effective development aid.
Health Affects Minds
A disturbing link: disease and intelligence
For me personally and for the Bill & Melinda Gates Foundation, improving global health is a way to fight poverty as well as to save lives. The role of health in social and economic development is highlighted by new research on infectious disease and IQ.

Central to our work in global health has been the effort to reduce infectious diseases such as diarrhea and malaria in developing countries. Because these diseases no longer affect the rich world, they haven’t received the attention they should given their truly devastating impacts on poor communities, where they’re prevalent.
Infectious diseases in developing countries are important not only because of the tragic toll they take in human lives lost, but also because of the tremendous social and economic costs associated with them.
Recently I read an article in The Economist, which looks at growing evidence that disease and intelligence are connected in ways that are pretty shocking and troubling. Although more studies are needed, the evidence makes me even more convinced that we need to get after malaria and diarrhea – and many other diseases far too common in the developing world – in a big way.
Specifically, new research by University of New Mexico researchers has found that cognitive ability (IQ) is generally lower in places where infectious diseases are widespread, i.e., poor countries.
People are just now realizing this. It’s a huge scandal and yet another reason why it’s so critically important to fight infectious disease, which takes a huge toll on people’s ability to learn and climb out of poverty.
What’s going on is that fighting off parasites and microbes associated with things like diarrhea and malaria takes away energy that the body needs for brain development. This is especially true among children and infants. Newborns use almost all their metabolic energy for their rapidly developing brains. Analyzing IQ and epidemiological data from around the world, the UNM researchers found that the burden of infectious disease plays a much bigger role in depressing IQ than other possible explanations that have been talked about.
There’s also clinical evidence. For example, research in Uganda found that children who survive cerebral malaria, which affects more than a half-million African children every year, continue to suffer significant cognitive impairments, mainly memory and attention deficit, even two years later. The Ugandan researchers found that these children can be helped by weekly sessions where they use cognitive training software on PCs. But this is an expensive, intensive and only partially effective approach to a problem that could have been prevented to begin with.
The cognitive problems created by malaria are another strong reason why our foundation has made fighting it a priority. We’re trying to help develop a safe, highly effective and affordable malaria vaccine, while also supporting efforts to improve treatment, diagnostics and other malaria control measures.
Widespread infectious disease may even impair kids who don’t get sick themselves. Adults who are ill are less productive; farmers grow less food, for example. Less food means less energy available for their kids and their kids’ brain development. An article in The Lancet medical journal estimates that because of malnutrition, poverty and poor health, over 200 million children under five years are not fulfilling their developmental potential.
In the past, some people have suggested that poor countries are poor because the people there have lower IQs. But it’s really the other way around. Poverty breeds disease, which can affect brain development, which reinforces poverty. Improving global health is a way to break this cycle.
More and Better Crops
Better farms – improved lives
With support from the foundation, six nonprofit agricultural development organizations are helping hundreds of thousands of poor farmers in Sub-Saharan Africa and South Asia grow more productive, profitable, and sustainable crops.

Three-quarters of the world’s poorest people rely on farming small plots of land to feed themselves and their families. Helping these small farmers grow more crops and get them to market can have a tremendous impact on reducing hunger and poverty and associated problems.
But it’s a complicated challenge that requires support and investments across the agricultural value chain—from cultivating better seeds and soil conditions to improving farm management, access to markets, and government policies.
In 2008, we announced $306 million in grants to six organizations to help poor farming families in Sub-Saharan Africa and South Asia boost their productivity, increase their incomes, and improve their lives. When we announced the grants, I promised to post annual updates about the projects as a way to share the progress, setbacks, and lessons of our work in agricultural development.
Looking at the 2010 updates that have just been posted to the foundation website, I’m amazed at the life-changing results that our grantees have achieved in such a short time. In the last year, these organizations have touched the lives of hundreds of thousands of farmers and they are on track to help more than 5 million farming families in the years ahead.
Highlights From the 2010 Updates
In many parts of India and Africa, small farmers rely solely on rainwater to grow their crops and can produce barely enough food for their own subsistence. International Development Enterprises (IDE) last year worked with 731 agricultural equipment dealers to make affordable small-scale irrigation systems available to more than 100,000 farmers. IDE also helped about 12,000 farmers secure microfinancing to pay for the new systems. As a result, these small-farm families have been able to produce and sell surplus crops and increase their incomes by an average of $600 per year—enough to pay for school, healthcare, and invest in their farms.
The International Rice Research Institute (IRRI) is making steady progress toward its goals of providing 400,000 farmers with heartier varieties of rice that can withstand drought, flood, extreme cold, and harsh soil conditions. IRRI has trained more than 750 scientists in rice breeding and crop management, developed more than 200 new varieties of stress-tolerant seeds, and distributed over 6,500 tons of seed to farmers in the last year. And through a process called “participatory variety selection,” IRRI gets farmers directly involved in developing rice varieties that will grow best under local conditions.
In 2009, TechnoServe used its foundation grant to help provide 67,000 small-holder coffee growers in East Africa with access to equipment that enables them to process their beans into high-quality coffee. TechnoServe also helped train thousands of farmers in sustainable agronomy practices, and how to evaluate the quality of their coffee beans.
Working in Bangladesh, CARE organized more than 15,400 dairy farmers into groups that can collectively buy better feed and receive training in animal husbandry to produce larger amounts of higher-quality milk from their cows. Largely because of a sudden drop in demand for fresh milk in Bangladesh, CARE managed to link only about 5,400 farmers—a quarter of its target—to refrigeration facilities where they could store surplus milk for sale. But the organization met its goal of deploying 120 community veterinary workers, and more than 4,400 local dairy farmers used artificial insemination services provided by CARE.
In East Africa, more than 47,000 dairy farmers received help from Heifer International to form business associations and establish chilling plants that will help get the farmers’ milk to market. Although Heifer was able only to secure financing for five new chilling plants instead of 23 as planned, the new and existing plants helped farmers sell more than 118,000 liters of milk per day, more than we had expected. Heifer also helped local breeding services perform more than 56,000 artificial inseminations and is investigating new approaches to substantially increase that number in the next two years.
In Kenya and other sub-Saharan countries, the Alliance for a Green Revolution in Africa (AGRA) is bringing affordable fertilizers and training in integrated soil fertility management techniques to farmers. Although the start of these projects was delayed in 2008 because of political unrest in Kenya and rising fuel costs, AGRA has begun to make progress in helping farmers adopt more environmentally sustainable farming practices.
The annual progress reports on these organizations enable us to see what’s been working well in each program, and to adjust our strategies to address unexpected challenges and to adapt to the evolving needs of local communities and individual farmers. I’m encouraged by the strides that our nonprofit partners and the farmers are making through these programs despite challenging conditions. At the same time, I see how much more needs to be done.
Since 2006, the foundation has committed more than $1.5 billion in grants to support agricultural development efforts. The G8 and G20 nations have committed $22 billion to food security over three years and African countries and leaders are also making big increases in their domestic investment in agriculture.
This renewed attention to agricultural development is important. We know that better farming is the most important solution for overcoming hunger and poverty, and that the investments the foundation and others are making can have an incredible impact in a relatively short period of time.
An Encouraging Visit
Nigeria advances the fight against polio
In a visit to Africa’s most populous nation, I witnessed remarkable progress against polio, with lessons for the fight against infectious diseases worldwide.

With continued hard work and investment the world is on a path toward something pretty incredible, the eradication of polio. In the past two decades, polio cases around the world have been reduced by 99 percent. If we can get rid of the last 1 percent, polio will become the second major infectious disease, after smallpox, that has ever been completely eliminated. There are still gaps in funding for polio eradication, and new outbreaks could reverse some of the progress made so far. But if polio is eliminated, never again will a child be crippled by this terrible virus.
We have a chance to get there because of some great efforts, particularly by the Global Polio Eradication Initiative, which involves the World Health Organization, Rotary International, the US Centers for Disease Control and Prevention (CDC) and the United Nations Children's Fund (UNICEF). The Gates Foundation is very involved in supporting polio immunization campaigns and other efforts to educate parents and communities about the importance of immunization. We’re also supporting work to improve polio surveillance and to develop better vaccines and anti-poliovirus drugs.
Northern India and northern Nigeria are two areas where polio continues to be a problem. I visited northern India in May this year to see the progress there. I was very excited to visit northern Nigeria in June, because the progress there since my last visit in February 2009 has been especially impressive. As of July 14th, only five cases due to wild polio viruses were reported in Nigeria this year, versus hundreds last year.
I spent most of my first day in Kano, one of the northern states most vulnerable to polio. I met with community leaders, visited a local health center and stopped in at an informal school where students study the Koran in Arabic. On the streets and most everywhere else we went, I noticed so many young children around. Nigeria has more people by far than any other African country, and more than 40 percent of them are under the age of 15. That makes polio immunization a big challenge. Kano had just begun a campaign to immunize more than 6 million children under the age of five.
Part of the challenge is overcoming fear and suspicion. In Kano in the past, false rumors linked immunization to sterility and HIV. Community leaders told me that because polio vaccine is free and brought to people in their homes, some people think there must be something wrong with it. Community leaders play a critically important role in helping to overcome mistrust, and a big focus of anti-polio efforts is on informing these leaders and enlisting their support.
Another ironic thing I noticed was that because polio cases have been dramatically reduced, it’s more difficult to know whether local immunization campaigns are reaching everyone they need to reach, particularly sub-populations that may be more at risk. Without many actual cases, you have to rely on other ways of monitoring immunization rates, and the different measures are sometimes quite inconsistent. I think we need to look at how to help get more reliable data to guide our efforts and ensure they’re effective.
Also of concern is the risk that progress against polio in Kano might be undermined by the virus filtering back in from neighboring countries and other parts of northern Nigeria. Increasingly, the problem needs to be approached on a regional basis.
The school we visited was very interesting. It didn’t really look like a school. There were no classrooms, just children sitting on the street, against a wall or under a tree, holding slates with Arabic script written on them. I asked one of the boys to recite the lesson from his slate, and he did.
That night in Abuja, the Nigerian capital, I had dinner with government officials including the Minister of Health, Onyebuchi Chukwu. It was interesting to learn about some of the creative approaches being used to inform Nigerians about the importance of immunization. Pro-immunization messages are being embedded in the plotlines of popular TV entertainment programs, for example. One of Nigeria’s largest mobile phone service providers has agreed to send out about 25 million free text messages on polio and health.
The next day I had a number of meetings including a session with several state governors and one with Nigeria’s new President, Goodluck Jonathan. Commitment from Nigeria’s leaders has been crucial in advancing the nation’s fight against polio.
A recurring theme I picked up from the people I talked to was the importance of using what we’ve learned and accomplished in the drive against polio to fight other illnesses such as infant diarrhea, respiratory ailments and malaria. I do believe that polio eradication helps strengthen routine immunization, which has the potential to save the lives of large numbers of children.
Wherever I go, I always find that saving children’s lives is a universal concern. I was very impressed with Nigeria’s progress against polio. I tried to encourage everyone to not let up.
Microbicide Trial
Exciting News for HIV Prevention
I believe that one important way to stop the spread of AIDS is by empowering women to protect themselves from infection. I'm encouraged that new research shows positive results from women using antiretrovirals for HIV/AIDS prevention.

As I mentioned in my speech to the XVIII International AIDS Conference on Monday, one promising area in the fight against HIV/AIDS is antiretroviral (ARV) -based prevention: pills, injections, and gels that contain the drugs now used for treatment.
And so it really was a privilege to be in Vienna when the incredibly exciting results of a new study were released. The Centre for the AIDS Programme of Research in Africa (CAPRISA) microbicide trial, the first of a new generation of ARV-based microbicides, showed reduced risk of HIV and herpes infections in women. This is the first time that a microbicide has been found to be effective.
What makes this so important is that we are a big step further in putting HIV prevention in the hands of women, who account for the majority of HIV infections worldwide.
The CAPRISA microbicide is a topical gel that contains tenofovir—an antiretroviral drug widely used to treat HIV infections which women in the study inserted up to 12 hours before sex and soon after having sex for a maximum of two doses in 24 hours.
The tenofovir gel was found to be 39 percent effective in reducing a woman's risk of becoming infected with HIV during sex. The study also found that the microbicide is 51 percent effective in preventing genital herpes, important because women with genital herpes are at greater risk for HIV infection. Widespread use of the gel, at this level of protection, could prevent more than half a million new HIV infections in South Africa alone over the next ten years saving many lives.
The CAPRISA microbicide trial findings are an exciting advance for HIV prevention. They give us reason to be hopeful, not just for an effective microbicide, but also for other ARV-based prevention tools now in development. As with any promising new HIV prevention tool, we look forward to discussions on how we might collaborate with other funders to support projects to confirm and extend these findings.
I’m really glad I attended the conference this year. As I said in my speech, even as we advocate for more funding, we need to be much more efficient in our approaches for treatment and prevention. But there was tremendous energy in Vienna and I am optimistic that we can push ourselves to make the most of every dollar of funding, to identify the most effective ways to save lives, and to share what we learn as widely as possible.
A Hopeful Message
A Roadmap for HIV Prevention
I traveled to Vienna to speak at the 2010 International AIDS Conference, the premier gathering for those working to prevent and treat HIV infection, which is a priority of the Gates Foundation. My message was hopeful, but advocated for changes to make anti-AIDS efforts more effective.

I’m honored to speak at the XVIII International AIDS Conference in Vienna today. This conference marks an important turning point in the fight against AIDS.
There are good reasons to be hopeful—we have seen amazing progress. The number of people getting treatment for AIDS has increased twelve-fold since 2003. The people at this conference and major partners such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR have helped make this possible.
At the same time, we have to recognize that these are tough times for those of us who are passionate about fighting HIV. Economic turbulence has driven up government deficits, and some countries have responded by reducing their investments in global health. These are the challenges we all face, but they don’t have to define our time.
And that is why, even as we are hopeful, we have to be honest with ourselves: We don’t have the money to treat our way out of this epidemic. Even as we continue to advocate for more funding, we need to make sure we’re getting the most benefit from each dollar of funding and every ounce of effort.
If we push for a new focus on efficiency, especially in prevention, we can, over the next two decades, drive down the number of new infections dramatically.
Here’s how we can do that:
- We need to scale up existing tools, like male circumcision and preventing mother-to-child transmission.
- We need to focus prevention efforts on the communities where transmission is the highest, such as men who have sex with men, injecting drug users, and sex workers.
- We also need innovations in basic science, diagnostics, computer modeling, and our understanding of the virus itself. This would make it possible to create new weapons for our fight against AIDS, prevent even more infections, and save even more lives. Vaccines, new diagnostics, and antiretroviral-based prevention (pills, injections and gels) are some of the new tools I’m really excited about.
If we scale up existing interventions and add new tools in the hardest-hit countries, it would change the face of AIDS. New cases would plunge. Millions more could be treated. The control of HIV would stand alongside the eradication of smallpox as one of the great public health victories in history.
This is the opportunity we have. We can keep doing things the old way, and keep getting the same result. Or we can push ourselves to make the most of every dollar of funding and every ounce of effort: to identify the most effective ways to save lives, and to share what we learn as widely as possible.
If we do that, we will have matched our compassion with the growing capacities of science, and we will start to write the story of the end of AIDS.
Travels in India
Seeing self-help in action in India
I was on the road again in May 2010 on a visit to northern India. I came back excited by the progress I saw in villages that have suffered from dire poverty and the persistence of polio.

India is always a fascinating place to visit. I’ve now been there more than a dozen times. I went in July 2009 to look at the government’s efforts to improve health care in poor communities. I returned in May 2010 to see how things are going with projects that are trying to help eliminate polio and other infectious diseases, and help improve things for people in some of the poorest areas, specifically the states of Uttar Pradesh and Bihar in the north of the country.
I traveled to Uttar Pradesh with Rahul Gandhi, a member of Parliament. He has been a real innovator in organizing women’s self-help groups, and one of our first stops was a meeting of self-help group leaders. It was incredible to listen in on their discussions and hear them encouraging one another with songs and chants about vaccinations, sanitation and safe birthing practices. You could hear in their voices how they had gained optimism and confidence from their experiences working together.
These women go out to other villages and in the past three years they’ve helped form over 20,000 new self-help groups. The groups enable women to get microloans at lower rates than the moneylenders charge and work to improve services, like health and education, in their villages. I really can't express how uplifting it was to listen to these women talk about how they organized. If one woman couldn't get something to be done, then ten would show up. If that didn't work, 100 would show up. Rahul was making the point that self-help groups are a key enabler, not super expensive, with all sorts of additional benefits that contribute to our health and education goals.
I also went to Bihar, the poorest state in India, but one that’s making lots of progress. Polio is still a significant problem there, and the campaign against it is very intense. As in Utter Pradesh, self-help groups play an important role in Bihar, particularly groups organized by PRADAN, a nonprofit group of professionals who provide development assistance to India’s remotest villages whom we support through the Bill & Melinda Gates Foundation.
Among other things, PRADAN helps farmers improve their agricultural practices so they can increase their crop yields and even find new sources of income, such as by developing arjuna tree plantations for rearing silkworms and weaving silk. It was amazing to see how self-help groups aided by PRADAN expertise had completely transformed the villages we visited, keeping kids in school, encouraging girls to marry later and to take control of their family size, all things that improve the well being of their families and the village as a whole.
While in Bihar, I also met with the Chief Minister of the state. Under his leadership, Bihar has made significant progress, improving health outcomes and increasing vaccination rates. It’s really encouraging to see progress being made in one of the poorest places in India. You realize if it can happen here, it can happen almost anywhere.
My last few days were spent in India’s capital, New Delhi. I met with innovators from some of the Indian companies that make inexpensive vaccines, which are helping make vaccination more affordable for kids around the world. I also met with government officials including Prime Minister Manmohan Singh and Health Minister Ghulam Azad, whose energy and commitment were also very impressive.
So it was an uplifting trip. India has a good chance of eliminating polio in the next few years, which would be a huge achievement. And the progress being made toward many development goals is truly inspiring.
Making Medicines Available
Eliminating killer diseases with new medicines
For people suffering from serious but treatable diseases like pneumonia and tuberculosis, access to drugs can mean the difference between life and death. A new report and two recent announcements are signs of progress in efforts to expand access.

In the developed world, we sometimes take life-saving medicines for granted. But as I’ve traveled in the developing world, I’ve seen first-hand the huge difference they can make. A new report and two recent announcements are reminders of the important role of the pharmaceutical industry, especially in helping save the lives of people in poor countries.
The new report is the Access to Medicine Index 2010 from the Access to Medicine Foundation, based in the Netherlands. The index ranks 20 of the world's largest pharmaceutical companies on their efforts to make sure that medicines are made for and reach people in developing countries. The latest index found that companies are being more transparent about their efforts to expand access. They’ve also taken steps to make drug pricing more equitable and to increase R&D on diseases affecting poor countries. But in the words of the Index’s founder Wim Leereveld, “the industry as a whole still has a long way to go.”
One example of progress on access is the announcement by GlaxoSmithKline and Pfizer Inc. that they will accelerate production and distribution of new vaccines against pneumococcal disease, which kills 1.6 million people a year—mostly in developing countries, and half of them children under the age of five.
Glaxo and Pfizer will supply 30 million doses a year, for 10 years, at a price that is more affordable for developing countries. Estimates are that the vaccines could save 900,000 lives by 2015, and up to 7 million lives by 2030. Key to this effort was an innovative financing mechanism, known as an Advance Market Commitment, piloted by the GAVI Alliance. I am pleased that our foundation was able to support this effort in partnership with GAVI, the World Bank, the World Health Organization, UNICEF and the national governments of Italy, Canada, Norway, Russia, and the United Kingdom.
In another important effort supported by the foundation, the non-profit Critical Path Institute (C-Path) and the Global Alliance for TB Drug Development (TB Alliance) will coordinate testing of promising combinations of tuberculosis drug candidates from at least 11 different pharmaceutical companies early in the development pipeline.
If you used the historical approach to testing and getting regulatory approval for new TB drugs—individually and then in combination with other drugs—it could take 24 years. This new approach, which the foundation created in partnership with C-Path and the TB Alliance, hopes to develop effective new combination TB treatments in just six years. Importantly, the U.S. Food and Drug Administration and regulatory authorities in Europe have indicated strong support for accelerating approvals of safe, effective new treatments.
Although many people think of TB as a disease that was conquered long ago, it still kills 1.8 million people a year, mainly in the poorest countries on earth. The current four-drug course of treatment for TB is now 50 years old and requires patients to take numerous pills for six months or longer, which many find difficult, especially given the often-unpleasant side effects. When patients don't complete their course of treatment, the disease can become resistant to the initial drugs. In 2007, there were more than 500,000 cases of drug-resistant TB. New and easier ways to treat TB would be a great step forward.
I believe that these kinds of innovative collaborations between pharmaceutical companies, governments and the non-profit sector are critical to accelerating the delivery of medicines, which is critical to saving lives.
A Gates Foundation Trip
Simple advances, amazing benefits in Africa
On this trip to Africa, I saw simple technologies having big impacts.

In December 2009, I went to Africa on a Gates Foundation trip. It’s really helpful to get a view on the ground of work we’re doing, and to meet the people who are making it happen.
For all the benefits that modern healthcare technology has to offer, it was amazing to see how simple advances in basic sanitation and personal hygiene are making such a difference for the poor in South Africa. And in Kenya, I saw first-hand how the innovative use of cellphones and modest investments in food handling are improving people’s lives.
My trip started in Durban, South Africa, where I met with Neal Macleod, head of Durban Water and Sanitation. Neal has been a leader in thinking through how to improve sanitation for the poor in Durban. Most of us take for granted the convenience and sanitation benefits of flush toilets. But in Durban, many people don’t have access to water. So reducing the incidence of diarrheal diseases and worm infections associated with the use of pit toilets is important – especially for young children who are the most vulnerable. Neal showed me the VIP toilet – which isn’t as fancy as its name suggests, but is a breakthrough in basic sanitation through the use of simple ventilation methods and other inexpensive construction methods, such as installing a fly screen on the ventilation pipe.
After that, I travelled 590 kilometers northwest of Durban to Bophelo Pele, a male circumcision center near Johannesburg that has had incredible success demonstrating how this simple procedure can reduce—by more than 60 percent—the transmission of AIDS from women to men. I met with Professor Bertran Auvert, a French scientist, whose research also proves to skeptics that teenage and adult men are willing to be circumcised. Since the project began, more than 14,000 men have been circumcised, in a procedure that takes a doctor just 7 minutes and costs less than $40. It’s a remarkable example of how modest and wise investments can save lives and significantly reduce the financial impact of AIDS, especially in countries where the infection rate is so high.
In Kenya, I visited Eldoret, where we saw how M-PESA, an innovative cell phone service offered by Safaricom, the local telecommunications provider, is making basic financial services available to poor people. This is a big goal of the foundation, so I was excited to see how popular M-PESA has become. Everywhere I went, I saw the M-PESA logo (“pesa” is Swahili for “money”). M-PESA is an affordable, fast and safe way for people to deposit, save and transfer money anywhere in Kenya. Safaricom is now getting banks and insurance companies involved and the service is spreading to other countries.
In the nearby town of Kabiyet, I saw how an even simpler and older technology—a chilling plant—is helping improve the lives of local dairy farmers. In the past, farmers had to sell their milk within two to three hours or it would go sour. With the new chilling plant at Kabiyet Dairies Company, Ltd. (which the foundation’s grantee, Heifer International, helped finance), the milk can be properly chilled and checked for quality. Now, farmers are getting almost double the price. I met one farmer who told me that he is now able to send his kids to school because of the extra income he earns. In addition, the Kabiyet facility has become a center for a lot of other services that local farmers need, including artificial insemination of cows, veterinary services, and supplements that help dairy cows produce more milk.
Africa is home to 15 percent of the world’s population and many of its poorest citizens. While the continent faces many challenges in reaching the targets of the Millennium Development Goals, the projects I visited show how progress in reaching these goals is possible and can be accelerated. That’s why Africa is a particular focus for the foundation.
Visiting Health Clinics
Delivering health care in India
In July, I traveled to India to see how new investments by the Indian government are improving medical care in poor communities. During the trip, I visited health clinics in the state of Uttar Pradesh and saw how vaccines and other basic health care is being delivered to mothers and children.

My visit to India is a part of my ongoing efforts to see first-hand the impact of issues that people in poor rural and urban communities are facing and to assess how innovative approaches to addressing these issues are working. Look for additional videos in the future as I travel to other regions where the Bill & Melinda Gates Foundation is supporting programs in global health and development.
How to Help
We need productivity and sustainability
Helping poor farmers improve productivity is a critical step in reducing global hunger. But there is an ideological divide over how best to help them. The truth is that both sides have something important to offer.

While the World Summit on Food Security in Rome in November did not achieve all it should, it shined a welcome spotlight on small farmers who make up the vast majority of hungry and poor people in the world. Coming on the heels of a commitment by the G20 to invest $22 billion in developing-country agriculture, the summit provided reason to be optimistic that after decades of neglect, we’ll start investing in the single best strategy to reduce global hunger and poverty.
At the same time, I am worried that as momentum builds behind agricultural development as a long-term alternative to food aid, a growing ideological divide may cause the world to squander a real opportunity to fight hunger and poverty.
The global movement to help small farmers is increasingly divided into two camps. On one side is a technological approach focused on improving productivity. On the other side is an environmental approach that promotes sustainability. Productivity or sustainability – they say you have to choose.
A recent Time Magazine article “Different Shades of Green in Africa,”for example, pits the idea of organic development to help African farmers against the heavy input approach being promoted by the Alliance for a Green Revolution in African (AGRA) and the Bill & Melinda Gates Foundation, calling it “a battle between two very different agricultural philosophies.”
As I said during my speech at the World Food Prize in October, this is a false choice that is dangerous for the field of agricultural development.
At a time of rising population and climate change, we need both organic solutions that promote sustainability and the technological approaches that increase productivity—and there is no reason we can’t have them both.
Many environmental advocates highlight the excesses of the original Green Revolution. They have a point. The Green Revolution increased yields dramatically in many poor countries in the second half of the 20th century, but it also led to over-irrigation and over-fertilization. The next Green Revolution has to be greener than the first.
Some have tried to restrict the spread of biotechnology regardless of its potential to increase productivity. They act as if there is no emergency, even though there are already 1 billion hungry people in the world, and climate change is going to make conditions harsher in the future. The Food and Agriculture Organization estimates that developing countries will have to boost their yields by half to meet the challenge of global hunger. We simply won’t be able to meet that goal without using all the scientific tools at our disposal.
Of course, new technologies must be proven safe for farmers, consumers, and the environment before they’re adopted. That’s why countries should have a strong regulatory infrastructure guided by experts with access to the latest science-based information.
I have seen proof that agricultural science can make people’s lives better. This summer, I attended a roundtable discussion in New Delhi with scientists who developed a new variety of rice called Swarna-sub1. The amazing thing about Swarna-sub1 is that it can survive underwater for more than two weeks, which means it could revolutionize life for millions of farmers in flood-prone areas of India. The researchers used a fascinating technique called marker assisted selection to introduce a single allele, a version of a gene, into an existing rice variety to make it flood tolerant.
I also met with representatives from local NGOs, seed companies, and the government of India to talk about their plans for delivering new seeds to farmers. The government’s goal is to have more than 5 million hectares planted with Swarna-sub1 in just five years.
The tendentious debate pitting productivity against sustainability doesn’t just threaten important scientific advances. It also obscures another crucial lesson from the first Green Revolution: that developing more productive seeds is just one element of an effective strategy. In addition to new seeds, farmers also need training, access to new markets, and organizations to represent their interests. Governments need better data so they can devise sound agricultural policies. By placing so much emphasis on just one link in a very long agricultural value chain, we distract ourselves from a goal we can all agree on: helping small farmers and their families.
Success requires progress on many fronts. African countries must lead the way by spending more on agriculture. Donor countries must do a better job of listening so they can understand what poor countries really need. They should explain more clearly how the money they’re pledging will be spent. I am optimistic that these obstacles can be cleared away and that the world can tap into the opportunity offered by agricultural development. That’s why the Bill & Melinda Gates Foundation has committed more than $1.4 billion to initiatives that support small farmers.
However, if the field doesn’t move past this counterproductive debate, hungry and poor people will suffer. We have a choice: We can let our disagreements get in the way of real progress, or we can agree to help more than a billion people live healthier, happier lives.




